1,1TM1,E:I,RI65A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,monitoring the hydrolysis of sAAPFpNA,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,3.62E-10,3.10E+06,9.60E+05,6.10E-06,3.47E-04,-15.98,3.1,,,,,
2,1TM1,E:I,RI67A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,monitoring the hydrolysis of sAAPFpNA,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,2.78E-10,3.10E+06,1.13E+06,6.10E-06,3.15E-04,-15.98,2.95,,,,,
3,1TM1,E:I,"RI67A,RI65A",Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Stopped-flow fluorescence,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,1.01E-08,5.60E+06,7.80E+05,1.06E-05,7.92E-03,-15.98,5.07,,,,,
4,1TM1,E:I,RI67C,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,monitoring the hydrolysis of sAAPFpNA,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,4.71E-10,3.10E+06,6.40E+05,6.10E-06,3.03E-04,-15.98,3.26,,,,,
5,1TM1,E:I,YI61A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Stopped-flow fluorescence,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,7.92E-11,5.60E+06,3.20E+06,1.06E-05,2.56E-04,-15.98,2.2,,,,,
6,1TM1,E:I,YI61G,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Stopped-flow fluorescence,100 mM Tris-HCl,298,8.6,SKEMPI,"10065709 (Table II, p. 44)",1.92E-12,5.40E-09,5.60E+06,3.50E+06,1.06E-05,1.88E-02,-15.98,4.7,,,,,
7,3HFM,Y:LH,"DH32A,KY97M",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,2.00E-10,1.88E+06,2.90E+06,5.40E-05,5.80E-04,-14.37,1.15,,,,,
8,3HFM,Y:LH,"DH32N,KY97A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,1.16E-07,,,,,-14.37,4.92,,,,,
9,3HFM,Y:LH,"DH32N,KY97M",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,5.00E-11,1.88E+06,2.46E+06,5.40E-05,1.12E-04,-14.37,0.33,,,,,
10,3HFM,Y:LH,DH32N,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,4.00E-11,1.88E+06,2.01E+06,5.40E-05,3.30E-05,-14.37,0.2,,,,,
11,3HFM,Y:LH,KY97M,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,1.90E-10,1.88E+06,1.53E+06,5.40E-05,2.80E-04,-14.37,1.12,,,,,
12,3HFM,Y:LH,NL31D,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,2.90E-10,1.88E+06,1.26E+06,5.40E-05,3.68E-04,-14.37,1.37,,,,,
13,3HFM,Y:LH,NL31E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,4.60E-07,,,,,-14.37,5.73,,,,,
14,3HFM,Y:LH,QL53A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,1.50E-10,1.88E+06,1.37E+06,5.40E-05,2.00E-04,-14.37,0.98,,,,,
15,3HFM,Y:LH,SH31A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,4.00E-11,1.88E+06,1.24E+06,5.40E-05,4.80E-05,-14.37,0.2,,,,,
16,3HFM,Y:LH,"WH98A,KY96A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,1.40E-05,,,,,-14.37,7.76,,,,,
17,3HFM,Y:LH,WH98A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,3.30E-07,,,,,-14.37,5.54,,,,,
18,3HFM,Y:LH,"WH98F,YY20A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,1.11E-06,,,,,-14.37,6.26,,,,,
19,3HFM,Y:LH,WH98F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,7.20E-09,,,,,-14.37,3.27,,,,,
20,3HFM,Y:LH,YH50A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,7.00E-06,,,,,-14.37,7.35,,,,,
21,3HFM,Y:LH,"YH50A,RY21A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,2.00E-05,,,,,-14.37,7.97,,,,,
22,3HFM,Y:LH,YL50L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,5.00E-08,,,,,-14.37,4.42,,,,,
23,3HFM,Y:LH,YL96A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,2.90E-09,1.88E+06,8.00E+05,5.40E-05,2.30E-03,-14.37,2.73,,,,,
24,3HFM,Y:LH,"YL96A,RY21A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,5.00E-07,,,,,-14.37,5.78,,,,,
25,3HFM,Y:LH,YL96F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,3.20E-10,1.88E+06,1.40E+06,5.40E-05,4.50E-04,-14.37,1.43,,,,,
26,3HFM,Y:LH,"YL96F,RY21A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Appendix, pp. 966-7)",2.87E-11,3.50E-08,,,,,-14.37,4.21,,,,,
27,3HFM,Y:LH,"DH32A,KY97A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,7.00E-08,,,,,-14.37,4.62,,,,,
28,3HFM,Y:LH,DH32A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,7.40E-10,1.88E+06,1.60E+06,5.40E-05,1.19E-03,-14.37,1.92,,,,,
29,3HFM,Y:LH,"NL31A,KY96A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,9.00E-06,,,,,-14.37,7.49,,,,,
30,3HFM,Y:LH,NL31A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,2.00E-07,,,,,-14.37,5.24,,,,,
31,3HFM,Y:LH,NL32A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,1.67E-07,,,,,-14.37,5.13,,,,,
32,3HFM,Y:LH,YH33A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,8.00E-07,,,,,-14.37,6.06,,,,,
33,3HFM,Y:LH,"YH33A,KY96A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,6.00E-06,,,,,-14.37,7.25,,,,,
34,3HFM,Y:LH,"YL50A,KY96A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 2, p. 962)",2.87E-11,1.40E-05,,,,,-14.37,7.76,,,,,
35,3HFM,Y:LH,YL50A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,6.60E-08,,,,,-14.37,4.58,,,,,
36,3HFM,Y:LH,"YL50A,KY97A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,7.00E-06,,,,,-14.37,7.35,,,,,
37,3HFM,Y:LH,"YL50A,RY21A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,1.40E-06,,,,,-14.37,6.39,,,,,
38,3HFM,Y:LH,YL50F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,1.60E-09,1.88E+06,1.25E+06,5.40E-05,2.06E-03,-14.37,2.38,,,,,
39,3HFM,Y:LH,"YL50F,RY21A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,4.50E-08,,,,,-14.37,4.36,,,,,
40,3HFM,Y:LH,"YL50F,YY20A",Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Table 4, p. 965)",2.87E-11,1.10E-06,,,,,-14.37,6.25,,,,,
41,3HFM,Y:LH,YY20A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Tables 2 and 3, pp. 962-3, Table 4, p. 965)",2.87E-11,1.13E-07,,,,,-14.37,4.9,,,,,
42,3HFM,Y:LH,KY96A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Tables 2 and 4, pp. 962 and 965)",2.87E-11,4.00E-06,,,,,-14.37,7.01,,,,,
43,3HFM,Y:LH,KY97A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Tables 2 and 4, pp. 962 and 965)",2.87E-11,1.00E-06,,,,,-14.37,6.19,,,,,
44,3HFM,Y:LH,RY21A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,monitoring the rate of recovery of active HEWL,,298,7,SKEMPI,"10338006 (Tables 2 and 4, pp. 962 and 965)",2.87E-11,1.70E-10,1.88E+06,1.56E+06,5.40E-05,2.71E-04,-14.37,1.05,,,,,
45,1CBW,FGH:I,KI15A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,4.76E-07,,,,,-10.72,2.19,,,,,
46,1CBW,FGH:I,KI15D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,8.33E-05,,,,,-10.72,5.22,,,,,
47,1CBW,FGH:I,KI15E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,8.33E-06,,,,,-10.72,3.87,,,,,
48,1CBW,FGH:I,KI15F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,4.00E-10,,,,,-10.72,-1.96,,,,,
49,1CBW,FGH:I,KI15G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.27E-05,,,,,-10.72,4.11,,,,,
50,1CBW,FGH:I,KI15H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.35E-08,,,,,-10.72,0.1,,,,,
51,1CBW,FGH:I,KI15I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.69E-06,,,,,-10.72,2.93,,,,,
52,1CBW,FGH:I,KI15L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,7.69E-10,,,,,-10.72,-1.58,,,,,
53,1CBW,FGH:I,KI15M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.02E-09,,,,,-10.72,-1.42,,,,,
54,1CBW,FGH:I,KI15N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.09E-07,,,,,-10.72,1.32,,,,,
55,1CBW,FGH:I,KI15Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.92E-08,,,,,-10.72,0.31,,,,,
56,1CBW,FGH:I,KI15R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,4.00E-09,,,,,-10.72,-0.61,,,,,
57,1CBW,FGH:I,KI15S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,3.70E-06,,,,,-10.72,3.39,,,,,
58,1CBW,FGH:I,KI15T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,4.00E-07,,,,,-10.72,2.09,,,,,
59,1CBW,FGH:I,KI15V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,4.35E-07,,,,,-10.72,2.13,,,,,
60,1CBW,FGH:I,KI15W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.79E-10,,,,,-10.72,-2.44,,,,,
61,1CBW,FGH:I,KI15Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.14E-08,1.32E-10,,,,,-10.72,-2.61,,,,,
62,2FTL,E:I,KI15A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,3.70E-06,,,,,-17.86,10.53,,,,,
63,2FTL,E:I,KI15D,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,1.59E-05,,,,,-17.86,11.38,,,,,
64,2FTL,E:I,KI15E,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,4.76E-07,,,,,-17.86,9.32,,,,,
65,2FTL,E:I,KI15F,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,8.33E-09,,,,,-17.86,6.95,,,,,
66,2FTL,E:I,KI15G,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,6.67E-05,,,,,-17.86,12.22,,,,,
67,2FTL,E:I,KI15H,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,1.61E-07,,,,,-17.86,8.69,,,,,
68,2FTL,E:I,KI15I,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,9.09E-06,,,,,-17.86,11.05,,,,,
69,2FTL,E:I,KI15L,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,1.85E-07,,,,,-17.86,8.77,,,,,
70,2FTL,E:I,KI15M,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,2.56E-08,,,,,-17.86,7.61,,,,,
71,2FTL,E:I,KI15N,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,4.55E-08,,,,,-17.86,7.95,,,,,
72,2FTL,E:I,KI15Q,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,4.35E-07,,,,,-17.86,9.27,,,,,
73,2FTL,E:I,KI15S,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,2.70E-08,,,,,-17.86,7.64,,,,,
74,2FTL,E:I,KI15T,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,3.45E-06,,,,,-17.86,10.49,,,,,
75,2FTL,E:I,KI15V,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,2.44E-05,,,,,-17.86,11.63,,,,,
76,2FTL,E:I,KI15W,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,1.32E-07,,,,,-17.86,8.57,,,,,
77,2FTL,E:I,KI15Y,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",5.88E-14,6.25E-09,,,,,-17.86,6.78,,,,,
78,3BTD,E:I,DI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.59E-05,5.88E-14,,,,,-12.6,-11.38,,,,,
79,3BTE,E:I,EI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",4.76E-07,5.88E-14,,,,,-12.6,-9.32,,,,,
80,3BTF,E:I,FI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",8.33E-09,5.88E-14,,,,,-12.6,-6.95,,,,,
81,3BTG,E:I,GI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",6.67E-05,5.88E-14,,,,,-12.6,-12.22,,,,,
82,3BTH,E:I,HI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.61E-07,5.88E-14,,,,,-12.6,-8.69,,,,,
83,3BTM,E:I,MI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",2.56E-08,5.88E-14,,,,,-12.6,-7.61,,,,,
84,3BTQ,E:I,QI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",4.35E-07,5.88E-14,,,,,-12.6,-9.27,,,,,
85,3BTT,E:I,TI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",3.45E-06,5.88E-14,,,,,-12.6,-10.49,,,,,
86,3BTW,E:I,WI515K,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,Spectroscopy,"50mM Tris, 20mM CaCl2, 0.01 % (v/v) Triton X-100",295,8.3,SKEMPI,"10339415 (Table 1, p. 177)",1.32E-07,5.88E-14,,,,,-12.6,-8.57,,,,,
87,1A4Y,A:B,YA434F,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 2, p. 9278)",3.90E-16,1.00E-15,2.80E+08,1.60E+08,1.10E-07,1.60E-07,-21.01,0.56,,,,,
88,1A4Y,A:B,YA437F,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 2, p. 9278)",3.90E-16,5.90E-16,2.80E+08,1.50E+08,1.10E-07,9.00E-08,-21.01,0.25,,,,,
89,,,Y*434F,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 2, p. 9278)",3.10E-14,3.80E-14,3.80E+08,2.60E+08,1.20E-05,1.00E-05,-18.42,0.12,,,,,mutation in hRI
90,,,Y*437F,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 2, p. 9278)",3.10E-14,1.20E-12,3.80E+08,2.50E+08,1.20E-05,2.90E-04,-18.42,2.17,,,,,mutation in hRI
91,1A4Y,A:B,"YA434A,DA435A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 3, p. 9278)",3.90E-16,3.90E-11,2.80E+08,7.00E+07,1.10E-07,2.70E-03,-21.01,6.82,,,,,
92,1A4Y,A:B,"YA434A,YA437A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 3, p. 9278)",3.90E-16,2.90E-11,2.80E+08,5.90E+07,1.10E-07,1.70E-03,-21.01,6.64,,,,,
93,,,"Y*434A,D*435A","Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 3, p. 9278)",3.10E-14,5.60E-09,,,,,-18.42,7.17,,,,,mutation in hRI
94,,,"Y*434A,Y*437A","Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 3, p. 9278)",3.10E-14,6.30E-09,,,,,-18.42,7.24,,,,,mutation in hRI
95,1A4Y,A:B,KB40G,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,9.20E-14,2.80E+08,1.30E+08,1.10E-07,1.20E-05,-21.01,3.24,,,,,
96,1A4Y,A:B,"KB40G,DA435A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,4.00E-13,2.80E+08,4.70E+07,1.10E-07,1.90E-05,-21.01,4.11,,,,,
97,1A4Y,A:B,"KB40G,YA434A,DA435A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,1.40E-11,2.80E+08,1.40E+08,1.10E-07,1.90E-03,-21.01,6.21,,,,,
98,1A4Y,A:B,"KB40G,YA434A,YA437A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,1.90E-09,2.80E+08,1.00E+07,1.10E-07,1.90E-02,-21.01,9.12,,,,,
99,1A4Y,A:B,"KB40G,YA434F",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,3.00E-11,2.80E+08,3.10E+07,1.10E-07,9.30E-04,-21.01,6.66,,,,,
100,1A4Y,A:B,"KB40G,YA437A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,2.10E-11,2.80E+08,2.70E+07,1.10E-07,5.60E-04,-21.01,6.45,,,,,
101,1A4Y,A:B,"RB5A,DA435A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,3.60E-11,2.80E+08,7.60E+07,1.10E-07,2.70E-03,-21.01,6.77,,,,,
102,1A4Y,A:B,"RB5A,YA434A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,5.10E-11,2.80E+08,5.50E+07,1.10E-07,2.80E-03,-21.01,6.98,,,,,
103,1A4Y,A:B,"RB5A,YA434A,DA435A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,1.00E-08,2.80E+08,6.20E+07,1.10E-07,6.20E-01,-21.01,10.1,,,,,
104,1A4Y,A:B,"RB5A,YA434A,YA437A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,measurement of dissociated ligand at various times,"0.1 M Mes, 0.1 M NaCl, 1 mM EDTA",298,6,SKEMPI,"10413501 (Table 4, p. 9280)",3.90E-16,7.00E-10,2.80E+08,4.00E+07,1.10E-07,2.80E-02,-21.01,8.53,,,,,
105,1FCC,A:C,DC40A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,3.80E-07,,,,,-9.03,0.27,,,,,Wild-type is Q32C mutant of Protein G B1 domain
106,1FCC,A:C,EC42A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,4.60E-07,,,,,-9.03,0.39,,,,,Wild-type is Q32C mutant of Protein G B1 domain
107,1FCC,A:C,KC28A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,2.00E-06,,,,,-9.03,1.26,,,,,Wild-type is Q32C mutant of Protein G B1 domain
108,1FCC,A:C,KC31A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,8.50E-05,,,,,-9.03,3.48,,,,,Wild-type is Q32C mutant of Protein G B1 domain
109,1FCC,A:C,NC35A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,1.30E-05,,,,,-9.03,2.36,,,,,Wild-type is Q32C mutant of Protein G B1 domain
110,1FCC,A:C,TC25A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,3.60E-07,,,,,-9.03,0.24,,,,,Wild-type is Q32C mutant of Protein G B1 domain
111,1FCC,A:C,"TC44A,YC45A",Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,6.50E-06,,,,,-9.03,1.95,,,,,Wild-type is Q32C mutant of Protein G B1 domain
112,1FCC,A:C,WC43A,Human IgG Fc fragment,Streptococcus sp. IgG-binding protein G domain B1,Ag-Ab,Fluorescence,20mM phosphate,298,6,SKEMPI,"10452608 (Table 1, p. 1644)",2.40E-07,1.40E-04,,,,,-9.03,3.77,,,,,Wild-type is Q32C mutant of Protein G B1 domain
113,1XD3,A:B,DB39A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,1.50E-07,,,,,-9.25,-0.43,,,,,
114,1XD3,A:B,DB52A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.00E-07,,,,,-9.25,-0.25,,,,,
115,1XD3,A:B,DB58A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.00E-07,,,,,-9.25,-0.25,,,,,
116,1XD3,A:B,EB24A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.00E-07,,,,,-9.25,-0.25,,,,,
117,1XD3,A:B,EB51A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,4.00E-06,,,,,-9.25,1.6,,,,,
118,1XD3,A:B,HB68N,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,3.00E-07,,,,,-9.25,0,,,,,
119,1XD3,A:B,IB44A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,4.70E-07,,,,,-9.25,0.28,,,,,
120,1XD3,A:B,KB11R,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,3.20E-06,,,,,-9.25,1.46,,,,,
121,1XD3,A:B,KB27A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.70E-07,,,,,-9.25,-0.06,,,,,
122,1XD3,A:B,KB27R,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,4.70E-07,,,,,-9.25,0.28,,,,,
123,1XD3,A:B,KB33R,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,3.00E-07,,,,,-9.25,0,,,,,
124,1XD3,A:B,KB6A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.90E-06,,,,,-9.25,1.4,,,,,
125,1XD3,A:B,KB6R,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,5.00E-07,,,,,-9.25,0.31,,,,,
126,1XD3,A:B,LB8A,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.75E-05,,,,,-9.25,2.78,,,,,
127,1XD3,A:B,RB42L,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,7.00E-08,,,,,-9.25,-0.9,,,,,
128,1XD3,A:B,RB54L,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,1.30E-06,,,,,-9.25,0.9,,,,,
129,1XD3,A:B,RB72L,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,2.70E-06,,,,,-9.25,1.35,,,,,
130,1XD3,A:B,RB74L,Human ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3),Human polyubiquitin-C,,Competitive Inhibition,"50mM Tris-HCl, 10mM DTT",310,7.5,SKEMPI,"10518943 (Table 1, p. 1071)",3.00E-07,1.66E-05,,,,,-9.25,2.47,,,,,
131,1CZ8,V:LH,"HH97Y,YH99R,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,4.00E-10,4.10E+04,2.60E+04,1.20E-04,9.00E-06,-11.64,-1.17,,,,,
132,1CZ8,V:LH,"HH97Y,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",,,4.10E+04,1.30E+04,,,,,,,,,
133,1CZ8,V:LH,"HH97Y,YH99I,GH100A,SH100K",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,1.40E-09,4.10E+04,5.70E+03,1.20E-04,8.00E-06,-11.64,-0.43,,,,,
134,1CZ8,V:LH,"HH97Y,YH99W,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",,,4.10E+04,1.10E+04,,,,,,,,,
135,1CZ8,V:LH,"HH97Y,YH99R,GH100N,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,8.00E-10,4.10E+04,1.20E+04,1.20E-04,9.00E-06,-11.64,-0.76,,,,,
136,1CZ8,V:LH,YH53W,Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,2.30E-09,4.10E+04,3.80E+04,1.20E-04,8.60E-05,-11.64,-0.14,,,,,
137,1CZ8,V:LH,"TH28D,NH31H,IH34M",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,9.00E-10,4.10E+04,4.80E+04,1.20E-04,4.50E-05,-11.64,-0.69,,,,,
138,1CZ8,V:LH,"LH71V,TH73V",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,9.00E-09,4.10E+04,3.00E+04,1.20E-04,2.70E-04,-11.64,0.67,,,,,
139,1CZ8,V:LH,"LH71I,TH73K",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,3.30E-09,4.10E+04,5.20E+04,1.20E-04,1.70E-04,-11.64,0.08,,,,,
140,1CZ8,V:LH,"TH28D,NH31H,IH34M,YH53W,HH97Y,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,3.80E-10,4.10E+04,4.00E+04,1.20E-04,1.50E-05,-11.64,-1.2,,,,,
141,1CZ8,V:LH,"TH28D,NH31H,IH34M,HH97Y,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",,,4.10E+04,3.50E+04,,,,,,,,,
142,1CZ8,V:LH,TH28D,Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,2.00E-09,4.10E+04,6.80E+04,1.20E-04,1.40E-04,-11.64,-0.22,,,,,
143,1CZ8,V:LH,NH31H,Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,8.00E-10,4.10E+04,4.80E+04,1.20E-04,3.70E-05,-11.64,-0.76,,,,,
144,1CZ8,V:LH,HH97Y,Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,2.00E-10,4.10E+04,2.50E+04,1.20E-04,4.50E-06,-11.64,-1.58,,,,,
145,1CZ8,V:LH,SH100T,Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",2.90E-09,1.50E-09,4.10E+04,6.80E+04,1.20E-04,1.00E-04,-11.64,-0.39,,,,,
146,1CZ8,V:LH,"RL24S,NL26S,EL27Q,QL28D,LL29I,TH28D,NH31H,IH34M,HH97Y,SH100T",Human vascular endothelial growth factor A (VEGF A),Mouse antibody Y0192/humanized anti-VEGF Fab-12,Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,298,,Literature,"10543973 (Table 6, p. 870)",,,4.10E+04,3.60E+04,,,,,,,,,
147,4CPA,A:I,PI36G,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,Continuous photometric assay with chromogenic substrate,"50mM Tris-HCl, 100mM NaCl",298,7.5,SKEMPI,"10691989 (Table 1, p. 1505)",1.50E-09,1.20E-07,,,,,-12.03,2.59,,,,,
148,4CPA,A:I,VI38G,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,Continuous photometric assay with chromogenic substrate,"50mM Tris-HCl, 100mM NaCl",298,7.5,SKEMPI,"10691989 (Table 1, p. 1505)",1.50E-09,8.20E-07,,,,,-12.03,3.73,,,,,
149,4CPA,A:I,YI37F,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,Continuous photometric assay with chromogenic substrate,"50mM Tris-HCl, 100mM NaCl",298,7.5,SKEMPI,"10691989 (Table 1, p. 1505)",1.50E-09,1.50E-09,,,,,-12.03,0,,,,,
150,4CPA,A:I,YI37G,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,Continuous photometric assay with chromogenic substrate,"50mM Tris-HCl, 100mM NaCl",298,7.5,SKEMPI,"10691989 (Table 1, p. 1505)",1.50E-09,3.50E-09,,,,,-12.03,0.5,,,,,
151,,,A*1Q,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.04E-08,,,,,-11.86,0.98,,,,,mutation in delta-dendrotoxin
152,,,K*3A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.30E-07,,,,,-11.86,2.81,,,,,mutation in delta-dendrotoxin
153,,,Y*4A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.34E-08,,,,,-11.86,1.67,,,,,mutation in delta-dendrotoxin
154,,,K*6A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.18E-07,,,,,-11.86,3.29,,,,,mutation in delta-dendrotoxin
155,,,L*7A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.10E-09,,,,,-11.86,0.03,,,,,mutation in delta-dendrotoxin
156,,,P*8A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.10E-08,,,,,-11.86,1.92,,,,,mutation in delta-dendrotoxin
157,,,V*9A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.30E-09,,,,,-11.86,-0.26,,,,,mutation in delta-dendrotoxin
158,,,R*10A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.42E-07,,,,,-11.86,2.52,,,,,mutation in delta-dendrotoxin
159,,,Y*11A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.30E-09,,,,,-11.86,0.08,,,,,mutation in delta-dendrotoxin
160,,,P*13A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.70E-09,,,,,-11.86,0.51,,,,,mutation in delta-dendrotoxin
161,,,K*15A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.90E-09,,,,,-11.86,0.22,,,,,mutation in delta-dendrotoxin
162,,,K*16A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.90E-10,,,,,-11.86,-1.14,,,,,mutation in delta-dendrotoxin
163,,,K*17A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.00E-09,,,,,-11.86,0,,,,,mutation in delta-dendrotoxin
164,,,K*24A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.01E-08,,,,,-11.86,0.96,,,,,mutation in delta-dendrotoxin
165,,,W*25A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.06E-08,,,,,-11.86,0.99,,,,,mutation in delta-dendrotoxin
166,,,K*26A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,7.10E-08,,,,,-11.86,2.11,,,,,mutation in delta-dendrotoxin
167,,,K*28A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.10E-08,,,,,-11.86,1.01,,,,,mutation in delta-dendrotoxin
168,,,L*31A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.10E-09,,,,,-11.86,0.26,,,,,mutation in delta-dendrotoxin
169,,,D*34A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.30E-09,,,,,-11.86,-0.26,,,,,mutation in delta-dendrotoxin
170,,,N*41A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.20E-09,,,,,-11.86,0.06,,,,,mutation in delta-dendrotoxin
171,,,A*42Q,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.16E-08,,,,,-11.86,1.04,,,,,mutation in delta-dendrotoxin
172,,,R*44A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.30E-08,,,,,-11.86,1.82,,,,,mutation in delta-dendrotoxin
173,,,K*46A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,8.50E-09,,,,,-11.86,0.86,,,,,mutation in delta-dendrotoxin
174,,,E*49A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.50E-09,,,,,-11.86,0.13,,,,,mutation in delta-dendrotoxin
175,,,E*50A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.30E-10,,,,,-11.86,-0.91,,,,,mutation in delta-dendrotoxin
176,,,R*52A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,7.70E-09,,,,,-11.86,0.8,,,,,mutation in delta-dendrotoxin
177,,,R*53A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,9.40E-09,,,,,-11.86,0.92,,,,,mutation in delta-dendrotoxin
178,,,T*54A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,6.90E-09,,,,,-11.86,0.73,,,,,mutation in delta-dendrotoxin
179,,,"L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.20E-12,,,,,-11.86,-4.03,,,,,mutation in ShaKv1.1
180,,,"A*1Q,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.22E-11,,,,,-11.86,-3.02,,,,,"A1Q mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
181,,,"K*3A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.01E-09,6.75E-10,,,,,-11.86,-0.65,,,,,"K3A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
182,,,"Y*4A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.01E-09,5.50E-11,,,,,-11.86,-2.13,,,,,"Y4A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
183,,,"K*6A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,6.10E-10,,,,,-11.86,-0.7,,,,,"K6A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
184,,,"L*7A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.89E-11,,,,,-11.86,-2.51,,,,,"L7A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
185,,,"P*8A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.56E-11,,,,,-11.86,-2.12,,,,,"P8A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
186,,,"V*9A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.30E-12,,,,,-11.86,-3.51,,,,,"V9A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
187,,,"R*10A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.86E-11,,,,,-11.86,-2.2,,,,,"R10A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
188,,,"Y*11A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.50E-12,,,,,-11.86,-3.96,,,,,"Y11A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
189,,,"P*13A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,9.40E-12,,,,,-11.86,-3.17,,,,,"P13A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
190,,,"K*15A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.60E-12,,,,,-11.86,-3.48,,,,,"K15A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
191,,,"K*16A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,8.40E-13,,,,,-11.86,-4.6,,,,,"K16A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
192,,,"K*17A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.50E-12,,,,,-11.86,-3.96,,,,,"K17A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
193,,,"K*24A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,9.50E-12,,,,,-11.86,-3.17,,,,,"K24A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
194,,,"W*25A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.06E-11,,,,,-11.86,-2.48,,,,,"W25A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
195,,,"K*26A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,8.17E-11,,,,,-11.86,-1.89,,,,,"K26A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
196,,,"K*28A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,7.00E-12,,,,,-11.86,-3.35,,,,,"K28A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
197,,,"L*31A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.50E-12,,,,,-11.86,-3.76,,,,,"L31A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
198,,,"D*34A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.10E-12,,,,,-11.86,-4.06,,,,,"D34A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
199,,,"N*41A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,8.10E-12,,,,,-11.86,-3.26,,,,,"N41A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
200,,,"A*42Q,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.58E-11,,,,,-11.86,-2.38,,,,,"A42Q mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
201,,,"R*44A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.56E-11,,,,,-11.86,-2.12,,,,,"R44A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
202,,,"K*46A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.90E-12,,,,,-11.86,-3.7,,,,,"K46A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
203,,,"E*49A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.00E-12,,,,,-11.86,-4.09,,,,,"E49A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
204,,,"E*50A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,9.90E-13,,,,,-11.86,-4.51,,,,,"E50A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
205,,,"R*52A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.08E-11,,,,,-11.86,-3.09,,,,,"R52A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
206,,,"R*53A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.50E-12,,,,,-11.86,-3.49,,,,,"R53A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
207,,,"T*54A,L*425H,N*427S",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.90E-12,,,,,-11.86,-3.87,,,,,"T54A mutation in delta-dendrotoxin; L425H, N427S double mutation in ShaKv1.1"
208,,,E*423A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.55E-08,,,,,-11.86,1.21,,,,,mutation in ShaKv1.1
209,,,"K*3A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.01E-06,,,,,-11.86,3.69,,,,,K3A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
210,,,"Y*4A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.21E-07,,,,,-11.86,3.01,,,,,Y4A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
211,,,"K*6A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.95E-06,,,,,-11.86,4.08,,,,,K6A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
212,,,"L*7A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.32E-07,,,,,-11.86,2.48,,,,,L7A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
213,,,"P*8A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.72E-07,,,,,-11.86,3.24,,,,,P8A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
214,,,"R*10A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.91E-07,,,,,-11.86,2.95,,,,,R10A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
215,,,"K*26A,E*423A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.65E-07,,,,,-11.86,2.89,,,,,K26A mutation in delta-dendrotoxin;E423A double mutation in ShaKv1.1
216,,,D*431A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.16E-07,,,,,-11.86,3,,,,,mutation in ShaKv1.1
217,,,"K*3A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,6.14E-07,,,,,-11.86,3.39,,,,,K3A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
218,,,"Y*4A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.92E-06,,,,,-11.86,4.07,,,,,Y4A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
219,,,"K*6A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.63E-06,,,,,-11.86,4.59,,,,,K6A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
220,,,"L*7A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.08E-07,,,,,-11.86,3.15,,,,,L7A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
221,,,"P*8A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.87E-06,,,,,-11.86,4.05,,,,,P8A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
222,,,"R*10A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.90E-06,,,,,-11.86,4.31,,,,,R10A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
223,,,"K*26A,D*431A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.60E-06,,,,,-11.86,4.25,,,,,K26A mutation in delta-dendrotoxin;E431A double mutation in ShaKv1.1
224,,,Y*449A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.14E-07,,,,,-11.86,2.77,,,,,mutation in ShaKv1.1
225,,,"K*3A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.24E-06,,,,,-11.86,3.81,,,,,K3A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
226,,,"Y*4A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.22E-07,,,,,-11.86,3.17,,,,,Y4A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
227,,,"K*6A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,5.28E-06,,,,,-11.86,4.67,,,,,K6A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
228,,,"L*7A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.23E-07,,,,,-11.86,2.79,,,,,L7A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
229,,,"P*8A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,3.30E-07,,,,,-11.86,3.02,,,,,P8A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
230,,,"R*10A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.95E-06,,,,,-11.86,4.32,,,,,R10A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
231,,,"K*26A,Y*449A",Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.85E-06,,,,,-11.86,4.04,,,,,K26A mutation in delta-dendrotoxin;E449A double mutation in ShaKv1.1
232,,,Y*415A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.90E-09,,,,,-11.86,0.22,,,,,mutation in ShaKv1.1
233,,,F*416A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.80E-09,,,,,-11.86,0.2,,,,,mutation in ShaKv1.1
234,,,E*420A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,7.50E-09,,,,,-11.86,0.78,,,,,mutation in ShaKv1.1
235,,,E*421A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.20E-09,,,,,-11.86,0.44,,,,,mutation in ShaKv1.1
236,,,L*425A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,7.60E-09,,,,,-11.86,0.79,,,,,mutation in ShaKv1.1
237,,,F*426A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.40E-09,,,,,-11.86,0.47,,,,,mutation in ShaKv1.1
238,,,N*427A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.20E-09,,,,,-11.86,0.06,,,,,mutation in ShaKv1.1
239,,,V*451A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,6.20E-09,,,,,-11.86,0.67,,,,,mutation in ShaKv1.1
240,,,G*452A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,4.00E-10,,,,,-11.86,-0.95,,,,,mutation in ShaKv1.1
241,,,V*453A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,2.30E-09,,,,,-11.86,0.08,,,,,mutation in ShaKv1.1
242,,,W*454A,Dendroaspis angusticeps Kunitz-type serine protease inhibitor homolog delta-dendrotoxin,Drosophila melanogaster potassium voltage-gated channel protein shaker,RC,Electrophysiology,"5 mM HEPES, 100mM TEACl, 2 mM KCl, 0.3 mM CaCl2, 1 mM MgCl2",298,7.6,PINT,"10698633 (Table 1, p. 1287)",2.00E-09,1.70E-09,,,,,-11.86,-0.1,,,,,mutation in ShaKv1.1
243,1JCK,AC:BD,EA56A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,14,,,,,
244,1JCK,AC:BD,EA73A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,-0.31,,,,,
245,1JCK,AC:BD,LA106A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,0.07,,,,,
246,1JCK,AC:BD,NA27A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,0.14,,,,,
247,1JCK,AC:BD,NA28A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,1.36,,,,,
248,1JCK,AC:BD,NA31A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,-0.04,,,,,
249,1JCK,AC:BD,PA70A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,0.3,,,,,
250,1JCK,AC:BD,QA72A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,1.5,,,,,
251,1JCK,AC:BD,SA71A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,0.43,,,,,
252,1JCK,AC:BD,SA76A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,-0.27,,,,,
253,1JCK,AC:BD,TA105A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,-0.09,,,,,
254,1JCK,AC:BD,TA26A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,-0.07,,,,,
255,1JCK,AC:BD,TA55A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,1.13,,,,,
256,1JCK,AC:BD,YA107A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,,,,,,-9.18,0.16,,,,,
257,1JCK,AC:BD,FA100A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,2.20E-07,,,,,-9.18,0.1,,,,,
258,1JCK,AC:BD,GA97A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,4.00E-07,,,,,-9.18,0.46,,,,,
259,1JCK,AC:BD,KA57A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,1.40E-06,,,,,-9.18,1.2,,,,,
260,1JCK,AC:BD,KA66A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,1.20E-07,,,,,-9.18,-0.26,,,,,
261,1JCK,AC:BD,NA74A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,2.00E-07,,,,,-9.18,0.05,,,,,
262,1JCK,AC:BD,YA48A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,8.80E-07,,,,,-9.18,0.92,,,,,
263,1JCK,AC:BD,YA50A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Surface Plasmon Resonance,"150mM NaCl, 10mM Na-Hepes, 3.4mM EDTA, 0.005% Surfactant P20",298,7.5,ASEdb,"10704464 (Table 1, p. 840)",1.85E-07,1.60E-07,,,,,-9.18,-0.09,,,,,
264,1JTG,A:B,DB49A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.46E-07,4.10E+04,5.40E+04,2.80E-04,7.89E-03,-11.13,1.81,,,,,
265,1JTG,A:B,KA234A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,7.47E-08,4.10E+04,1.50E+04,2.80E-04,1.12E-03,-11.13,1.42,,,,,
266,1JTG,A:B,"KA234A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,9.41E-08,4.10E+04,5.60E+04,2.80E-04,5.27E-03,-11.13,1.55,,,,,
267,1JTG,A:B,"KA234A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.93E-07,4.10E+04,6.00E+03,2.80E-04,1.16E-03,-11.13,1.98,,,,,
268,1JTG,A:B,"KA234A,SA130A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,6.32E-08,4.10E+04,2.50E+04,2.80E-04,1.58E-03,-11.13,1.32,,,,,
269,1JTG,A:B,"KA234A,SA130A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,4.72E-07,4.10E+04,4.00E+03,2.80E-04,1.89E-03,-11.13,2.51,,,,,
270,1JTG,A:B,"KA234A,SA130A,RA243A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,8.46E-08,4.10E+04,3.70E+04,2.80E-04,3.13E-03,-11.13,1.49,,,,,
271,1JTG,A:B,"KA234A,SA235A,SA130A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,7.56E-07,4.10E+04,5.00E+03,2.80E-04,3.78E-03,-11.13,2.79,,,,,
272,1JTG,A:B,"KA234A,SA235A,SA130A,RA243A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.26E-07,4.10E+04,3.10E+04,2.80E-04,3.90E-03,-11.13,1.73,,,,,
273,1JTG,A:B,RA243A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,6.55E-08,4.10E+04,1.10E+04,2.80E-04,7.20E-04,-11.13,1.34,,,,,
274,1JTG,A:B,"RA243A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,4.46E-08,4.10E+04,4.60E+04,2.80E-04,2.05E-03,-11.13,1.11,,,,,
275,1JTG,A:B,"RA243A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,6.85E-07,4.10E+04,4.00E+03,2.80E-04,2.74E-03,-11.13,2.73,,,,,
276,1JTG,A:B,"RA243A,KA234A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.70E-07,4.10E+04,3.00E+04,2.80E-04,5.10E-03,-11.13,1.9,,,,,
277,1JTG,A:B,"RA243A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.55E-07,4.10E+04,1.00E+04,2.80E-04,1.55E-03,-11.13,1.85,,,,,
278,1JTG,A:B,"RA243A,SA130A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,5.68E-08,4.10E+04,4.00E+04,2.80E-04,2.27E-03,-11.13,1.25,,,,,
279,1JTG,A:B,"RA243A,SA235A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,2.38E-08,4.10E+04,1.30E+04,2.80E-04,3.10E-04,-11.13,0.74,,,,,
280,1JTG,A:B,"RA243A,SA235A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.36E-08,4.10E+04,4.70E+04,2.80E-04,6.40E-04,-11.13,0.41,,,,,
281,1JTG,A:B,"RA243A,SA235A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,6.70E-07,4.10E+04,4.00E+03,2.80E-04,2.68E-03,-11.13,2.72,,,,,
282,1JTG,A:B,"RA243A,SA235A,KA234A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,2.11E-07,4.10E+04,2.30E+04,2.80E-04,4.86E-03,-11.13,2.03,,,,,
283,1JTG,A:B,"RA243A,SA235A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.18E-07,4.10E+04,9.00E+03,2.80E-04,1.06E-03,-11.13,1.69,,,,,
284,1JTG,A:B,"RA243A,SA235A,SA130A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,3.09E-08,4.10E+04,3.40E+04,2.80E-04,1.05E-03,-11.13,0.89,,,,,
285,1JTG,A:B,SA130A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,2.60E-08,4.10E+04,2.50E+04,2.80E-04,6.50E-04,-11.13,0.79,,,,,
286,1JTG,A:B,"SA130A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,7.07E-08,4.10E+04,5.60E+04,2.80E-04,3.96E-03,-11.13,1.38,,,,,
287,1JTG,A:B,SA235A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,5.53E-08,4.10E+04,4.70E+04,2.80E-04,2.60E-03,-11.13,1.24,,,,,
288,1JTG,A:B,"SA235A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.09E-07,4.10E+04,5.70E+04,2.80E-04,6.22E-03,-11.13,1.64,,,,,
289,1JTG,A:B,"SA235A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,2.34E-07,4.10E+04,8.00E+03,2.80E-04,1.87E-03,-11.13,2.09,,,,,
290,1JTG,A:B,"SA235A,KA234A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,9.11E-08,4.10E+04,3.50E+04,2.80E-04,3.19E-03,-11.13,1.53,,,,,
291,1JTG,A:B,"SA235A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,4.78E-08,4.10E+04,2.30E+04,2.80E-04,1.10E-03,-11.13,1.15,,,,,
292,1JTG,A:B,"SA235A,SA130A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,4.33E-08,4.10E+04,5.70E+04,2.80E-04,2.47E-03,-11.13,1.09,,,,,
293,1JTG,A:B,"SA235A,SA130A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.55E-07,4.10E+04,1.30E+04,2.80E-04,2.02E-03,-11.13,1.85,,,,,
294,1JTG,A:B,"SA235A,SA130A,KA234A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"10772866 (Table 1, p. 506)",6.83E-09,1.91E-08,4.10E+04,5.70E+04,2.80E-04,1.09E-03,-11.13,0.61,,,,,
295,1DQJ,AB:C,DC101A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"10828942 (Table 8, p. 6308)",2.78E-09,3.23E-08,,,,,-11.67,1.45,,,,,
296,1DQJ,AB:C,KC97A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"10828942 (Table 8, p. 6308)",2.78E-09,1.06E-06,,,,,-11.67,3.52,,,,,
297,1DQJ,AB:C,RC21A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"10828942 (Table 8, p. 6308)",2.78E-09,2.00E-08,,,,,-11.67,1.17,,,,,
298,1DQJ,AB:C,WC63A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"10828942 (Table 8, p. 6308)",2.78E-09,2.70E-08,,,,,-11.67,1.35,,,,,
299,1DQJ,AB:C,YC20A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"10828942 (Table 8, p. 6308)",2.78E-09,7.14E-07,,,,,-11.67,3.29,,,,,
300,2I9B,A:E,HE143A,Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,SKEMPI,"10864923 (Table III, p. 28536)",9.10E-10,2.78E-09,,,,,-12.33,0.66,,,,,
301,2I9B,A:E,KE139A,Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,SKEMPI,"10864923 (Table III, p. 28536)",9.10E-10,2.84E-09,,,,,-12.33,0.67,,,,,
302,2I9B,A:E,RE137A,Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,SKEMPI,"10864923 (Table III, p. 28536)",9.10E-10,5.60E-10,,,,,-12.33,-0.29,,,,,
303,2I9B,A:E,RE142A,Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,SKEMPI,"10864923 (Table III, p. 28536)",9.10E-10,1.68E-09,,,,,-12.33,0.36,,,,,
304,2I9B,A:E,RE145A,Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,SKEMPI,"10864923 (Table III, p. 28536)",9.10E-10,1.85E-09,,,,,-12.33,0.42,,,,,
305,2I9B,A:E,"KE139A,HE143A",Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,Literature,"10864923 (Tables II and III, p. 28535-6)",3.30E-10,1.40E-09,6.30E+06,7.00E+06,2.10E-03,1.00E-02,-12.93,0.86,,,,,
306,2I9B,A:E,"RE137A,RE142A,RE145A",Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,Literature,"10864923 (Tables II and III, p. 28535-6)",3.30E-10,3.30E-08,6.30E+06,4.00E+05,2.10E-03,1.30E-02,-12.93,2.73,,,,,
307,2I9B,A:E,"RE137A,KE139A,RE142A,HE143A,RE145A",Human urokinase plasminogen activator receptor (uPAR),Human single chain urokinase-type plasminogen activator (scuPA),RC,Surface Plasmon Resonance,PBS with 0.005% Tween 20,298,7.4,Literature,"10864923 (Tables II and III, p. 28535-6)",3.30E-10,5.50E-08,6.30E+06,8.00E+04,2.10E-03,4.60E-03,-12.93,3.03,,,,,
308,1JTG,A:B,DB163A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,1.30E-10,2.20E+05,1.80E+06,2.80E-04,2.40E-04,-12.14,-1.34,,,,,
309,1JTG,A:B,DB163K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,4.40E-11,2.20E+05,5.00E+06,2.80E-04,2.20E-04,-12.14,-1.98,,,,,
310,1JTG,A:B,"DB163K,DB135K,VB134K",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,7.20E-12,2.20E+05,3.31E+07,2.80E-04,2.40E-04,-12.14,-3.05,,,,,
311,1JTG,A:B,NB89K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,5.80E-10,2.20E+05,6.20E+05,2.80E-04,3.60E-04,-12.14,-0.45,,,,,
312,1JTG,A:B,TB140K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,1.22E-09,2.20E+05,5.40E+05,2.80E-04,6.60E-04,-12.14,-0.01,,,,,
313,1JTG,A:B,"TB140K,QB157K",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,6.40E-10,2.20E+05,1.05E+06,2.80E-04,6.70E-04,-12.14,-0.4,,,,,
314,1JTG,A:B,TB32K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,1.75E-09,2.20E+05,3.40E+05,2.80E-04,6.00E-04,-12.14,0.2,,,,,
315,1JTG,A:B,"VB165K,DB163K,DB135K,NB89K",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,4.30E-12,2.20E+05,5.30E+07,2.80E-04,2.30E-04,-12.14,-3.36,,,,,
316,1JTG,A:B,"VB165K,DB163K,NB89K",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,2.20E-11,2.20E+05,1.23E+07,2.80E-04,2.70E-04,-12.14,-2.39,,,,,
317,1JTG,A:B,VB93K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,,298,,SKEMPI,"10876236 (Table 1, p. 540)",1.25E-09,5.60E-10,2.20E+05,5.40E+05,2.80E-04,3.00E-04,-12.14,-0.48,,,,,
318,1F47,A:B,DA4A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,6.94E-05,,,,,-6.36,0.69,,,,,
319,1F47,A:B,DA7A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,4.03E-04,,,,,-6.36,1.73,,,,,
320,1F47,A:B,FA11A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,1.34E-03,,,,,-6.36,2.44,,,,,
321,1F47,A:B,IA8A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,1.51E-03,,,,,-6.36,2.52,,,,,
322,1F47,A:B,KA14A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,2.01E-05,,,,,-6.36,-0.04,,,,,
323,1F47,A:B,LA12A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,1.04E-03,,,,,-6.36,2.29,,,,,
324,1F47,A:B,LA6A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,1.03E-04,,,,,-6.36,0.93,,,,,
325,1F47,A:B,PA9A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,1.96E-05,,,,,-6.36,-0.06,,,,,
326,1F47,A:B,QA15A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,2.00E-05,,,,,-6.36,-0.05,,,,,
327,1F47,A:B,YA5A,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20",298,7.5,SKEMPI,"10880432 (Table II, p. 3185)",2.16E-05,9.37E-05,,,,,-6.36,0.87,,,,,
328,1REW,AB:C,"AA34D,AB34D",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,6.67E-10,6.00E+05,3.36E+05,4.00E-04,2.24E-04,-12.51,0,,,,,
329,1REW,AB:C,"AA34D,DA53A,AB34D,DB53A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,4.89E-10,6.00E+05,9.00E+05,4.00E-04,4.40E-04,-12.51,-0.18,,,,,
330,1REW,AB:C,"DA30A,AA34D,DB30A,AB34D",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,1.49E-09,6.00E+05,5.10E+05,4.00E-04,7.60E-04,-12.51,0.48,,,,,
331,1REW,AB:C,"DA30A,DB30A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,2.06E-09,6.00E+05,5.82E+05,4.00E-04,1.20E-03,-12.51,0.67,,,,,
332,1REW,AB:C,"DA30A,WA31A,DB30A,WB31A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,2.17E-08,6.00E+05,5.52E+05,4.00E-04,1.20E-02,-12.51,2.06,,,,,
333,1REW,AB:C,"DA53A,DB53A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,6.11E-10,6.00E+05,7.20E+05,4.00E-04,4.40E-04,-12.51,-0.05,,,,,
334,1REW,AB:C,"DA53A,EA109R,DB53A,EB109R",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,7.18E-10,6.00E+05,7.80E+05,4.00E-04,5.60E-04,-12.51,0.04,,,,,
335,1REW,AB:C,"EA109R,EB109R",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,1.05E-09,6.00E+05,4.56E+05,4.00E-04,4.80E-04,-12.51,0.27,,,,,
336,1REW,AB:C,"FA49A,FB49A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,6.67E-09,6.00E+05,6.00E+04,4.00E-04,4.00E-04,-12.51,1.36,,,,,
337,1REW,AB:C,"FA49A,PA50A,FB49A,PB50A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,8.67E-08,6.00E+05,1.20E+04,4.00E-04,1.04E-03,-12.51,2.88,,,,,
338,1REW,AB:C,"HA39D,HB39D",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,9.28E-10,6.00E+05,4.74E+05,4.00E-04,4.40E-04,-12.51,0.2,,,,,
339,1REW,AB:C,"HA39D,LA100A,HB39D,LB100A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,8.15E-10,6.00E+05,5.40E+05,4.00E-04,4.40E-04,-12.51,0.12,,,,,
340,1REW,AB:C,"HA39D,SA88A,HB39D,SB88A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,9.09E-10,6.00E+05,5.28E+05,4.00E-04,4.80E-04,-12.51,0.18,,,,,
341,1REW,AB:C,"LA100A,LB100A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,9.88E-10,6.00E+05,4.86E+05,4.00E-04,4.80E-04,-12.51,0.23,,,,,
342,1REW,AB:C,"PA50A,PB50A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,5.93E-09,6.00E+05,5.40E+04,4.00E-04,3.20E-04,-12.51,1.29,,,,,
343,1REW,AB:C,"SA88A,SB88A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,9.40E-10,6.00E+05,4.68E+05,4.00E-04,4.40E-04,-12.51,0.2,,,,,
344,1REW,AB:C,"WA31A,WB31A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"10880444 (Table 1, p. 3319)",6.67E-10,4.18E-09,6.00E+05,5.46E+05,4.00E-04,2.28E-03,-12.51,1.09,,,,,
345,1A4Y,A:B,EA287A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,6.40E-16,2.00E+08,1.40E+08,1.10E-07,8.80E-08,-20.82,0.1,,,,,
346,1A4Y,A:B,EA344A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,7.30E-16,2.00E+08,1.40E+08,1.10E-07,9.80E-08,-20.82,0.18,,,,,
347,1A4Y,A:B,EA401A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,2.40E-15,2.00E+08,1.40E+08,1.10E-07,3.20E-07,-20.82,0.88,,,,,
348,1A4Y,A:B,HB84A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,7.20E-16,2.00E+08,1.90E+08,1.10E-07,1.40E-07,-20.82,0.17,,,,,
349,1A4Y,A:B,IA459A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,1.70E-15,2.00E+08,1.20E+08,1.10E-07,2.00E-07,-20.82,0.68,,,,,
350,1A4Y,A:B,KA320A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,3.20E-16,2.00E+08,2.90E+08,1.10E-07,9.40E-08,-20.82,-0.31,,,,,
351,1A4Y,A:B,"QA430A,VA432A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,6.10E-16,2.00E+08,1.40E+08,1.10E-07,8.40E-08,-20.82,0.07,,,,,
352,1A4Y,A:B,RA457A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,3.70E-16,2.00E+08,1.50E+08,1.10E-07,5.80E-08,-20.82,-0.22,,,,,
353,1A4Y,A:B,SA289A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,5.80E-16,2.00E+08,1.10E+08,1.10E-07,6.30E-08,-20.82,0.04,,,,,
354,1A4Y,A:B,WA261A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,6.40E-16,2.00E+08,1.60E+08,1.10E-07,1.00E-07,-20.82,0.1,,,,,
355,1A4Y,A:B,WA263A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,3.90E-15,2.00E+08,1.80E+08,1.10E-07,6.90E-07,-20.82,1.17,,,,,
356,1A4Y,A:B,WA318A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,6.80E-15,2.00E+08,2.00E+08,1.10E-07,1.30E-06,-20.82,1.5,,,,,
357,1A4Y,A:B,WA375A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,3.10E-15,2.00E+08,1.00E+08,1.10E-07,3.10E-07,-20.82,1.03,,,,,
358,1A4Y,A:B,"WA438A,SA439A,EA440A",Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,1.10E-14,2.00E+08,1.30E+08,1.10E-07,1.70E-06,-20.82,1.78,,,,,
359,1A4Y,A:B,WB89A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 120&micro;M DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",5.40E-16,8.10E-16,2.00E+08,2.00E+08,1.10E-07,1.60E-07,-20.82,0.24,,,,,
360,,,E*206A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,2.40E-13,2.80E+08,3.20E+08,1.20E-05,7.60E-05,-18.23,1.02,,,,,mutation in hRI
361,,,E*287A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,4.00E-13,2.80E+08,1.30E+08,1.20E-05,5.20E-05,-18.23,1.32,,,,,mutation in hRI
362,,,E*344A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,6.00E-13,2.80E+08,1.80E+08,1.20E-05,1.10E-04,-18.23,1.56,,,,,mutation in hRI
363,,,E*401A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,3.90E-13,2.80E+08,1.10E+08,1.20E-05,4.30E-05,-18.23,1.31,,,,,mutation in hRI
364,,,I*459A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,7.60E-14,2.80E+08,1.60E+08,1.20E-05,1.20E-05,-18.23,0.34,,,,,mutation in hRI
365,,,K*320A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,4.00E-13,2.80E+08,1.50E+08,1.20E-05,5.60E-05,-18.23,1.32,,,,,mutation in hRI
366,,,"Q*430A,V*432A","Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,2.10E-13,2.80E+08,1.90E+08,1.20E-05,4.00E-05,-18.23,0.94,,,,,mutation in hRI
367,,,R*457A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,1.80E-13,2.80E+08,1.80E+08,1.20E-05,3.20E-05,-18.23,0.85,,,,,mutation in hRI
368,,,S*289A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,1.70E-13,2.80E+08,2.10E+08,1.20E-05,3.40E-05,-18.23,0.81,,,,,mutation in hRI
369,,,W*261A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,4.10E-13,2.80E+08,2.00E+08,1.20E-05,8.00E-05,-18.23,1.34,,,,,mutation in hRI
370,,,W*263A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,1.80E-12,2.80E+08,2.50E+08,1.20E-05,4.60E-04,-18.23,2.21,,,,,mutation in hRI
371,,,W*318A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,2.30E-13,2.80E+08,3.40E+08,1.20E-05,7.80E-05,-18.23,0.99,,,,,mutation in hRI
372,,,W*375A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,7.20E-13,2.80E+08,1.40E+08,1.20E-05,9.90E-05,-18.23,1.67,,,,,mutation in hRI
373,,,"W*438A,S*439A,E*440A","Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,Stopped-flow Fluorescence; Competitive Inhibition,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA, 5mM DTT",298,6,SKEMPI;ASEdb;,"10970748 ( Table 2, p. 503, Table 3, p. 504, Tables  4 and 5, p. 508)",4.30E-14,1.20E-12,2.80E+08,2.00E+08,1.20E-05,2.50E-04,-18.23,1.97,,,,,mutation in hRI
374,1E50,A:B,RB3A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,3.20E-07,,,,,0,0,,,,,
375,1E50,A:B,VB4A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,4.80E-07,,,,,0,0,,,,,
376,1E50,A:B,GB61A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,1.50E-06,,,,,0,0,,,,,
377,1E50,A:B,QB67A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,4.50E-07,,,,,0,0,,,,,
378,1E50,A:B,LB103A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,2.20E-07,,,,,0,0,,,,,
379,1E50,A:B,NB104A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,,,SKEMPI,"10984496 (Table III, p. 39584)",4.50E-08,2.20E-06,,,,,0,0,,,,,
380,1JRH,LH:I,DH54A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.90E-07,,,,,-10.8,1.89,,,,,
381,1JRH,LH:I,DH55A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.00E-07,,,,,-10.8,1.67,,,,,
382,1JRH,LH:I,DH56A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.75E-07,,,,,-10.8,1.85,,,,,
383,1JRH,LH:I,DL28A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.50E-08,,,,,-10.8,0.43,,,,,
384,1JRH,LH:I,EI55P,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.00E-11,,,,,-10.8,-3.79,,,,,
385,1JRH,LH:I,"EI55P,II57L",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,3.50E-11,,,,,-10.8,-3.46,,,,,
386,1JRH,LH:I,"EI55P,II57R",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,3.60E-11,,,,,-10.8,-3.44,,,,,
387,1JRH,LH:I,EL27A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,3.00E-08,,,,,-10.8,0.54,,,,,
388,1JRH,LH:I,FH98A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.20E-08,,,,,-10.8,0,,,,,
389,1JRH,LH:I,HH100A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.11E-07,,,,,-10.8,1.7,,,,,
390,1JRH,LH:I,RH95A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,3.00E-08,,,,,-10.8,0.54,,,,,
391,1JRH,LH:I,"SI54G,EI55G,II57R",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,4.00E-11,,,,,-10.8,-3.38,,,,,
392,1JRH,LH:I,"SI54G,EI55P,II57K",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.70E-11,,,,,-10.8,-3.88,,,,,
393,1JRH,LH:I,SL93A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,4.00E-09,,,,,-10.8,-0.65,,,,,
394,1JRH,LH:I,TL94A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.30E-08,,,,,-10.8,0.39,,,,,
395,1JRH,LH:I,WH52A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.12E-06,,,,,-10.8,2.69,,,,,
396,1JRH,LH:I,WH53A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,7.16E-07,,,,,-10.8,2.42,,,,,
397,1JRH,LH:I,WL92A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.40E-06,,,,,-10.8,2.82,,,,,
398,1JRH,LH:I,WL96A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,2.00E-07,,,,,-10.8,1.67,,,,,
399,1JRH,LH:I,YH32A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.35E-07,,,,,-10.8,1.43,,,,,
400,1JRH,LH:I,YH58A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,1.00E-07,,,,,-10.8,1.26,,,,,
401,1JRH,LH:I,YH99A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,7.20E-08,,,,,-10.8,1.06,,,,,
402,1JRH,LH:I,YL30A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,7.80E-08,,,,,-10.8,1.11,,,,,
403,1JRH,LH:I,YL91A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"11123892 (Table I, p. 15676)",1.20E-08,3.20E-08,,,,,-10.8,0.58,,,,,
404,1HE8,A:B,KA223V,"Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,2.90E-06,,,,,-7.89,0.47,,,,,
405,1HE8,A:B,"KA223V,DA238A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,7.50E-06,,,,,-7.89,1.02,,,,,
406,1HE8,A:B,"KA223V,DA260A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,6.40E-06,,,,,-7.89,0.93,,,,,
407,1HE8,A:B,"KA223V,EA267K","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,1.10E-06,,,,,-7.89,-0.1,,,,,
408,1HE8,A:B,"KA223V,EA919A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,2.80E-06,,,,,-7.89,0.45,,,,,
409,1HE8,A:B,"KA223V,EA919K","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,6.00E-07,,,,,-7.89,-0.45,,,,,
410,1HE8,A:B,"KA223V,KA234A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,1.70E-05,,,,,-7.89,1.5,,,,,
411,1HE8,A:B,"KA223V,KA254A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,3.60E-05,,,,,-7.89,1.93,,,,,
412,1HE8,A:B,"KA223V,KA256A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,2.20E-05,,,,,-7.89,1.65,,,,,
413,1HE8,A:B,"KA223V,RA226A","Human phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)",Human GTPase HRas,OE,Fluorescence Anisotropy/Polarization,"20mM Tris, 2mM MgCl2, 1mM DTT",293,7.5,SKEMPI,"11136978 (Figure 2, p. 933)",1.30E-06,3.20E-05,,,,,-7.89,1.87,,,,,
414,2PCC,A:B,AB81G,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,2.85E-05,,,,,-8.1,1.9,-2.6,-2.4,18.4,12.7,
415,2PCC,A:B,"AB81G,DA34A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,9.75E-07,,,,,-8.1,-0.1,-2.6,-0.8,18.4,24.8,
416,2PCC,A:B,"AB81G,VA197A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,4.00E-05,,,,,-8.1,2.1,-2.6,-2.2,18.4,12.7,
417,2PCC,A:B,DA34A,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,2.53E-07,,,,,-8.1,-0.9,-2.6,-0.9,18.4,27.2,
418,2PCC,A:B,EA290A,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,4.05E-02,,,,,-8.1,6.2,-2.6,-5.8,18.4,-13.1,
419,2PCC,A:B,KB72A,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,1.92E-06,,,,,-8.1,0.3,-2.6,-1.1,18.4,22.5,
420,2PCC,A:B,"KB72A,EA290A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,7.39E-06,,,,,-8.1,1.1,-2.6,-1.2,18.4,19.5,
421,2PCC,A:B,"KB72A,VA197A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,1.30E-04,,,,,-8.1,2.8,-2.6,-0.5,18.4,16.1,
422,2PCC,A:B,KB87A,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,5.27E-06,,,,,-8.1,0.9,-2.6,-0.8,18.4,21.5,
423,2PCC,A:B,"KB87A,DA34A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,1.62E-06,,,,,-8.1,0.2,-2.6,-0.7,18.4,24.1,
424,2PCC,A:B,"KB87A,VA197A","Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,1.45E-05,,,,,-8.1,1.5,-2.6,-0.9,18.4,19.1,
425,2PCC,A:B,VA197A,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50 mM Dimethylglutaric acid (DMG),298,6,SKEMPI;PINT;,"11148036 (Table I, p. 423)",1.15E-06,4.00E-05,,,,,-8.1,2.1,-2.6,-2.3,18.4,12.4,
426,1CHO,EFG:I,AI15C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.03E-12,,,,,-15.17,-0.32,,,,,
427,1CHO,EFG:I,AI15D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.26E-12,,,,,-15.17,0,,,,,
428,1CHO,EFG:I,AI15E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-12,,,,,-15.17,0.22,,,,,
429,1CHO,EFG:I,AI15F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.52E-12,,,,,-15.17,-0.73,,,,,
430,1CHO,EFG:I,AI15G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-12,,,,,-15.17,0.07,,,,,
431,1CHO,EFG:I,AI15H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.03E-12,,,,,-15.17,-0.32,,,,,
432,1CHO,EFG:I,AI15I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.59E-11,,,,,-15.17,0.65,,,,,
433,1CHO,EFG:I,AI15K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.57E-10,,,,,-15.17,2.46,,,,,
434,1CHO,EFG:I,AI15L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-12,,,,,-15.17,0.14,,,,,
435,1CHO,EFG:I,AI15M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-12,,,,,-15.17,0.14,,,,,
436,1CHO,EFG:I,AI15N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.23E-12,,,,,-15.17,-0.28,,,,,
437,1CHO,EFG:I,AI15P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-09,,,,,-15.17,3.07,,,,,
438,1CHO,EFG:I,AI15Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.11E-11,,,,,-15.17,0.44,,,,,
439,1CHO,EFG:I,AI15R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.16E-11,,,,,-15.17,0.46,,,,,
440,1CHO,EFG:I,AI15S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-12,,,,,-15.17,0.07,,,,,
441,1CHO,EFG:I,AI15T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-11,,,,,-15.17,0.96,,,,,
442,1CHO,EFG:I,AI15V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.63E-11,,,,,-15.17,0.94,,,,,
443,1CHO,EFG:I,AI15W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.04E-13,,,,,-15.17,-1.9,,,,,
444,1CHO,EFG:I,AI15Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.20E-12,,,,,-15.17,-0.86,,,,,
445,1CHO,EFG:I,EI19A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-10,,,,,-15.17,2.3,,,,,
446,1CHO,EFG:I,EI19C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.26E-10,,,,,-15.17,2.69,,,,,
447,1CHO,EFG:I,EI19D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.33E-11,,,,,-15.17,0.87,,,,,
448,1CHO,EFG:I,EI19F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.38E-09,,,,,-15.17,3.57,,,,,
449,1CHO,EFG:I,EI19G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.38E-09,,,,,-15.17,3.57,,,,,
450,1CHO,EFG:I,EI19H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.79E-10,,,,,-15.17,2.06,,,,,
451,1CHO,EFG:I,EI19I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.55E-10,,,,,-15.17,2.61,,,,,
452,1CHO,EFG:I,EI19K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.27E-09,,,,,-15.17,3.54,,,,,
453,1CHO,EFG:I,EI19L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-10,,,,,-15.17,2.83,,,,,
454,1CHO,EFG:I,EI19M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.00E-10,,,,,-15.17,2.66,,,,,
455,1CHO,EFG:I,EI19N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-10,,,,,-15.17,2.3,,,,,
456,1CHO,EFG:I,EI19P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.17E-10,,,,,-15.17,2.55,,,,,
457,1CHO,EFG:I,EI19Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.00E-11,,,,,-15.17,1.32,,,,,
458,1CHO,EFG:I,EI19R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.63E-09,,,,,-15.17,3.63,,,,,
459,1CHO,EFG:I,EI19S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-10,,,,,-15.17,2.76,,,,,
460,1CHO,EFG:I,EI19T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-10,,,,,-15.17,2.87,,,,,
461,1CHO,EFG:I,EI19V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.23E-10,,,,,-15.17,2.41,,,,,
462,1CHO,EFG:I,EI19W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.09E-09,,,,,-15.17,3.12,,,,,
463,1CHO,EFG:I,EI19Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.76E-10,,,,,-15.17,2.63,,,,,
464,1CHO,EFG:I,GI32A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,8.33E-13,,,,,-15.17,-1.08,,,,,
465,1CHO,EFG:I,GI32C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.85E-10,,,,,-15.17,2.51,,,,,
466,1CHO,EFG:I,GI32D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-09,,,,,-15.17,3.07,,,,,
467,1CHO,EFG:I,GI32E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.35E-10,,,,,-15.17,2.58,,,,,
468,1CHO,EFG:I,GI32F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.25E-12,,,,,-15.17,0.1,,,,,
469,1CHO,EFG:I,GI32H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-12,,,,,-15.17,-0.97,,,,,
470,1CHO,EFG:I,GI32I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.86E-10,,,,,-15.17,2.33,,,,,
471,1CHO,EFG:I,GI32K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-11,,,,,-15.17,1.57,,,,,
472,1CHO,EFG:I,GI32L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.01E-10,,,,,-15.17,1.73,,,,,
473,1CHO,EFG:I,GI32M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,8.33E-11,,,,,-15.17,1.61,,,,,
474,1CHO,EFG:I,GI32N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.63E-11,,,,,-15.17,0.94,,,,,
475,1CHO,EFG:I,GI32P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,9.09E-12,,,,,-15.17,0.32,,,,,
476,1CHO,EFG:I,GI32Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.94E-10,,,,,-15.17,2.35,,,,,
477,1CHO,EFG:I,GI32R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-10,,,,,-15.17,1.72,,,,,
478,1CHO,EFG:I,GI32S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.17E-12,,,,,-15.17,-0.14,,,,,
479,1CHO,EFG:I,GI32T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.75E-10,,,,,-15.17,2.05,,,,,
480,1CHO,EFG:I,GI32V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.72E-11,,,,,-15.17,0.69,,,,,
481,1CHO,EFG:I,GI32W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.13E-11,,,,,-15.17,1.04,,,,,
482,1CHO,EFG:I,GI32Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-12,,,,,-15.17,-0.97,,,,,
483,1CHO,EFG:I,KI13A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-12,,,,,-15.17,0.18,,,,,
484,1CHO,EFG:I,KI13C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.23E-11,,,,,-15.17,0.5,,,,,
485,1CHO,EFG:I,KI13D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.22E-12,,,,,-15.17,-0.5,,,,,
486,1CHO,EFG:I,KI13E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-12,,,,,-15.17,0.18,,,,,
487,1CHO,EFG:I,KI13F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.33E-11,,,,,-15.17,1.08,,,,,
488,1CHO,EFG:I,KI13G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.14E-10,,,,,-15.17,1.8,,,,,
489,1CHO,EFG:I,KI13H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-12,,,,,-15.17,0.14,,,,,
490,1CHO,EFG:I,KI13I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-11,,,,,-15.17,1.52,,,,,
491,1CHO,EFG:I,KI13L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-11,,,,,-15.17,0.38,,,,,
492,1CHO,EFG:I,KI13M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.08E-11,,,,,-15.17,0.42,,,,,
493,1CHO,EFG:I,KI13N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.86E-12,,,,,-15.17,-0.36,,,,,
494,1CHO,EFG:I,KI13P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.75E-10,,,,,-15.17,2.05,,,,,
495,1CHO,EFG:I,KI13Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.00E-12,,,,,-15.17,-0.56,,,,,
496,1CHO,EFG:I,KI13R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.78E-12,,,,,-15.17,-0.37,,,,,
497,1CHO,EFG:I,KI13S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.56E-12,,,,,-15.17,-0.42,,,,,
498,1CHO,EFG:I,KI13T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-11,,,,,-15.17,0.38,,,,,
499,1CHO,EFG:I,KI13V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.00E-11,,,,,-15.17,1.19,,,,,
500,1CHO,EFG:I,KI13W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.94E-11,,,,,-15.17,1.01,,,,,
501,1CHO,EFG:I,KI13Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.23E-11,,,,,-15.17,1.06,,,,,
502,1CHO,EFG:I,NI36A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.26E-13,,,,,-15.17,-1.35,,,,,
503,1CHO,EFG:I,NI36C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.35E-12,,,,,-15.17,-0.11,,,,,
504,1CHO,EFG:I,NI36D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,9.09E-13,,,,,-15.17,-1.03,,,,,
505,1CHO,EFG:I,NI36E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-10,,,,,-15.17,2.3,,,,,
506,1CHO,EFG:I,NI36F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.86E-10,,,,,-15.17,2.33,,,,,
507,1CHO,EFG:I,NI36G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.00E-13,,,,,-15.17,-1.37,,,,,
508,1CHO,EFG:I,NI36H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.52E-12,,,,,-15.17,-0.73,,,,,
509,1CHO,EFG:I,NI36I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.00E-12,,,,,-15.17,-0.03,,,,,
510,1CHO,EFG:I,NI36K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-10,,,,,-15.17,2.3,,,,,
511,1CHO,EFG:I,NI36L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.49E-11,,,,,-15.17,0.61,,,,,
512,1CHO,EFG:I,NI36M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.70E-12,,,,,-15.17,-0.21,,,,,
513,1CHO,EFG:I,NI36P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.38E-13,,,,,-15.17,-1.81,,,,,
514,1CHO,EFG:I,NI36Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.85E-12,,,,,-15.17,-0.18,,,,,
515,1CHO,EFG:I,NI36R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-11,,,,,-15.17,1.57,,,,,
516,1CHO,EFG:I,NI36S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.35E-13,,,,,-15.17,-1.46,,,,,
517,1CHO,EFG:I,NI36T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-13,,,,,-15.17,-1.28,,,,,
518,1CHO,EFG:I,NI36V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.56E-12,,,,,-15.17,0.03,,,,,
519,1CHO,EFG:I,NI36W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.08E-10,,,,,-15.17,2.15,,,,,
520,1CHO,EFG:I,NI36Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.00E-10,,,,,-15.17,2.53,,,,,
521,1CHO,EFG:I,PI14A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-11,,,,,-15.17,0.38,,,,,
522,1CHO,EFG:I,PI14C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-12,,,,,-15.17,-0.97,,,,,
523,1CHO,EFG:I,PI14D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.25E-12,,,,,-15.17,-0.84,,,,,
524,1CHO,EFG:I,PI14E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.56E-12,,,,,-15.17,-0.71,,,,,
525,1CHO,EFG:I,PI14F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.13E-12,,,,,-15.17,-0.3,,,,,
526,1CHO,EFG:I,PI14G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.54E-11,,,,,-15.17,0.63,,,,,
527,1CHO,EFG:I,PI14H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.35E-12,,,,,-15.17,-0.11,,,,,
528,1CHO,EFG:I,PI14I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.22E-12,,,,,-15.17,-0.5,,,,,
529,1CHO,EFG:I,PI14K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.01E-11,,,,,-15.17,0.38,,,,,
530,1CHO,EFG:I,PI14L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.17E-12,,,,,-15.17,-0.52,,,,,
531,1CHO,EFG:I,PI14M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.30E-12,,,,,-15.17,-0.82,,,,,
532,1CHO,EFG:I,PI14N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.41E-12,,,,,-15.17,-0.77,,,,,
533,1CHO,EFG:I,PI14Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.54E-12,,,,,-15.17,-0.72,,,,,
534,1CHO,EFG:I,PI14R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.03E-11,,,,,-15.17,0.39,,,,,
535,1CHO,EFG:I,PI14S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.50E-12,,,,,-15.17,-0.43,,,,,
536,1CHO,EFG:I,PI14T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.08E-12,,,,,-15.17,-0.54,,,,,
537,1CHO,EFG:I,PI14V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.08E-12,,,,,-15.17,-0.54,,,,,
538,1CHO,EFG:I,PI14W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.70E-12,,,,,-15.17,-0.21,,,,,
539,1CHO,EFG:I,PI14Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-12,,,,,-15.17,-0.39,,,,,
540,1CHO,EFG:I,RI21A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.15E-09,,,,,-15.17,3.15,,,,,
541,1CHO,EFG:I,RI21C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.04E-09,,,,,-15.17,3.48,,,,,
542,1CHO,EFG:I,RI21D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.12E-09,,,,,-15.17,3.73,,,,,
543,1CHO,EFG:I,RI21E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.96E-09,,,,,-15.17,3.46,,,,,
544,1CHO,EFG:I,RI21F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-10,,,,,-15.17,2.91,,,,,
545,1CHO,EFG:I,RI21G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.89E-09,,,,,-15.17,3.44,,,,,
546,1CHO,EFG:I,RI21H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-10,,,,,-15.17,2.76,,,,,
547,1CHO,EFG:I,RI21I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.85E-10,,,,,-15.17,2.08,,,,,
548,1CHO,EFG:I,RI21K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.61E-11,,,,,-15.17,0.65,,,,,
549,1CHO,EFG:I,RI21L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.25E-10,,,,,-15.17,2.79,,,,,
550,1CHO,EFG:I,RI21M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.35E-10,,,,,-15.17,2.58,,,,,
551,1CHO,EFG:I,RI21N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.04E-09,,,,,-15.17,3.48,,,,,
552,1CHO,EFG:I,RI21P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.16E-06,,,,,-15.17,7.19,,,,,
553,1CHO,EFG:I,RI21Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.45E-10,,,,,-15.17,2.44,,,,,
554,1CHO,EFG:I,RI21S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.14E-09,,,,,-15.17,3.14,,,,,
555,1CHO,EFG:I,RI21T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.76E-10,,,,,-15.17,2.63,,,,,
556,1CHO,EFG:I,RI21V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.72E-10,,,,,-15.17,2.04,,,,,
557,1CHO,EFG:I,RI21W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.23E-10,,,,,-15.17,2.41,,,,,
558,1CHO,EFG:I,RI21Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,8.33E-10,,,,,-15.17,2.96,,,,,
559,1CHO,EFG:I,TI17A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-09,,,,,-15.17,4.1,,,,,
560,1CHO,EFG:I,TI17C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.45E-09,,,,,-15.17,3.28,,,,,
561,1CHO,EFG:I,TI17D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.26E-07,,,,,-15.17,6.73,,,,,
562,1CHO,EFG:I,TI17E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.70E-07,,,,,-15.17,6.34,,,,,
563,1CHO,EFG:I,TI17F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-09,,,,,-15.17,4.17,,,,,
564,1CHO,EFG:I,TI17G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.00E-08,,,,,-15.17,5.22,,,,,
565,1CHO,EFG:I,TI17H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.50E-09,,,,,-15.17,3.6,,,,,
566,1CHO,EFG:I,TI17I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.50E-09,,,,,-15.17,3.6,,,,,
567,1CHO,EFG:I,TI17K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.26E-09,,,,,-15.17,4.04,,,,,
568,1CHO,EFG:I,TI17L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,9.09E-09,,,,,-15.17,4.36,,,,,
569,1CHO,EFG:I,TI17M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.17E-09,,,,,-15.17,3.9,,,,,
570,1CHO,EFG:I,TI17N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-09,,,,,-15.17,4.26,,,,,
571,1CHO,EFG:I,TI17P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-09,,,,,-15.17,4.17,,,,,
572,1CHO,EFG:I,TI17Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.63E-09,,,,,-15.17,3.63,,,,,
573,1CHO,EFG:I,TI17R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.70E-09,,,,,-15.17,3.83,,,,,
574,1CHO,EFG:I,TI17S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.78E-10,,,,,-15.17,2.32,,,,,
575,1CHO,EFG:I,TI17V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.22E-09,,,,,-15.17,3.53,,,,,
576,1CHO,EFG:I,TI17W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,5.88E-09,,,,,-15.17,4.1,,,,,
577,1CHO,EFG:I,TI17Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-08,,,,,-15.17,4.41,,,,,
578,1CHO,EFG:I,YI20A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.85E-10,,,,,-15.17,2.51,,,,,
579,1CHO,EFG:I,YI20C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,3.85E-10,,,,,-15.17,2.51,,,,,
580,1CHO,EFG:I,YI20D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.17E-07,,,,,-15.17,6.21,,,,,
581,1CHO,EFG:I,YI20E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,2.50E-08,,,,,-15.17,4.95,,,,,
582,1CHO,EFG:I,YI20F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-12,,,,,-15.17,0.18,,,,,
583,1CHO,EFG:I,YI20G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.12E-09,,,,,-15.17,3.13,,,,,
584,1CHO,EFG:I,YI20H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.69E-11,,,,,-15.17,1.57,,,,,
585,1CHO,EFG:I,YI20I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.85E-10,,,,,-15.17,2.08,,,,,
586,1CHO,EFG:I,YI20K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.10E-09,,,,,-15.17,3.12,,,,,
587,1CHO,EFG:I,YI20L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.67E-11,,,,,-15.17,0.67,,,,,
588,1CHO,EFG:I,YI20M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,4.17E-11,,,,,-15.17,1.21,,,,,
589,1CHO,EFG:I,YI20N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,8.33E-10,,,,,-15.17,2.96,,,,,
590,1CHO,EFG:I,YI20P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.00E-05,,,,,-15.17,8.45,,,,,
591,1CHO,EFG:I,YI20Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.08E-09,,,,,-15.17,3.11,,,,,
592,1CHO,EFG:I,YI20R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,7.14E-10,,,,,-15.17,2.87,,,,,
593,1CHO,EFG:I,YI20S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,6.67E-10,,,,,-15.17,2.83,,,,,
594,1CHO,EFG:I,YI20T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.39E-09,,,,,-15.17,3.26,,,,,
595,1CHO,EFG:I,YI20V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.82E-09,,,,,-15.17,3.42,,,,,
596,1CHO,EFG:I,YI20W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",5.26E-12,1.02E-11,,,,,-15.17,0.39,,,,,
597,1PPF,E:I,AI15C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.26E-11,,,,,-13.16,-0.66,,,,,
598,1PPF,E:I,AI15D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.12E-09,,,,,-13.16,1.12,,,,,
599,1PPF,E:I,AI15E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.96E-10,,,,,-13.16,0.1,,,,,
600,1PPF,E:I,AI15F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.45E-10,,,,,-13.16,-0.07,,,,,
601,1PPF,E:I,AI15G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.12E-09,,,,,-13.16,1.12,,,,,
602,1PPF,E:I,AI15H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.17E-10,,,,,-13.16,0.55,,,,,
603,1PPF,E:I,AI15I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.86E-10,,,,,-13.16,0.32,,,,,
604,1PPF,E:I,AI15K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.10E-09,,,,,-13.16,1.11,,,,,
605,1PPF,E:I,AI15L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.69E-10,,,,,-13.16,0.02,,,,,
606,1PPF,E:I,AI15M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-11,,,,,-13.16,-0.4,,,,,
607,1PPF,E:I,AI15N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-10,,,,,-13.16,0.9,,,,,
608,1PPF,E:I,AI15P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.76E-09,,,,,-13.16,1.97,,,,,
609,1PPF,E:I,AI15Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.50E-10,,,,,-13.16,0.25,,,,,
610,1PPF,E:I,AI15R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.05E-10,,,,,-13.16,-0.26,,,,,
611,1PPF,E:I,AI15S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-10,,,,,-13.16,0.75,,,,,
612,1PPF,E:I,AI15T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-10,,,,,-13.16,0.95,,,,,
613,1PPF,E:I,AI15V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.33E-10,,,,,-13.16,0.21,,,,,
614,1PPF,E:I,AI15W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-11,,,,,-13.16,-0.63,,,,,
615,1PPF,E:I,AI15Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.20E-10,,,,,-13.16,-0.18,,,,,
616,1PPF,E:I,EI19A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.25E-09,,,,,-13.16,1.19,,,,,
617,1PPF,E:I,EI19C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.75E-09,,,,,-13.16,1.38,,,,,
618,1PPF,E:I,EI19D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.35E-10,,,,,-13.16,0.57,,,,,
619,1PPF,E:I,EI19F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.64E-09,,,,,-13.16,1.35,,,,,
620,1PPF,E:I,EI19G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-09,,,,,-13.16,2.09,,,,,
621,1PPF,E:I,EI19H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.26E-10,,,,,-13.16,0.68,,,,,
622,1PPF,E:I,EI19I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-10,,,,,-13.16,0.71,,,,,
623,1PPF,E:I,EI19K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-09,,,,,-13.16,2.09,,,,,
624,1PPF,E:I,EI19L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.00E-09,,,,,-13.16,1.06,,,,,
625,1PPF,E:I,EI19M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.14E-09,,,,,-13.16,1.13,,,,,
626,1PPF,E:I,EI19N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.27E-09,,,,,-13.16,1.2,,,,,
627,1PPF,E:I,EI19P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.70E-08,,,,,-13.16,3.17,,,,,
628,1PPF,E:I,EI19Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.00E-10,,,,,-13.16,0.65,,,,,
629,1PPF,E:I,EI19R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.96E-09,,,,,-13.16,1.45,,,,,
630,1PPF,E:I,EI19S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.70E-09,,,,,-13.16,1.82,,,,,
631,1PPF,E:I,EI19T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.08E-09,,,,,-13.16,1.48,,,,,
632,1PPF,E:I,EI19V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.16E-09,,,,,-13.16,1.14,,,,,
633,1PPF,E:I,EI19W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.17E-09,,,,,-13.16,1.51,,,,,
634,1PPF,E:I,EI19Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.35E-09,,,,,-13.16,1.23,,,,,
635,1PPF,E:I,GI32A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.44E-10,,,,,-13.16,0.23,,,,,
636,1PPF,E:I,GI32C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.20E-09,,,,,-13.16,1.16,,,,,
637,1PPF,E:I,GI32D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.11E-08,,,,,-13.16,2.46,,,,,
638,1PPF,E:I,GI32E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.92E-09,,,,,-13.16,1.44,,,,,
639,1PPF,E:I,GI32F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.00E-09,,,,,-13.16,1.46,,,,,
640,1PPF,E:I,GI32H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.08E-09,,,,,-13.16,1.48,,,,,
641,1PPF,E:I,GI32I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.63E-07,,,,,-13.16,4.31,,,,,
642,1PPF,E:I,GI32K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.35E-08,,,,,-13.16,3.26,,,,,
643,1PPF,E:I,GI32L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.23E-08,,,,,-13.16,3.09,,,,,
644,1PPF,E:I,GI32M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-09,,,,,-13.16,2.16,,,,,
645,1PPF,E:I,GI32N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.50E-09,,,,,-13.16,1.59,,,,,
646,1PPF,E:I,GI32P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.56E-10,,,,,-13.16,0.26,,,,,
647,1PPF,E:I,GI32Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.85E-08,,,,,-13.16,2.76,,,,,
648,1PPF,E:I,GI32R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-07,,,,,-13.16,4.78,,,,,
649,1PPF,E:I,GI32S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-10,,,,,-13.16,0.9,,,,,
650,1PPF,E:I,GI32T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.89E-08,,,,,-13.16,2.77,,,,,
651,1PPF,E:I,GI32V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.22E-08,,,,,-13.16,2.52,,,,,
652,1PPF,E:I,GI32W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.63E-09,,,,,-13.16,1.62,,,,,
653,1PPF,E:I,GI32Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.25E-09,,,,,-13.16,1.19,,,,,
654,1PPF,E:I,KI13A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-10,,,,,-13.16,0.75,,,,,
655,1PPF,E:I,KI13C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-10,,,,,-13.16,0.95,,,,,
656,1PPF,E:I,KI13D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.76E-10,,,,,-13.16,0.62,,,,,
657,1PPF,E:I,KI13E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.11E-09,,,,,-13.16,1.12,,,,,
658,1PPF,E:I,KI13F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-10,,,,,-13.16,0.95,,,,,
659,1PPF,E:I,KI13G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.35E-09,,,,,-13.16,1.23,,,,,
660,1PPF,E:I,KI13H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,9.09E-10,,,,,-13.16,1,,,,,
661,1PPF,E:I,KI13I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.76E-10,,,,,-13.16,0.62,,,,,
662,1PPF,E:I,KI13L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.23E-10,,,,,-13.16,0.4,,,,,
663,1PPF,E:I,KI13M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.33E-10,,,,,-13.16,0.21,,,,,
664,1PPF,E:I,KI13N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.00E-10,,,,,-13.16,0.65,,,,,
665,1PPF,E:I,KI13P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.39E-09,,,,,-13.16,1.25,,,,,
666,1PPF,E:I,KI13Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.50E-10,,,,,-13.16,0.25,,,,,
667,1PPF,E:I,KI13R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-11,,,,,-13.16,-0.63,,,,,
668,1PPF,E:I,KI13S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.57E-10,,,,,-13.16,0.45,,,,,
669,1PPF,E:I,KI13T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.17E-10,,,,,-13.16,0.16,,,,,
670,1PPF,E:I,KI13V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-10,,,,,-13.16,0.86,,,,,
671,1PPF,E:I,KI13W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-10,,,,,-13.16,0.82,,,,,
672,1PPF,E:I,KI13Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.85E-10,,,,,-13.16,0.5,,,,,
673,1PPF,E:I,NI36A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.02E-11,,,,,-13.16,-1.62,,,,,
674,1PPF,E:I,NI36C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.55E-10,,,,,-13.16,0.6,,,,,
675,1PPF,E:I,NI36D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,9.09E-13,,,,,-13.16,-3.04,,,,,
676,1PPF,E:I,NI36E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.94E-11,,,,,-13.16,-1,,,,,
677,1PPF,E:I,NI36F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.70E-09,,,,,-13.16,1.82,,,,,
678,1PPF,E:I,NI36G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.25E-11,,,,,-13.16,-0.56,,,,,
679,1PPF,E:I,NI36H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-11,,,,,-13.16,-0.53,,,,,
680,1PPF,E:I,NI36I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-10,,,,,-13.16,0.86,,,,,
681,1PPF,E:I,NI36K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.37E-08,,,,,-13.16,2.59,,,,,
682,1PPF,E:I,NI36L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.43E-08,,,,,-13.16,2.61,,,,,
683,1PPF,E:I,NI36M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.04E-09,,,,,-13.16,1.08,,,,,
684,1PPF,E:I,NI36P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.11E-12,,,,,-13.16,-2.92,,,,,
685,1PPF,E:I,NI36Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.13E-10,,,,,-13.16,0.38,,,,,
686,1PPF,E:I,NI36R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.85E-09,,,,,-13.16,1.84,,,,,
687,1PPF,E:I,NI36S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.69E-11,,,,,-13.16,-1.33,,,,,
688,1PPF,E:I,NI36T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.17E-10,,,,,-13.16,0.55,,,,,
689,1PPF,E:I,NI36V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.94E-10,,,,,-13.16,0.34,,,,,
690,1PPF,E:I,NI36W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.03E-09,,,,,-13.16,1.7,,,,,
691,1PPF,E:I,NI36Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.78E-09,,,,,-13.16,1.65,,,,,
692,1PPF,E:I,PI14A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.33E-10,,,,,-13.16,-0.12,,,,,
693,1PPF,E:I,PI14C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-12,,,,,-13.16,-1.98,,,,,
694,1PPF,E:I,PI14D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-11,,,,,-13.16,-0.49,,,,,
695,1PPF,E:I,PI14E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.47E-11,,,,,-13.16,-1.41,,,,,
696,1PPF,E:I,PI14F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-12,,,,,-13.16,-1.83,,,,,
697,1PPF,E:I,PI14G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.92E-10,,,,,-13.16,0.09,,,,,
698,1PPF,E:I,PI14H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-12,,,,,-13.16,-1.74,,,,,
699,1PPF,E:I,PI14I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.01E-11,,,,,-13.16,-1.63,,,,,
700,1PPF,E:I,PI14K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-11,,,,,-13.16,-0.44,,,,,
701,1PPF,E:I,PI14L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.18E-12,,,,,-13.16,-2.88,,,,,
702,1PPF,E:I,PI14M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.15E-11,,,,,-13.16,-1.55,,,,,
703,1PPF,E:I,PI14N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-11,,,,,-13.16,-0.63,,,,,
704,1PPF,E:I,PI14Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.17E-11,,,,,-13.16,-0.8,,,,,
705,1PPF,E:I,PI14R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.30E-10,,,,,-13.16,-0.14,,,,,
706,1PPF,E:I,PI14S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.25E-11,,,,,-13.16,-0.56,,,,,
707,1PPF,E:I,PI14T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.05E-10,,,,,-13.16,-0.26,,,,,
708,1PPF,E:I,PI14V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.25E-11,,,,,-13.16,-1.5,,,,,
709,1PPF,E:I,PI14W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-12,,,,,-13.16,-1.98,,,,,
710,1PPF,E:I,PI14Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.23E-11,,,,,-13.16,-0.95,,,,,
711,1PPF,E:I,RI21A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.33E-10,,,,,-13.16,0.21,,,,,
712,1PPF,E:I,RI21C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.43E-10,,,,,-13.16,-0.08,,,,,
713,1PPF,E:I,RI21D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.33E-10,,,,,-13.16,0.21,,,,,
714,1PPF,E:I,RI21E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.57E-10,,,,,-13.16,0.45,,,,,
715,1PPF,E:I,RI21F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.13E-11,,,,,-13.16,-0.97,,,,,
716,1PPF,E:I,RI21G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.35E-10,,,,,-13.16,0.57,,,,,
717,1PPF,E:I,RI21H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-11,,,,,-13.16,-0.49,,,,,
718,1PPF,E:I,RI21I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.17E-11,,,,,-13.16,-0.8,,,,,
719,1PPF,E:I,RI21K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.55E-10,,,,,-13.16,0.6,,,,,
720,1PPF,E:I,RI21L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.85E-11,,,,,-13.16,-0.85,,,,,
721,1PPF,E:I,RI21M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.55E-11,,,,,-13.16,-0.75,,,,,
722,1PPF,E:I,RI21N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.86E-10,,,,,-13.16,0.32,,,,,
723,1PPF,E:I,RI21P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.35E-05,,,,,-13.16,6.61,,,,,
724,1PPF,E:I,RI21Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.59E-10,,,,,-13.16,-0.02,,,,,
725,1PPF,E:I,RI21S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.33E-10,,,,,-13.16,0.41,,,,,
726,1PPF,E:I,RI21T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.59E-10,,,,,-13.16,-0.02,,,,,
727,1PPF,E:I,RI21V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,9.09E-11,,,,,-13.16,-0.34,,,,,
728,1PPF,E:I,RI21W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-11,,,,,-13.16,-0.53,,,,,
729,1PPF,E:I,RI21Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.38E-10,,,,,-13.16,0.22,,,,,
730,1PPF,E:I,TI17A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.88E-08,,,,,-13.16,3.44,,,,,
731,1PPF,E:I,TI17C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-09,,,,,-13.16,2.06,,,,,
732,1PPF,E:I,TI17D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-07,,,,,-13.16,4.86,,,,,
733,1PPF,E:I,TI17E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.78E-08,,,,,-13.16,3,,,,,
734,1PPF,E:I,TI17F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.94E-09,,,,,-13.16,1.69,,,,,
735,1PPF,E:I,TI17G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.14E-08,,,,,-13.16,3.55,,,,,
736,1PPF,E:I,TI17H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.86E-09,,,,,-13.16,1.67,,,,,
737,1PPF,E:I,TI17I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.04E-09,,,,,-13.16,1.47,,,,,
738,1PPF,E:I,TI17K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.00E-08,,,,,-13.16,3.34,,,,,
739,1PPF,E:I,TI17L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-09,,,,,-13.16,2.25,,,,,
740,1PPF,E:I,TI17M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.12E-08,,,,,-13.16,2.47,,,,,
741,1PPF,E:I,TI17N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.56E-08,,,,,-13.16,2.66,,,,,
742,1PPF,E:I,TI17P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.94E-08,,,,,-13.16,3.03,,,,,
743,1PPF,E:I,TI17Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.55E-09,,,,,-13.16,1.94,,,,,
744,1PPF,E:I,TI17R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-08,,,,,-13.16,3.4,,,,,
745,1PPF,E:I,TI17S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.08E-09,,,,,-13.16,1.48,,,,,
746,1PPF,E:I,TI17V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.00E-09,,,,,-13.16,1.46,,,,,
747,1PPF,E:I,TI17W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,6.67E-09,,,,,-13.16,2.16,,,,,
748,1PPF,E:I,TI17Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.08E-08,,,,,-13.16,2.45,,,,,
749,1PPF,E:I,YI20A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.70E-08,,,,,-13.16,3.17,,,,,
750,1PPF,E:I,YI20C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,5.56E-08,,,,,-13.16,3.4,,,,,
751,1PPF,E:I,YI20D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-06,,,,,-13.16,6.33,,,,,
752,1PPF,E:I,YI20E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-06,,,,,-13.16,6.33,,,,,
753,1PPF,E:I,YI20F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.70E-10,,,,,-13.16,0.48,,,,,
754,1PPF,E:I,YI20G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.92E-07,,,,,-13.16,4.13,,,,,
755,1PPF,E:I,YI20H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,9.09E-09,,,,,-13.16,2.35,,,,,
756,1PPF,E:I,YI20I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.25E-07,,,,,-13.16,3.88,,,,,
757,1PPF,E:I,YI20K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,3.23E-07,,,,,-13.16,4.43,,,,,
758,1PPF,E:I,YI20L,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.67E-09,,,,,-13.16,1.36,,,,,
759,1PPF,E:I,YI20M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.89E-08,,,,,-13.16,2.77,,,,,
760,1PPF,E:I,YI20N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-08,,,,,-13.16,3.59,,,,,
761,1PPF,E:I,YI20P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.41E-06,,,,,-13.16,5.29,,,,,
762,1PPF,E:I,YI20Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,4.55E-07,,,,,-13.16,4.63,,,,,
763,1PPF,E:I,YI20R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.63E-07,,,,,-13.16,4.31,,,,,
764,1PPF,E:I,YI20S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,7.69E-08,,,,,-13.16,3.59,,,,,
765,1PPF,E:I,YI20T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,8.33E-07,,,,,-13.16,4.99,,,,,
766,1PPF,E:I,YI20V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,1.92E-07,,,,,-13.16,4.13,,,,,
767,1PPF,E:I,YI20W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.64E-10,2.44E-10,,,,,-13.16,0.23,,,,,
768,1R0R,E:I,AI15C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.30E-11,,,,,-14.17,-0.48,,,,,
769,1R0R,E:I,AI15D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.00E-07,,,,,-14.17,5.16,,,,,
770,1R0R,E:I,AI15E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-08,,,,,-14.17,4.51,,,,,
771,1R0R,E:I,AI15F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-13,,,,,-14.17,-2.21,,,,,
772,1R0R,E:I,AI15G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.92E-10,,,,,-14.17,1.1,,,,,
773,1R0R,E:I,AI15H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-10,,,,,-14.17,1.75,,,,,
774,1R0R,E:I,AI15I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.41E-12,,,,,-14.17,-1.77,,,,,
775,1R0R,E:I,AI15K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.26E-09,,,,,-14.17,3.03,,,,,
776,1R0R,E:I,AI15L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.52E-12,,,,,-14.17,-1.73,,,,,
777,1R0R,E:I,AI15M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.56E-12,,,,,-14.17,-1.72,,,,,
778,1R0R,E:I,AI15N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.01E-09,,,,,-14.17,2.07,,,,,
779,1R0R,E:I,AI15P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,8.33E-09,,,,,-14.17,3.3,,,,,
780,1R0R,E:I,AI15Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.25E-10,,,,,-14.17,1.79,,,,,
781,1R0R,E:I,AI15R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.33E-07,,,,,-14.17,5.45,,,,,
782,1R0R,E:I,AI15S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.56E-10,,,,,-14.17,1.72,,,,,
783,1R0R,E:I,AI15T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.50E-10,,,,,-14.17,1.25,,,,,
784,1R0R,E:I,AI15V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-12,,,,,-14.17,-0.94,,,,,
785,1R0R,E:I,AI15W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-11,,,,,-14.17,0.2,,,,,
786,1R0R,E:I,AI15Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-12,,,,,-14.17,-0.83,,,,,
787,1R0R,E:I,EI19A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.00E-09,,,,,-14.17,2.06,,,,,
788,1R0R,E:I,EI19C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.61E-09,,,,,-14.17,2.34,,,,,
789,1R0R,E:I,EI19D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.55E-11,,,,,-14.17,0.26,,,,,
790,1R0R,E:I,EI19F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.32E-08,,,,,-14.17,3.57,,,,,
791,1R0R,E:I,EI19G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.86E-09,,,,,-14.17,2.67,,,,,
792,1R0R,E:I,EI19H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.26E-10,,,,,-14.17,1.69,,,,,
793,1R0R,E:I,EI19I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.02E-10,,,,,-14.17,0.73,,,,,
794,1R0R,E:I,EI19K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.86E-09,,,,,-14.17,2.67,,,,,
795,1R0R,E:I,EI19L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
796,1R0R,E:I,EI19M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-10,,,,,-14.17,1.55,,,,,
797,1R0R,E:I,EI19N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.05E-09,,,,,-14.17,2.09,,,,,
798,1R0R,E:I,EI19P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.69E-08,,,,,-14.17,3.71,,,,,
799,1R0R,E:I,EI19Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.56E-10,,,,,-14.17,1.26,,,,,
800,1R0R,E:I,EI19R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.01E-09,,,,,-14.17,2.07,,,,,
801,1R0R,E:I,EI19S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.25E-09,,,,,-14.17,3.13,,,,,
802,1R0R,E:I,EI19T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.85E-08,,,,,-14.17,4.19,,,,,
803,1R0R,E:I,EI19V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.45E-11,,,,,-14.17,0.09,,,,,
804,1R0R,E:I,EI19W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-10,,,,,-14.17,1.82,,,,,
805,1R0R,E:I,EI19Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-10,,,,,-14.17,1.86,,,,,
806,1R0R,E:I,GI32A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.63E-10,,,,,-14.17,1.28,,,,,
807,1R0R,E:I,GI32C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.23E-10,,,,,-14.17,1.4,,,,,
808,1R0R,E:I,GI32D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.85E-09,,,,,-14.17,2.85,,,,,
809,1R0R,E:I,GI32E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,8.33E-10,,,,,-14.17,1.95,,,,,
810,1R0R,E:I,GI32F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.57E-11,,,,,-14.17,0.11,,,,,
811,1R0R,E:I,GI32H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.19E-09,,,,,-14.17,2.16,,,,,
812,1R0R,E:I,GI32I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,8.33E-10,,,,,-14.17,1.95,,,,,
813,1R0R,E:I,GI32K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-09,,,,,-14.17,2.89,,,,,
814,1R0R,E:I,GI32L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.72E-09,,,,,-14.17,2.38,,,,,
815,1R0R,E:I,GI32M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.12E-09,,,,,-14.17,2.13,,,,,
816,1R0R,E:I,GI32N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.56E-10,,,,,-14.17,1.26,,,,,
817,1R0R,E:I,GI32P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.82E-10,,,,,-14.17,1.07,,,,,
818,1R0R,E:I,GI32Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,9.09E-10,,,,,-14.17,2,,,,,
819,1R0R,E:I,GI32R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.03E-08,,,,,-14.17,3.42,,,,,
820,1R0R,E:I,GI32S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.37E-10,,,,,-14.17,0.9,,,,,
821,1R0R,E:I,GI32T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.00E-10,,,,,-14.17,1.66,,,,,
822,1R0R,E:I,GI32V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-10,,,,,-14.17,1.91,,,,,
823,1R0R,E:I,GI32W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.13E-10,,,,,-14.17,1.38,,,,,
824,1R0R,E:I,GI32Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-11,,,,,-14.17,0.48,,,,,
825,1R0R,E:I,KI13A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.05E-11,,,,,-14.17,-0.6,,,,,
826,1R0R,E:I,KI13C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.04E-11,,,,,-14.17,-0.61,,,,,
827,1R0R,E:I,KI13D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.08E-11,,,,,-14.17,-0.59,,,,,
828,1R0R,E:I,KI13E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.44E-11,,,,,-14.17,-0.11,,,,,
829,1R0R,E:I,KI13F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-12,,,,,-14.17,-0.78,,,,,
830,1R0R,E:I,KI13G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-12,,,,,-14.17,-0.83,,,,,
831,1R0R,E:I,KI13H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.08E-11,,,,,-14.17,-0.59,,,,,
832,1R0R,E:I,KI13I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.96E-10,,,,,-14.17,1.11,,,,,
833,1R0R,E:I,KI13L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.69E-11,,,,,-14.17,-0.32,,,,,
834,1R0R,E:I,KI13M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.14E-11,,,,,-14.17,-0.55,,,,,
835,1R0R,E:I,KI13N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.52E-11,,,,,-14.17,-0.39,,,,,
836,1R0R,E:I,KI13P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.86E-10,,,,,-14.17,1.33,,,,,
837,1R0R,E:I,KI13Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.20E-11,,,,,-14.17,-0.52,,,,,
838,1R0R,E:I,KI13R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.70E-11,,,,,-14.17,0.13,,,,,
839,1R0R,E:I,KI13S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.75E-11,,,,,-14.17,-0.3,,,,,
840,1R0R,E:I,KI13T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.32E-10,,,,,-14.17,0.88,,,,,
841,1R0R,E:I,KI13V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-11,,,,,-14.17,0.4,,,,,
842,1R0R,E:I,KI13W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.55E-12,,,,,-14.17,-1.09,,,,,
843,1R0R,E:I,KI13Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,9.09E-12,,,,,-14.17,-0.69,,,,,
844,1R0R,E:I,NI36A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.78E-11,,,,,-14.17,-0.03,,,,,
845,1R0R,E:I,NI36C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
846,1R0R,E:I,NI36D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
847,1R0R,E:I,NI36E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.08E-11,,,,,-14.17,-0.2,,,,,
848,1R0R,E:I,NI36F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.17E-11,,,,,-14.17,-0.18,,,,,
849,1R0R,E:I,NI36G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.76E-11,,,,,-14.17,0.28,,,,,
850,1R0R,E:I,NI36H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.76E-11,,,,,-14.17,0.28,,,,,
851,1R0R,E:I,NI36I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.00E-11,,,,,-14.17,0.31,,,,,
852,1R0R,E:I,NI36K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.04E-10,,,,,-14.17,1.13,,,,,
853,1R0R,E:I,NI36L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.00E-10,,,,,-14.17,1.53,,,,,
854,1R0R,E:I,NI36M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.00E-11,,,,,-14.17,0.31,,,,,
855,1R0R,E:I,NI36P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.57E-10,,,,,-14.17,1.46,,,,,
856,1R0R,E:I,NI36Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.85E-11,,,,,-14.17,-0.27,,,,,
857,1R0R,E:I,NI36R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.45E-10,,,,,-14.17,1.44,,,,,
858,1R0R,E:I,NI36S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-11,,,,,-14.17,0.48,,,,,
859,1R0R,E:I,NI36T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
860,1R0R,E:I,NI36V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,9.09E-11,,,,,-14.17,0.66,,,,,
861,1R0R,E:I,NI36W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.23E-11,,,,,-14.17,0.05,,,,,
862,1R0R,E:I,NI36Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.00E-11,,,,,-14.17,0.18,,,,,
863,1R0R,E:I,PI14A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.00E-11,,,,,-14.17,-0.63,,,,,
864,1R0R,E:I,PI14C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.56E-12,,,,,-14.17,-0.97,,,,,
865,1R0R,E:I,PI14D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-13,,,,,-14.17,-2.49,,,,,
866,1R0R,E:I,PI14E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-13,,,,,-14.17,-2.21,,,,,
867,1R0R,E:I,PI14F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.03E-10,,,,,-14.17,1.36,,,,,
868,1R0R,E:I,PI14G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.64E-11,,,,,-14.17,-0.34,,,,,
869,1R0R,E:I,PI14H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.04E-11,,,,,-14.17,-0.21,,,,,
870,1R0R,E:I,PI14I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.56E-10,,,,,-14.17,1.72,,,,,
871,1R0R,E:I,PI14K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.26E-11,,,,,-14.17,0.34,,,,,
872,1R0R,E:I,PI14L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.17E-10,,,,,-14.17,1.17,,,,,
873,1R0R,E:I,PI14M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.78E-11,,,,,-14.17,-0.03,,,,,
874,1R0R,E:I,PI14N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.25E-12,,,,,-14.17,-0.9,,,,,
875,1R0R,E:I,PI14Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.70E-12,,,,,-14.17,-1.4,,,,,
876,1R0R,E:I,PI14R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.89E-10,,,,,-14.17,1.09,,,,,
877,1R0R,E:I,PI14S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.70E-11,,,,,-14.17,0.13,,,,,
878,1R0R,E:I,PI14T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.22E-10,,,,,-14.17,1.18,,,,,
879,1R0R,E:I,PI14V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.78E-10,,,,,-14.17,1.31,,,,,
880,1R0R,E:I,PI14W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-11,,,,,-14.17,0.48,,,,,
881,1R0R,E:I,PI14Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.25E-10,,,,,-14.17,0.85,,,,,
882,1R0R,E:I,RI21A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.50E-11,,,,,-14.17,-0.09,,,,,
883,1R0R,E:I,RI21C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.57E-11,,,,,-14.17,0.11,,,,,
884,1R0R,E:I,RI21D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.17E-11,,,,,-14.17,-0.18,,,,,
885,1R0R,E:I,RI21E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.26E-11,,,,,-14.17,0.34,,,,,
886,1R0R,E:I,RI21F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.25E-11,,,,,-14.17,0.44,,,,,
887,1R0R,E:I,RI21G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.00E-09,,,,,-14.17,2.06,,,,,
888,1R0R,E:I,RI21H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-11,,,,,-14.17,0.52,,,,,
889,1R0R,E:I,RI21I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-11,,,,,-14.17,0.2,,,,,
890,1R0R,E:I,RI21K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.50E-11,,,,,-14.17,-0.09,,,,,
891,1R0R,E:I,RI21L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.35E-11,,,,,-14.17,0.23,,,,,
892,1R0R,E:I,RI21M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.25E-11,,,,,-14.17,0.44,,,,,
893,1R0R,E:I,RI21N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.70E-11,,,,,-14.17,-0.05,,,,,
894,1R0R,E:I,RI21P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-06,,,,,-14.17,7.29,,,,,
895,1R0R,E:I,RI21Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.00E-11,,,,,-14.17,0.18,,,,,
896,1R0R,E:I,RI21S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.86E-11,,,,,-14.17,-0.02,,,,,
897,1R0R,E:I,RI21T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.26E-11,,,,,-14.17,0.34,,,,,
898,1R0R,E:I,RI21V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.57E-11,,,,,-14.17,0.11,,,,,
899,1R0R,E:I,RI21W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.45E-10,,,,,-14.17,0.93,,,,,
900,1R0R,E:I,RI21Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.18E-10,,,,,-14.17,0.81,,,,,
901,1R0R,E:I,TI17A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.13E-10,,,,,-14.17,1.16,,,,,
902,1R0R,E:I,TI17C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.16E-10,,,,,-14.17,0.8,,,,,
903,1R0R,E:I,TI17D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.85E-09,,,,,-14.17,2.85,,,,,
904,1R0R,E:I,TI17E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-09,,,,,-14.17,3.17,,,,,
905,1R0R,E:I,TI17F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.63E-11,,,,,-14.17,-0.07,,,,,
906,1R0R,E:I,TI17G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-09,,,,,-14.17,3.1,,,,,
907,1R0R,E:I,TI17H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-11,,,,,-14.17,0.52,,,,,
908,1R0R,E:I,TI17I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.55E-11,,,,,-14.17,0.26,,,,,
909,1R0R,E:I,TI17K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.69E-10,,,,,-14.17,1.91,,,,,
910,1R0R,E:I,TI17L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,9.09E-11,,,,,-14.17,0.66,,,,,
911,1R0R,E:I,TI17M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.78E-10,,,,,-14.17,1.31,,,,,
912,1R0R,E:I,TI17N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.03E-11,,,,,-14.17,0.02,,,,,
913,1R0R,E:I,TI17P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.25E-07,,,,,-14.17,4.88,,,,,
914,1R0R,E:I,TI17Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.25E-09,,,,,-14.17,2.19,,,,,
915,1R0R,E:I,TI17R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,8.33E-09,,,,,-14.17,3.3,,,,,
916,1R0R,E:I,TI17S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.32E-10,,,,,-14.17,0.88,,,,,
917,1R0R,E:I,TI17V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.43E-10,,,,,-14.17,0.92,,,,,
918,1R0R,E:I,TI17W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,4.17E-09,,,,,-14.17,2.89,,,,,
919,1R0R,E:I,TI17Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,6.67E-12,,,,,-14.17,-0.87,,,,,
920,1R0R,E:I,YI20A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.03E-07,,,,,-14.17,5.4,,,,,
921,1R0R,E:I,YI20C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-09,,,,,-14.17,3.21,,,,,
922,1R0R,E:I,YI20D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.00E-07,,,,,-14.17,5.69,,,,,
923,1R0R,E:I,YI20E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,7.14E-08,,,,,-14.17,4.55,,,,,
924,1R0R,E:I,YI20F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,8.33E-11,,,,,-14.17,0.61,,,,,
925,1R0R,E:I,YI20G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.45E-06,,,,,-14.17,6.31,,,,,
926,1R0R,E:I,YI20H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.03E-08,,,,,-14.17,3.42,,,,,
927,1R0R,E:I,YI20I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.70E-09,,,,,-14.17,2.82,,,,,
928,1R0R,E:I,YI20K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.23E-07,,,,,-14.17,5.44,,,,,
929,1R0R,E:I,YI20L,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.27E-09,,,,,-14.17,2.54,,,,,
930,1R0R,E:I,YI20M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-09,,,,,-14.17,3.1,,,,,
931,1R0R,E:I,YI20N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.85E-07,,,,,-14.17,5.54,,,,,
932,1R0R,E:I,YI20P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,2.22E-06,,,,,-14.17,6.56,,,,,
933,1R0R,E:I,YI20Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.88E-08,,,,,-14.17,4.44,,,,,
934,1R0R,E:I,YI20R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,5.56E-08,,,,,-14.17,4.41,,,,,
935,1R0R,E:I,YI20S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.79E-07,,,,,-14.17,5.09,,,,,
936,1R0R,E:I,YI20T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,3.03E-07,,,,,-14.17,5.4,,,,,
937,1R0R,E:I,YI20V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.10E-08,,,,,-14.17,3.46,,,,,
938,1R0R,E:I,YI20W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",2.94E-11,1.59E-11,,,,,-14.17,-0.36,,,,,
939,3SGB,E:I,AI15C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.92E-11,,,,,-14.46,0.04,,,,,
940,3SGB,E:I,AI15D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.00E-11,,,,,-14.46,0.47,,,,,
941,3SGB,E:I,AI15E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-11,,,,,-14.46,0.66,,,,,
942,3SGB,E:I,AI15F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.44E-12,,,,,-14.46,-1.16,,,,,
943,3SGB,E:I,AI15G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.19E-09,,,,,-14.46,2.45,,,,,
944,3SGB,E:I,AI15H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-12,,,,,-14.46,-0.45,,,,,
945,3SGB,E:I,AI15I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-12,,,,,-14.46,-0.45,,,,,
946,3SGB,E:I,AI15K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.20E-09,,,,,-14.46,2.46,,,,,
947,3SGB,E:I,AI15L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.38E-11,,,,,-14.46,0.17,,,,,
948,3SGB,E:I,AI15M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.08E-11,,,,,-14.46,0.09,,,,,
949,3SGB,E:I,AI15N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.54E-11,,,,,-14.46,-0.09,,,,,
950,3SGB,E:I,AI15P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.55E-11,,,,,-14.46,0.55,,,,,
951,3SGB,E:I,AI15Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.70E-11,,,,,-14.46,0.42,,,,,
952,3SGB,E:I,AI15R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-10,,,,,-14.46,2.01,,,,,
953,3SGB,E:I,AI15S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-11,,,,,-14.46,0.9,,,,,
954,3SGB,E:I,AI15T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.13E-11,,,,,-14.46,0.33,,,,,
955,3SGB,E:I,AI15V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-12,,,,,-14.46,-0.77,,,,,
956,3SGB,E:I,AI15W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.30E-12,,,,,-14.46,-1.53,,,,,
957,3SGB,E:I,AI15Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.11E-12,,,,,-14.46,-1.62,,,,,
958,3SGB,E:I,EI19A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.00E-10,,,,,-14.46,1.01,,,,,
959,3SGB,E:I,EI19C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.30E-10,,,,,-14.46,1.16,,,,,
960,3SGB,E:I,EI19D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.55E-11,,,,,-14.46,0.55,,,,,
961,3SGB,E:I,EI19F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-10,,,,,-14.46,1.92,,,,,
962,3SGB,E:I,EI19G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-10,,,,,-14.46,2.08,,,,,
963,3SGB,E:I,EI19H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.35E-11,,,,,-14.46,0.52,,,,,
964,3SGB,E:I,EI19I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-12,,,,,-14.46,-0.61,,,,,
965,3SGB,E:I,EI19K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.38E-11,,,,,-14.46,0.17,,,,,
966,3SGB,E:I,EI19L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-11,,,,,-14.46,0.77,,,,,
967,3SGB,E:I,EI19M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.30E-11,,,,,-14.46,-0.19,,,,,
968,3SGB,E:I,EI19N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.15E-10,,,,,-14.46,1.09,,,,,
969,3SGB,E:I,EI19P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-10,,,,,-14.46,2.24,,,,,
970,3SGB,E:I,EI19Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.44E-11,,,,,-14.46,0.18,,,,,
971,3SGB,E:I,EI19R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.54E-10,,,,,-14.46,1.26,,,,,
972,3SGB,E:I,EI19S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-10,,,,,-14.46,1.92,,,,,
973,3SGB,E:I,EI19T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-10,,,,,-14.46,2.11,,,,,
974,3SGB,E:I,EI19V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.22E-11,,,,,-14.46,0.13,,,,,
975,3SGB,E:I,EI19W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.44E-10,,,,,-14.46,1.53,,,,,
976,3SGB,E:I,EI19Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-11,,,,,-14.46,0.77,,,,,
977,3SGB,E:I,GI32A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.41E-10,,,,,-14.46,1.21,,,,,
978,3SGB,E:I,GI32C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.47E-09,,,,,-14.46,2.58,,,,,
979,3SGB,E:I,GI32D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.78E-10,,,,,-14.46,1.6,,,,,
980,3SGB,E:I,GI32E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.00E-10,,,,,-14.46,1.95,,,,,
981,3SGB,E:I,GI32F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.94E-09,,,,,-14.46,2.98,,,,,
982,3SGB,E:I,GI32H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.82E-09,,,,,-14.46,2.7,,,,,
983,3SGB,E:I,GI32I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.79E-08,,,,,-14.46,4.04,,,,,
984,3SGB,E:I,GI32K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.27E-09,,,,,-14.46,2.49,,,,,
985,3SGB,E:I,GI32L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.59E-09,,,,,-14.46,2.62,,,,,
986,3SGB,E:I,GI32M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.04E-09,,,,,-14.46,2.77,,,,,
987,3SGB,E:I,GI32N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-10,,,,,-14.46,2.24,,,,,
988,3SGB,E:I,GI32P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.14E-10,,,,,-14.46,1.08,,,,,
989,3SGB,E:I,GI32Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.63E-09,,,,,-14.46,2.92,,,,,
990,3SGB,E:I,GI32R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-09,,,,,-14.46,3.46,,,,,
991,3SGB,E:I,GI32S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.70E-10,,,,,-14.46,1.59,,,,,
992,3SGB,E:I,GI32T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.03E-09,,,,,-14.46,3,,,,,
993,3SGB,E:I,GI32V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.79E-09,,,,,-14.46,2.69,,,,,
994,3SGB,E:I,GI32W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.32E-08,,,,,-14.46,3.86,,,,,
995,3SGB,E:I,GI32Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.33E-09,,,,,-14.46,3.05,,,,,
996,3SGB,E:I,KI13A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.33E-13,,,,,-14.46,-2.54,,,,,
997,3SGB,E:I,KI13C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-12,,,,,-14.46,-0.58,,,,,
998,3SGB,E:I,KI13D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-12,,,,,-14.46,-0.61,,,,,
999,3SGB,E:I,KI13E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.89E-11,,,,,-14.46,0.03,,,,,
1000,3SGB,E:I,KI13F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.26E-12,,,,,-14.46,-0.72,,,,,
1001,3SGB,E:I,KI13G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.26E-12,,,,,-14.46,-0.72,,,,,
1002,3SGB,E:I,KI13H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,9.09E-12,,,,,-14.46,-0.4,,,,,
1003,3SGB,E:I,KI13I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.85E-12,,,,,-14.46,-1.33,,,,,
1004,3SGB,E:I,KI13L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-13,,,,,-14.46,-1.79,,,,,
1005,3SGB,E:I,KI13M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.50E-12,,,,,-14.46,-1.15,,,,,
1006,3SGB,E:I,KI13N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.88E-12,,,,,-14.46,-0.65,,,,,
1007,3SGB,E:I,KI13P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.79E-11,,,,,-14.46,0,,,,,
1008,3SGB,E:I,KI13Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-12,,,,,-14.46,-0.61,,,,,
1009,3SGB,E:I,KI13R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-12,,,,,-14.46,-0.68,,,,,
1010,3SGB,E:I,KI13S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.27E-13,,,,,-14.46,-2.55,,,,,
1011,3SGB,E:I,KI13T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-13,,,,,-14.46,-1.92,,,,,
1012,3SGB,E:I,KI13V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.57E-12,,,,,-14.46,-0.94,,,,,
1013,3SGB,E:I,KI13W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.75E-11,,,,,-14.46,-0.01,,,,,
1014,3SGB,E:I,KI13Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-12,,,,,-14.46,-0.58,,,,,
1015,3SGB,E:I,NI36A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.13E-11,,,,,-14.46,0.33,,,,,
1016,3SGB,E:I,NI36C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.23E-11,,,,,-14.46,0.34,,,,,
1017,3SGB,E:I,NI36D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-11,,,,,-14.46,0.9,,,,,
1018,3SGB,E:I,NI36E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,9.09E-11,,,,,-14.46,0.95,,,,,
1019,3SGB,E:I,NI36F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.41E-11,,,,,-14.46,-0.14,,,,,
1020,3SGB,E:I,NI36G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.03E-11,,,,,-14.46,0.31,,,,,
1021,3SGB,E:I,NI36H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.45E-11,,,,,-14.46,-0.12,,,,,
1022,3SGB,E:I,NI36I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.50E-11,,,,,-14.46,0.2,,,,,
1023,3SGB,E:I,NI36K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-11,,,,,-14.46,0.57,,,,,
1024,3SGB,E:I,NI36L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-11,,,,,-14.46,0.73,,,,,
1025,3SGB,E:I,NI36M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.27E-11,,,,,-14.46,0.14,,,,,
1026,3SGB,E:I,NI36P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-11,,,,,-14.46,0.57,,,,,
1027,3SGB,E:I,NI36Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.70E-11,,,,,-14.46,0.24,,,,,
1028,3SGB,E:I,NI36R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-11,,,,,-14.46,0.57,,,,,
1029,3SGB,E:I,NI36S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.57E-11,,,,,-14.46,0.4,,,,,
1030,3SGB,E:I,NI36T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.82E-11,,,,,-14.46,0.01,,,,,
1031,3SGB,E:I,NI36V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.19E-11,,,,,-14.46,-0.24,,,,,
1032,3SGB,E:I,NI36W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.35E-11,,,,,-14.46,0.52,,,,,
1033,3SGB,E:I,NI36Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.49E-11,,,,,-14.46,-0.11,,,,,
1034,3SGB,E:I,PI14A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.30E-11,,,,,-14.46,-0.19,,,,,
1035,3SGB,E:I,PI14C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.03E-11,,,,,-14.46,-0.32,,,,,
1036,3SGB,E:I,PI14D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.13E-12,,,,,-14.46,-1.02,,,,,
1037,3SGB,E:I,PI14E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.25E-12,,,,,-14.46,-0.61,,,,,
1038,3SGB,E:I,PI14F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.00E-11,,,,,-14.46,-0.34,,,,,
1039,3SGB,E:I,PI14G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.96E-11,,,,,-14.46,0.05,,,,,
1040,3SGB,E:I,PI14H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.86E-11,,,,,-14.46,0.27,,,,,
1041,3SGB,E:I,PI14I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.72E-11,,,,,-14.46,-0.02,,,,,
1042,3SGB,E:I,PI14K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.17E-11,,,,,-14.46,0.11,,,,,
1043,3SGB,E:I,PI14L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.41E-11,,,,,-14.46,-0.14,,,,,
1044,3SGB,E:I,PI14M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-12,,,,,-14.46,-0.49,,,,,
1045,3SGB,E:I,PI14N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.45E-11,,,,,-14.46,-0.12,,,,,
1046,3SGB,E:I,PI14Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.05E-11,,,,,-14.46,-0.31,,,,,
1047,3SGB,E:I,PI14R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.03E-11,,,,,-14.46,0.31,,,,,
1048,3SGB,E:I,PI14S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.00E-11,,,,,-14.46,0.06,,,,,
1049,3SGB,E:I,PI14T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.49E-11,,,,,-14.46,-0.11,,,,,
1050,3SGB,E:I,PI14V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.06E-11,,,,,-14.46,-0.31,,,,,
1051,3SGB,E:I,PI14W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-12,,,,,-14.46,-0.49,,,,,
1052,3SGB,E:I,PI14Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,9.09E-12,,,,,-14.46,-0.4,,,,,
1053,3SGB,E:I,RI21A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.96E-11,,,,,-14.46,0.05,,,,,
1054,3SGB,E:I,RI21C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.55E-11,,,,,-14.46,0.55,,,,,
1055,3SGB,E:I,RI21D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.26E-11,,,,,-14.46,0.63,,,,,
1056,3SGB,E:I,RI21E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-11,,,,,-14.46,0.66,,,,,
1057,3SGB,E:I,RI21F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.63E-11,,,,,-14.46,0.22,,,,,
1058,3SGB,E:I,RI21G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.16E-10,,,,,-14.46,1.09,,,,,
1059,3SGB,E:I,RI21H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.85E-11,,,,,-14.46,0.45,,,,,
1060,3SGB,E:I,RI21I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.70E-11,,,,,-14.46,0.24,,,,,
1061,3SGB,E:I,RI21K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.12E-11,,,,,-14.46,-0.27,,,,,
1062,3SGB,E:I,RI21L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.63E-11,,,,,-14.46,0.22,,,,,
1063,3SGB,E:I,RI21M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.22E-11,,,,,-14.46,0.13,,,,,
1064,3SGB,E:I,RI21N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.13E-11,,,,,-14.46,0.33,,,,,
1065,3SGB,E:I,RI21P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-06,,,,,-14.46,7.58,,,,,
1066,3SGB,E:I,RI21Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.92E-11,,,,,-14.46,0.04,,,,,
1067,3SGB,E:I,RI21S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.86E-11,,,,,-14.46,0.27,,,,,
1068,3SGB,E:I,RI21T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.85E-11,,,,,-14.46,0.45,,,,,
1069,3SGB,E:I,RI21V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.72E-11,,,,,-14.46,-0.02,,,,,
1070,3SGB,E:I,RI21W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.03E-11,,,,,-14.46,0.31,,,,,
1071,3SGB,E:I,RI21Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.94E-11,,,,,-14.46,0.29,,,,,
1072,3SGB,E:I,TI17A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-09,,,,,-14.46,3.54,,,,,
1073,3SGB,E:I,TI17C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.50E-09,,,,,-14.46,2.89,,,,,
1074,3SGB,E:I,TI17D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-08,,,,,-14.46,4.89,,,,,
1075,3SGB,E:I,TI17E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.88E-08,,,,,-14.46,4.73,,,,,
1076,3SGB,E:I,TI17F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,8.33E-09,,,,,-14.46,3.59,,,,,
1077,3SGB,E:I,TI17G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.22E-07,,,,,-14.46,5.51,,,,,
1078,3SGB,E:I,TI17H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-09,,,,,-14.46,3.46,,,,,
1079,3SGB,E:I,TI17I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.45E-10,,,,,-14.46,1.73,,,,,
1080,3SGB,E:I,TI17K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-10,,,,,-14.46,2.01,,,,,
1081,3SGB,E:I,TI17L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.16E-09,,,,,-14.46,2.44,,,,,
1082,3SGB,E:I,TI17M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-10,,,,,-14.46,2.01,,,,,
1083,3SGB,E:I,TI17N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.35E-09,,,,,-14.46,3.21,,,,,
1084,3SGB,E:I,TI17P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.85E-09,,,,,-14.46,3.14,,,,,
1085,3SGB,E:I,TI17Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.56E-09,,,,,-14.46,2.9,,,,,
1086,3SGB,E:I,TI17R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.00E-10,,,,,-14.46,1.95,,,,,
1087,3SGB,E:I,TI17S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.15E-09,,,,,-14.46,2.43,,,,,
1088,3SGB,E:I,TI17V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.32E-09,,,,,-14.46,2.51,,,,,
1089,3SGB,E:I,TI17W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.03E-09,,,,,-14.46,3,,,,,
1090,3SGB,E:I,TI17Y,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.26E-09,,,,,-14.46,3.32,,,,,
1091,3SGB,E:I,YI20A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.76E-10,,,,,-14.46,1.92,,,,,
1092,3SGB,E:I,YI20C,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.13E-10,,,,,-14.46,1.67,,,,,
1093,3SGB,E:I,YI20D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.44E-09,,,,,-14.46,2.87,,,,,
1094,3SGB,E:I,YI20E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-10,,,,,-14.46,2.01,,,,,
1095,3SGB,E:I,YI20F,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.38E-11,,,,,-14.46,0.17,,,,,
1096,3SGB,E:I,YI20G,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.17E-09,,,,,-14.46,2.8,,,,,
1097,3SGB,E:I,YI20H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.23E-10,,,,,-14.46,1.69,,,,,
1098,3SGB,E:I,YI20I,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.69E-09,,,,,-14.46,3.54,,,,,
1099,3SGB,E:I,YI20K,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.88E-09,,,,,-14.46,3.39,,,,,
1100,3SGB,E:I,YI20L,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,2.56E-10,,,,,-14.46,1.55,,,,,
1101,3SGB,E:I,YI20M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.26E-10,,,,,-14.46,1.98,,,,,
1102,3SGB,E:I,YI20N,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.70E-09,,,,,-14.46,3.11,,,,,
1103,3SGB,E:I,YI20P,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,7.14E-07,,,,,-14.46,6.19,,,,,
1104,3SGB,E:I,YI20Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,4.55E-09,,,,,-14.46,3.24,,,,,
1105,3SGB,E:I,YI20R,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,1.89E-09,,,,,-14.46,2.72,,,,,
1106,3SGB,E:I,YI20S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,5.56E-10,,,,,-14.46,2.01,,,,,
1107,3SGB,E:I,YI20T,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,6.67E-08,,,,,-14.46,4.8,,,,,
1108,3SGB,E:I,YI20V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.12E-08,,,,,-14.46,4.36,,,,,
1109,3SGB,E:I,YI20W,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"11171964 (data previously accessible online <a href=""http://www.chem.purdue.edu/LASKOWSKI/webp1allCC.html"">here</a>, please check <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> Notes for details on the data source)",1.79E-11,3.45E-11,,,,,-14.46,0.38,,,,,
1110,1JDH,A:B,DB16A,Human catenin beta-1/beta-catenin,Human T-cell-specific transcription factor 4 (TCF-4),,Isothermal Titration Calorimetry,"50mM Na2PO4, 100mM NaCl",298,7.4,PINT,"11237626 (Table 3, p. 1185)",2.00E-09,2.94E-07,,,,,-11.86,2.96,,,,,
1111,1JDH,A:B,EB17A,Human catenin beta-1/beta-catenin,Human T-cell-specific transcription factor 4 (TCF-4),,Isothermal Titration Calorimetry,"50mM Na2PO4, 100mM NaCl",298,7.4,PINT,"11237626 (Table 3, p. 1185)",2.41E-09,1.05E-08,,,,,-11.75,0.87,,,,,
1112,1JDH,A:B,LB48A,Human catenin beta-1/beta-catenin,Human T-cell-specific transcription factor 4 (TCF-4),,Isothermal Titration Calorimetry,"50mM Na2PO4, 100mM NaCl",298,7.4,PINT,"11237626 (Table 3, p. 1185)",2.50E-09,1.82E-08,,,,,-11.73,1.18,,,,,
1113,1JDH,A:B,"DB16A,EB17A",Human catenin beta-1/beta-catenin,Human T-cell-specific transcription factor 4 (TCF-4),,Isothermal Titration Calorimetry,"50mM Na2PO4, 100mM NaCl",298,7.4,PINT,"11237626 (Table 3, p. 1185)",3.57E-09,1.10E-06,,,,,-11.52,3.39,,,,,
1114,,,E*64A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,1.34E-07,2.80E+04,7.11E+03,1.30E-03,9.50E-04,-10,0.63,,,,,mutation in the receptor
1115,,,F*85A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,7.23E-07,2.80E+04,4.98E+03,1.30E-03,3.60E-03,-10,1.63,,,,,mutation in the receptor
1116,,,I*62A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,8.33E-07,2.80E+04,4.09E+03,1.30E-03,3.41E-03,-10,1.71,,,,,mutation in the receptor
1117,,,T*72A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,1.68E-07,2.80E+04,7.11E+03,1.30E-03,1.20E-03,-10,0.76,,,,,mutation in the receptor
1118,,,T*64A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,1.88E-07,2.80E+04,5.88E+03,1.30E-03,1.10E-03,-10,0.83,,,,,mutation in the receptor
1119,,,Y*80A,Mouse bone morphogenetic protein receptor type-1A (BMPR-1A),Human recombinant bone morphogenetic protein 4 (BMP-4),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.05% Tween20",298,7.4,ASEdb,"11241215 (Table I, p. 403)",4.64E-08,6.85E-08,2.80E+04,2.18E+04,1.30E-03,1.49E-03,-10,0.23,,,,,mutation in the receptor
1120,,,F*93A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,5.00E-09,9.00E+04,3.00E+04,5.00E-06,9.00E-05,-13.94,2.62,,,,,mutation in hIL-18BP
1121,,,I*95A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,3.00E-10,9.00E+04,7.70E+04,5.00E-06,2.00E-05,-13.94,0.95,,,,,mutation in hIL-18BP
1122,,,Y*97A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,4.50E-08,9.00E+04,4.00E+04,5.00E-06,1.90E-03,-13.94,3.92,,,,,mutation in hIL-18BP
1123,,,L*99A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,7.00E-10,9.00E+04,8.00E+04,5.00E-06,5.90E-05,-13.94,1.45,,,,,mutation in hIL-18BP
1124,,,F*104A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.10E-08,9.00E+04,1.00E+05,5.00E-06,9.00E-04,-13.94,3.09,,,,,mutation in hIL-18BP
1125,,,E*106A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,9.00E-10,9.00E+04,1.10E+05,5.00E-06,9.10E-05,-13.94,1.6,,,,,mutation in hIL-18BP
1126,,,H*107A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.70E-10,9.00E+04,1.20E+05,5.00E-06,1.90E-05,-13.94,0.62,,,,,mutation in hIL-18BP
1127,,,L*108A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,5.00E-10,9.00E+04,7.00E+04,5.00E-06,3.40E-05,-13.94,1.26,,,,,mutation in hIL-18BP
1128,,,L*112A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.40E-10,9.00E+04,6.00E+04,5.00E-06,9.00E-06,-13.94,0.5,,,,,mutation in hIL-18BP
1129,,,E*114A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.20E-09,9.00E+04,5.00E+04,5.00E-06,5.00E-05,-13.94,1.77,,,,,mutation in hIL-18BP
1130,,,E*114D,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.20E-09,9.00E+04,4.00E+04,5.00E-06,3.80E-05,-13.94,1.77,,,,,mutation in hIL-18BP
1131,,,E*114K,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,6.00E-09,9.00E+04,5.00E+04,5.00E-06,1.72E-04,-13.94,2.73,,,,,mutation in hIL-18BP
1132,,,E*114Q,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.00E-08,9.00E+04,3.00E+04,5.00E-06,2.00E-04,-13.94,3.03,,,,,mutation in hIL-18BP
1133,,,R*119A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,2.00E-10,9.00E+04,7.00E+04,5.00E-06,1.00E-05,-13.94,0.71,,,,,mutation in hIL-18BP
1134,,,R*121A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,4.00E-11,9.00E+04,7.00E+04,5.00E-06,4.00E-06,-13.94,-0.24,,,,,mutation in hIL-18BP
1135,,,K*130A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.00E-10,9.00E+04,5.00E+04,5.00E-06,5.00E-06,-13.94,0.3,,,,,mutation in hIL-18BP
1136,,,K*130T,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,9.00E-11,9.00E+04,7.00E+04,5.00E-06,5.00E-06,-13.94,0.24,,,,,mutation in hIL-18BP
1137,,,K*130R,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,1.00E-10,9.00E+04,4.50E+04,5.00E-06,4.00E-06,-13.94,0.3,,,,,mutation in hIL-18BP
1138,,,V*151A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,8.00E-11,9.00E+04,6.00E+04,5.00E-06,5.00E-06,-13.94,0.17,,,,,mutation in hIL-18BP
1139,,,P*153A,Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",6.00E-11,2.50E-10,9.00E+04,5.00E+04,5.00E-06,1.10E-05,-13.94,0.85,,,,,mutation in hIL-18BP
1140,,,"E*106A,E*114A,R*119A,K*130A",Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",6.00E-11,9.00E-07,9.00E+04,2.00E+04,5.00E-06,6.00E-03,-13.94,5.69,,,,,mutations in hIL-18BP
1141,,,"H*107A,E*114A,R*121A,K*130A",Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",6.00E-11,6.00E-09,9.00E+04,3.00E+04,5.00E-06,1.50E-04,-13.94,2.73,,,,,mutations in hIL-18BP
1142,,,"E*106A,E*114A,R*121A,K*130A",Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",6.00E-11,9.00E-08,9.00E+04,1.20E+04,5.00E-06,1.00E-03,-13.94,4.33,,,,,mutations in hIL-18BP
1143,,,"H*107A,E*114A,R*119A,K*130A",Human interleukin-18 (hIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",6.00E-11,2.00E-08,9.00E+04,3.50E+04,5.00E-06,7.00E-04,-13.94,3.44,,,,,mutations in hIL-18BP
1144,,,F*93A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.30E-09,7.96E+05,2.00E+05,1.60E+03,2.70E+04,-14.62,2.5,,,,,mutation in hIL-18BP
1145,,,I*95A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,8.00E-11,7.96E+05,7.00E+05,1.60E+03,5.00E+03,-14.62,0.85,,,,,mutation in hIL-18BP
1146,,,Y*97A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.10E-08,7.96E+05,2.30E+05,1.60E+03,2.40E+05,-14.62,3.77,,,,,mutation in hIL-18BP
1147,,,L*99A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.40E-10,7.96E+05,7.00E+05,1.60E+03,9.20E+03,-14.62,1.18,,,,,mutation in hIL-18BP
1148,,,F*104A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,4.00E-09,7.96E+05,6.00E+05,1.60E+03,2.00E+05,-14.62,3.17,,,,,mutation in hIL-18BP
1149,,,E*106A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.10E-10,7.96E+05,1.20E+06,1.60E+03,1.31E+04,-14.62,1.04,,,,,mutation in hIL-18BP
1150,,,H*107A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.90E-11,7.96E+05,1.00E+06,1.60E+03,1.90E+03,-14.62,0,,,,,mutation in hIL-18BP
1151,,,L*108A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,7.00E-11,7.96E+05,7.00E+05,1.60E+03,4.60E+03,-14.62,0.77,,,,,mutation in hIL-18BP
1152,,,L*112A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,4.00E-11,7.96E+05,5.00E+05,1.60E+03,1.90E+03,-14.62,0.44,,,,,mutation in hIL-18BP
1153,,,E*114A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.30E-10,7.96E+05,6.00E+05,1.60E+03,8.00E+03,-14.62,1.14,,,,,mutation in hIL-18BP
1154,,,E*114D,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.30E-10,7.96E+05,5.00E+05,1.60E+03,7.00E+03,-14.62,1.14,,,,,mutation in hIL-18BP
1155,,,E*114K,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.00E-09,7.96E+05,4.00E+05,1.60E+03,2.70E+04,-14.62,2.35,,,,,mutation in hIL-18BP
1156,,,E*114Q,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,8.00E-10,7.96E+05,4.20E+05,1.60E+03,3.40E+04,-14.62,2.21,,,,,mutation in hIL-18BP
1157,,,R*119A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,4.00E-11,7.96E+05,9.00E+05,1.60E+03,3.60E+03,-14.62,0.44,,,,,mutation in hIL-18BP
1158,,,R*121A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.40E-11,7.96E+05,1.10E+06,1.60E+03,1.50E+03,-14.62,-0.18,,,,,mutation in hIL-18BP
1159,,,K*130A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,2.20E-11,7.96E+05,8.00E+05,1.60E+03,1.70E+03,-14.62,0.09,,,,,mutation in hIL-18BP
1160,,,K*130T,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.60E-11,7.96E+05,8.00E+05,1.60E+03,1.10E+03,-14.62,-0.1,,,,,mutation in hIL-18BP
1161,,,K*130R,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,2.00E-11,7.96E+05,8.00E+05,1.60E+03,1.30E+03,-14.62,0.03,,,,,mutation in hIL-18BP
1162,,,V*151A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,1.10E-11,7.96E+05,8.00E+05,1.60E+03,6.00E+02,-14.62,-0.32,,,,,mutation in hIL-18BP
1163,,,P*153A,Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,ASEdb,"11278524 (Table 1, p. 17385)",1.90E-11,3.50E-11,7.96E+05,6.30E+05,1.60E+03,2.20E+03,-14.62,0.36,,,,,mutation in hIL-18BP
1164,,,"E*106A,E*114A,R*119A,K*130A",Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",1.90E-11,2.70E-08,7.96E+05,3.10E+05,1.60E+03,8.40E+05,-14.62,4.3,,,,,mutations in hIL-18BP
1165,,,"H*107A,E*114A,R*121A,K*130A",Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",1.90E-11,1.10E-10,7.96E+05,6.00E+05,1.60E+03,6.00E+03,-14.62,1.04,,,,,mutations in hIL-18BP
1166,,,"E*106A,E*114A,R*121A,K*130A",Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",1.90E-11,1.50E-09,7.96E+05,5.00E+05,1.60E+03,6.80E+04,-14.62,2.59,,,,,mutations in hIL-18BP
1167,,,"H*107A,E*114A,R*119A,K*130A",Mouse interleukin-18 (mIL-18),Human interleukin-18 binding protein (hIL-18BP),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3mM EDTA, 0.1% Tween 20",298,7.4,Literature,"11278524 (Table 1, p. 17385)",1.90E-11,5.40E-10,7.96E+05,7.00E+05,1.60E+03,3.80E+04,-14.62,1.98,,,,,mutations in hIL-18BP
1168,1F47,A:B,DA7G,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,ELISA,"10mM Na2HPO4, 1.8mM KH2PO4, 140mM NaCl, 2.7mM KCl, 0.05% Tween 20",298,7.5,SKEMPI,"11278571 (Table I, p. 11982)",1.90E-07,1.30E-06,,,,,-9.16,1.14,,,,,
1169,1F47,A:B,DA7S,Escherichia coli cell division protein/eukaryotic tubulin homolog FtsZ,Escherichia coli cell division protein ZipA,,ELISA,"10mM Na2HPO4, 1.8mM KH2PO4, 140mM NaCl, 2.7mM KCl, 0.05% Tween 20",298,7.5,SKEMPI,"11278571 (Table I, p. 11982)",1.90E-07,6.20E-06,,,,,-9.16,2.06,,,,,
1170,1GCQ,AB:C,AC632G,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,1.65E-04,,,,,-6.51,1.35,,,,,
1171,1GCQ,AB:C,GC611V,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,1.61E-05,,,,,-6.51,-0.03,,,,,
1172,1GCQ,AB:C,PC595A,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,6.14E-05,,,,,-6.51,0.77,,,,,
1173,1GCQ,AB:C,PC608A,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,2.06E-05,,,,,-6.51,0.12,,,,,
1174,1GCQ,AB:C,PC609A,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,1.94E-05,,,,,-6.51,0.09,,,,,
1175,1GCQ,AB:C,PC657A,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,1.55E-04,,,,,-6.51,1.32,,,,,
1176,1GCQ,AB:C,WC637Y,Human growth factor receptor-bound protein 2 (GRB2),"Mouse proto-oncogene Vav1, SH3 domain",,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% (v/v) polysorbate 20, 2.5mM 2-mercaptoethanol",298,7.4,SKEMPI,"11406576 (Table III, p. 3003)",1.68E-05,6.30E-04,,,,,-6.51,2.15,,,,,
1177,1F5R,A:I,KA156Q,Rattus norvegicus anionic trypsin-2,Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"100mM NaCl, 10mM CaCl2, and 50mM Hepes",298,8,SKEMPI,"11420435 (Table 1, p. 1334)",6.50E-05,9.00E-06,,,,,-5.71,-1.17,,,,,
1178,1FY8,E:I,DE194N,Rattus norvegicus anionic trypsin-2,Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"100mM NaCl, 10mM CaCl2, and 50mM Hepes",298,8,SKEMPI,"11420435 (Table 1, p. 1334)",9.00E-06,1.20E-05,,,,,-6.88,0.17,,,,,
1179,1FY8,E:I,QE156K,Rattus norvegicus anionic trypsin-2,Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"100mM NaCl, 10mM CaCl2, and 50mM Hepes",298,8,SKEMPI,"11420435 (Table 1, p. 1334)",9.00E-06,6.50E-05,,,,,-6.88,1.17,,,,,
1180,,,"C*17S,C*20S",Enterococcus hirae copper chaperone (CopZ),Enterococcus hirae probable copper-importing P-type ATPase A (CopA),OE,Surface Plasmon Resonance,"50mM NaP, 2% acetonitrile, 0.05% dodecylmaltoside",293,7.4,PINT,"11594769 (Table 1, p. 175)",5.80E-06,3.90E-06,,,,,-7.02,-0.23,,,,,double mutation in CopA
1181,,,"C*17S,C*20S",Enterococcus hirae copper chaperone (CopZ),Enterococcus hirae probable copper-importing P-type ATPase A (CopA),OE,Surface Plasmon Resonance,"50mM NaP, 2% acetonitrile, 0.05% dodecylmaltoside, 10&micro;M copper(I)acetonitrile",293,7.4,PINT,"11594769 (Table 1, p. 175)",3.60E-07,3.70E-06,,,,,-8.64,1.36,,,,,double mutation in CopA
1182,,,"C*17S,C*20S",Enterococcus hirae copper chaperone (CopZ),Enterococcus hirae probable copper-importing P-type ATPase A (CopA),OE,Surface Plasmon Resonance,"50mM NaP, 2% acetonitrile, 0.05% dodecylmaltoside, 100&micro;M copper(I)acetonitrile",293,7.4,PINT,"11594769 (Table 1, p. 175)",7.90E-07,5.50E-06,,,,,-8.18,1.13,,,,,double mutation in CopA
1183,1IAR,A:B,YB13A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.01E-06,,,,,-13.4,5.22,,,,,
1184,1IAR,A:B,YB13F,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,3.80E-09,,,,,-13.4,1.91,,,,,
1185,1IAR,A:B,MB14A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.00E-10,,,,,-13.4,0.17,,,,,
1186,1IAR,A:B,SB15A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.60E-10,,,,,-13.4,0.04,,,,,
1187,1IAR,A:B,LB39A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.00E-10,1.60E-08,,,,,-13.64,3.01,,,,,
1188,1IAR,A:B,FB41A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,6.80E-09,,,,,-13.4,2.26,,,,,
1189,1IAR,A:B,LB42A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.50E-10,,,,,-13.4,0,,,,,
1190,1IAR,A:B,LB43A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.60E-10,,,,,-13.4,0.33,,,,,
1191,1IAR,A:B,DB66A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,5.10E-10,,,,,-13.4,0.72,,,,,
1192,1IAR,A:B,DB67A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,8.00E-09,,,,,-13.4,2.35,,,,,
1193,1IAR,A:B,VB68A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,6.20E-10,,,,,-13.4,0.84,,,,,
1194,1IAR,A:B,VB69A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,5.20E-09,,,,,-13.4,2.1,,,,,
1195,1IAR,A:B,SB70A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.00E-10,,,,,-13.4,-0.24,,,,,
1196,1IAR,A:B,DB72A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.30E-07,,,,,-13.4,4.34,,,,,
1197,1IAR,A:B,DB72N,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,3.30E-07,,,,,-13.4,4.56,,,,,
1198,1IAR,A:B,NB73A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.40E-10,,,,,-13.4,0.28,,,,,
1199,1IAR,A:B,YB74A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.00E-10,1.50E-08,,,,,-13.64,2.97,,,,,
1200,1IAR,A:B,KB91A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,3.70E-10,,,,,-13.4,0.53,,,,,
1201,1IAR,A:B,PB92A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.70E-09,,,,,-13.4,1.44,,,,,
1202,1IAR,A:B,SB93A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.10E-10,,,,,-13.4,-0.18,,,,,
1203,1IAR,A:B,EB94A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.50E-10,,,,,-13.4,0,,,,,
1204,1IAR,A:B,DB125A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,5.80E-10,,,,,-13.4,0.8,,,,,
1205,1IAR,A:B,NB126A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,4.70E-10,,,,,-13.4,0.68,,,,,
1206,1IAR,A:B,YB127A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,5.80E-09,,,,,-13.4,2.16,,,,,
1207,1IAR,A:B,YB127F,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,1.10E-10,,,,,-13.4,-0.18,,,,,
1208,1IAR,A:B,LB128A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,9.70E-10,,,,,-13.4,1.11,,,,,
1209,1IAR,A:B,YB129A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.40E-10,,,,,-13.4,0.28,,,,,
1210,1IAR,A:B,YB183A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.00E-10,7.50E-08,,,,,-13.64,3.92,,,,,
1211,1IAR,A:B,YB183F,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.00E-10,3.10E-08,,,,,-13.64,3.4,,,,,
1212,1IAR,A:B,RA53A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,2.70E-09,,,,,-13.4,1.71,,,,,
1213,1IAR,A:B,YA56A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 1, p. 400)",1.50E-10,7.20E-10,,,,,-13.4,0.93,,,,,
1214,1IAR,A:B,"YB13F,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,3.24E-07,,,,,-13.4,4.55,,,,,
1215,1IAR,A:B,"YB13F,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,1.78E-07,,,,,-13.4,4.19,,,,,
1216,1IAR,A:B,"YB13F,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,3.93E-07,,,,,-13.4,4.66,,,,,
1217,1IAR,A:B,"YB13F,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,2.55E-07,,,,,-13.4,4.4,,,,,
1218,1IAR,A:B,"YB13F,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,1.00E-05,,,,,-13.4,6.58,,,,,
1219,1IAR,A:B,"YB13F,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,1.18E-07,,,,,-13.4,3.95,,,,,
1220,1IAR,A:B,"YB13F,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,4.23E-07,,,,,-13.4,4.7,,,,,
1221,1IAR,A:B,"DB72N,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.00E-08,8.41E-06,,,,,-10.91,3.99,,,,,
1222,1IAR,A:B,"DB72N,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,5.34E-06,,,,,-13.4,6.21,,,,,
1223,1IAR,A:B,"DB72N,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,5.59E-06,,,,,-13.4,6.23,,,,,
1224,1IAR,A:B,"DB72N,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.00E-08,2.54E-06,,,,,-10.91,3.28,,,,,
1225,1IAR,A:B,"DB72N,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.00E-07,3.03E-05,,,,,-9.54,3.38,,,,,
1226,1IAR,A:B,"DB72N,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 2, p. 402)",1.50E-10,6.76E-05,,,,,-13.4,7.71,,,,,
1227,1IAR,A:B,"IA5A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.40E-08,,,,,-13.64,2.93,,,,,
1228,1IAR,A:B,"EA9Q,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.30E-07,,,,,-13.4,4.34,,,,,
1229,1IAR,A:B,"TA13A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,2.80E-08,,,,,-13.64,3.34,,,,,
1230,1IAR,A:B,"NA89A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,3.80E-08,,,,,-13.64,3.52,,,,,
1231,1IAR,A:B,"RA53A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,4.80E-08,,,,,-13.64,3.66,,,,,
1232,1IAR,A:B,"YA56A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.50E-08,,,,,-13.64,2.97,,,,,
1233,1IAR,A:B,"RA88A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,5.18E-06,,,,,-13.4,6.19,,,,,
1234,1IAR,A:B,"WA91A,YB13F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.50E-08,,,,,-13.64,2.97,,,,,
1235,1IAR,A:B,"IA5A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,8.10E-08,,,,,-13.64,3.97,,,,,
1236,1IAR,A:B,"EA9Q,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,7.34E-07,,,,,-13.4,5.03,,,,,
1237,1IAR,A:B,"TA13A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.00E-08,,,,,-13.4,2.49,,,,,
1238,1IAR,A:B,"NA89A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,8.10E-08,,,,,-13.64,3.97,,,,,
1239,1IAR,A:B,"RA53A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.12E-07,,,,,-13.4,4.3,,,,,
1240,1IAR,A:B,"YA56A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,5.10E-08,,,,,-13.64,3.69,,,,,
1241,1IAR,A:B,"RA88A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.45E-05,,,,,-13.4,6.8,,,,,
1242,1IAR,A:B,"WA91A,YB127A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.90E-08,,,,,-13.64,3.11,,,,,
1243,1IAR,A:B,"IA5A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,3.35E-07,,,,,-13.4,4.57,,,,,
1244,1IAR,A:B,"EA9Q,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.73E-06,,,,,-13.4,5.54,,,,,
1245,1IAR,A:B,"TA13A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,9.00E-08,,,,,-13.64,4.03,,,,,
1246,1IAR,A:B,"NA89A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,3.62E-07,,,,,-13.4,4.61,,,,,
1247,1IAR,A:B,"RA53A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.23E-06,,,,,-13.4,5.34,,,,,
1248,1IAR,A:B,"YA56A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,6.58E-07,,,,,-13.4,4.97,,,,,
1249,1IAR,A:B,"RA88A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,4.62E-05,,,,,-13.4,7.48,,,,,
1250,1IAR,A:B,"WA91A,YB183A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,3.19E-07,,,,,-13.4,4.54,,,,,
1251,1IAR,A:B,"IA5A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,9.50E-08,,,,,-13.64,4.06,,,,,
1252,1IAR,A:B,"EA9Q,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,6.92E-07,,,,,-13.4,5,,,,,
1253,1IAR,A:B,"TA13A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,4.60E-08,,,,,-13.64,3.63,,,,,
1254,1IAR,A:B,"NA89A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,7.60E-08,,,,,-13.64,3.93,,,,,
1255,1IAR,A:B,"RA53A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,4.06E-07,,,,,-13.4,4.68,,,,,
1256,1IAR,A:B,"YA56A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.52E-07,,,,,-13.4,4.1,,,,,
1257,1IAR,A:B,"RA88A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,3.03E-05,,,,,-13.4,7.23,,,,,
1258,1IAR,A:B,"WA91A,YB183F",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,8.80E-08,,,,,-13.64,4.01,,,,,
1259,1IAR,A:B,"IA5A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.76E-07,,,,,-13.4,4.45,,,,,
1260,1IAR,A:B,"EA9Q,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.06E-06,,,,,-13.4,5.64,,,,,
1261,1IAR,A:B,"TA13A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.08E-07,,,,,-13.4,3.9,,,,,
1262,1IAR,A:B,"NA89A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,6.20E-07,,,,,-13.4,4.93,,,,,
1263,1IAR,A:B,"RA53A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.15E-07,,,,,-13.4,3.93,,,,,
1264,1IAR,A:B,"YA56A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,5.00E-08,,,,,-13.64,3.68,,,,,
1265,1IAR,A:B,"RA88A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.01E-06,,,,,-13.4,5.63,,,,,
1266,1IAR,A:B,"WA91A,LB39A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.00E-07,,,,,-13.64,4.09,,,,,
1267,1IAR,A:B,"IA5A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.35E-07,,,,,-13.4,4.36,,,,,
1268,1IAR,A:B,"EA9Q,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.20E-06,,,,,-13.4,5.32,,,,,
1269,1IAR,A:B,"TA13A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,8.20E-08,,,,,-13.64,3.97,,,,,
1270,1IAR,A:B,"NA89A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,5.50E-07,,,,,-13.4,4.86,,,,,
1271,1IAR,A:B,"RA53A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.70E-08,,,,,-13.64,3.04,,,,,
1272,1IAR,A:B,"YA56A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,1.50E-08,,,,,-13.64,2.97,,,,,
1273,1IAR,A:B,"RA88A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.32E-06,,,,,-13.4,5.38,,,,,
1274,1IAR,A:B,"WA91A,FB41A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,2.10E-08,,,,,-13.64,3.17,,,,,
1275,1IAR,A:B,"IA5A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.30E-07,,,,,-13.4,4.01,,,,,
1276,1IAR,A:B,"EA9Q,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.05E-06,,,,,-13.4,5.24,,,,,
1277,1IAR,A:B,"TA13A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,3.80E-08,,,,,-13.64,3.52,,,,,
1278,1IAR,A:B,"NA89A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,4.90E-08,,,,,-13.64,3.67,,,,,
1279,1IAR,A:B,"RA53A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.78E-07,,,,,-13.4,4.19,,,,,
1280,1IAR,A:B,"YA56A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,5.10E-08,,,,,-13.64,3.69,,,,,
1281,1IAR,A:B,"RA88A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,6.82E-06,,,,,-13.4,6.35,,,,,
1282,1IAR,A:B,"WA91A,VB69A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,2.30E-08,,,,,-13.64,3.22,,,,,
1283,1IAR,A:B,"IA5A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,7.30E-06,,,,,-13.4,6.39,,,,,
1284,1IAR,A:B,"TA13A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.96E-06,,,,,-13.4,5.86,,,,,
1285,1IAR,A:B,"NA89A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,4.08E-06,,,,,-13.4,6.05,,,,,
1286,1IAR,A:B,"RA53A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.13E-06,,,,,-13.4,5.29,,,,,
1287,1IAR,A:B,"YA56A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,8.01E-07,,,,,-13.4,5.08,,,,,
1288,1IAR,A:B,"RA88A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.10E-06,,,,,-13.4,5.27,,,,,
1289,1IAR,A:B,"WA91A,DB72A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.68E-06,,,,,-13.4,5.52,,,,,
1290,1IAR,A:B,"IA5A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,6.65E-06,,,,,-13.4,6.34,,,,,
1291,1IAR,A:B,"TA13A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,3.45E-06,,,,,-13.4,5.95,,,,,
1292,1IAR,A:B,"NA89A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,8.67E-06,,,,,-13.4,6.49,,,,,
1293,1IAR,A:B,"RA53A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.51E-06,,,,,-13.4,5.76,,,,,
1294,1IAR,A:B,"YA56A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.00E-06,,,,,-13.4,5.21,,,,,
1295,1IAR,A:B,"RA88A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,4.60E-07,,,,,-13.4,4.75,,,,,
1296,1IAR,A:B,"WA91A,DB72N",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.98E-06,,,,,-13.4,5.62,,,,,
1297,1IAR,A:B,"IA5A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.93E-07,,,,,-13.4,4.49,,,,,
1298,1IAR,A:B,"EA9Q,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,7.15E-06,,,,,-13.4,6.38,,,,,
1299,1IAR,A:B,"TA13A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,8.50E-08,,,,,-13.64,3.99,,,,,
1300,1IAR,A:B,"NA89A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.09E-07,,,,,-13.4,3.9,,,,,
1301,1IAR,A:B,"RA53A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,2.04E-07,,,,,-13.4,4.27,,,,,
1302,1IAR,A:B,"YA56A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,7.00E-08,,,,,-13.64,3.88,,,,,
1303,1IAR,A:B,"RA88A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.50E-10,1.95E-05,,,,,-13.4,6.97,,,,,
1304,1IAR,A:B,"WA91A,DB67A",Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl",298,7.4,PINT,"11786020 (Table 3, p. 404)",1.00E-10,3.60E-08,,,,,-13.64,3.49,,,,,
1305,,,I*485A,Human fibroblast growth factor receptor substrate 2/signaling adaptor SNT-1,Human high affinity nerve growth factor receptor/neurotrophic tyrosine kinase receptor type 1 (Trk-A),,Isothermal Titration Calorimetry,"50mM Na2PO4, 200mM NaCl",298,7,PINT,"11877385 (Table I, p. 17090)",7.70E-06,2.37E-05,,,,,-6.97,0.67,,,,,
1306,,,I*485A,Human fibroblast growth factor receptor substrate 2/signaling adaptor SNT-1,Human high affinity nerve growth factor receptor/neurotrophic tyrosine kinase receptor type 1 (Trk-A),,Isothermal Titration Calorimetry,"20mM Tris-HCl, 200mM NaCl",298,8,PINT,"11877385 (Table I, p. 17090)",1.53E-05,3.44E-05,,,,,-6.57,0.48,,,,,
1307,1S1Q,A:B,DA46A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,3.24E-03,,,,,-4.29,0.95,,,,,
1308,1S1Q,A:B,FA44A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,8.89E-04,,,,,-4.29,0.2,,,,,
1309,1S1Q,A:B,FA88A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,2.35E-03,,,,,-4.29,0.76,,,,,
1310,1S1Q,A:B,NA45A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,5.08E-03,,,,,-4.29,1.21,,,,,
1311,1S1Q,A:B,VA43A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,1.97E-03,,,,,-4.29,0.66,,,,,
1312,1S1Q,A:B,WA75A,Human tumor susceptibility gene 101 protein (Tsg101),Human polyubiquitin-C,,Surface Plasmon Resonance,"20mM sodium phosphate, 150mM NaCl, 0.05% BSA, 0.01% P20",293,7.2,SKEMPI,"12006492 (Table II, p.2401)",6.35E-04,1.02E-03,,,,,-4.29,0.28,,,,,
1313,,,E*736K,Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 10 mM MgCl2, 3 mM CaCl2, 2 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",6.45E-08,5.49E-08,,,,,-9.8,-0.1,,,,,mutation in NOS-I
1314,,,"K*733V,E*736K,K*739F",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 10 mM MgCl2, 3 mM CaCl2, 2 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",6.45E-08,2.03E-08,,,,,-9.8,-0.68,,,,,mutations in NOS-I
1315,,,"K*733V,E*736K,K*739F,K*743M",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 10 mM MgCl2, 3 mM CaCl2, 2 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",6.45E-08,4.40E-09,,,,,-9.8,-1.59,,,,,mutations in NOS-I
1316,,,E*736K,Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",,1.36E-06,,,,,,,,,,,mutation in NOS-I
1317,,,"K*733V,E*736K,K*739F",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",,3.56E-07,,,,,,,,,,,mutations in NOS-I
1318,,,"K*733V,E*736K,K*739F,K*743M",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Isothermal Titration Calorimetry,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 1, p. 8601)",,1.82E-07,,,,,,,,,,,mutations in NOS-I
1319,,,E*736K,Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Fluorescence,"10 mM Hepes, 150 mM NaCl, 10 mM MgCl2, 3 mM CaCl2, 2 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 2, p. 8602)",6.15E-08,8.80E-08,,,,,-9.83,0.21,,,,,mutation in NOS-I
1320,,,"K*733V,E*736K,K*739F",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Fluorescence,"10 mM Hepes, 150 mM NaCl, 10 mM MgCl2, 3 mM CaCl2, 2 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 2, p. 8602)",6.15E-08,5.20E-08,,,,,-9.83,-0.1,,,,,mutations in NOS-I
1321,,,E*736K,Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Fluorescence,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 2, p. 8602)",,4.92E-07,,,,,,,,,,,mutation in NOS-I
1322,,,"K*733V,E*736K,K*739F",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Fluorescence,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 2, p. 8602)",,6.90E-08,,,,,,,,,,,mutations in NOS-I
1323,,,"K*733V,E*736K,K*739F,K*743M",Xenopus laevis calmodulin,"Rattus norvegicus nitric-oxide synthase, brain (NOS-1)",,Fluorescence,"10 mM Hepes, 150 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 0.005% (v/v) Tween 20",298,7.4,PINT,"12093276 (Table 2, p. 8602)",,9.00E-08,,,,,,,,,,,mutations in NOS-I
1324,1DQJ,AB:C,DB32A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,8.33E-08,,,,,-11.67,2.01,,,,,
1325,1DQJ,AB:C,"DB32A,KC97A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.85E-08,,,,,-11.67,1.12,,,,,
1326,1DQJ,AB:C,DC101A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.50E-08,,,,,-11.67,1.3,,,,,
1327,1DQJ,AB:C,KC96A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,9.09E-05,,,,,-11.67,6.16,,,,,
1328,1DQJ,AB:C,KC97A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.06E-06,,,,,-11.67,3.52,,,,,
1329,1DQJ,AB:C,LC75A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,3.23E-08,,,,,-11.67,1.45,,,,,
1330,1DQJ,AB:C,NA31A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,8.33E-08,,,,,-11.67,2.01,,,,,
1331,1DQJ,AB:C,NA32A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.78E-06,,,,,-11.67,4.09,,,,,
1332,1DQJ,AB:C,"NA32A,KC96A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,5.00E-05,,,,,-11.67,5.8,,,,,
1333,1DQJ,AB:C,NC93A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,8.33E-09,,,,,-11.67,0.65,,,,,
1334,1DQJ,AB:C,RC21A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.33E-08,,,,,-11.67,1.26,,,,,
1335,1DQJ,AB:C,SA91A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,3.12E-08,,,,,-11.67,1.43,,,,,
1336,1DQJ,AB:C,"SA91A,RC21A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,5.88E-07,,,,,-11.67,3.17,,,,,
1337,1DQJ,AB:C,"SA91A,YC20A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.16E-06,,,,,-11.67,3.57,,,,,
1338,1DQJ,AB:C,SC100A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.03E-08,,,,,-11.67,0.78,,,,,
1339,1DQJ,AB:C,TC89A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.15E-08,,,,,-11.67,0.84,,,,,
1340,1DQJ,AB:C,WB98A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.15E-05,,,,,-11.67,4.93,,,,,
1341,1DQJ,AB:C,"WB98A,KC97A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.13E-04,,,,,-11.67,6.66,,,,,
1342,1DQJ,AB:C,"WB98A,SC100A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.38E-05,,,,,-11.67,5.36,,,,,
1343,1DQJ,AB:C,"WB98A,YC20A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.56E-05,,,,,-11.67,5.11,,,,,
1344,1DQJ,AB:C,WC62A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.00E-08,,,,,-11.67,0.76,,,,,
1345,1DQJ,AB:C,WC63A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.70E-08,,,,,-11.67,1.35,,,,,
1346,1DQJ,AB:C,YA50A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.56E-07,,,,,-11.67,2.68,,,,,
1347,1DQJ,AB:C,YA96A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.89E-08,,,,,-11.67,1.14,,,,,
1348,1DQJ,AB:C,"YA96A,RC21A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.00E-06,,,,,-11.67,3.49,,,,,
1349,1DQJ,AB:C,"YA96A,SC100A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.30E-08,,,,,-11.67,0.91,,,,,
1350,1DQJ,AB:C,YB33A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,3.13E-05,,,,,-11.67,5.52,,,,,
1351,1DQJ,AB:C,YB50A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,3.13E-04,,,,,-11.67,6.89,,,,,
1352,1DQJ,AB:C,YB53A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.04E-08,,,,,-11.67,1.18,,,,,
1353,1DQJ,AB:C,"YB53A,DC101A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.78E-07,,,,,-11.67,2.73,,,,,
1354,1DQJ,AB:C,"YB53A,LC75A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.17E-08,,,,,-11.67,1.22,,,,,
1355,1DQJ,AB:C,"YB53A,WC62A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,2.44E-08,,,,,-11.67,1.29,,,,,
1356,1DQJ,AB:C,"YB53A,WC63A",Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,1.14E-07,,,,,-11.67,2.2,,,,,
1357,1DQJ,AB:C,YC20A,Mouse anti-lysozyme HyHEL-63 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI,"12515535 (Table 2, p.15)",2.78E-09,7.14E-07,,,,,-11.67,3.29,,,,,
1358,1UEA,A:B,SB68A,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,3.20E-08,,,,,-13.76,3.13,,,,,
1359,1UEA,A:B,SB68E,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.40E-08,,,,,-13.76,2.62,,,,,
1360,1UEA,A:B,SB68R,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,4.90E-08,,,,,-13.76,3.39,,,,,
1361,1UEA,A:B,SB68Y,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,3.00E-10,,,,,-13.76,0.25,,,,,
1362,1UEA,A:B,TB2L,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.30E-09,,,,,-13.76,1.15,,,,,
1363,1UEA,A:B,"TB2L,VB4S",Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,6.00E-09,,,,,-13.76,2.1,,,,,
1364,1UEA,A:B,"TB2L,VB4S,SB68A",Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.40E-08,,,,,-13.76,2.62,,,,,
1365,1UEA,A:B,TB2R,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.10E-08,,,,,-13.76,2.47,,,,,
1366,1UEA,A:B,"TB2R,VB4I",Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,4.00E-09,,,,,-13.76,1.85,,,,,
1367,1UEA,A:B,TB2S,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,2.00E-10,,,,,-13.76,0,,,,,
1368,1UEA,A:B,"TB2S,VB4A",Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.00E-10,,,,,-13.76,-0.43,,,,,
1369,1UEA,A:B,"TB2S,VB4A,SB68Y",Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,5.00E-11,,,,,-13.76,-0.85,,,,,
1370,1UEA,A:B,VB4A,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.00E-10,,,,,-13.76,-0.43,,,,,
1371,1UEA,A:B,VB4I,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,2.00E-10,,,,,-13.76,0,,,,,
1372,1UEA,A:B,VB4K,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,2.60E-09,,,,,-13.76,1.58,,,,,
1373,1UEA,A:B,VB4S,Human stromelysin-1/matrix metalloproteinase-3 (MMP-3),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",2.00E-10,1.70E-09,,,,,-13.76,1.32,,,,,
1374,2J0T,A:D,SD68A,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,5.20E-09,,,,,-13.33,1.58,,,,,
1375,2J0T,A:D,SD68E,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,3.20E-09,,,,,-13.33,1.28,,,,,
1376,2J0T,A:D,SD68R,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,1.80E-08,,,,,-13.33,2.35,,,,,
1377,2J0T,A:D,SD68Y,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,2.70E-09,,,,,-13.33,1.18,,,,,
1378,2J0T,A:D,TD2L,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,4.00E-10,,,,,-13.33,0,,,,,
1379,2J0T,A:D,"TD2L,VD4S",Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,3.00E-10,,,,,-13.33,-0.18,,,,,
1380,2J0T,A:D,"TD2L,VD4S,SD68A",Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,4.00E-09,,,,,-13.33,1.42,,,,,
1381,2J0T,A:D,TD2R,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,4.80E-09,,,,,-13.33,1.53,,,,,
1382,2J0T,A:D,"TD2R,VD4I",Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,1.00E-08,,,,,-13.33,1.98,,,,,
1383,2J0T,A:D,TD2S,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,8.00E-10,,,,,-13.33,0.43,,,,,
1384,2J0T,A:D,"TD2S,VD4A",Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,4.00E-10,,,,,-13.33,0,,,,,
1385,2J0T,A:D,"TD2S,VD4A,SD68Y",Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,1.00E-10,,,,,-13.33,-0.85,,,,,
1386,2J0T,A:D,VD4A,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,5.00E-10,,,,,-13.33,0.14,,,,,
1387,2J0T,A:D,VD4I,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,3.00E-10,,,,,-13.33,-0.18,,,,,
1388,2J0T,A:D,VD4K,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,1.10E-09,,,,,-13.33,0.62,,,,,
1389,2J0T,A:D,VD4S,Human 72 kDa type IV collagenase/matrix metalloproteinase-2 (MMP-2),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,Fluorescence,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, and 0.02% Brij 35",310,7.5,SKEMPI,"12515831 (Table II, p. 9833)",4.00E-10,4.00E-10,,,,,-13.33,0,,,,,
1390,1MQ8,A:B,"KB287C,KB294C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,1.50E-07,3.10E-03,1.15E-01,4.60E+00,1.40E-02,-3.85,-5.45,,,,,
1391,1MQ8,A:B,"EB284C,EB301C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,3.60E-07,3.10E-03,1.05E-01,4.60E+00,4.50E-02,-3.85,-4.94,,,,,
1392,1MQ8,A:B,"LB161C,FB299C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,3.00E-06,3.10E-03,1.33E-01,4.60E+00,4.30E-01,-3.85,-3.68,,,,,
1393,1MQ8,A:B,"KB160C,FB299C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,8.40E-06,3.10E-03,1.03E-01,4.60E+00,7.70E-01,-3.85,-3.07,,,,,
1394,1MQ8,A:B,"LB161C,TB300C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,9.40E-06,3.10E-03,8.90E-02,4.60E+00,7.60E-01,-3.85,-3,,,,,
1395,1MQ8,A:B,"KB160C,TB300C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,4.50E-04,3.10E-03,3.40E-03,4.60E+00,1.20E+00,-3.85,-0.71,,,,,
1396,1MQ8,A:B,"LB289C,KB294C",Human integrin &alpha;L&beta;2,Human intercellular adhesion molecule 1 (ICAM-1),,Surface Plasmon Resonance,Tris buffer with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",1.50E-03,1.60E-03,3.10E-03,2.30E-03,4.60E+00,3.60E+00,-3.85,0.04,,,,,
1397,1MQ8,A:B,"CB161L,CB299F",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,1.50E-03,1.33E+05,3.10E+03,4.30E-01,4.60E+00,-7.53,3.68,,,,,
1398,1MQ8,A:B,"CB161L,CB299F,EB284C,EB301C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,3.60E-07,1.33E+05,1.05E+05,4.30E-01,4.50E-02,-7.53,-1.26,,,,,
1399,1MQ8,A:B,"CB161L,CB299F,KB160C,TB300C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,4.50E-04,1.33E+05,3.40E+03,4.30E-01,1.20E+00,-7.53,2.97,,,,,
1400,1MQ8,A:B,"CB161L,CB299F,KB287C,KB294C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,1.50E-07,1.33E+05,1.15E+05,4.30E-01,1.40E-02,-7.53,-1.77,,,,,
1401,1MQ8,A:B,"CB161L,CB299F,LB289C,KB294C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,1.60E-03,1.33E+05,2.30E+03,4.30E-01,3.60E+00,-7.53,3.72,,,,,
1402,1MQ8,A:B,"CB161L,KB160C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,8.40E-06,1.33E+05,1.03E+05,4.30E-01,7.70E-01,-7.53,0.61,,,,,
1403,1MQ8,A:B,"CB299F,TB300C",Human intercellular adhesion molecule 1 (ICAM-1),Human integrin alpha-L (LFA-1A),,Surface Plasmon Resonance,Tris-buffered saline with 1mM MgCl2,298,,SKEMPI,"12526797 (Table 1, p. 100)",3.00E-06,9.40E-06,1.33E+05,8.90E+04,4.30E-01,7.60E-01,-7.53,0.68,,,,,
1404,1KAC,A:B,PA417S,Human adenovirus A serotype 12 fiber protein (ad12 knob),Human coxsackie virus and adenovirus receptor (CAR),RC,Fluorescence Anisotropy/Polarization,"10mM Tris-HCl, 0.1mM EDTA, 0.0125% Nonidet P-40",298,8,SKEMPI,"12716886 (Table 1, p. 26211)",2.90E-07,7.60E-08,,,,,-8.91,-0.79,,,,,
1405,1KAC,A:B,SA489Y,Human adenovirus A serotype 12 fiber protein (ad12 knob),Human coxsackie virus and adenovirus receptor (CAR),RC,Fluorescence Anisotropy/Polarization,"10mM Tris-HCl, 0.1mM EDTA, 0.0125% Nonidet P-40",298,8,SKEMPI,"12716886 (Table 1, p. 26211)",2.90E-07,3.50E-08,,,,,-8.91,-1.25,,,,,
1406,1KAC,A:B,"PA417S,SA489Y",Human adenovirus A serotype 12 fiber protein (ad12 knob),Human coxsackie virus and adenovirus receptor (CAR),RC,Fluorescence Anisotropy/Polarization,"10mM Tris-HCl, 0.1mM EDTA, 0.0125% Nonidet P-40",298,8,SKEMPI,"12716886 (Table 1, p. 26211)",2.90E-07,2.80E-08,,,,,-8.91,-1.38,,,,,
1407,,,S*408P,Human adenovirus A serotype 2 fiber protein (ad2 knob),Human coxsackie virus and adenovirus receptor (CAR),RC,Fluorescence Anisotropy/Polarization,"10mM Tris-HCl, 0.1mM EDTA, 0.0125% Nonidet P-40",298,8,SKEMPI,"12716886 (Table 1, p. 26211)",3.50E-08,8.50E-08,,,,,-10.17,0.53,,,,,mutation in ad2 knob
1408,,,Y*477S,Human adenovirus A serotype 2 fiber protein (ad2 knob),Human coxsackie virus and adenovirus receptor (CAR),RC,Fluorescence Anisotropy/Polarization,"10mM Tris-HCl, 0.1mM EDTA, 0.0125% Nonidet P-40",298,8,SKEMPI,"12716886 (Table 1, p. 26211)",3.50E-08,3.60E-06,,,,,-10.17,2.74,,,,,mutation in ad2 knob
1409,1CHO,EFG:I,"AI15R,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,2.15E-08,,,,,-15.22,4.91,,,,,
1410,1CHO,EFG:I,"AI15R,TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,3.46E-06,,,,,-15.22,7.88,,,,,
1411,1CHO,EFG:I,"AI15R,TI17K,LI18R,EI19S",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,6.86E-06,,,,,-15.22,8.28,,,,,
1412,1CHO,EFG:I,"AI15R,TI17P,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,1.67E-05,,,,,-15.22,8.8,,,,,
1413,1CHO,EFG:I,"KI13R,AI15R,TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,3.70E-06,,,,,-15.22,7.92,,,,,
1414,1CHO,EFG:I,"KI13R,PI14F,AI15R,TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,4.17E-06,,,,,-15.22,7.99,,,,,
1415,1CHO,EFG:I,"PI14S,AI15L,TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,1.08E-06,,,,,-15.22,7.2,,,,,
1416,1CHO,EFG:I,"PI14S,AI15R,TI17P,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,8.00E-06,,,,,-15.22,8.37,,,,,
1417,1CHO,EFG:I,"TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,1.45E-06,,,,,-15.22,7.37,,,,,
1418,1CHO,EFG:I,"TI17R,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",4.83E-12,9.58E-07,,,,,-15.22,7.13,,,,,
1419,1PPF,E:I,"AI15R,LI18R",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.025% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.53E-10,3.60E-05,,,,,-13.2,7.23,,,,,
1420,1R0R,E:I,"AI15R,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",2.72E-11,1.31E-05,,,,,-14.21,7.64,,,,,
1421,1R0R,E:I,"AI15R,TI17K,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",2.72E-11,1.83E-04,,,,,-14.21,9.19,,,,,
1422,1R0R,E:I,"PI14S,AI15L,TI17K,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",2.72E-11,1.05E-07,,,,,-14.21,4.82,,,,,
1423,1R0R,E:I,"TI17K,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",2.72E-11,1.95E-07,,,,,-14.21,5.19,,,,,
1424,1R0R,E:I,"TI17R,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",2.72E-11,1.60E-06,,,,,-14.21,6.42,,,,,
1425,3SGB,E:I,"AI15R,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,1.00E-07,,,,,-14.5,5.08,,,,,
1426,3SGB,E:I,"AI15R,TI17K,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,1.55E-06,,,,,-14.5,6.69,,,,,
1427,3SGB,E:I,"AI15R,TI17K,LI18R,EI19S",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,3.12E-06,,,,,-14.5,7.09,,,,,
1428,3SGB,E:I,"AI15R,TI17K,LI18R,RI21L",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,2.18E-06,,,,,-14.5,6.89,,,,,
1429,3SGB,E:I,"AI15R,TI17P,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,3.25E-05,,,,,-14.5,8.46,,,,,
1430,3SGB,E:I,"KI13R,AI15R,TI17K,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,2.09E-07,,,,,-14.5,5.52,,,,,
1431,3SGB,E:I,"KI13R,PI14F,AI15R,TI17K,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,2.66E-07,,,,,-14.5,5.66,,,,,
1432,3SGB,E:I,"PI14S,AI15L,TI17K,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,7.36E-08,,,,,-14.5,4.91,,,,,
1433,3SGB,E:I,"PI14S,AI15R,TI17P,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,1.79E-05,,,,,-14.5,8.12,,,,,
1434,3SGB,E:I,"TI17K,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,1.29E-07,,,,,-14.5,5.23,,,,,
1435,3SGB,E:I,"TI17R,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"12767228 (Tables 1 and 2, p. 6462, Table 3, p. 6463)",1.66E-11,1.95E-07,,,,,-14.5,5.48,,,,,
1436,1E50,A:B,DA66A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,7.10E-09,,,,,-9.81,-0.37,,,,,
1437,1E50,A:B,NA69A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,4.40E-08,,,,,-9.81,0.62,,,,,
1438,1E50,A:B,MA106A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,1.30E-07,,,,,-9.81,1.21,,,,,
1439,1E50,A:B,NA109A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,8.50E-07,,,,,-9.81,2.23,,,,,
1440,1E50,A:B,YA113A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,6.90E-08,,,,,-9.81,0.87,,,,,
1441,1E50,A:B,SA114A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,7.30E-08,,,,,-9.81,0.9,,,,,
1442,1E50,A:B,TA149A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,1.80E-07,,,,,-9.81,1.39,,,,,
1443,1E50,A:B,VA159A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,1.30E-08,,,,,-9.81,-0.04,,,,,
1444,1E50,A:B,TA161A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,5.60E-07,,,,,-9.81,2,,,,,
1445,1E50,A:B,RB33A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,2.80E-07,,,,,-9.81,1.63,,,,,
1446,1E50,A:B,VB58A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,1.40E-08,,,,,-9.81,0,,,,,
1447,1E50,A:B,NB63A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,6.50E-08,,,,,-9.81,0.83,,,,,
1448,1E50,A:B,SB65A,Human runt-related transcription factor 1/core-binding factor alpha (CBF-&alpha;),Human core binding factor beta (CBF-&beta;),,Electrophoretic Mobility Shift Assay,,273,,Literature,"12807883 (Table III and IV, p. 33101)",1.40E-08,1.70E-08,,,,,-9.81,0.11,,,,,
1449,1A4Y,A:B,RB33A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",3.80E-16,6.60E-16,4.00E+08,3.30E+08,1.50E-07,2.20E-07,-21.03,0.33,,,,,wild-type value for (Met-(-1)) angiogenin (chain B) derivative
1450,1A4Y,A:B,RB31A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",3.80E-16,5.80E-16,4.00E+08,2.80E+08,1.50E-07,1.60E-07,-21.03,0.25,,,,,wild-type value for (Met-(-1)) angiogenin (chain B) derivative
1451,1A4Y,A:B,RB32A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",7.10E-16,3.30E-15,1.80E+08,2.40E+08,1.30E-07,7.80E-07,-20.66,0.91,,,,,
1452,1A4Y,A:B,RB5A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",7.10E-16,3.50E-14,1.80E+08,1.10E+08,1.30E-07,3.90E-08,-20.66,2.31,,,,,
1453,1A4Y,A:B,RB66A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",7.10E-16,1.00E-15,1.80E+08,1.80E+08,1.30E-07,1.80E-07,-20.66,0.2,,,,,
1454,1A4Y,A:B,RB70A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"1281426 (Table VI, p. 12482)",7.10E-16,4.80E-16,1.80E+08,2.40E+08,1.30E-07,1.10E-07,-20.66,-0.23,,,,,
1455,1JTG,A:B,EB31A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.00E-09,,,,,-12.68,0.82,,,,,
1456,1JTG,A:B,SB35A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,5.00E-10,,,,,-12.68,0,,,,,
1457,1JTG,A:B,FB36A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,4.00E-08,,,,,-12.68,2.59,,,,,
1458,1JTG,A:B,SB39A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,3.00E-10,,,,,-12.68,-0.3,,,,,
1459,1JTG,A:B,HB41A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,3.40E-08,,,,,-12.68,2.5,,,,,
1460,1JTG,A:B,GB48A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,7.00E-10,,,,,-12.68,0.2,,,,,
1461,1JTG,A:B,DB49A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.00E-08,,,,,-12.68,2.18,,,,,
1462,1JTG,A:B,YB50A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.10E-11,,,,,-12.68,-2.26,,,,,
1463,1JTG,A:B,YB51A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,5.00E-10,,,,,-12.68,0,,,,,
1464,1JTG,A:B,YB53A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.10E-08,,,,,-12.68,2.21,,,,,
1465,1JTG,A:B,SB71A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.00E-10,,,,,-12.68,-0.54,,,,,
1466,1JTG,A:B,EB73A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,4.00E-10,,,,,-12.68,-0.13,,,,,
1467,1JTG,A:B,KB74A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,4.60E-08,,,,,-12.68,2.68,,,,,
1468,1JTG,A:B,WB112A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.30E-08,,,,,-12.68,1.93,,,,,
1469,1JTG,A:B,SB113A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.10E-10,,,,,-12.68,-0.9,,,,,
1470,1JTG,A:B,GB141A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.80E-09,,,,,-12.68,0.76,,,,,
1471,1JTG,A:B,FB142A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.60E-08,,,,,-12.68,2.05,,,,,
1472,1JTG,A:B,YB143A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,6.00E-10,,,,,-12.68,0.11,,,,,
1473,1JTG,A:B,RB144A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,6.00E-10,,,,,-12.68,0.11,,,,,
1474,1JTG,A:B,HB148A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.10E-08,,,,,-12.68,2.21,,,,,
1475,1JTG,A:B,WB150A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.84E-07,,,,,-12.68,3.5,,,,,
1476,1JTG,A:B,RB160A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,1.10E-08,,,,,-12.68,1.83,,,,,
1477,1JTG,A:B,WB162A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,2.00E-08,,,,,-12.68,2.18,,,,,
1478,1JTG,A:B,"EB73A,YB50A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",5.00E-10,4.00E-11,,,,,-12.68,-1.5,,,,,
1479,1JTG,A:B,"YB50A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",5.00E-10,7.00E-11,,,,,-12.68,-1.16,,,,,
1480,1JTG,A:B,"EB73A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",5.00E-10,2.50E-09,,,,,-12.68,0.95,,,,,
1481,1JTG,A:B,"WB112A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",5.00E-10,1.20E-08,,,,,-12.68,1.88,,,,,
1482,1JTG,A:B,"WB150A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",5.00E-10,7.84E-07,,,,,-12.68,4.36,,,,,
1483,,,E*31A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,7.70E-09,,,,,-11.75,0.69,,,,,mutation in BLIP
1484,,,S*35A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.80E-09,,,,,-11.75,-0.17,,,,,mutation in BLIP
1485,,,F*36A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.20E-07,,,,,-11.75,2.32,,,,,mutation in BLIP
1486,,,S*39A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.40E-09,,,,,-11.75,-0.32,,,,,mutation in BLIP
1487,,,H*41A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.89E-07,,,,,-11.75,2.59,,,,,mutation in BLIP
1488,,,G*48A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,2.60E-09,,,,,-11.75,0.05,,,,,mutation in BLIP
1489,,,D*49A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.85E-07,,,,,-11.75,2.57,,,,,mutation in BLIP
1490,,,Y*50A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,3.20E-08,,,,,-11.75,1.53,,,,,mutation in BLIP
1491,,,Y*51A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,7.60E-08,,,,,-11.75,2.05,,,,,mutation in BLIP
1492,,,Y*53A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,2.23E-07,,,,,-11.75,2.68,,,,,mutation in BLIP
1493,,,S*71A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.90E-09,,,,,-11.75,-0.14,,,,,mutation in BLIP
1494,,,E*73A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,2.70E-06,,,,,-11.75,4.16,,,,,mutation in BLIP
1495,,,K*74A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.00E-10,,,,,-11.75,-1.88,,,,,mutation in BLIP
1496,,,W*112A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,2.60E-06,,,,,-11.75,4.14,,,,,mutation in BLIP
1497,,,S*113A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,2.70E-09,,,,,-11.75,0.07,,,,,mutation in BLIP
1498,,,G*141A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,3.10E-09,,,,,-11.75,0.15,,,,,mutation in BLIP
1499,,,F*142A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.50E-08,,,,,-11.75,1.09,,,,,mutation in BLIP
1500,,,Y*143A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.10E-08,,,,,-11.75,0.9,,,,,mutation in BLIP
1501,,,R*144A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.70E-09,,,,,-11.75,-0.2,,,,,mutation in BLIP
1502,,,H*148A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,1.40E-06,,,,,-11.75,3.77,,,,,mutation in BLIP
1503,,,W*150A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,8.30E-07,,,,,-11.75,3.46,,,,,mutation in BLIP
1504,,,R*160A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,3.22E-07,,,,,-11.75,2.9,,,,,mutation in BLIP
1505,,,W*162A,Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,9.70E-08,,,,,-11.75,2.19,,,,,mutation in BLIP
1506,,,"E*73A,Y*50A",Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,hydrolysis of cephalosporin C using spectrophotometry,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"12933802 (Table II, p. 45709)",2.40E-09,4.40E-05,,,,,-11.75,5.81,,,,,mutations in BLIP
1507,,,"Y*50A,Y*143A",Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.40E-09,6.20E-08,,,,,-11.75,1.93,,,,,mutations in BLIP
1508,,,"W*112A,Y*143A",Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.40E-09,1.80E-06,,,,,-11.75,3.92,,,,,mutations in BLIP
1509,,,"W*150A,Y*143A",Serratia marcescens carbapenem-hydrolyzing beta-lactamase SME-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.40E-09,1.10E-05,,,,,-11.75,4.99,,,,,mutations in BLIP
1510,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,
1511,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1512,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1513,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1514,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1515,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.94,,,,,mutation in hGH
1516,,,D*107A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,3.64,,,,,mutation in hGH
1517,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1518,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1519,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1520,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
1521,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.76,,,,,mutation in hGH
1522,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1523,,,D*112A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,3.64,,,,,mutation in hGH
1524,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1525,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1526,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1527,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
1528,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,2.49,,,,,mutation in hGH
1529,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1530,,,D*116A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,3.64,,,,,mutation in hGH
1531,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1532,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1533,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1534,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1535,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1536,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1537,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1538,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1539,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1540,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1541,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1542,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1543,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1544,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1545,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1546,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1547,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1548,,,D*11A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1549,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1550,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,3.64,,,,,mutation in hGH
1551,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1552,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1553,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1554,,,D*130A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1555,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,0.41,,,,,mutation in hGH
1556,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1557,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1558,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1559,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1560,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1561,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1562,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1563,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.41,,,,,mutation in hGH
1564,,,D*147A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1565,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1566,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1567,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1568,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1569,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1570,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1571,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1572,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.64,,,,,mutation in hGH
1573,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1574,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1575,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1576,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1577,,,D*153A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1578,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1579,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1580,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1581,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1582,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1583,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1584,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1585,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1586,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1587,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,1.22,,,,,mutation in hGH
1588,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,0.81,,,,,mutation in hGH
1589,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.41,,,,,mutation in hGH
1590,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1591,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1592,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1593,,,D*154A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1594,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1595,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1596,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1597,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1598,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1599,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1600,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1601,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1602,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1603,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1604,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1605,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1606,,,D*169A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1607,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1608,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1609,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1610,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1611,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1612,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1613,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1614,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1615,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1616,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1617,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1618,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1619,,,D*171A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1620,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1621,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1622,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1623,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1624,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1625,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1626,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1627,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1628,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1629,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1630,,,D*26A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1631,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1632,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1633,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1634,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1635,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1636,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1637,,,E*118A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,1.35,,,,,mutation in hGH
1638,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1639,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1640,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1641,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1642,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1643,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.41,,,,,mutation in hGH
1644,,,E*119A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,2.64,,,,,mutation in hGH
1645,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1646,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,0.81,,,,,mutation in hGH
1647,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1648,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1649,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1650,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1651,,,E*129A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1652,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1653,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1654,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1655,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1656,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1657,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1658,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1659,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1660,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1661,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1662,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1663,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1664,,,E*174A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
1665,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1666,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1667,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1668,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1669,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1670,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1671,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
1672,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1673,,,E*186A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1674,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1675,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1676,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1677,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1678,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1679,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1680,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1681,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1682,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1683,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1684,,,E*30A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1685,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1686,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1687,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1688,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1689,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1690,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1691,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
1692,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1693,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1694,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,0.81,,,,,mutation in hGH
1695,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.41,,,,,mutation in hGH
1696,,,E*32A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,-0.71,,,,,mutation in hGH
1697,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1698,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1699,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1700,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1701,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1702,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1703,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1704,,,E*33A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1705,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1706,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,1.99,,,,,mutation in hGH
1707,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1708,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1709,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1710,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.76,,,,,mutation in hGH
1711,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,3.11,,,,,mutation in hGH
1712,,,E*39A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1713,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1714,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1715,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1716,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1717,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1718,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1719,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1720,,,E*56A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1721,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,0.81,,,,,mutation in hGH
1722,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1723,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
1724,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1725,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1726,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1727,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1728,,,E*65A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1729,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1730,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1731,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1732,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.41,,,,,mutation in hGH
1733,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
1734,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1735,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1736,,,E*66A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
1737,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1738,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1739,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1740,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1741,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1742,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1743,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1744,,,E*74A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1745,,,E*88A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1746,,,E*88A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1747,,,E*88A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,1.35,,,,,mutation in hGH
1748,,,E*88A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,1.22,,,,,mutation in hGH
1749,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1750,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,-0.71,,,,,mutation in hGH
1751,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1752,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1753,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1754,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,0.41,,,,,mutation in hGH
1755,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1756,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,0.41,,,,,mutation in hGH
1757,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1758,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1759,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1760,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1761,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1762,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1763,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1764,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1765,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1766,,,F*10A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1767,,,F*139A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,3.64,,,,,mutation in hGH
1768,,,F*139A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1769,,,F*139A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1770,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1771,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1772,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1773,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1774,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1775,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1776,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1777,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1778,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1779,,,F*146A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1780,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1781,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1782,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1783,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1784,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1785,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1786,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1787,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1788,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1789,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1790,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1791,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,-0.71,,,,,mutation in hGH
1792,,,F*166A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1793,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1794,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1795,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.94,,,,,mutation in hGH
1796,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1797,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1798,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1799,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1800,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1801,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1802,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1803,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1804,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1805,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1806,,,F*176A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
1807,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1808,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1809,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1810,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1811,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
1812,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1813,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1814,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,2.29,,,,,mutation in hGH
1815,,,F*191A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1816,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1817,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1818,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1819,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1820,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1821,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1822,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1823,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1824,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1825,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1826,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1827,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1828,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1829,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1830,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1831,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1832,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1833,,,F*1A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1834,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1835,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1836,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1837,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1838,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1839,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1840,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1841,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1842,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1843,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1844,,,F*25A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1845,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1846,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1847,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1848,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1849,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1850,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1851,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1852,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1853,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1854,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1855,,,F*31A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1856,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1857,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1858,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1859,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1860,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1861,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1862,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,3.64,,,,,mutation in hGH
1863,,,F*44A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,3.64,,,,,mutation in hGH
1864,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1865,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1866,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1867,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1868,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1869,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1870,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1871,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1872,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1873,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1874,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1875,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1876,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1877,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1878,,,F*54A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1879,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1880,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1881,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1882,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1883,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1884,,,F*92A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1885,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1886,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
1887,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1888,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
1889,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.94,,,,,mutation in hGH
1890,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1891,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1892,,,F*97A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.41,,,,,mutation in hGH
1893,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1894,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,1.29,,,,,mutation in hGH
1895,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1896,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1897,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1898,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1899,,,G*126A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1900,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1901,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1902,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.94,,,,,mutation in hGH
1903,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.64,,,,,mutation in hGH
1904,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.64,,,,,mutation in hGH
1905,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1906,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1907,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,0.41,,,,,mutation in hGH
1908,,,G*187A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1909,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1910,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1911,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1912,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1913,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1914,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,0.41,,,,,mutation in hGH
1915,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1916,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1917,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1918,,,H*151A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1919,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1920,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1921,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1922,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1923,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1924,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1925,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1926,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1927,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1928,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1929,,,H*18A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1930,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1931,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1932,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1933,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1934,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1935,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1936,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1937,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1938,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1939,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1940,,,H*21A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1941,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1942,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1943,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1944,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1945,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1946,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1947,,,I*121A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1948,,,I*138A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1949,,,I*138A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1950,,,I*138A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
1951,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1952,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1953,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,2.16,,,,,mutation in hGH
1954,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,2.29,,,,,mutation in hGH
1955,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1956,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1957,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1958,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1959,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1960,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1961,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1962,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1963,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1964,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1965,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1966,,,I*179A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1967,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1968,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,0.64,,,,,mutation in hGH
1969,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.99,,,,,mutation in hGH
1970,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.35,,,,,mutation in hGH
1971,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.64,,,,,mutation in hGH
1972,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,3.64,,,,,mutation in hGH
1973,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,3.11,,,,,mutation in hGH
1974,,,I*36A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,-0.71,,,,,mutation in hGH
1975,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.14,,,,,mutation in hGH
1976,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1977,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1978,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1979,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1980,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
1981,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1982,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
1983,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
1984,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1985,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1986,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1987,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
1988,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1989,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
1990,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
1991,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
1992,,,I*4A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1993,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
1994,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
1995,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1996,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
1997,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
1998,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
1999,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2000,,,I*58A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2001,,,I*83A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2002,,,I*83A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2003,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2004,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2005,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2006,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2007,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2008,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.41,,,,,mutation in hGH
2009,,,K*115A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2010,,,K*145A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,0.41,,,,,mutation in hGH
2011,,,K*145A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2012,,,K*145A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2013,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2014,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2015,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2016,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2017,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2018,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2019,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2020,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2021,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2022,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2023,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2024,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2025,,,K*158A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2026,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2027,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2028,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2029,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2030,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2031,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2032,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2033,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2034,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2035,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2036,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2037,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2038,,,K*168A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2039,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2040,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2041,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2042,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2043,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2044,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2045,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2046,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2047,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2048,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2049,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2050,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2051,,,K*172A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2052,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2053,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,1.35,,,,,mutation in hGH
2054,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2055,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2056,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2057,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2058,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2059,,,K*38A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2060,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2061,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2062,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2063,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2064,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2065,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.76,,,,,mutation in hGH
2066,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.94,,,,,mutation in hGH
2067,,,K*45A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,3.64,,,,,mutation in hGH
2068,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2069,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2070,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2071,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2072,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2073,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.35,,,,,mutation in hGH
2074,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2075,,,K*70A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2076,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2077,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2078,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2079,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
2080,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.41,,,,,mutation in hGH
2081,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2082,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2083,,,L*101A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2084,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2085,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2086,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2087,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2088,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2089,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2090,,,L*113A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2091,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2092,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2093,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2094,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2095,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2096,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2097,,,L*117A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2098,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2099,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2100,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2101,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2102,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2103,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2104,,,L*124A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2105,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2106,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2107,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2108,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2109,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2110,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2111,,,L*128A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2112,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2113,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2114,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2115,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2116,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2117,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2118,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.35,,,,,mutation in hGH
2119,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2120,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.41,,,,,mutation in hGH
2121,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2122,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2123,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2124,,,L*156A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2125,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2126,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2127,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2128,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2129,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2130,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,1.99,,,,,mutation in hGH
2131,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2132,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2133,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.41,,,,,mutation in hGH
2134,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.05,,,,,mutation in hGH
2135,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.41,,,,,mutation in hGH
2136,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2137,,,L*157A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2138,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2139,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2140,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2141,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2142,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2143,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2144,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2145,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2146,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2147,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2148,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2149,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2150,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2151,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2152,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2153,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2154,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2155,,,L*15A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2156,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2157,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2158,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2159,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2160,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2161,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2162,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2163,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2164,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2165,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2166,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2167,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2168,,,L*162A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2169,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2170,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2171,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2172,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2173,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2174,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2175,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2176,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2177,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2178,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2179,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2180,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2181,,,L*163A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2182,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2183,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2184,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2185,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2186,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2187,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2188,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2189,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2190,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2191,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2192,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2193,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2194,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2195,,,L*177A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2196,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2197,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2198,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2199,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2200,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2201,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2202,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2203,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2204,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2205,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2206,,,L*20A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2207,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2208,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2209,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2210,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2211,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2212,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2213,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2214,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2215,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2216,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2217,,,L*23A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2218,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2219,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2220,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2221,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2222,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2223,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2224,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2225,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2226,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2227,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2228,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2229,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2230,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2231,,,L*52A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2232,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.99,,,,,mutation in hGH
2233,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2234,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2235,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2236,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2237,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2238,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2239,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,0.41,,,,,mutation in hGH
2240,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2241,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2242,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2243,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2244,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2245,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2246,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2247,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2248,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2249,,,L*6A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2250,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2251,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2252,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2253,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2254,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
2255,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2256,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2257,,,L*73A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2258,,,L*82A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2259,,,L*82A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2260,,,L*87A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2261,,,L*87A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2262,,,L*87A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2263,,,L*87A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2264,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2265,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2266,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2267,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2268,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2269,,,L*93A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2270,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2271,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2272,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2273,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2274,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2275,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2276,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2277,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2278,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2279,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2280,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2281,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2282,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2283,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2284,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2285,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2286,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2287,,,L*9A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2288,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2289,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2290,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2291,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2292,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2293,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2294,,,M*125A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2295,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2296,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2297,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2298,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2299,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,1.29,,,,,mutation in hGH
2300,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2301,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2302,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2303,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2304,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2305,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2306,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2307,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2308,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2309,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2310,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2311,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2312,,,M*14A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2313,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2314,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2315,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2316,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2317,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2318,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2319,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2320,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2321,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2322,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2323,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2324,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2325,,,M*170A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2326,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2327,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2328,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2329,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2330,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2331,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2332,,,N*109A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,3.64,,,,,mutation in hGH
2333,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2334,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2335,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2336,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2337,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2338,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2339,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2340,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2341,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2342,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2343,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,2.29,,,,,mutation in hGH
2344,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2345,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2346,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.76,,,,,mutation in hGH
2347,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2348,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2349,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2350,,,N*12A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2351,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2352,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2353,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2354,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2355,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2356,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2357,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2358,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2359,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2360,,,N*149A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2361,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2362,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2363,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2364,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2365,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2366,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2367,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2368,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2369,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2370,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2371,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2372,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2373,,,N*152A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2374,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2375,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2376,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2377,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2378,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2379,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2380,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2381,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2382,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2383,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2384,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2385,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2386,,,N*159A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2387,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2388,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2389,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2390,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2391,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2392,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2393,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2394,,,N*47A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,3.64,,,,,mutation in hGH
2395,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2396,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2397,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2398,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.41,,,,,mutation in hGH
2399,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
2400,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2401,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2402,,,N*63A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2403,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2404,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2405,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2406,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2407,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2408,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2409,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2410,,,N*99A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2411,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2412,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,3.64,,,,,mutation in hGH
2413,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2414,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2415,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2416,,,P*133A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2417,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2418,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2419,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2420,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2421,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2422,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2423,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2424,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2425,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2426,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2427,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2428,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2429,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2430,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2431,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2432,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2433,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2434,,,P*2A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2435,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2436,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2437,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2438,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2439,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2440,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2441,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2442,,,P*48A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,3.64,,,,,mutation in hGH
2443,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2444,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2445,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2446,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2447,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2448,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2449,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2450,,,P*59A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2451,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.11,,,,,mutation in hGH
2452,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2453,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2454,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2455,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2456,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,4.05,,,,,mutation in hGH
2457,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2458,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2459,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2460,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2461,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2462,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2463,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2464,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2465,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2466,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2467,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2468,,,P*5A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2469,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2470,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2471,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2472,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.41,,,,,mutation in hGH
2473,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
2474,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2475,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2476,,,P*61A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
2477,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2478,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2479,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2480,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2481,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,2.16,,,,,mutation in hGH
2482,,,P*89A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2483,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2484,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2485,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2486,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2487,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2488,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,0.41,,,,,mutation in hGH
2489,,,Q*122A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2490,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2491,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2492,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,0.41,,,,,mutation in hGH
2493,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2494,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2495,,,Q*137A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2496,,,Q*141A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,3.64,,,,,mutation in hGH
2497,,,Q*141A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2498,,,Q*141A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2499,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2500,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2501,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2502,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2503,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2504,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2505,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2506,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2507,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2508,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2509,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2510,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2511,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2512,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2513,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2514,,,Q*181A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2515,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2516,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2517,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2518,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2519,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2520,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2521,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2522,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2523,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2524,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2525,,,Q*22A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2526,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2527,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2528,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2529,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2530,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2531,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2532,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2533,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2534,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2535,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2536,,,Q*29A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2537,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2538,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,0.64,,,,,mutation in hGH
2539,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2540,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2541,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2542,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,0.64,,,,,mutation in hGH
2543,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.41,,,,,mutation in hGH
2544,,,Q*40A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2545,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2546,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2547,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2548,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2549,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2550,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.35,,,,,mutation in hGH
2551,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2552,,,Q*46A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,3.64,,,,,mutation in hGH
2553,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,0.64,,,,,mutation in hGH
2554,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2555,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2556,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2557,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2558,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2559,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2560,,,Q*49A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,0.41,,,,,mutation in hGH
2561,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2562,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2563,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.14,,,,,mutation in hGH
2564,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2565,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2566,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2567,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2568,,,Q*68A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2569,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,0.41,,,,,mutation in hGH
2570,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2571,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2572,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2573,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2574,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
2575,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,0.41,,,,,mutation in hGH
2576,,,Q*69A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2577,,,Q*84A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2578,,,Q*84A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2579,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2580,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2581,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2582,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2583,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2584,,,Q*91A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2585,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.11,,,,,mutation in hGH
2586,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,3.64,,,,,mutation in hGH
2587,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,4.05,,,,,mutation in hGH
2588,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2589,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2590,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2591,,,R*127A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2592,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2593,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2594,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2595,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2596,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2597,,,R*134A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2598,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2599,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2600,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2601,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2602,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2603,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2604,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2605,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2606,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2607,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2608,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2609,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2610,,,R*167A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2611,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2612,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2613,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2614,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2615,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2616,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2617,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2618,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2619,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2620,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2621,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2622,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2623,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2624,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2625,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2626,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2627,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2628,,,R*16A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2629,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2630,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2631,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2632,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2633,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2634,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2635,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,0.41,,,,,mutation in hGH
2636,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2637,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2638,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2639,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2640,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2641,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2642,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2643,,,R*178A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.76,,,,,mutation in hGH
2644,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2645,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2646,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2647,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,3.64,,,,,mutation in hGH
2648,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,3.64,,,,,mutation in hGH
2649,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2650,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2651,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,2.7,,,,,mutation in hGH
2652,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2653,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2654,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2655,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2656,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2657,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2658,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2659,,,R*183A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.76,,,,,mutation in hGH
2660,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2661,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2662,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2663,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2664,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2665,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2666,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2667,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2668,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2669,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2670,,,R*19A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2671,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2672,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2673,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,2.16,,,,,mutation in hGH
2674,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.41,,,,,mutation in hGH
2675,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.41,,,,,mutation in hGH
2676,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
2677,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,1.35,,,,,mutation in hGH
2678,,,R*64A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2679,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.11,,,,,mutation in hGH
2680,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2681,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2682,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2683,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2684,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,4.05,,,,,mutation in hGH
2685,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2686,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2687,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2688,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2689,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,3.64,,,,,mutation in hGH
2690,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2691,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2692,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,2.7,,,,,mutation in hGH
2693,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2694,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2695,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2696,,,R*8A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2697,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2698,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2699,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2700,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2701,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2702,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2703,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,2.29,,,,,mutation in hGH
2704,,,R*94A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,2.29,,,,,mutation in hGH
2705,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2706,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2707,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2708,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2709,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2710,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2711,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2712,,,S*100A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2713,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2714,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2715,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2716,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2717,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2718,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2719,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2720,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2721,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2722,,,S*106A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2723,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2724,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2725,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2726,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2727,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2728,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2729,,,S*108A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2730,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2731,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,3.64,,,,,mutation in hGH
2732,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2733,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2734,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2735,,,S*132A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2736,,,S*144A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2737,,,S*144A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2738,,,S*144A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2739,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2740,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2741,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2742,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2743,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2744,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2745,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2746,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2747,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2748,,,S*150A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2749,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2750,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2751,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2752,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2753,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2754,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2755,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2756,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2757,,,S*184A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2758,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2759,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2760,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2761,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2762,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2763,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2764,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2765,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2766,,,S*188A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2767,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2768,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2769,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2770,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2771,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2772,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2773,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2774,,,S*43A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,0.41,,,,,mutation in hGH
2775,,,S*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,0.64,,,,,mutation in hGH
2776,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2777,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2778,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2779,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2780,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2781,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2782,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2783,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2784,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2785,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2786,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2787,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2788,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2789,,,S*51A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2790,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2791,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2792,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2793,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2794,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2795,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2796,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2797,,,S*55A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2798,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2799,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2800,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2801,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2802,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2803,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2804,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2805,,,S*57A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2806,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2807,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2808,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2809,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2810,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2811,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2812,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2813,,,S*62A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2814,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2815,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2816,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2817,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2818,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2819,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2820,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2821,,,S*71A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2822,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2823,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2824,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2825,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2826,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2827,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2828,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2829,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2830,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2831,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2832,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2833,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2834,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2835,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2836,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2837,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2838,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2839,,,S*7A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2840,,,S*85A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2841,,,S*85A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2842,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2843,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2844,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2845,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2846,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2847,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2848,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2849,,,S*95A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,3.64,,,,,mutation in hGH
2850,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2851,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2852,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2853,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2854,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2855,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2856,,,T*123A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2857,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2858,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2859,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2860,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2861,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2862,,,T*135A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2863,,,T*142A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2864,,,T*142A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2865,,,T*142A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2866,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2867,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2868,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2869,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2870,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2871,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2872,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2873,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2874,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2875,,,T*148A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2876,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2877,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2878,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2879,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2880,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2881,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2882,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2883,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2884,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2885,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2886,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2887,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2888,,,T*175A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2889,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2890,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2891,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2892,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,1.99,,,,,mutation in hGH
2893,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2894,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
2895,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2896,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2897,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.14,,,,,mutation in hGH
2898,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,1.35,,,,,mutation in hGH
2899,,,T*27A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2900,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2901,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2902,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2903,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2904,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2905,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2906,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2907,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2908,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2909,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2910,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2911,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2912,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2913,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2914,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2915,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2916,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2917,,,T*3A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2918,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2919,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2920,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2921,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2922,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2923,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2924,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2925,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2926,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2927,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2928,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2929,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2930,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,0.64,,,,,mutation in hGH
2931,,,T*50A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2932,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2933,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
2934,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2935,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2936,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2937,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2938,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2939,,,T*60A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2940,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2941,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2942,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2943,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2944,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2945,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2946,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2947,,,V*102A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2948,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2949,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2950,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2951,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2952,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2953,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2954,,,V*110A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2955,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2956,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2957,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2958,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2959,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2960,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2961,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2962,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2963,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2964,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2965,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2966,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2967,,,V*173A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2968,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2969,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2970,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2971,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,0.64,,,,,mutation in hGH
2972,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
2973,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2974,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2975,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2976,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2977,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2978,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2979,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2980,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
2981,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
2982,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
2983,,,V*180A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2984,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2985,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
2986,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.94,,,,,mutation in hGH
2987,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
2988,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,0.64,,,,,mutation in hGH
2989,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
2990,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2991,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
2992,,,V*185A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2993,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
2994,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2995,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
2996,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
2997,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2998,,,V*90A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
2999,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3000,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3001,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3002,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3003,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3004,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3005,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3006,,,V*96A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3007,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3008,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.41,,,,,mutation in hGH
3009,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3010,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,0.64,,,,,mutation in hGH
3011,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3012,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3013,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3014,,,Y*103A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3015,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3016,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 10 (mAb 10),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.6,,,,,,mutation in hGH
3017,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
3018,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3019,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3020,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3021,,,Y*111A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3022,,,Y*143A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,3.64,,,,,mutation in hGH
3023,,,Y*143A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 8 (mAb 8),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3024,,,Y*143A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 9 (mAb 9),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.1,,,,,,mutation in hGH
3025,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3026,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
3027,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
3028,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3029,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
3030,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,0.41,,,,,mutation in hGH
3031,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3032,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3033,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,0.41,,,,,mutation in hGH
3034,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,1.35,,,,,mutation in hGH
3035,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,0.81,,,,,mutation in hGH
3036,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,-0.94,,,,,mutation in hGH
3037,,,Y*160A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3038,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 12 (mAb 12),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3039,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 13 (mAb 13),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.6,,,,,,mutation in hGH
3040,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 14 (mAb 14),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.5,,,,,,mutation in hGH
3041,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 16 (mAb 16),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3042,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 17 (mAb 17),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.8,,,,,,mutation in hGH
3043,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3044,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3045,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3046,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3047,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
3048,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
3049,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,-0.71,,,,,mutation in hGH
3050,,,Y*164A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 7 (mAb 7),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3051,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 1 (mAb 1),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3052,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 15 (mAb 15),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.7,,,,,,mutation in hGH
3053,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3054,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3055,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 2 (mAb 2),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3056,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3057,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3058,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 3 (mAb 3),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3059,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
3060,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
3061,,,Y*28A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
3062,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
3063,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3064,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3065,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3066,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3067,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
3068,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
3069,,,Y*35A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,,,,,,mutation in hGH
3070,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 11 (mAb 11),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.2,,,,,,mutation in hGH
3071,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 18 (mAb 18),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.85,,,,,,mutation in hGH
3072,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 19 (mAb 19),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3073,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 20 (mAb 20),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-13.1,,,,,,mutation in hGH
3074,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 21 (mAb 21),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-12.45,,,,,,mutation in hGH
3075,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 4 (mAb 4),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-11.2,,,,,,mutation in hGH
3076,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 5 (mAb 5),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-14.2,,,,,,mutation in hGH
3077,,,Y*42A,Human growth hormone/somatotropin (hGH),anti-hGH mouse monoclonal antibody 6 (mAb 6),Ag-Ab,Robot-aided enzyme-linked immunoabsorbant assay,"50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 5 mg/mL BSA (in 0.05% (w/v) Tween 20 and 0.02% (w/v) sodium azide)",298,7.5,ASEdb,"1380563 (Table 4, p. 855-6)",,,,,,,-10.8,1.76,,,,,mutation in hGH
3078,,,Q*141D,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",1.50E-11,4.00E-10,,,,,-15.35,2.02,,,,,mutation in mIL-2
3079,,,Q*141K,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",1.50E-11,7.00E-10,,,,,-15.35,2.37,,,,,mutation in mIL-2
3080,,,D*34G,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",1.50E-11,5.50E-10,,,,,-15.35,2.22,,,,,mutation in mIL-2
3081,,,D*34H,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",1.50E-11,5.00E-09,,,,,-15.35,3.58,,,,,mutation in mIL-2
3082,,,D*34K,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",1.50E-11,1.50E-08,,,,,-15.35,4.26,,,,,mutation in mIL-2
3083,,,Q*141D,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",6.00E-12,2.50E-10,,,,,-15.92,2.3,,,,,mutation in mIL-2
3084,,,Q*141K,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Binding performed with <sup>125</sup>I-labelled hIL-2 as 'hot' ligand; radioacitivity measured after separation of bound and free ligand,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"1396584 (Table III, p. 3908)",6.00E-12,2.00E-10,,,,,-15.92,2.16,,,,,mutation in mIL-2
3085,,,E*30A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,2.90E-14,,,,,-19.65,1.19,,,,,mutation in Im2
3086,,,D*33A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,1.60E-11,,,,,-19.65,4.93,,,,,mutation in Im2
3087,,,N*34A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,4.40E-15,,,,,-19.65,0.07,,,,,mutation in Im2
3088,,,V*37A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",4.00E-15,1.80E-13,,,,,-19.63,2.25,,,,,mutation in Im2
3089,,,R*38A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,4.10E-14,,,,,-19.65,1.39,,,,,mutation in Im2
3090,,,E*41A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,1.10E-14,,,,,-19.65,0.61,,,,,mutation in Im2
3091,,,R*42A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,3.00E-15,,,,,-19.65,-0.16,,,,,mutation in Im2
3092,,,S*50A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,1.30E-14,,,,,-19.65,0.71,,,,,mutation in Im2
3093,,,D*51A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,1.70E-10,,,,,-19.65,6.33,,,,,mutation in Im2
3094,,,Y*54A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,1.40E-10,,,,,-19.65,6.21,,,,,mutation in Im2
3095,,,Y*55A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,2.20E-11,,,,,-19.65,5.12,,,,,mutation in Im2
3096,,,P*56A,Escherichia coli colicin-E2,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",3.90E-15,8.00E-14,,,,,-19.65,1.79,,,,,mutation in Im2
3097,,,E*30A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,6.90E-08,,,,,-10.8,1.04,,,,,mutation in Im9
3098,,,L*33A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,5.40E-09,,,,,-10.8,-0.47,,,,,mutation in Im9
3099,,,V*34A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,1.80E-08,,,,,-10.8,0.24,,,,,mutation in Im9
3100,,,V*37A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,4.70E-07,,,,,-10.8,2.17,,,,,mutation in Im9
3101,,,T*38A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,2.00E-08,,,,,-10.8,0.3,,,,,mutation in Im9
3102,,,E*41A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,5.10E-08,,,,,-10.8,0.86,,,,,mutation in Im9
3103,,,E*42A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,1.40E-08,,,,,-10.8,0.09,,,,,mutation in Im9
3104,,,S*50A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.00E-08,1.80E-06,,,,,-10.91,3.08,,,,,mutation in Im9
3105,,,Y*54A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,5.20E-07,,,,,-10.8,2.23,,,,,mutation in Im9
3106,,,P*56A,Escherichia coli colicin-E2,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Subunit exchange method,"50mM MOPS, 200mM NaCl",298,7,PINT,"15019791 (Table 2, p. 748)",1.20E-08,1.70E-08,,,,,-10.8,0.21,,,,,mutation in Im9
3107,1REW,AB:C,"DA53A,DB53A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10 mM Hepes, 500 mM NaCl, 3.4 mM EDTA, 0.005% Surfactant P20",298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,8.00E-10,,,,,-12.33,-0.07,,,,,
3108,1REW,AB:C,"DA53P,DB53P",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,,298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,4.80E-08,,,,,-12.33,2.35,,,,,
3109,1REW,AB:C,QC86A,Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,,298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,8.00E-08,,,,,-12.33,2.66,,,,,
3110,1REW,AB:C,"SA69R,SB69R",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,,298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,1.50E-08,,,,,-12.33,1.67,,,,,
3111,1REW,AB:C,"WA28F,WB28F",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,,298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,2.80E-09,,,,,-12.33,0.67,,,,,
3112,1REW,AB:C,"YA103A,YB103A",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,,298,7.4,SKEMPI,"15064755 (Table 2, p. 484)",9.00E-10,7.00E-09,,,,,-12.33,1.21,,,,,
3113,1DKG,AB:D,RA183A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.00E-07,1.06E-05,,,,,-8.98,2.31,,,,,
3114,1DKG,AB:D,RA73A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,4.35E-06,,,,,-8.95,1.76,,,,,
3115,1DKG,AB:D,KA82A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.20E-07,4.17E-06,,,,,-8.93,1.71,,,,,
3116,1DKG,AB:D,PA151A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,3.03E-06,,,,,-8.95,1.55,,,,,
3117,1DKG,AB:D,VA192A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,2.70E-06,,,,,-8.95,1.49,,,,,
3118,1DKG,AB:D,MA159A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,2.50E-06,,,,,-8.95,1.44,,,,,
3119,1DKG,AB:D,RA74A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,2.00E-06,,,,,-8.95,1.31,,,,,
3120,1DKG,AB:D,RA104A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,1.92E-06,,,,,-8.95,1.29,,,,,
3121,1DKG,AB:D,MA189A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.20E-07,1.59E-06,,,,,-8.93,1.15,,,,,
3122,1DKG,AB:D,IA157A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.10E-07,1.56E-06,,,,,-8.95,1.17,,,,,
3123,1DKG,AB:D,RA186A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.12E-07,8.33E-07,,,,,-8.95,0.8,,,,,
3124,1DKG,AB:D,EA107A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.13E-07,5.88E-07,,,,,-8.94,0.59,,,,,
3125,1DKG,AB:D,QA155A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.12E-07,5.26E-07,,,,,-8.95,0.53,,,,,
3126,1DKG,AB:D,LA149A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.13E-07,4.00E-07,,,,,-8.94,0.37,,,,,
3127,1DKG,AB:D,VA108A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.13E-07,2.33E-07,,,,,-8.94,0.05,,,,,
3128,1DKG,AB:D,MA174A,Escherichia coli protein GrpE/heat shock protein B25.3,Escherichia coli chaperone protein DnaK/Heat shock protein 70,,Sedimentation Velocity Analytical Ultracentrifugation,"25mM Mopso, 100mM NaCl, 1mM MgCl2, 1mM CaCl2, 5 &micro;M ADP",293,6.8,PINT,"15136046 (Table 1, p. 451)",2.12E-07,2.17E-07,,,,,-8.95,0.01,,,,,
3129,1LFD,A:B,DA51A,Rattus norvegicus Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,7.30E-07,7.70E+06,1.75E+07,1.49E+01,1.28E+01,-7.79,-0.58,-11.2,-12.5,-10.4,-12.7,
3130,1LFD,A:B,DA51K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,3.10E-07,7.70E+06,3.03E+07,1.49E+01,9.30E+00,-7.79,-1.09,-11.2,-13.1,-10.4,-13.8,
3131,1LFD,A:B,"DA51K,DA56K,EA57K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.40E-07,7.70E+06,4.30E+07,1.49E+01,6.00E+00,-7.79,-1.56,-11.2,-12.5,-10.4,-10.7,
3132,1LFD,A:B,DA56A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.21E-06,7.70E+06,1.85E+07,1.49E+01,2.23E+01,-7.79,-0.28,-11.2,-13.1,-10.4,-15.4,
3133,1LFD,A:B,DA58K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,4.20E-07,7.70E+06,1.52E+07,1.49E+01,6.40E+00,-7.79,-0.91,-11.2,-14.2,-10.4,-18.8,
3134,1LFD,A:B,"DA58K,DA94K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,7.00E-07,7.70E+06,2.84E+07,1.49E+01,1.99E+01,-7.79,-0.6,-11.2,-13.7,-10.4,-16.4,
3135,1LFD,A:B,DA94K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,2.80E-07,7.70E+06,2.79E+07,1.49E+01,7.90E+00,-7.79,-1.15,-11.2,-12.7,-10.4,-12.4,
3136,1LFD,A:B,EA57A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.28E-06,7.70E+06,1.63E+07,1.49E+01,2.09E+01,-7.79,-0.25,-11.2,-11.2,-10.4,-9.06,
3137,1LFD,A:B,EA57K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.20E-06,7.70E+06,1.91E+07,1.49E+01,2.30E+01,-7.79,-0.28,-11.2,-12.2,-10.4,-13.4,
3138,1LFD,A:B,KA32A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.82E-05,7.70E+06,2.20E+06,1.49E+01,4.00E+01,-7.79,1.33,-11.2,-10.2,-10.4,-12.1,
3139,1LFD,A:B,KA48A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,3.00E-06,7.70E+06,5.60E+06,1.49E+01,1.68E+01,-7.79,0.26,-11.2,-11.7,-10.4,-13.1,
3140,1LFD,A:B,KA52A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.42E-05,7.70E+06,2.00E+06,1.49E+01,2.83E+01,-7.79,1.18,-11.2,-13.2,-10.4,-23.1,
3141,1LFD,A:B,LA23K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.89E-06,7.70E+06,8.90E+06,1.49E+01,1.68E+01,-7.79,-0.02,-11.2,-14.4,-10.4,-19.5,
3142,1LFD,A:B,LA55K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,7.40E-07,7.70E+06,1.51E+07,1.49E+01,1.11E+01,-7.79,-0.57,-11.2,-10.3,-10.4,-7.38,
3143,1LFD,A:B,MA30K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,4.10E-07,7.70E+06,1.62E+07,1.49E+01,6.70E+00,-7.79,-0.92,-11.2,-11.5,-10.4,-10.1,
3144,1LFD,A:B,"MA30K,DA51K,DA58K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,7.10E-08,7.70E+06,1.10E+08,1.49E+01,7.80E+00,-7.79,-1.96,-11.2,-12.5,-10.4,-8.72,
3145,1LFD,A:B,"MA30K,DA51K,DA58K,DA94K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.00E-07,7.70E+06,9.63E+07,1.49E+01,1.00E+01,-7.79,-1.76,-11.2,-9.4,-10.4,-1.34,
3146,1LFD,A:B,"MA30K,DA58K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,3.30E-07,7.70E+06,1.73E+07,1.49E+01,5.80E+00,-7.79,-1.05,-11.2,-12.8,-10.4,-15.1,
3147,1LFD,A:B,"MA30K,DA94K",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,4.20E-07,7.70E+06,4.75E+07,1.49E+01,1.99E+01,-7.79,-0.91,-11.2,-10.3,-10.4,-6.04,
3148,1LFD,A:B,NA27K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,3.83E-06,7.70E+06,1.17E+07,1.49E+01,4.46E+01,-7.79,0.4,-11.2,-9.8,-10.4,-7.04,
3149,1LFD,A:B,NA54K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,2.70E-07,7.70E+06,1.58E+07,1.49E+01,4.20E+00,-7.79,-1.17,-11.2,-11.3,-10.4,-10.4,
3150,1LFD,A:B,NA92K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,7.50E-07,7.70E+06,2.14E+07,1.49E+01,1.61E+01,-7.79,-0.56,-11.2,-14.6,-10.4,-20.5,
3151,1LFD,A:B,RA20A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.32E-05,7.70E+06,2.50E+06,1.49E+01,3.30E+01,-7.79,1.14,-11.2,-11.3,-10.4,-16.1,
3152,1LFD,A:B,SA22K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,1.59E-06,7.70E+06,1.60E+07,1.49E+01,2.54E+01,-7.79,-0.12,-11.2,-14,-10.4,-22.8,
3153,1LFD,A:B,YA93K,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,GC,Stopped-flow Fluorescence,"15mM Hepes, 5mM MgCl2",298,7.4,SKEMPI,"15197281 (Table 2, <a href=""http://www.pnas.org/content/suppl/2004/06/04/0401160101.DC1/01160Table2.html"">supporting information</a>)",1.94E-06,2.21E-06,7.70E+06,2.17E+07,1.49E+01,4.80E+01,-7.79,0.08,-11.2,-12.4,-10.4,-15.1,
3154,1LFD,AC:BD,IA18A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,3.76E-06,,,,,-8.4,1,,-8.8,,,
3155,1LFD,AC:BD,RA20A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,2.85E-05,,,,,-8.39,2.19,,-10,,,
3156,1LFD,AC:BD,NA27A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,3.76E-06,,,,,-8.4,1,,-9.9,,,
3157,1LFD,AC:BD,NA29A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.91E-07,1.15E-06,,,,,-8.4,0.3,,-10,,,
3158,1LFD,AC:BD,YA31F,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,3.76E-06,,,,,-8.4,1,,-10.7,,,
3159,1LFD,AC:BD,KA32A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,1.45E-05,,,,,-8.39,1.79,,-5.4,,,
3160,1LFD,AC:BD,SA33A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,2.68E-06,,,,,-8.4,0.8,,-9.5,,,
3161,1LFD,AC:BD,KA48A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.91E-07,1.15E-06,,,,,-8.4,0.3,,-10.8,,,
3162,1LFD,AC:BD,DA51A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.95E-07,4.19E-07,,,,,-8.4,-0.3,,0,,,
3163,1LFD,AC:BD,KA52A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,4.00E-05,,,,,-8.39,2.4,,-6,,,
3164,1LFD,AC:BD,HA53A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,3.76E-06,,,,,-8.4,1,,-12.2,,,
3165,1LFD,AC:BD,E*52A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.95E-07,4.96E-07,,,,,-8.4,-0.2,,-12.8,,,
3166,1LFD,AC:BD,EA57A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,5.88E-07,,,,,-8.4,-0.1,,-10.9,,,
3167,1LFD,AC:BD,QB225A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,3.18E-06,,,,,-8.39,0.9,,-11.8,,,
3168,1LFD,AC:BD,EB231A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,9.75E-07,,,,,-8.4,0.2,,-6.4,,,
3169,1LFD,AC:BD,DB233A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,4.45E-06,,,,,-8.4,1.1,,-7.5,,,
3170,1LFD,AC:BD,SB239A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,2.53E-07,,,,,-8.4,-0.6,,-9.5,,,
3171,1LFD,AC:BD,YB240F,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,3.38E-05,,,,,-8.39,2.3,,-14.6,,,
3172,1LFD,AC:BD,RB241A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,3.18E-06,,,,,-8.39,0.9,,-10.7,,,
3173,1LFD,AC:BD,"NA29A,QB225A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.91E-07,1.15E-06,,,,,-8.4,0.3,,-11.1,,,
3174,1LFD,AC:BD,"KA32A,QB225A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,4.73E-05,,,,,-8.39,2.49,,-7.6,,,
3175,1LFD,AC:BD,"HA53A,EB231A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.40E-07,1.04E-05,,,,,-8.36,1.57,,-8.6,,,
3176,1LFD,AC:BD,"DA51A,DB233A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,9.75E-07,,,,,-8.4,0.2,,-11.6,,,
3177,1LFD,AC:BD,"HA53A,DB233A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,2.85E-05,,,,,-8.39,2.19,,-14.3,,,
3178,1LFD,AC:BD,"NA29A,SB239A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,6.96E-07,,,,,-8.4,0,,-9,,,
3179,1LFD,AC:BD,"YA31F,SB239A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.90E-07,2.68E-06,,,,,-8.4,0.8,,-11.1,,,
3180,1LFD,AC:BD,"KA48A,SB239A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.96E-07,5.88E-07,,,,,-8.4,-0.1,,-9,,,
3181,1LFD,AC:BD,"HA53A,SB239A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.98E-07,1.62E-06,,,,,-8.39,0.5,,-11.5,,,
3182,1LFD,AC:BD,"NA29A,YB240F",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,3.38E-05,,,,,-8.39,2.3,,-15.4,,,
3183,1LFD,AC:BD,"YA31F,YB240F",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,5.60E-05,,,,,-8.39,2.59,,-6.7,,,
3184,1LFD,AC:BD,"SA33A,YB240F",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,1.45E-05,,,,,-8.39,1.79,,-7.2,,,
3185,1LFD,AC:BD,"NA27A,RB241A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.40E-07,1.04E-05,,,,,-8.36,1.57,,-9.8,,,
3186,1LFD,AC:BD,"NA29A,RB241A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,7.39E-06,,,,,-8.39,1.4,,-11.4,,,
3187,1LFD,AC:BD,"YA31F,RB241A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.00E-07,1.45E-05,,,,,-8.39,1.79,,-12,,,
3188,1LFD,AC:BD,IA18A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,2.63E-05,,,,,-8.4,1.9,,,,,
3189,1LFD,AC:BD,RA20A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,5.91E-05,,,,,-8.4,2.4,,,,,
3190,1LFD,AC:BD,NA27A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,5.19E-06,,,,,-8.39,0.9,,,,,
3191,1LFD,AC:BD,NA29A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,3.75E-06,,,,,-8.39,0.7,,,,,
3192,1LFD,AC:BD,YA31F,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.90E-05,,,,,-8.4,1.7,,,,,
3193,1LFD,AC:BD,YA31A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,4.14E-04,,,,,-8.51,3.71,,,,,
3194,1LFD,AC:BD,KA32A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",2.00E-06,2.17E-04,,,,,-8.08,2.89,,,,,
3195,1LFD,AC:BD,SA33A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,7.17E-06,,,,,-8.4,1.1,,,,,
3196,1LFD,AC:BD,KA48A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,3.19E-06,,,,,-8.39,0.6,,,,,
3197,1LFD,AC:BD,DA51A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,7.40E-07,,,,,-8.4,-0.3,,,,,
3198,1LFD,AC:BD,KA52A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",2.00E-06,2.17E-04,,,,,-8.08,2.89,,,,,
3199,1LFD,AC:BD,HA53A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.09E-05,,,,,-8.4,2,,,,,
3200,1LFD,AC:BD,EA57A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,1.67E-06,,,,,-8.39,0.2,,,,,
3201,1LFD,AC:BD,VB229A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,2.71E-06,,,,,-8.4,0.5,,,,,
3202,1LFD,AC:BD,EB231A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.96E-06,,,,,-8.4,0.3,,,,,
3203,1LFD,AC:BD,EB237A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,8.44E-06,,,,,-8.39,1.2,,,,,
3204,1LFD,AC:BD,DB238A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,6.74E-04,,,,,-8.51,4.01,,,,,
3205,1LFD,AC:BD,SB239A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,2.79E-07,,,,,-8.4,-0.9,,,,,
3206,1LFD,AC:BD,YB240F,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.09E-05,,,,,-8.4,2,,,,,
3207,1LFD,AC:BD,YB240A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,4.87E-04,,,,,-8.51,3.81,,,,,
3208,1LFD,AC:BD,RB241A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,4.41E-06,,,,,-8.4,0.8,,,,,
3209,1LFD,AC:BD,EB262A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.21E-06,1.67E-06,,,,,-8.39,0.2,,,,,
3210,1LFD,AC:BD,EB263A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.96E-06,,,,,-8.4,0.3,,,,,
3211,1LFD,AC:BD,"HA53A,VB229A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.09E-05,,,,,-8.4,2,,,,,
3212,1LFD,AC:BD,"DA51A,EB231A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.17E-05,,,,,-8.4,1.4,,,,,
3213,1LFD,AC:BD,"RA20A,EB237A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.63E-05,,,,,-8.4,2.1,,,,,
3214,1LFD,AC:BD,"NA27A,EB237A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.09E-05,,,,,-8.4,2,,,,,
3215,1LFD,AC:BD,"YA31F,EB237A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,9.92E-06,,,,,-8.4,1.3,,,,,
3216,1LFD,AC:BD,"YA31A,EB237A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,4.14E-04,,,,,-8.51,3.71,,,,,
3217,1LFD,AC:BD,"SA33A,EB237A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,5.03E-05,,,,,-8.4,2.3,,,,,
3218,1LFD,AC:BD,"YA31A,DB238A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,3.42E-03,,,,,-8.4,4.9,,,,,
3219,1LFD,AC:BD,"SA33A,DB238A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,2.55E-04,,,,,-8.51,3.41,,,,,
3220,1LFD,AC:BD,"KA52A,DB238A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,2.39E-02,,,,,-8.4,6.1,,,,,
3221,1LFD,AC:BD,"YA31A,SB239A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-06,9.33E-04,,,,,-8.51,4.21,,,,,
3222,1LFD,AC:BD,"NA27A,RB241A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.37E-05,,,,,-8.4,1.5,,,,,
3223,1LFD,AC:BD,"NA29A,RB241A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,4.41E-06,,,,,-8.4,0.8,,,,,
3224,1LFD,AC:BD,"KA48A,EB263A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human GTPase HRas,,Fluorescence,"50mM Tris-HCl, 5 mM MgCl2",310,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.20E-06,1.96E-06,,,,,-8.4,0.3,,,,,
3225,1GUA,A:B,RB59A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.90E-07,2.68E-06,,,,,-8.6,1.01,,-4.5,,,
3226,1GUA,A:B,NB64A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.97E-07,2.53E-07,,,,,-8.6,-0.4,,-2.9,,,
3227,1GUA,A:B,KB65A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.97E-07,2.53E-07,,,,,-8.6,-0.4,,-3.8,,,
3228,1GUA,A:B,QB66A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.97E-07,5.88E-07,,,,,-8.6,0.1,,-4.3,,,
3229,1GUA,A:B,TB68A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-07,1.62E-06,,,,,-8.59,0.7,,-4.2,,,
3230,1GUA,A:B,VB69A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.97E-07,5.88E-07,,,,,-8.6,0.1,,-4.5,,,
3231,1GUA,A:B,KB84A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-07,1.45E-05,,,,,-8.59,1.99,,-4.3,,,
3232,1GUA,A:B,KB87A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.90E-07,1.91E-06,,,,,-8.6,0.81,,-4.2,,,
3233,1GUA,A:B,VB88A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.97E-07,6.96E-07,,,,,-8.6,0.2,,-6.8,,,
3234,1GUA,A:B,EA37A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.90E-07,4.45E-06,,,,,-8.6,1.31,,-2.7,,,
3235,1GUA,A:B,SA39A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.90E-07,5.27E-06,,,,,-8.6,1.41,,-8,,,
3236,1GUA,A:B,"RB59A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",4.90E-07,4.45E-06,,,,,-8.6,1.31,,-1.5,,,
3237,1GUA,A:B,"VB69A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-07,8.75E-06,,,,,-8.59,1.69,,-3.3,,,
3238,,,R*16A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,1.15E-06,,,,,-9.96,1.86,,-8.6,,,
3239,,,N*23A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.50E-08,3.54E-07,,,,,-9.9,1.1,,-7,,,mutation in RalGDS
3240,,,N*25A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.50E-08,1.52E-07,,,,,-9.9,0.6,,-8.2,,,mutation in RalGDS
3241,,,Y*27F,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.60E-08,6.96E-07,,,,,-9.89,1.49,,-12.4,,,mutation in RalGDS
3242,,,K*28A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,4.45E-06,,,,,-9.96,2.66,,-6.7,,,mutation in RalGDS
3243,,,S*29A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.60E-08,2.53E-07,,,,,-9.89,0.89,,-8.9,,,mutation in RalGDS
3244,,,K*44A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.53E-08,5.53E-08,,,,,-9.9,0,,-12.3,,,mutation in RalGDS
3245,,,D*47A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.53E-08,3.95E-08,,,,,-9.9,-0.2,,-9.8,,,mutation in RalGDS
3246,,,K*48A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,4.45E-06,,,,,-9.96,2.66,,-9.8,,,mutation in RalGDS
3247,,,H*49A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.50E-08,9.75E-07,,,,,-9.9,1.7,,-10.5,,,mutation in RalGDS
3248,,,E*52A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.53E-08,9.18E-08,,,,,-9.9,0.3,,-1.9,,,mutation in RalGDS
3249,,,E*53A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.57E-08,1.09E-07,,,,,-9.89,0.4,,-12.5,,,mutation in RalGDS
3250,,,P*34A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.57E-08,1.09E-07,,,,,-9.89,0.4,,-8.2,,,mutation in Rap
3251,,,I*36A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,1.15E-06,,,,,-9.96,1.86,,-10.5,,,mutation in Rap
3252,,,D*38A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-07,1.04E-05,,,,,-9.54,2.75,,-8,,,mutation in Rap
3253,,,R*41A,Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-07,1.04E-05,,,,,-9.54,2.75,,-8.2,,,mutation in Rap
3254,,,"Y*27F,D*38A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",7.69E-08,2.03E-05,,,,,-9.7,3.3,,,,,Y27F mutation in RalGDS; D38A mutation in Rap
3255,,,"K*28A,D*38A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,3.76E-06,,,,,-9.96,2.56,,,,,K28A mutation in RalGDS; D38A mutation in Rap
3256,,,"S*29A,D*38A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.00E-08,8.75E-06,,,,,-9.85,2.95,,,,,S29A mutation in RalGDS; D38A mutation in Rap
3257,,,"D*47A,D*38A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",6.00E-08,7.39E-06,,,,,-9.85,2.85,,,,,D47A mutation in RalGDS; D38A mutation in Rap
3258,,,"K*48A,D*38A",Human Ral guanine nucleotide dissociation stimulator (RalGDS),Human Ras-related protein Rap-1A,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5 mM MgCl2",298,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",5.00E-08,3.76E-06,,,,,-9.96,2.56,,,,,K48A mutation in RalGDS; D38A mutation in Rap
3259,3KUD,A:B,RB59A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.30E-06,,,,,-10,1.71,,-6.7,,,
3260,3KUD,A:B,NB64A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,9.51E-08,,,,,-10,0.1,,-7.6,,,
3261,3KUD,A:B,QB66A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.30E-06,,,,,-10,1.71,,-8.1,,,
3262,3KUD,A:B,RB67A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,2.12E-06,,,,,-10,2.01,,-6.5,,,
3263,3KUD,A:B,TB68A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,9.36E-07,,,,,-9.99,1.5,,-7.3,,,
3264,3KUD,A:B,VB69A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,4.14E-07,,,,,-9.99,1,,-7.1,,,
3265,3KUD,A:B,KB84A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",9.00E-08,2.94E-06,,,,,-9.93,2.13,,-6.9,,,
3266,3KUD,A:B,VB88A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,9.51E-08,,,,,-10,0.1,,-8,,,
3267,3KUD,A:B,IA21A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,3.51E-07,,,,,-10,0.91,,-9.9,,,
3268,3KUD,A:B,HA27A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,4.95E-08,,,,,-10,-0.3,,-8.1,,,
3269,3KUD,A:B,EA31A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,1.83E-07,,,,,-9.99,0.5,,-7.4,,,
3270,3KUD,A:B,DA33A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,4.87E-07,,,,,-9.99,1.1,,-6.5,,,
3271,3KUD,A:B,IA36A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.53E-06,,,,,-10,1.81,,-7.7,,,
3272,3KUD,A:B,EA37A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.53E-06,,,,,-10,1.81,,-6.3,,,
3273,3KUD,A:B,DA38A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-07,1.77E-05,,,,,-9.87,3.17,,-6,,,
3274,3KUD,A:B,SA39A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.09E-08,1.32E-07,,,,,-9.99,0.3,,-7.7,,,
3275,3KUD,A:B,RA41A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,3.03E-08,,,,,-10,-0.6,,-8.3,,,
3276,3KUD,A:B,VA45A,Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,4.95E-08,,,,,-10,-0.3,,-7.9,,,
3277,3KUD,A:B,"TB68A,IA21A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",9.00E-08,2.94E-06,,,,,-9.93,2.13,,-9.7,,,
3278,3KUD,A:B,"VB69A,IA21A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.10E-06,,,,,-10,1.6,,-9.3,,,
3279,3KUD,A:B,"VB88A,IA21A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.09E-08,1.32E-07,,,,,-9.99,0.3,,-14.4,,,
3280,3KUD,A:B,"VB88A,HA27A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,1.12E-07,,,,,-10,0.2,,-8.4,,,
3281,3KUD,A:B,"RB59A,EA31A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",9.00E-08,2.94E-06,,,,,-9.93,2.13,,-5.6,,,
3282,3KUD,A:B,"TB68A,EA31A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.10E-06,,,,,-10,1.6,,-5.8,,,
3283,3KUD,A:B,"KB84A,EA31A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,2.49E-06,,,,,-10,2.1,,-7.6,,,
3284,3KUD,A:B,"RB59A,DA33A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,5.64E-06,,,,,-10,2.6,,-6,,,
3285,3KUD,A:B,"KB84A,DA33A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,6.64E-06,,,,,-10,2.7,,-8,,,
3286,3KUD,A:B,"RB59A,IA36A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.07E-04,,,,,-10,4.41,,-8.9,,,
3287,3KUD,A:B,"TB68A,IA36A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-07,1.28E-05,,,,,-9.87,2.97,,-7.7,,,
3288,3KUD,A:B,"VB69A,IA36A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,6.64E-06,,,,,-10,2.7,,-4.6,,,
3289,3KUD,A:B,"RB59A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,4.07E-06,,,,,-10,2.41,,-5.7,,,
3290,3KUD,A:B,"TB68A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,9.21E-06,,,,,-10,2.9,,-4.7,,,
3291,3KUD,A:B,"VB69A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,7.82E-06,,,,,-10,2.8,,-6.7,,,
3292,3KUD,A:B,"KB84A,EA37A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,2.45E-05,,,,,-10,3.5,,-2.8,,,
3293,3KUD,A:B,"RB59A,DA38A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.48E-04,,,,,-10,4.6,,-4.7,,,
3294,3KUD,A:B,"TB68A,DA38A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",1.00E-07,1.28E-05,,,,,-9.87,2.97,,-4.9,,,
3295,3KUD,A:B,"QB66A,SA39A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,2.49E-06,,,,,-10,2.1,,-7.5,,,
3296,3KUD,A:B,"RB67A,SA39A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,3.46E-06,,,,,-10,2.31,,-6.6,,,
3297,3KUD,A:B,"TB68A,SA39A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,2.12E-06,,,,,-10,2.01,,-7,,,
3298,3KUD,A:B,"NB64A,RA41A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,3.03E-08,,,,,-10,-0.6,,-7.8,,,
3299,3KUD,A:B,"QB66A,RA41A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,6.75E-07,,,,,-9.99,1.3,,-6.1,,,
3300,3KUD,A:B,"NB64A,VA45A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.08E-08,8.08E-08,,,,,-10,0,,-6.4,,,
3301,3KUD,A:B,"QB66A,VA45A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.10E-06,,,,,-10,1.6,,-6.7,,,
3302,3KUD,A:B,"RB67A,VA45A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.00E-08,1.53E-06,,,,,-10,1.81,,-7.5,,,
3303,3KUD,A:B,"TB68A,VA45A",Human RAF proto-oncogene serine/threonine-protein kinase (c-Raf),Human GTPase HRas,,Isothermal Titration Calorimetry,"50mM Tris-HCl, 5mM MgCl2, 100mM NaCl",308,7.4,PINT,"15236966 (Tables 3, 4 and 6, pp. 1046, 1047 and 1051 respectively)",8.10E-08,4.87E-07,,,,,-9.99,1.1,,-7.8,,,
3304,3N4I,A:B,EB31A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,3.39E-06,,,,,-8.11,0.65,,,,,
3305,3N4I,A:B,SB35A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,2.27E-07,,,,,-8.11,-0.95,,,,,
3306,3N4I,A:B,SB39A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,2.25E-07,,,,,-8.11,-0.96,,,,,
3307,3N4I,A:B,HB41A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,2.05E-05,,,,,-8.11,1.72,,,,,
3308,3N4I,A:B,GB48A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.50E-07,,,,,-8.11,-0.43,,,,,
3309,3N4I,A:B,YB50A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,3.40E-08,,,,,-8.11,-2.07,,,,,
3310,3N4I,A:B,YB51A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,3.91E-07,,,,,-8.11,-0.63,,,,,
3311,3N4I,A:B,SB71A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,4.76E-07,,,,,-8.11,-0.51,,,,,
3312,3N4I,A:B,EB73A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,4.00E-08,,,,,-8.11,-1.98,,,,,
3313,3N4I,A:B,KB74A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,7.83E-07,,,,,-8.11,-0.22,,,,,
3314,3N4I,A:B,WB112A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.70E-06,,,,,-8.11,0.96,,,,,
3315,3N4I,A:B,SB113A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,4.02E-07,,,,,-8.11,-0.61,,,,,
3316,3N4I,A:B,GB141A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.62E-07,,,,,-8.11,-0.41,,,,,
3317,3N4I,A:B,FB142A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,1.80E-06,,,,,-8.11,0.28,,,,,
3318,3N4I,A:B,YB143A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.00E-08,,,,,-8.11,-1.85,,,,,
3319,3N4I,A:B,RB144A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,6.34E-07,,,,,-8.11,-0.34,,,,,
3320,3N4I,A:B,HB148A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,7.47E-06,,,,,-8.11,1.12,,,,,
3321,3N4I,A:B,WB150A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,2.30E-05,,,,,-8.11,1.78,,,,,
3322,3N4I,A:B,RB160A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,3.50E-06,,,,,-8.11,0.67,,,,,
3323,3N4I,A:B,WB162A,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,2.77E-06,,,,,-8.11,0.53,,,,,
3324,3N4I,A:B,"EB73A,YB50A",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,1.80E-08,,,,,-8.11,-2.45,,,,,
3325,3N4I,A:B,"YB50A,YB143A",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,3.40E-08,,,,,-8.11,-2.07,,,,,
3326,3N4I,A:B,"EB73A,YB143A",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.10E-08,,,,,-8.11,-1.83,,,,,
3327,3N4I,A:B,"WB112A,YB143A",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,5.66E-07,,,,,-8.11,-0.41,,,,,
3328,3N4I,A:B,"WB150A,YB143A",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,Literature,"15284234 (Table II, p. 42862)",1.13E-06,6.00E-06,,,,,-8.11,0.99,,,,,
3329,,,E*31A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.50E-09,,,,,-11.73,0.47,,,,,mutation in BLIP
3330,,,S*35A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.00E-10,,,,,-11.73,-0.95,,,,,mutation in BLIP
3331,,,F*36A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.11E-07,,,,,-11.73,3.15,,,,,mutation in BLIP
3332,,,S*39A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,2.00E-10,,,,,-11.73,-1.5,,,,,mutation in BLIP
3333,,,H*41A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.73E-07,,,,,-11.73,2.51,,,,,mutation in BLIP
3334,,,G*48A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.30E-09,,,,,-11.73,-0.39,,,,,mutation in BLIP
3335,,,D*49A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.67E-07,,,,,-11.73,2.49,,,,,mutation in BLIP
3336,,,Y*50A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.10E-09,,,,,-11.73,-0.49,,,,,mutation in BLIP
3337,,,Y*51A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,2.30E-09,,,,,-11.73,-0.05,,,,,mutation in BLIP
3338,,,Y*53A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,3.90E-08,,,,,-11.73,1.63,,,,,mutation in BLIP
3339,,,S*71A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.00E-10,,,,,-11.73,-0.95,,,,,mutation in BLIP
3340,,,E*73A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,6.00E-11,,,,,-11.73,-2.21,,,,,mutation in BLIP
3341,,,K*74A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.10E-09,,,,,-11.73,-0.49,,,,,mutation in BLIP
3342,,,W*112A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.80E-08,,,,,-11.73,1.17,,,,,mutation in BLIP
3343,,,S*113A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,7.00E-10,,,,,-11.73,-0.75,,,,,mutation in BLIP
3344,,,G*141A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,6.00E-10,,,,,-11.73,-0.85,,,,,mutation in BLIP
3345,,,F*142A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,4.30E-09,,,,,-11.73,0.32,,,,,mutation in BLIP
3346,,,Y*143A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.00E-10,,,,,-11.73,-0.95,,,,,mutation in BLIP
3347,,,R*144A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,3.00E-10,,,,,-11.73,-1.26,,,,,mutation in BLIP
3348,,,H*148A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.10E-07,,,,,-11.73,2.24,,,,,mutation in BLIP
3349,,,W*150A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,6.24E-07,,,,,-11.73,3.27,,,,,mutation in BLIP
3350,,,R*160A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,2.50E-08,,,,,-11.73,1.36,,,,,mutation in BLIP
3351,,,W*162A,Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,5.50E-08,,,,,-11.73,1.83,,,,,mutation in BLIP
3352,,,"E*73A,Y*50A",Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.70E-09,,,,,-11.73,-0.23,,,,,mutations in BLIP
3353,,,"Y*50A,Y*143A",Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,8.00E-10,,,,,-11.73,-0.67,,,,,mutations in BLIP
3354,,,"E*73A,Y*143A",Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,7.00E-10,,,,,-11.73,-0.75,,,,,mutations in BLIP
3355,,,"W*112A,Y*143A",Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,8.90E-09,,,,,-11.73,0.75,,,,,mutations in BLIP
3356,,,"W*150A,Y*143A",Bacillus anthracis beta-lactamase bla1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectroscopy,50 mm phosphate buffer with 1 mg/ml BSA,298,7,SKEMPI,"15284234 (Table II, p. 42862)",2.50E-09,1.75E-07,,,,,-11.73,2.52,,,,,mutations in BLIP
3357,,,W*302A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",6.00E-09,2.38E-07,,,,,-11.21,2.18,,,,,mutation in NP
3358,,,I*305A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",6.00E-09,1.29E-07,,,,,-11.21,1.82,,,,,mutation in NP
3359,,,Q*307A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",6.04E-09,1.26E-08,,,,,-11.21,0.44,,,,,mutation in NP
3360,,,Q*307D,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",6.00E-09,2.01E-07,,,,,-11.21,2.08,,,,,mutation in NP
3361,,,R*55A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",1.59E-07,7.19E-07,,,,,-9.27,0.89,,,,,mutation in hCypA
3362,,,R*55D,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",1.59E-07,2.15E-07,,,,,-9.27,0.18,,,,,mutation in hCypA
3363,,,Q*63A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",2.00E-07,3.72E-05,,,,,-9.13,3.09,,,,,mutation in hCypA
3364,,,W*121F,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",2.00E-07,2.63E-05,,,,,-9.13,2.89,,,,,mutation in hCypA
3365,,,R*69A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",1.59E-07,7.46E-08,,,,,-9.27,-0.45,,,,,mutation in hCypA
3366,,,R*69K,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin A (hCypA),Human SARS coronavirus nucleocapsid protein (NP),,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% (v/v) surfactant P20",298,7.4,PINT,"15358143 (Table 1, p. 561)",1.60E-07,3.16E-06,,,,,-9.27,1.77,,,,,mutation in hCypA
3367,1TM1,E:I,MI59A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,1.70E-11,,,,,-15.71,1.03,,,,,
3368,1TM1,E:I,MI59F,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,1.70E-11,,,,,-15.71,1.03,,,,,
3369,1TM1,E:I,MI59G,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,1.30E-10,,,,,-15.71,2.23,,,,,
3370,1TM1,E:I,MI59K,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,1.90E-11,,,,,-15.71,1.09,,,,,
3371,1TM1,E:I,MI59Y,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,3.30E-12,,,,,-15.71,0.06,,,,,
3372,1TM1,E:I,YI61A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.00E-12,4.60E-10,,,,,-15.71,2.98,,,,,
3373,1TM3,E:I,KI59M,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",1.90E-11,3.00E-12,,,,,-13.1,-1.09,,,,,
3374,1TM4,E:I,GI59M,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",1.30E-10,3.00E-12,,,,,-13.1,-2.23,,,,,
3375,1TM5,E:I,AI59M,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",1.70E-11,3.00E-12,,,,,-13.1,-1.03,,,,,
3376,1TM7,E:I,YI59M,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",3.30E-12,3.00E-12,,,,,-13.1,-0.06,,,,,
3377,1TMG,E:I,FI59M,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",1.70E-11,3.00E-12,,,,,-13.1,-1.03,,,,,
3378,1TO1,E:I,AI61Y,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1 mM DTT",298,8.6,SKEMPI,"15504027 (Table 1, p. 13650)",4.60E-10,3.00E-12,,,,,-13.1,-2.98,,,,,
3379,1JTG,A:B,DB49A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.82E-08,,,,,-11.35,1.79,,,,,
3380,1JTG,A:B,"DB49A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,7.11E-08,,,,,-11.35,1.6,,,,,
3381,1JTG,A:B,"DB49A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.05E-08,,,,,-11.35,1.1,,,,,
3382,1JTG,A:B,"DB49A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,8.73E-09,,,,,-11.35,0.36,,,,,
3383,1JTG,A:B,EA104A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,6.56E-08,,,,,-11.35,1.55,,,,,
3384,1JTG,A:B,"EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.70E-08,,,,,-11.35,1.03,,,,,
3385,1JTG,A:B,FB142A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.66E-07,,,,,-11.35,2.1,,,,,
3386,1JTG,A:B,"FB142A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,4.93E-07,,,,,-11.35,2.75,,,,,
3387,1JTG,A:B,"FB142A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,6.05E-08,,,,,-11.35,1.5,,,,,
3388,1JTG,A:B,"FB142A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.47E-06,,,,,-11.35,3.39,,,,,
3389,1JTG,A:B,"FB142A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.47E-06,,,,,-11.35,3.39,,,,,
3390,1JTG,A:B,"FB142A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,5.79E-07,,,,,-11.35,2.84,,,,,
3391,1JTG,A:B,"FB142A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.54E-08,,,,,-11.35,0.69,,,,,
3392,1JTG,A:B,"FB142A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,5.79E-07,,,,,-11.35,2.84,,,,,
3393,1JTG,A:B,"FB142A,YB143A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,6.28E-07,,,,,-11.35,2.89,,,,,
3394,1JTG,A:B,"FB142A,YB143A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,5.79E-07,,,,,-11.35,2.84,,,,,
3395,1JTG,A:B,"FB142A,YB143A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.29E-05,,,,,-11.35,4.68,,,,,
3396,1JTG,A:B,"FB142A,YB143A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.02E-05,,,,,-11.35,4.54,,,,,
3397,1JTG,A:B,"FB142A,YB143A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,5.33E-06,,,,,-11.35,4.16,,,,,
3398,1JTG,A:B,"FB142A,YB143A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,7.38E-07,,,,,-11.35,2.99,,,,,
3399,1JTG,A:B,KA234A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.70E-08,,,,,-11.35,1.03,,,,,
3400,1JTG,A:B,KB74A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.94E-06,,,,,-11.35,3.56,,,,,
3401,1JTG,A:B,"KB74A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,6.83E-08,,,,,-11.35,1.58,,,,,
3402,1JTG,A:B,"KB74A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,4.95E-08,,,,,-11.35,1.39,,,,,
3403,1JTG,A:B,"KB74A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.72E-05,,,,,-11.35,4.85,,,,,
3404,1JTG,A:B,"KB74A,FB142A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.40E-07,,,,,-11.35,3.13,,,,,
3405,1JTG,A:B,"KB74A,FB142A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.40E-07,,,,,-11.35,3.13,,,,,
3406,1JTG,A:B,"KB74A,FB142A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,8.97E-05,,,,,-11.35,5.83,,,,,
3407,1JTG,A:B,"KB74A,FB142A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,5.10E-05,,,,,-11.35,5.49,,,,,
3408,1JTG,A:B,"KB74A,FB142A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.90E-05,,,,,-11.35,5.16,,,,,
3409,1JTG,A:B,"KB74A,FB142A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.52E-05,,,,,-11.35,4.78,,,,,
3410,1JTG,A:B,"KB74A,FB142A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.42E-06,,,,,-11.35,3.89,,,,,
3411,1JTG,A:B,"KB74A,FB142A,YB143A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.69E-07,,,,,-11.35,2.39,,,,,
3412,1JTG,A:B,"KB74A,FB142A,YB143A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.80E-07,,,,,-11.35,2.41,,,,,
3413,1JTG,A:B,"KB74A,FB142A,YB143A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,4.90E-05,,,,,-11.35,5.47,,,,,
3414,1JTG,A:B,"KB74A,FB142A,YB143A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.41E-05,,,,,-11.35,5.26,,,,,
3415,1JTG,A:B,"KB74A,FB142A,YB143A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.47E-05,,,,,-11.35,5.06,,,,,
3416,1JTG,A:B,"KB74A,FB142A,YB143A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,6.01E-06,,,,,-11.35,4.23,,,,,
3417,1JTG,A:B,"KB74A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.01E-04,,,,,-11.35,6.55,,,,,
3418,1JTG,A:B,"KB74A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.40E-04,,,,,-11.35,6.62,,,,,
3419,1JTG,A:B,"KB74A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.02E-06,,,,,-11.35,3.18,,,,,
3420,1JTG,A:B,"KB74A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.30E-06,,,,,-11.35,3.32,,,,,
3421,1JTG,A:B,"KB74A,YB143A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,8.33E-07,,,,,-11.35,3.06,,,,,
3422,1JTG,A:B,"KB74A,YB143A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.81E-08,,,,,-11.35,1.05,,,,,
3423,1JTG,A:B,"KB74A,YB143A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.43E-08,,,,,-11.35,1.77,,,,,
3424,1JTG,A:B,"KB74A,YB143A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.79E-05,,,,,-11.35,4.87,,,,,
3425,1JTG,A:B,"KB74A,YB143A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,7.66E-06,,,,,-11.35,4.37,,,,,
3426,1JTG,A:B,"KB74A,YB143A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.58E-06,,,,,-11.35,3.73,,,,,
3427,1JTG,A:B,"KB74A,YB143A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.47E-06,,,,,-11.35,3.39,,,,,
3428,1JTG,A:B,RA243A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,4.04E-08,,,,,-11.35,1.27,,,,,
3429,1JTG,A:B,SA130A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,8.38E-09,,,,,-11.35,0.33,,,,,
3430,1JTG,A:B,YA105A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.59E-09,,,,,-11.35,-0.17,,,,,
3431,1JTG,A:B,YB143A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.09E-09,,,,,-11.35,0.38,,,,,
3432,1JTG,A:B,"YB143A,EA104A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.11E-07,,,,,-11.35,1.86,,,,,
3433,1JTG,A:B,"YB143A,EA104A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,1.53E-07,,,,,-11.35,2.05,,,,,
3434,1JTG,A:B,"YB143A,KA234A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,3.57E-07,,,,,-11.35,2.56,,,,,
3435,1JTG,A:B,"YB143A,RA243A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.20E-07,,,,,-11.35,2.27,,,,,
3436,1JTG,A:B,"YB143A,SA130A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,9.82E-08,,,,,-11.35,1.79,,,,,
3437,1JTG,A:B,"YB143A,YA105A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",4.77E-09,2.93E-08,,,,,-11.35,1.07,,,,,
3438,1S0W,A:C,AC1142F,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",1.66E-07,4.77E-09,,,,,-9.24,-2.1,,,,,
3439,1XXM,A:C,"AC1074K,AC1142F,AC1143Y,AA104E,AA105Y",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,"10mM Hepes, 3.4mM EDTA, 150mM NaCl, 0.05% surfactant P20",298,7.4,SKEMPI,"15618400 (Table 1, p. 59)",2.80E-07,4.77E-09,,,,,-8.94,-2.41,,,,,
3440,,,T*12V,Anabaena sp. flavodoxin,Anabaena sp. Photosystem I,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,"20 mM Tricine-KOH, 2 mM MgCl2",295,7.5,PINT,"15628849 (Table 2, p. 100)",5.00E-06,1.00E-05,,,,,-7.16,0.41,,,,,mutation in flavodoxin
3441,,,E*16Q,Anabaena sp. flavodoxin,Anabaena sp. Photosystem I,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,"20 mM Tricine-KOH, 2 mM MgCl2",295,7.5,PINT,"15628849 (Table 2, p. 100)",5.00E-06,6.67E-06,,,,,-7.16,0.17,,,,,mutation in flavodoxin
3442,,,T*56G,Anabaena sp. flavodoxin,Anabaena sp. Photosystem I,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,"20 mM Tricine-KOH, 2 mM MgCl2",295,7.5,PINT,"15628849 (Table 2, p. 100)",5.00E-06,1.25E-05,,,,,-7.16,0.54,,,,,mutation in flavodoxin
3443,,,N*97K,Anabaena sp. flavodoxin,Anabaena sp. Photosystem I,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,"20 mM Tricine-KOH, 2 mM MgCl2",295,7.5,PINT,"15628849 (Table 2, p. 100)",5.00E-06,1.00E-05,,,,,-7.16,0.41,,,,,mutation in flavodoxin
3444,,,E*16Q,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,2.08E-05,,,,,-7.53,1.15,,,,,mutation in flavodoxin
3445,,,E*20K,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,1.45E-05,,,,,-7.53,0.93,,,,,mutation in flavodoxin
3446,,,T*56G,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,2.34E-05,,,,,-7.53,1.22,,,,,mutation in flavodoxin
3447,,,T*56S,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,1.50E-05,,,,,-7.53,0.95,,,,,mutation in flavodoxin
3448,,,N*58C,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,2.07E-05,,,,,-7.53,1.14,,,,,mutation in flavodoxin
3449,,,N*58K,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,3.00E-05,,,,,-7.53,1.36,,,,,mutation in flavodoxin
3450,,,E*61A,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,1.50E-05,,,,,-7.53,0.95,,,,,mutation in flavodoxin
3451,,,E*61K,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,1.14E-05,,,,,-7.53,0.79,,,,,mutation in flavodoxin
3452,,,D*65K,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,5.90E-06,,,,,-7.53,0.4,,,,,mutation in flavodoxin
3453,,,D*96N,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,1.94E-05,,,,,-7.53,1.11,,,,,mutation in flavodoxin
3454,,,N*97K,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,8.00E-06,,,,,-7.53,0.58,,,,,mutation in flavodoxin
3455,,,T*12V,Anabaena sp. flavodoxin,Anabaena sp. ferredoxin-NADP+ reductase,OE,FNR-dependent NADPH cytochrome c reductase activity assayed by using Fld as the electron carrier from FNR to cytochrome c,50 mM Tris-HCl,298,8,PINT,"15628849 (Table 2, p. 100)",3.00E-06,2.20E-06,,,,,-7.53,-0.18,,,,,mutation in flavodoxin
3456,2AJF,A:E,FE360S,Human angiotensin-converting enzyme 2/ACE-related carboxypeptidase,Human SARS coronavirus spike S glycoprotein,RC,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"15791205 (Table I, p. 1639)",1.62E-08,1.41E-08,7.12E+04,6.23E+04,1.16E-03,8.80E-04,-10.62,-0.08,,,,,
3457,2AJF,A:E,KE344R,Human angiotensin-converting enzyme 2/ACE-related carboxypeptidase,Human SARS coronavirus spike S glycoprotein,RC,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"15791205 (Table I, p. 1639)",1.62E-08,1.60E-08,7.12E+04,6.50E+04,1.16E-03,1.04E-03,-10.62,-0.01,,,,,
3458,2AJF,A:E,NE479K,Human angiotensin-converting enzyme 2/ACE-related carboxypeptidase,Human SARS coronavirus spike S glycoprotein,RC,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"15791205 (Table I, p. 1639)",1.62E-08,4.84E-07,7.12E+04,5.73E+04,1.16E-03,2.77E-02,-10.62,2.01,,,,,
3459,2AJF,A:E,TE487S,Human angiotensin-converting enzyme 2/ACE-related carboxypeptidase,Human SARS coronavirus spike S glycoprotein,RC,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3mM EDTA, 0.005% v/v Surfactant P20",298,7.4,SKEMPI,"15791205 (Table I, p. 1639)",1.62E-08,3.52E-07,7.12E+04,3.88E+04,1.16E-03,1.32E-02,-10.62,1.82,,,,,
3460,1FYT,AB:C,HB110N,Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,5.06E-08,,,,,-10.03,-0.32,,,,,
3461,1FYT,AB:C,"HB110N,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,6.44E-08,,,,,-10.03,-0.17,,,,,
3462,1FYT,AB:C,"HB110N,VC325S",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,7.52E-08,,,,,-10.03,-0.08,,,,,
3463,1FYT,AB:C,VC325S,Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,9.72E-08,,,,,-10.03,0.08,,,,,
3464,1FYT,AB:C,LC330P,Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.49E-08,1.02E-07,,,,,-10.03,0.11,,,,,
3465,1FYT,AB:C,"HB110N,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.49E-08,1.18E-07,,,,,-10.03,0.2,,,,,
3466,1FYT,AB:C,"HB110N,VC325S,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.54E-08,1.33E-07,,,,,-10.03,0.27,,,,,
3467,1FYT,AB:C,"VC325S,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.51E-08,1.40E-07,,,,,-10.03,0.31,,,,,
3468,1FYT,AB:C,AC333G,Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.54E-08,1.58E-07,,,,,-10.03,0.38,,,,,
3469,1FYT,AB:C,"HB110N,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.57E-08,1.85E-07,,,,,-10.02,0.47,,,,,
3470,1FYT,AB:C,"LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,2.25E-07,,,,,-10.03,0.6,,,,,
3471,1FYT,AB:C,KC326D,Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,3.19E-07,,,,,-10.03,0.81,,,,,
3472,1FYT,AB:C,"VC325S,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,3.73E-07,,,,,-10.03,0.91,,,,,
3473,1FYT,AB:C,"HB110N,VC325S,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,5.58E-07,,,,,-10.03,1.16,,,,,
3474,1FYT,AB:C,"VC325S,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,6.05E-07,,,,,-10.03,1.21,,,,,
3475,1FYT,AB:C,"HB110N,KC326D",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.50E-08,6.44E-07,,,,,-10.03,1.25,,,,,
3476,1FYT,AB:C,"KC326D,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.60E-08,6.85E-07,,,,,-10.02,1.28,,,,,
3477,1FYT,AB:C,"HB110N,VC325S,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.00E-08,1.17E-06,,,,,-10.07,1.65,,,,,
3478,1FYT,AB:C,"HB110N,KC326D,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.00E-08,2.48E-06,,,,,-10.07,2.12,,,,,
3479,1FYT,AB:C,"VC325S,KC326D",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",9.00E-08,3.57E-06,,,,,-9.99,2.27,,,,,
3480,1FYT,AB:C,"KC326D,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",9.00E-08,4.82E-06,,,,,-9.99,2.45,,,,,
3481,1FYT,AB:C,"HB110N,VC325S,KC326D",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",9.00E-08,9.17E-06,,,,,-9.99,2.85,,,,,
3482,1FYT,AB:C,"KC326D,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.00E-08,9.99E-06,,,,,-10.07,2.97,,,,,
3483,1FYT,AB:C,"VC325S,KC326D,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,1.33E-08,,,,,-10.03,-1.14,,,,,
3484,1FYT,AB:C,"HB110N,KC326D,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,1.40E-08,,,,,-10.03,-1.11,,,,,
3485,1FYT,AB:C,"HB110N,VC325S,KC326D,LC330P",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,3.34E-08,,,,,-10.03,-0.58,,,,,
3486,1FYT,AB:C,"HB110N,KC326D,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,3.54E-08,,,,,-10.03,-0.54,,,,,
3487,1FYT,AB:C,"VC325S,KC326D,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,8.89E-08,,,,,-10.03,0.03,,,,,
3488,1FYT,AB:C,"HB110N,VC325S,KC326D,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,2.61E-08,,,,,-10.03,-0.73,,,,,
3489,1FYT,AB:C,"VC325S,KC326D,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,3.13E-08,,,,,-10.03,-0.62,,,,,
3490,1FYT,AB:C,"HB110N,VC325S,KC326D,LC330P,AC333G",Human HLA class II histocompatibility antigen DR (MHCII HLA-DR),Influenza A virus hemagglutinin,,Competitive Peptide Binding Assay,"0.1% BSA, 0.01% Tween 20, 0.1 mg/mL 4-(2-aminoethyl)-benzene sulfonyl fluoride 0.1mM iodoacetamide, 5mM EDTA, 0.02% NaN3",310,7.2,PINT,"15823020 (Table 1, p. 5618)",8.53E-08,7.81E-08,,,,,-10.03,-0.05,,,,,
3491,1TM1,E:I,EI60A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,5.20E-10,,,,,-15.71,3.05,,,,,
3492,1TM1,E:I,EI60S,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,3.10E-10,,,,,-15.71,2.75,,,,,
3493,1TM1,E:I,"EI60S,MI59R",Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,1.20E-09,,,,,-15.71,3.55,,,,,
3494,1TM1,E:I,RI62A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,2.50E-11,,,,,-15.71,1.26,,,,,
3495,1TM1,E:I,RI65A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,1.70E-09,,,,,-15.71,3.75,,,,,
3496,1TM1,E:I,RI67A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,5.60E-10,,,,,-15.71,3.1,,,,,
3497,1TM1,E:I,TI58A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,3.00E-10,,,,,-15.71,2.73,,,,,
3498,1TM1,E:I,TI58P,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Inhibition constant K<sub>i</sub> calculated from the reduced rates of subtilisin hydrolysis of a chromogenic substrate,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-12,1.70E-09,,,,,-15.71,3.75,,,,,
3499,1Y1K,E:I,AI58T,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.00E-10,3.00E-12,,,,,-12.91,-2.73,,,,,
3500,1Y33,E:I,PI58T,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",1.70E-09,3.00E-12,,,,,-12.91,-3.75,,,,,
3501,1Y34,E:I,AI60E,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",5.20E-10,3.00E-12,,,,,-12.91,-3.05,,,,,
3502,1Y3B,E:I,SI60E,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",3.10E-10,3.00E-12,,,,,-12.91,-2.75,,,,,
3503,1Y3C,E:I,AI62R,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",2.50E-11,3.00E-12,,,,,-12.91,-1.26,,,,,
3504,1Y3D,E:I,AI67R,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",5.60E-10,3.00E-12,,,,,-12.91,-3.1,,,,,
3505,1Y48,E:I,AI65R,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",1.70E-09,3.00E-12,,,,,-12.91,-3.75,,,,,
3506,1Y4A,E:I,"SI60E,RI59M",Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectroscopy,"0.1 M Tris, 1mM DTT",298,8.6,SKEMPI,"15865427 (Table 1, p. 6825)",1.20E-09,3.00E-12,,,,,-12.91,-3.55,,,,,
3507,,,A*131N,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.00E-09,,,,,-10.8,0,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3508,,,"A*131N,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,8.10E-08,,,,,-10.8,1.81,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3509,,,D*34G,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,8.80E-08,,,,,-10.8,1.86,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3510,,,D*34H,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,8.20E-08,,,,,-10.8,1.82,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3511,,,F*135A,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.00E-08,,,,,-10.8,0.66,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3512,,,"F*135A,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.00E-08,,,,,-10.8,1.27,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3513,,,"F*135A,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,4.70E-08,,,,,-10.8,1.51,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3514,,,H*133A,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.60E-08,,,,,-10.8,1.37,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3515,,,"H*133A,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.10E-08,,,,,-10.8,1.29,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3516,,,"H*133A,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,6.00E-09,,,,,-10.8,0.38,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3517,,,"H*133A,D*34K",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.60E-08,,,,,-10.8,1.37,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3518,,,H*133D,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,5.30E-08,,,,,-10.8,1.58,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3519,,,"H*133D,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.40E-08,,,,,-10.8,0.85,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3520,,,"H*133D,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.10E-08,,,,,-10.8,0.72,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3521,,,"H*133D,D*34K",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.70E-08,,,,,-10.8,1.38,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3522,,,"H*133K,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.70E-08,,,,,-10.8,0.95,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3523,,,"H*133K,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,8.00E-09,,,,,-10.8,0.54,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3524,,,S*132A,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.10E-08,,,,,-10.8,0.72,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3525,,,"S*132A,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,3.90E-08,,,,,-10.8,1.41,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3526,,,"S*132A,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.30E-08,,,,,-10.8,0.81,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3527,,,S*132V,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,6.30E-08,,,,,-10.8,1.68,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3528,,,"S*132V,D*34G",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,1.30E-08,,,,,-10.8,0.81,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3529,,,"S*132V,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,5.00E-09,,,,,-10.8,0.28,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3530,,,Y*134A,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,5.30E-08,,,,,-10.8,1.58,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3531,,,"Y*134A,D*34H",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table I, p. 2048)",3.00E-09,5.10E-08,,,,,-10.8,1.56,,,,,experiments done with cos7 cells with expression vectors for hIL-2R&alpha; and hIL-2&beta; variants
3532,,,F*56V,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,3.60E-08,,,,,-12.07,2.64,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3533,,,"H*133A,F*56V",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,3.90E-08,,,,,-12.07,2.68,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3534,,,"H*133A,Q*141V",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,8.70E-09,,,,,-12.07,1.85,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3535,,,"H*133D,F*56V",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,1.18E-07,,,,,-12.07,3.29,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3536,,,"H*133D,Q*141V",Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,2.31E-08,,,,,-12.07,2.39,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3537,,,Q*141V,Mouse interleukin-2 (mIL-2),Human interleukin-2 receptor beta (hIL-2Rb),,Cold ligand competition assay,"200 &micro;L HBSS, 0.1% BSA",277,,ASEdb,"1600937 (Table II, p. 2051)",3.00E-10,4.00E-10,,,,,-12.07,0.16,,,,,experiments done with BAF3 cells with mIL-2R&alpha; and hIL-2&beta; variants
3538,2A9K,A:B,GB99D,Human ras-related protein Ral-A,Clostridium botulinum D phage mono-ADP-ribosyltransferase C3/exoenzyme C3,,Isothermal Titration Calorimetry,"20mM Tris-HCl, 50mM NaCl, 2mM MgCl2, 2mM DTE",310,7.5,SKEMPI,"16177825 (Table 1, p. 3671)",6.00E-08,3.00E-06,,,,,-10.24,2.41,-20,-25,-31.4,-55.3,
3539,2B0Z,A:B,IB82F,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50mM potassium phosphate,298,7,SKEMPI,"16227441 (Table 1, p. 15467)",1.00E-04,1.40E-06,,,,,-5.45,-2.53,,,,,
3540,2B10,A:B,SB82F,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50mM potassium phosphate,298,7,SKEMPI,"16227441 (Table 1, p. 15467)",1.00E-05,1.40E-06,,,,,-6.82,-1.16,,,,,
3541,2B11,A:B,WB382F,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50mM potassium phosphate,298,7,SKEMPI,"16227441 (Table 1, p. 15467)",5.00E-06,1.40E-06,,,,,-7.23,-0.75,,,,,
3542,2B12,A:B,YB82F,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Saccharomyces cerevisiae cytochrome c iso-1,OE,Isothermal Titration Calorimetry,50mM potassium phosphate,298,7,SKEMPI,"16227441 (Table 1, p. 15467)",2.00E-05,1.40E-06,,,,,-6.41,-1.57,,,,,
3543,2B42,A:B,HA374A,"Bacillus subtilis endo-1,4-beta-xylanase A",Triticum aestivum xylanase inhibitor TAXI-I,EI,Surface Plasmon Resonance,10mM sodium acetate,295,5,SKEMPI,"16279951 (Table 2, p. 5876)",1.07E-09,1.70E-08,3.61E+05,1.17E+05,3.60E-04,1.59E-03,-12.11,1.62,,,,,
3544,2B42,A:B,HA374K,"Bacillus subtilis endo-1,4-beta-xylanase A",Triticum aestivum xylanase inhibitor TAXI-I,EI,Surface Plasmon Resonance,10mM sodium acetate,295,5,SKEMPI,"16279951 (Table 2, p. 5876)",1.07E-09,8.16E-08,3.61E+05,4.57E+04,3.60E-04,3.44E-03,-12.11,2.54,,,,,
3545,2B42,A:B,HA374Q,"Bacillus subtilis endo-1,4-beta-xylanase A",Triticum aestivum xylanase inhibitor TAXI-I,EI,Surface Plasmon Resonance,10mM sodium acetate,295,5,SKEMPI,"16279951 (Table 2, p. 5876)",1.07E-09,6.58E-09,3.61E+05,2.56E+05,3.60E-04,1.18E-03,-12.11,1.06,,,,,
3546,1KTZ,A:B,DB118A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,2.69E-06,,,,,-8.86,1.26,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3547,1KTZ,A:B,DB32A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,8.87E-06,,,,,-8.86,1.97,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3548,1KTZ,A:B,DB32N,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.99E-05,,,,,-8.86,2.45,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3549,1KTZ,A:B,EB119A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,8.47E-06,,,,,-8.86,1.94,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3550,1KTZ,A:B,EB119Q,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.06E-05,,,,,-8.86,2.07,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3551,1KTZ,A:B,EB55A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,5.30E-06,,,,,-8.86,1.66,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3552,1KTZ,A:B,EB75A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,4.21E-06,,,,,-8.86,1.53,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3553,1KTZ,A:B,FB110A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,3.28E-06,,,,,-8.86,1.38,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3554,1KTZ,A:B,FB30A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.04E-04,,,,,-8.86,3.43,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3555,1KTZ,A:B,HB79A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.12E-06,,,,,-8.86,0.74,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3556,1KTZ,A:B,IB125A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.69E-06,,,,,-8.86,0.99,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3557,1KTZ,A:B,IB50A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.67E-05,,,,,-8.86,2.34,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3558,1KTZ,A:B,IB53A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,6.87E-06,,,,,-8.86,1.82,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3559,1KTZ,A:B,LB27A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.48E-05,,,,,-8.86,2.27,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3560,1KTZ,A:B,MB112A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,2.96E-06,,,,,-8.86,1.32,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3561,1KTZ,A:B,NB47A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.10E-06,,,,,-8.86,0.73,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3562,1KTZ,A:B,SB49A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.18E-06,,,,,-8.86,0.77,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3563,1KTZ,A:B,SB52A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,9.80E-07,,,,,-8.86,0.66,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3564,1KTZ,A:B,SB52L,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,6.20E-04,,,,,-8.86,4.48,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3565,1KTZ,A:B,TB51A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,8.75E-06,,,,,-8.86,1.96,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3566,1KTZ,A:B,VB62A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,2.03E-06,,,,,-8.86,1.09,,,,,experiment carried out with del(14) mutants of the receptor (T?RII-&Delta;14-ED)
3567,1KTZ,A:B,VB77A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% Tween-20",298,7.4,SKEMPI,"16300789 (Table 1, p. 53)",3.20E-07,1.37E-06,,,,,-8.86,0.86,,,,,
3568,2I26,N:L,AN30V,Ginglymostoma cirratum antigen receptor (type II IgNAR),Gallus gallus egg-white lysozyme C (HEL/HEWL),,Surface Plasmon Resonance,"10mM HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"16446445 (Table 2, p. 1850)",9.50E-09,1.00E-08,2.10E+05,1.40E+05,2.00E-03,1.60E-03,-10.94,0.03,,,,,
3569,2I26,N:L,SN61R,Ginglymostoma cirratum antigen receptor (type II IgNAR),Gallus gallus egg-white lysozyme C (HEL/HEWL),,Surface Plasmon Resonance,"10mM HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"16446445 (Table 2, p. 1850)",9.50E-09,3.30E-09,2.10E+05,3.50E+05,2.00E-03,1.20E-03,-10.94,-0.63,,,,,
3570,2G2U,A:B,DA104K,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Nitrocefin indicator to measure hydrolysis,10mM sodium PBS with 1 mg/ml BSA,298,7.4,SKEMPI,"16809340 (Table 1, p. 26746)",1.25E-06,5.82E-07,,,,,-8.05,-0.45,,,,,
3571,2G2W,A:B,KA104D,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Nitrocefin indicator to measure hydrolysis,10mM sodium PBS with 1 mg/ml BSA,298,7.4,SKEMPI,"16809340 (Table 1, p. 26746)",5.82E-07,1.25E-06,,,,,-8.5,0.45,,,,,
3572,2HLE,A:B,KA149Q,Human ephrin type-B receptor 4,Human ephrin-B2,RC,Isothermal Titration Calorimetry,"50mM Tris-Cl, 150mM NaCl, 1mM CaCl2",298,7.8,SKEMPI,"16867992 (Table 3, p. 28191)",4.00E-08,2.00E-08,,,,,-10.09,-0.41,3.3,3.7,44.9,48.3,
3573,2HLE,A:B,LA95R,Human ephrin type-B receptor 4,Human ephrin-B2,RC,Isothermal Titration Calorimetry,"50mM Tris-Cl, 150mM NaCl, 1mM CaCl2",298,7.8,SKEMPI,"16867992 (Table 3, p. 28191)",4.00E-08,1.90E-06,,,,,-10.09,2.29,3.3,5.2,44.9,43.6,
3574,2J12,A:B,SA299A,Human adenovirus D37 fiber protein,Human coxsackie virus and adenovirus receptor (CAR),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% P20 detergent",298,7.4,SKEMPI,"16923808 (Figure 6, p. 33713)",2.00E-08,1.00E-07,,,,,-10.5,0.95,,,,,
3575,2J1K,C:T,GC370D,Human adenovirus D37 fiber protein,Human coxsackie virus and adenovirus receptor (CAR),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% P20 detergent",298,7.4,SKEMPI,"16923808 (Figure 6, p. 33713)",1.10E-09,1.50E-09,,,,,-12.22,0.18,,,,,
3576,2J1K,C:T,RC384A,Human adenovirus D37 fiber protein,Human coxsackie virus and adenovirus receptor (CAR),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% P20 detergent",298,7.4,SKEMPI,"16923808 (Figure 6, p. 33713)",1.10E-09,4.00E-09,,,,,-12.22,0.76,,,,,
3577,2J1K,C:T,RC515A,Human adenovirus D37 fiber protein,Human coxsackie virus and adenovirus receptor (CAR),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, 0.005% P20 detergent",298,7.4,SKEMPI,"16923808 (Figure 6, p. 33713)",1.10E-09,1.20E-09,,,,,-12.22,0.05,,,,,
3578,1JTG,A:B,DB49A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,8.03E-08,6.70E+04,6.95E+04,1.50E-04,2.90E-03,-11.35,1.67,,,,,
3579,1JTG,A:B,EA104A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,9.43E-08,6.70E+04,1.79E+05,1.50E-04,8.67E-03,-11.35,1.77,,,,,
3580,1JTG,A:B,"EA104A,SB113A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.11E-07,6.70E+04,9.26E+04,1.50E-04,5.29E-03,-11.35,1.86,,,,,
3581,1JTG,A:B,"EA104A,SB113A,SB71A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.72E-07,6.70E+04,1.10E+05,1.50E-04,2.58E-02,-11.35,2.58,,,,,
3582,1JTG,A:B,EA110A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.53E-06,,,,,-11.35,4.06,,,,,
3583,1JTG,A:B,"EA110A,SB113A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.06E-05,,,,,-11.35,4.56,,,,,
3584,1JTG,A:B,"EA110A,SB113A,SB71A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.37E-05,6.70E+04,4.29E+04,1.50E-04,1.25E-03,-11.35,5.04,,,,,
3585,1JTG,A:B,"EA110A,SB71A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.28E-05,,,,,-11.35,5.02,,,,,
3586,1JTG,A:B,"EA110A,YB50A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.86E-06,,,,,-11.35,3.97,,,,,
3587,1JTG,A:B,EA168A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.22E-09,6.70E+04,7.00E+04,1.50E-04,1.78E-04,-11.35,-0.07,,,,,
3588,1JTG,A:B,"EA168A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.05E-08,6.70E+04,7.31E+04,1.50E-04,2.29E-03,-11.35,1.5,,,,,
3589,1JTG,A:B,"EA168A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.72E-07,6.70E+04,5.59E+04,1.50E-04,1.10E-02,-11.35,2.58,,,,,
3590,1JTG,A:B,"EA168A,KB74A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.53E-06,6.70E+04,2.38E+04,1.50E-04,6.83E-02,-11.35,4.06,,,,,
3591,1JTG,A:B,"EA168A,RB160A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.39E-07,6.70E+04,1.57E+04,1.50E-04,2.00E-03,-11.35,2.32,,,,,
3592,1JTG,A:B,"EA168A,WB112A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,5.34E-07,6.70E+04,5.44E+04,1.50E-04,1.65E-02,-11.35,2.79,,,,,
3593,1JTG,A:B,"EA168A,WB150A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.91E-06,6.70E+04,2.66E+04,1.50E-04,7.70E-02,-11.35,4.11,,,,,
3594,1JTG,A:B,"EA168A,WB162A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.59E-07,6.70E+04,6.04E+04,1.50E-04,5.17E-03,-11.35,2.08,,,,,
3595,1JTG,A:B,FB142A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.29E-07,6.70E+04,6.50E+04,1.50E-04,9.80E-03,-11.35,2.51,,,,,
3596,1JTG,A:B,FB36A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.06E-06,6.70E+04,2.58E+04,1.50E-04,1.52E-02,-11.35,3.2,,,,,
3597,1JTG,A:B,HB148A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.93E-07,6.70E+04,5.17E+04,1.50E-04,1.40E-02,-11.35,2.75,,,,,
3598,1JTG,A:B,HB41A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.15E-06,6.70E+04,5.79E+04,1.50E-04,3.70E-02,-11.35,3.25,,,,,
3599,1JTG,A:B,KB74A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.03E-06,,,,,-11.35,3.82,,,,,
3600,1JTG,A:B,MA129A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.66E-08,6.70E+04,4.06E+04,1.50E-04,3.35E-04,-11.35,0.74,,,,,
3601,1JTG,A:B,"MA129A,FB36A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.19E-06,6.70E+04,1.32E+04,1.50E-04,1.60E-02,-11.35,3.63,,,,,
3602,1JTG,A:B,"MA129A,SB113A,SB71A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,8.03E-08,6.70E+04,3.81E+04,1.50E-04,1.58E-03,-11.35,1.67,,,,,
3603,1JTG,A:B,"MA129A,YB50A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,8.73E-09,6.70E+04,5.49E+04,1.50E-04,2.27E-04,-11.35,0.36,,,,,
3604,1JTG,A:B,"MA129A,YB53A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.11E-06,6.70E+04,2.54E+04,1.50E-04,2.99E-02,-11.35,3.61,,,,,
3605,1JTG,A:B,NA100A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.21E-09,6.70E+04,1.12E+05,1.50E-04,1.16E-04,-11.35,-0.46,,,,,
3606,1JTG,A:B,"NA100A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.83E-08,6.70E+04,4.57E+04,1.50E-04,1.57E-03,-11.35,1.58,,,,,
3607,1JTG,A:B,"NA100A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.29E-07,6.70E+04,6.13E+04,1.50E-04,7.31E-03,-11.35,2.29,,,,,
3608,1JTG,A:B,"NA100A,HB148A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.66E-07,6.70E+04,9.22E+04,1.50E-04,8.11E-03,-11.35,2.1,,,,,
3609,1JTG,A:B,"NA100A,KB74A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.79E-06,6.70E+04,2.02E+04,1.50E-04,4.12E-02,-11.35,3.51,,,,,
3610,1JTG,A:B,"NA100A,RB160A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.83E-08,6.70E+04,5.03E+04,1.50E-04,1.77E-03,-11.35,1.58,,,,,
3611,1JTG,A:B,"NA100A,WB112A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,5.34E-07,6.70E+04,5.08E+04,1.50E-04,1.46E-02,-11.35,2.79,,,,,
3612,1JTG,A:B,"NA100A,WB150A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,7.36E-06,6.70E+04,2.53E+04,1.50E-04,1.10E-01,-11.35,4.35,,,,,
3613,1JTG,A:B,"NA100A,WB162A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.66E-07,6.70E+04,4.18E+04,1.50E-04,3.59E-03,-11.35,2.1,,,,,
3614,1JTG,A:B,PA107A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.50E-09,6.70E+04,1.75E+05,1.50E-04,2.01E-04,-11.35,-0.38,,,,,
3615,1JTG,A:B,"PA107A,HB41A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.20E-07,6.70E+04,4.63E+04,1.50E-04,1.03E-02,-11.35,2.65,,,,,
3616,1JTG,A:B,"PA107A,YB50A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.60E-09,6.70E+04,1.20E+05,1.50E-04,8.75E-05,-11.35,-0.65,,,,,
3617,1JTG,A:B,"PA107A,YB53A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.69E-07,6.70E+04,3.06E+04,1.50E-04,4.34E-03,-11.35,2.39,,,,,
3618,1JTG,A:B,QA99A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,9.85E-09,6.70E+04,6.61E+04,1.50E-04,3.19E-04,-11.35,0.43,,,,,
3619,1JTG,A:B,"QA99A,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.95E-07,6.70E+04,6.33E+04,1.50E-04,6.48E-03,-11.35,2.2,,,,,
3620,1JTG,A:B,"QA99A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,5.56E-07,6.70E+04,9.20E+04,1.50E-04,2.81E-02,-11.35,2.82,,,,,
3621,1JTG,A:B,"QA99A,HB148A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.06E-06,6.70E+04,1.38E+05,1.50E-04,8.00E-02,-11.35,3.2,,,,,
3622,1JTG,A:B,"QA99A,KB74A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,4.91E-06,6.70E+04,2.22E+04,1.50E-04,9.33E-02,-11.35,4.11,,,,,
3623,1JTG,A:B,"QA99A,RB160A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.68E-06,6.70E+04,7.61E+03,1.50E-04,1.14E-02,-11.35,3.75,,,,,
3624,1JTG,A:B,"QA99A,WB112A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.87E-06,6.70E+04,5.05E+04,1.50E-04,5.19E-02,-11.35,3.54,,,,,
3625,1JTG,A:B,"QA99A,WB150A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.03E-06,6.70E+04,2.17E+04,1.50E-04,3.81E-02,-11.35,3.82,,,,,
3626,1JTG,A:B,"QA99A,WB162A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.28E-07,6.70E+04,8.34E+04,1.50E-04,2.87E-02,-11.35,2.89,,,,,
3627,1JTG,A:B,RB160A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.03E-07,6.70E+04,3.34E+04,1.50E-04,4.50E-03,-11.35,2.22,,,,,
3628,1JTG,A:B,SB113A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,3.59E-09,6.70E+04,1.04E+05,1.50E-04,1.74E-04,-11.35,-0.17,,,,,
3629,1JTG,A:B,SB71A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,8.73E-09,6.70E+04,6.30E+04,1.50E-04,4.05E-04,-11.35,0.36,,,,,
3630,1JTG,A:B,"SB71A,SB113A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.03E-08,6.70E+04,6.30E+04,1.50E-04,6.08E-04,-11.35,0.46,,,,,
3631,1JTG,A:B,VA103A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.20E-07,6.70E+04,6.43E+04,1.50E-04,4.03E-03,-11.35,1.91,,,,,
3632,1JTG,A:B,"VA103A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,9.76E-06,,,,,-11.35,4.51,,,,,
3633,1JTG,A:B,"VA103A,RB160A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,7.36E-06,,,,,-11.35,4.35,,,,,
3634,1JTG,A:B,"VA103A,WB162A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.01E-06,6.70E+04,2.62E+04,1.50E-04,9.00E-02,-11.35,4.23,,,,,
3635,1JTG,A:B,VA216A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.40E-09,6.70E+04,2.65E+04,1.50E-04,2.96E-05,-11.35,-0.41,,,,,
3636,1JTG,A:B,"VA216A,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.95E-07,6.70E+04,2.16E+04,1.50E-04,2.17E-03,-11.35,2.2,,,,,
3637,1JTG,A:B,"VA216A,YB50A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.07E-09,6.70E+04,2.39E+04,1.50E-04,1.16E-05,-11.35,-0.89,,,,,
3638,1JTG,A:B,WB112A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,7.68E-07,6.70E+04,7.68E+04,1.50E-04,3.22E-02,-11.35,3.01,,,,,
3639,1JTG,A:B,WB150A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,6.26E-06,6.70E+04,2.46E+04,1.50E-04,9.08E-02,-11.35,4.25,,,,,
3640,1JTG,A:B,WB162A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.48E-07,6.70E+04,6.43E+04,1.50E-04,9.40E-03,-11.35,2.34,,,,,
3641,1JTG,A:B,YB50A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,2.40E-09,6.70E+04,3.58E+04,1.50E-04,3.92E-05,-11.35,-0.41,,,,,
3642,1JTG,A:B,YB53A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Surface Plasmon Resonance,PBS with 0.05% surfactant P20,298,7.4,SKEMPI,"17070843 (Table 1, p. 669, Table 2, p. 670, Tables 3 and 4, p. 671)",4.77E-09,1.59E-07,6.70E+04,9.82E+04,1.50E-04,8.27E-03,-11.35,2.08,,,,,
3643,2JEL,P:HL,FP2Y,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3644,2JEL,P:HL,FP2W,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,4.44E-11,,,,,,,,,,,
3645,2JEL,P:HL,QP3K,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-12,,,,,,,,,,,
3646,2JEL,P:HL,QP4K,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-10,,,,,,,,,,,
3647,2JEL,P:HL,EP5D,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3648,2JEL,P:HL,EP5Q,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.11E-09,,,,,,,,,,,
3649,2JEL,P:HL,VP6F,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3650,2JEL,P:HL,TP7N,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3651,2JEL,P:HL,TP7S,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3652,2JEL,P:HL,PP11E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3653,2JEL,P:HL,NP12D,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3654,2JEL,P:HL,RP17G,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3655,2JEL,P:HL,RP17K,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3656,2JEL,P:HL,KP24E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3657,2JEL,P:HL,KP27E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3658,2JEL,P:HL,TP34Q,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3659,2JEL,P:HL,TP36N,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3660,2JEL,P:HL,NP38Y,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3661,2JEL,P:HL,SP41K,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,2.96E-10,,,,,,,,,,,
3662,2JEL,P:HL,SP43N,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3663,2JEL,P:HL,SP46C,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3664,2JEL,P:HL,FP48M,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3665,2JEL,P:HL,QP57E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,7.40E-09,,,,,,,,,,,
3666,2JEL,P:HL,TP62N,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3667,2JEL,P:HL,TP62A,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3668,2JEL,P:HL,SP64Y,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-12,,,,,,,,,,,
3669,2JEL,P:HL,EP68A,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3670,2JEL,P:HL,DP69E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,7.40E-10,,,,,,,,,,,
3671,2JEL,P:HL,QP71E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-11,,,,,,,,,,,
3672,2JEL,P:HL,KP72R,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3673,2JEL,P:HL,KP72E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3674,2JEL,P:HL,EP75R,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-11,,,,,,,,,,,
3675,2JEL,P:HL,HP76D,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.11E-08,,,,,,,,,,,
3676,2JEL,P:HL,HP76A,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,7.40E-09,,,,,,,,,,,
3677,2JEL,P:HL,KP79E,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,1.85E-09,,,,,,,,,,,
3678,2JEL,P:HL,AP82S,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3679,2JEL,P:HL,EP83A,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3680,2JEL,P:HL,EP85Q,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3681,2JEL,P:HL,EP85D,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3682,2JEL,P:HL,EP85A,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3683,2JEL,P:HL,EP85K,Mouse JEL42 antibody (Fab),Escherichia coli phosphocarrier protein/histidine-containing protein (HPr),Ag-Ab,Competition solid-phase radioimmune assay,PBS with 1% fetal calf serum,298,,SKEMPI,"1711212 (Table 1, p.4879); wild-type binding affinity value: <a href=""https://www.ncbi.nlm.nih.gov/pubmed/9671548"">9671548</a> (Abstract, p. 765);",3.70E-09,3.70E-09,,,,,,,,,,,
3684,2O3B,A:B,DB75E,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,3.10E-08,,,,,-15.67,5.44,,,,,
3685,2O3B,A:B,DB75N,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,6.80E-08,,,,,-15.67,5.9,,,,,
3686,2O3B,A:B,EB24A,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,3.30E-08,,,,,-15.67,5.47,,,,,
3687,2O3B,A:B,EB24D,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,8.80E-12,,,,,-15.67,0.6,,,,,
3688,2O3B,A:B,EB24Q,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,2.90E-08,,,,,-15.67,5.4,,,,,
3689,2O3B,A:B,QB74A,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,7.50E-10,,,,,-15.67,3.23,,,,,
3690,2O3B,A:B,"QB74A,WB76A",Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,5.30E-08,,,,,-15.67,5.75,,,,,
3691,2O3B,A:B,WB76A,Nostoc sp. nuclease (nucA),Nostoc sp. sugar-non-specific nuclease inhibitor (nuiA),EI,Measurement of plasmid DNA cleavage using agarose gel assay,"50mM Tris-HCl, 50mM NaCl, 1mM EDTA, 0.01% Triton X-100, 0.01% BSA, 5mM MnCl2",298,7,SKEMPI,"17138564 (Table 3, p. 5688)",3.20E-12,3.10E-09,,,,,-15.67,4.07,,,,,
3692,2C0L,A:B,NA382A,Human peroxisomal targeting signal 1 receptor/peroxin-5 (PEX5) TPR domain,Human non-specific lipid-transfer protein/sterol carrier protein 2 (NSL-TP/SCP-2),,Isothermal Titration Microcalorimetry,"100mM potassium phosphate, 1mM DTT",308,7.4,SKEMPI,"17157249 (Table 1, p. 655)",1.09E-07,3.48E-07,,,,,-9.81,0.71,-10.1,-6.52,-0.96,8.38,
3693,2C0L,A:B,QA586R,Human peroxisomal targeting signal 1 receptor/peroxin-5 (PEX5) TPR domain,Human non-specific lipid-transfer protein/sterol carrier protein 2 (NSL-TP/SCP-2),,Isothermal Titration Microcalorimetry,"100mM potassium phosphate, 1mM DTT",308,7.4,SKEMPI,"17157249 (Table 1, p. 655)",1.09E-07,1.34E-06,,,,,-9.81,1.54,-10.1,-4.16,-0.96,13.4,
3694,2C0L,A:B,SA589Y,Human peroxisomal targeting signal 1 receptor/peroxin-5 (PEX5) TPR domain,Human non-specific lipid-transfer protein/sterol carrier protein 2 (NSL-TP/SCP-2),,Isothermal Titration Microcalorimetry,"100mM potassium phosphate, 1mM DTT",308,7.4,SKEMPI,"17157249 (Table 1, p. 655)",1.09E-07,1.73E-07,,,,,-9.81,0.28,-10.1,-9.25,-0.96,0.93,
3695,2NYY,A:CD,HC34Q,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,1.40E-10,,,,,-13.29,-0.06,,,,,
3696,2NYY,A:CD,KD30R,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,1.75E-10,,,,,-13.29,0.07,,,,,
3697,2NYY,A:CD,YD31D,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,1.73E-10,,,,,-13.29,0.06,,,,,
3698,2NYY,A:CD,YD31Q,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,1.93E-10,,,,,-13.29,0.13,,,,,
3699,2NYY,A:CD,YD57Q,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,3.75E-10,,,,,-13.29,0.52,,,,,
3700,2NYY,A:CD,SC28Q,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,3.13E-10,,,,,-13.29,0.41,,,,,
3701,2NYY,A:CD,DC30Y,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,4.61E-10,,,,,-13.29,0.64,,,,,
3702,2NYY,A:CD,SC31N,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,8.50E-11,,,,,-13.29,-0.35,,,,,
3703,2NYY,A:CD,HC34R,Clostridium botulinum neurotoxin type A,Human monoclonal antibody IgG Fab CR1,Ag-Ab,Flow cytometry,,296,,Literature,"17173035 (Table 2, p. 110)",1.55E-10,1.84E-10,,,,,-13.29,0.1,,,,,
3704,1UUZ,A:D,CA64A,Gallus gallus egg-white lysozyme C (HEL/HEWL),Pseudomonas aeruginosa inhibitor of vertebrate lysozyme,EI,Monitoring the change in turbidity due to lysis of cells,100 mM potassium phosphate,298,6.4,SKEMPI,"17405861 (SI Table 3, <a href=""http://www.pnas.org/content/suppl/2007/03/22/0611019104.DC1"">here</a>)",1.00E-09,3.00E-09,,,,,-12.27,0.65,,,,,
3705,1UUZ,A:D,HA62A,Gallus gallus egg-white lysozyme C (HEL/HEWL),Pseudomonas aeruginosa inhibitor of vertebrate lysozyme,EI,Monitoring the change in turbidity due to lysis of cells,,298,6.4,SKEMPI,"17405861 (SI Table 3, <a href=""http://www.pnas.org/content/suppl/2007/03/22/0611019104.DC1"">here</a>)",1.00E-09,2.00E-08,,,,,-12.27,1.77,,,,,
3706,1UUZ,A:D,HA62D,Gallus gallus egg-white lysozyme C (HEL/HEWL),Pseudomonas aeruginosa inhibitor of vertebrate lysozyme,EI,Monitoring the change in turbidity due to lysis of cells,,298,6.4,SKEMPI,"17405861 (SI Table 3, <a href=""http://www.pnas.org/content/suppl/2007/03/22/0611019104.DC1"">here</a>)",1.00E-09,3.00E-07,,,,,-12.27,3.38,,,,,
3707,1UUZ,A:D,HA62N,Gallus gallus egg-white lysozyme C (HEL/HEWL),Pseudomonas aeruginosa inhibitor of vertebrate lysozyme,EI,Monitoring the change in turbidity due to lysis of cells,,298,6.4,SKEMPI,"17405861 (SI Table 3, <a href=""http://www.pnas.org/content/suppl/2007/03/22/0611019104.DC1"">here</a>)",1.00E-09,1.30E-08,,,,,-12.27,1.52,,,,,
3708,1UUZ,A:D,HA62Q,Gallus gallus egg-white lysozyme C (HEL/HEWL),Pseudomonas aeruginosa inhibitor of vertebrate lysozyme,EI,Monitoring the change in turbidity due to lysis of cells,,298,6.4,SKEMPI,"17405861 (SI Table 3, <a href=""http://www.pnas.org/content/suppl/2007/03/22/0611019104.DC1"">here</a>)",1.00E-09,1.30E-08,,,,,-12.27,1.52,,,,,
3709,1C4Z,A:D,SD4A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.30E-05,,,,,-7.23,0.57,,,,,
3710,1C4Z,A:D,RD5A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.20E-05,,,,,-7.23,0.52,,,,,
3711,1C4Z,A:D,RD5E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.40E-05,,,,,-7.23,1.29,,,,,
3712,1C4Z,A:D,RD6A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.10E-05,,,,,-7.23,0.47,,,,,
3713,1C4Z,A:D,RD6E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,3.70E-05,,,,,-7.23,1.19,,,,,
3714,1C4Z,A:D,KD9A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.40E-05,,,,,-7.23,0.61,,,,,
3715,1C4Z,A:D,KD9E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,6.90E-05,,,,,-7.23,1.55,,,,,
3716,1C4Z,A:D,ND31A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,3.70E-06,,,,,-7.23,-0.18,,,,,
3717,1C4Z,A:D,LD33A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.80E-06,,,,,-7.23,-0.34,,,,,
3718,1C4Z,A:D,RD52A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.90E-06,,,,,-7.23,-0.01,,,,,
3719,1C4Z,A:D,AD59G,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.30E-05,,,,,-7.23,0.57,,,,,
3720,1C4Z,A:D,ED60A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,5.80E-06,,,,,-7.23,0.09,,,,,
3721,1C4Z,A:D,ED60R,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,5.60E-06,,,,,-7.23,0.07,,,,,
3722,1C4Z,A:D,PD62A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,5.40E-05,,,,,-7.23,1.41,,,,,
3723,1C4Z,A:D,FD63A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,8.10E-04,,,,,-7.23,3.01,,,,,
3724,1C4Z,A:D,KD64A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,8.20E-06,,,,,-7.23,0.29,,,,,
3725,1C4Z,A:D,KD64E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.70E-05,,,,,-7.23,0.72,,,,,
3726,1C4Z,A:D,ED93A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.40E-06,,,,,-7.23,-0.43,,,,,
3727,1C4Z,A:D,ED93R,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,9.20E-07,,,,,-7.23,-1,,,,,
3728,1C4Z,A:D,WD85A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.00E-05,,,,,-7.23,0.82,,,,,
3729,1C4Z,A:D,KD96A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,3.40E-05,,,,,-7.23,1.14,,,,,
3730,1C4Z,A:D,KD96E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,3.60E-05,,,,,-7.23,1.17,,,,,
3731,1C4Z,A:D,PD97A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.10E-05,,,,,-7.23,0.85,,,,,
3732,1C4Z,A:D,AD98G,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.00E-05,,,,,-7.23,0.41,,,,,
3733,1C4Z,A:D,KD100A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.50E-05,,,,,-7.23,1.3,,,,,
3734,1C4Z,A:D,KD100E,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,5.50E-05,,,,,-7.23,1.42,,,,,
3735,1C4Z,A:D,VA634A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.30E-05,,,,,-7.23,0.57,,,,,
3736,1C4Z,A:D,LA635A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,3.90E-05,,,,,-7.23,1.22,,,,,
3737,1C4Z,A:D,QA637A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.60E-06,,,,,-7.23,-0.39,,,,,
3738,1C4Z,A:D,SA638A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.00E-05,,,,,-7.23,0.41,,,,,
3739,1C4Z,A:D,LA639A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.70E-05,,,,,-7.23,1,,,,,
3740,1C4Z,A:D,DA641A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.60E-06,,,,,-7.23,-0.39,,,,,
3741,1C4Z,A:D,DA641K,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,7.10E-06,,,,,-7.23,0.21,,,,,
3742,1C4Z,A:D,LA642A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.40E-04,,,,,-7.23,1.97,,,,,
3743,1C4Z,A:D,YA645A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.40E-05,,,,,-7.23,1.29,,,,,
3744,1C4Z,A:D,DA652A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.20E-05,,,,,-7.23,0.52,,,,,
3745,1C4Z,A:D,DA652R,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,5.10E-05,,,,,-7.23,1.38,,,,,
3746,1C4Z,A:D,MA653A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.30E-04,,,,,-7.23,1.93,,,,,
3747,1C4Z,A:D,MA654A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.80E-05,,,,,-7.23,0.76,,,,,
3748,1C4Z,A:D,IA655A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.00E-05,,,,,-7.23,0.41,,,,,
3749,1C4Z,A:D,TA656A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.30E-05,,,,,-7.23,0.57,,,,,
3750,1C4Z,A:D,IA659A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.30E-06,,,,,-7.23,-0.09,,,,,
3751,1C4Z,A:D,SA660A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.50E-06,,,,,-7.23,-0.41,,,,,
3752,1C4Z,A:D,TA662A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.00E-06,,,,,-7.23,-0.13,,,,,
3753,1C4Z,A:D,MA670A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,1.90E-06,,,,,-7.23,-0.57,,,,,
3754,1C4Z,A:D,FA690A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,7.40E-05,,,,,-7.23,1.6,,,,,
3755,1C4Z,A:D,YA694L,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,2.00E-05,,,,,-7.23,0.82,,,,,
3756,1C4Z,A:D,"SA739P,NA741P",Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,4.40E-06,,,,,-7.23,-0.08,,,,,
3757,1C4Z,A:D,CA820A,Human ubiquitin-conjugating enzyme E2 L3 (UbcH7),Human ubiquitin-protein ligase E3A (E6AP),OE,Fluorescence Anisotropy/Polarization,"20 mM KH2PO4, 150 mM NaCl, 5 mM &beta;-ME",298,7,Literature,"17433363 (Table 1, p. 422)",5.00E-06,6.00E-06,,,,,-7.23,0.11,,,,,
3758,1EAW,A:B,DA217A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,2.14E-09,,,,,-14.05,2.23,,,,,
3759,1EAW,A:B,DA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,3.72E-11,,,,,-14.05,-0.17,,,,,
3760,1EAW,A:B,DA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,6.28E-10,,,,,-14.05,1.5,,,,,
3761,1EAW,A:B,DA96A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.50E-10,,,,,-14.05,0.65,,,,,
3762,1EAW,A:B,EA169A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.63E-10,,,,,-14.05,0.7,,,,,
3763,1EAW,A:B,FA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,2.41E-11,,,,,-14.05,-0.43,,,,,
3764,1EAW,A:B,FA94A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.70E-10,,,,,-14.05,0.73,,,,,
3765,1EAW,A:B,FA97A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,2.24E-10,,,,,-14.05,0.89,,,,,
3766,1EAW,A:B,HA143A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,4.85E-11,,,,,-14.05,-0.01,,,,,
3767,1EAW,A:B,IA41A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.24E-11,,,,,-14.05,-0.82,,,,,
3768,1EAW,A:B,IA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,3.58E-11,,,,,-14.05,-0.19,,,,,
3769,1EAW,A:B,KA224A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.11E-10,,,,,-14.05,0.48,,,,,
3770,1EAW,A:B,LA153A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.16E-10,,,,,-14.05,0.5,,,,,
3771,1EAW,A:B,NA95A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,8.36E-11,,,,,-14.05,0.31,,,,,
3772,1EAW,A:B,QA145A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,8.34E-11,,,,,-14.05,0.31,,,,,
3773,1EAW,A:B,QA174A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.29E-10,,,,,-14.05,0.56,,,,,
3774,1EAW,A:B,QA175A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,3.97E-11,,,,,-14.05,-0.13,,,,,
3775,1EAW,A:B,QA221A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,6.34E-11,,,,,-14.05,0.14,,,,,
3776,1EAW,A:B,QA38A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,2.07E-11,,,,,-14.05,-0.52,,,,,
3777,1EAW,A:B,RA222A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,4.28E-11,,,,,-14.05,-0.09,,,,,
3778,1EAW,A:B,RA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.34E-10,,,,,-14.05,0.59,,,,,
3779,1EAW,A:B,RA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,7.34E-11,,,,,-14.05,0.23,,,,,
3780,1EAW,A:B,RA87A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,3.86E-11,,,,,-14.05,-0.15,,,,,
3781,1EAW,A:B,TA150A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,5.78E-11,,,,,-14.05,0.09,,,,,
3782,1EAW,A:B,TA98A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,7.64E-11,,,,,-14.05,0.25,,,,,
3783,1EAW,A:B,YA146A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,1.16E-10,,,,,-14.05,0.5,,,,,
3784,1EAW,A:B,YA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),Bovine pancreatic trypsin inhibitor (BPTI),EI,Fluorescence,"50mM Tris-HCl, 50mM NaCl, 0.01% (v/v) Tween-20",298,8.8,SKEMPI,"17475279 (Table 2, p. 1046)",4.97E-11,4.35E-11,,,,,-14.05,-0.08,,,,,
3785,3BN9,B:CD,DB217A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,3.20E-11,,,,,-14.88,0.57,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3786,3BN9,B:CD,DB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,2.51E-11,,,,,-14.88,0.42,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3787,3BN9,B:CD,DB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,2.08E-11,,,,,-14.88,0.31,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3788,3BN9,B:CD,EB169A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,2.31E-11,,,,,-14.88,0.37,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3789,3BN9,B:CD,FB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.14E-11,,,,,-14.88,-0.04,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3790,3BN9,B:CD,FB94A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,3.62E-11,,,,,-14.88,0.64,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3791,3BN9,B:CD,HB143A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.42E-11,,,,,-14.88,0.09,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3792,3BN9,B:CD,IB41A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.23E-11,,,,,-14.88,0,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3793,3BN9,B:CD,IB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,5.04E-11,,,,,-14.88,0.84,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3794,3BN9,B:CD,KB224A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,4.63E-11,,,,,-14.88,0.78,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3795,3BN9,B:CD,LB153A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,2.17E-11,,,,,-14.88,0.34,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3796,3BN9,B:CD,NB95A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,4.54E-11,,,,,-14.88,0.77,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3797,3BN9,B:CD,QB145A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.54E-11,,,,,-14.88,0.13,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3798,3BN9,B:CD,QB174A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.16E-11,,,,,-14.88,-0.03,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3799,3BN9,B:CD,QB175A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,8.51E-10,,,,,-14.88,2.51,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3800,3BN9,B:CD,QB221A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,4.05E-11,,,,,-14.88,0.71,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3801,3BN9,B:CD,QB38A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,6.10E-12,,,,,-14.88,-0.42,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3802,3BN9,B:CD,RB222A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.05E-11,,,,,-14.88,-0.09,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3803,3BN9,B:CD,RB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.14E-11,,,,,-14.88,-0.04,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3804,3BN9,B:CD,RB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.09E-11,,,,,-14.88,-0.07,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3805,3BN9,B:CD,RB87A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,9.40E-12,,,,,-14.88,-0.16,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3806,3BN9,B:CD,TB150A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,2.01E-11,,,,,-14.88,0.29,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3807,3BN9,B:CD,TB98A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,8.32E-11,,,,,-14.88,1.13,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3808,3BN9,B:CD,YB146A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,7.68E-11,,,,,-14.88,1.08,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3809,3BN9,B:CD,YB60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv E2,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",1.23E-11,1.27E-11,,,,,-14.88,0.02,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3810,3NPS,A:BC,DA217A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,8.38E-10,,,,,-13.84,1.47,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3811,3NPS,A:BC,DA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.25E-10,,,,,-13.84,0.34,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3812,3NPS,A:BC,DA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,4.27E-10,,,,,-13.84,1.07,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3813,3NPS,A:BC,DA96A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,8.97E-10,,,,,-13.84,1.51,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3814,3NPS,A:BC,EA169A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.99E-10,,,,,-13.84,0.62,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3815,3NPS,A:BC,FA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.02E-10,,,,,-13.84,0.22,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3816,3NPS,A:BC,FA94A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.04E-09,,,,,-13.84,1.59,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3817,3NPS,A:BC,FA97A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.54E-10,,,,,-13.84,0.46,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3818,3NPS,A:BC,HA143A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.67E-09,,,,,-13.84,1.88,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3819,3NPS,A:BC,IA41A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,2.08E-10,,,,,-13.84,0.64,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3820,3NPS,A:BC,IA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,4.02E-11,,,,,-13.84,-0.33,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3821,3NPS,A:BC,KA224A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,5.91E-11,,,,,-13.84,-0.1,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3822,3NPS,A:BC,LA153A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.16E-10,,,,,-13.84,0.3,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3823,3NPS,A:BC,NA95A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.08E-10,,,,,-13.84,0.25,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3824,3NPS,A:BC,QA145A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.16E-10,,,,,-13.84,0.3,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3825,3NPS,A:BC,QA174A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,6.37E-11,,,,,-13.84,-0.06,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3826,3NPS,A:BC,QA175A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,2.46E-10,,,,,-13.84,0.74,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3827,3NPS,A:BC,QA221A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,6.57E-11,,,,,-13.84,-0.04,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3828,3NPS,A:BC,QA38A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,7.36E-11,,,,,-13.84,0.03,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3829,3NPS,A:BC,RA222A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,6.11E-11,,,,,-13.84,-0.08,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3830,3NPS,A:BC,RA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.17E-11,,,,,-13.84,-1.06,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3831,3NPS,A:BC,RA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,8.89E-11,,,,,-13.84,0.14,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3832,3NPS,A:BC,RA87A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,5.45E-11,,,,,-13.84,-0.15,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3833,3NPS,A:BC,TA150A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,9.46E-11,,,,,-13.84,0.17,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3834,3NPS,A:BC,TA98A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,2.39E-10,,,,,-13.84,0.72,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3835,3NPS,A:BC,YA146A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.41E-09,,,,,-13.84,1.77,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3836,3NPS,A:BC,YA60A,Human membrane-type serine protease 1/suppressor of tumorigenicity 14 protein (matriptase/MT-SP1),HuCAL scFv S4,Ag-Ab,Stopped-flow Spectroscopy,,298,,SKEMPI,"17475279 (Table 2, p. 1046)",7.04E-11,1.51E-10,,,,,-13.84,0.45,,,,,"HuCAL: fully synthetic Human Combinatorial Antibody Library, MorphoSys AG"
3837,2NOJ,A:B,"RB75A,NB82A",Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb homolog Ehp,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"17699522 (Table 1, p. 30056)",1.80E-10,7.30E-07,,,,,-13.29,4.92,,,,,
3838,2NOJ,A:B,"RB75E,NB82E",Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb homolog Ehp,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"17699522 (Table 1, p. 30056)",1.80E-10,2.40E-07,,,,,-13.29,4.26,,,,,
3839,2NOJ,A:B,NB63E,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb homolog Ehp,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"17699522 (Table 1, p. 30056)",1.80E-10,1.30E-08,,,,,-13.29,2.53,,,,,
3840,2NOJ,A:B,"NB63E,RB75A,NB82A",Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb homolog Ehp,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"17699522 (Table 1, p. 30056)",1.80E-10,4.60E-08,,,,,-13.29,3.28,,,,,
3841,2HRK,A:B,KA159A,"Saccharomyces cerevisiae glutamate-tRNA ligase, cytoplasmic",Saccharomyces cerevisiae tRNA-aminoacylation cofactor ARC1,,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 2mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"17976650 (Table 2, p. 1083, Table 3, p. 1084)",5.30E-08,2.65E-07,,,,,-9.92,0.95,,,,,
3842,2HRK,A:B,TA125V,"Saccharomyces cerevisiae glutamate-tRNA ligase, cytoplasmic",Saccharomyces cerevisiae tRNA-aminoacylation cofactor ARC1,,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 2mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"17976650 (Table 2, p. 1083, Table 3, p. 1084)",5.30E-08,1.79E-07,,,,,-9.92,0.72,,,,,
3843,2HRK,A:B,TB55V,"Saccharomyces cerevisiae glutamate-tRNA ligase, cytoplasmic",Saccharomyces cerevisiae tRNA-aminoacylation cofactor ARC1,,Surface Plasmon Resonance,"20mM Hepes, 150mM NaCl, 2mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"17976650 (Table 2, p. 1083, Table 3, p. 1084)",5.30E-08,1.52E-07,,,,,-9.92,0.62,,,,,
3844,1REW,AB:C,"KC88R,SC90T,KC92I,AC93P,QC94H,LC95Q,TC98D",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",7.00E-10,2.40E-09,3.40E+05,4.00E+05,2.40E-04,9.70E-04,-13.1,0.73,,,,,
3845,1REW,AB:C,"KC88R,SC90T,KC92I,AC93P,QC94H,LC95Q,TC98D,AC74T,MC78L,KC79G,YC80L",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",7.00E-10,1.10E-09,3.40E+05,3.00E+05,2.40E-04,3.40E-04,-13.1,0.27,,,,,
3846,1REW,AB:C,"KC88R,SC90T,KC92I,AC93P,QC94H,LC95Q,TC98D,AC74T,MC78L,KC79G,YC80L,GC42H,DC46E,AC61T,IC62M",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",7.00E-10,4.90E-09,3.40E+05,2.80E+05,2.40E-04,1.11E-03,-13.1,1.15,,,,,
3847,2QJ9,A:C,"AC74T,MC78L,KC79G,YC80L",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",2.40E-09,1.10E-09,4.00E+05,3.00E+05,9.70E-04,3.40E-04,-12.8,-0.46,,,,,
3848,2QJ9,A:C,"AC74T,MC78L,KC79G,YC80L,GC42H,DC46E,AC61T,IC62M",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",2.40E-09,4.90E-09,4.00E+05,2.80E+05,9.70E-04,1.11E-03,-12.8,0.42,,,,,
3849,2QJ9,A:C,"RC88K,TC90S,IC92K,PC93A,HC94Q,QC95L,SC98T",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",2.40E-09,7.00E-10,4.00E+05,3.40E+05,9.70E-04,2.40E-04,-12.8,-0.73,,,,,
3850,2QJA,A:C,"GC42H,DC46E,AC61T,IC62M",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",1.10E-09,4.90E-09,3.00E+05,2.80E+05,3.40E-04,1.11E-03,-12.8,0.88,,,,,
3851,2QJA,A:C,"RC88K,TC90S,IC92K,PC93A,HC94Q,QC95L,SC98T,TC74A,LC78M,GC79K,LC80Y",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",1.10E-09,7.00E-10,3.00E+05,3.40E+05,3.40E-04,2.40E-04,-12.8,-0.27,,,,,
3852,2QJA,A:C,"TC74A,LC78M,GC79K,LC80Y",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",1.10E-09,2.40E-09,3.00E+05,4.00E+05,3.40E-04,9.70E-04,-12.8,0.46,,,,,
3853,2QJB,A:C,"HC42G,EC46D,TC61A,MC62I",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",4.90E-09,1.10E-09,2.80E+05,3.00E+05,1.11E-03,3.40E-04,-12.8,-0.88,,,,,
3854,2QJB,A:C,"RC88K,TC90S,IC92K,PC93A,HC94Q,QC95L,SC98T,TC74A,LC78M,GC79K,LC80Y,HC42G,EC46D,TC61A,MC62I",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",4.90E-09,7.00E-10,2.80E+05,3.40E+05,1.11E-03,2.40E-04,-12.8,-1.15,,,,,
3855,2QJB,A:C,"TC74A,LC78M,GC79K,LC80Y,HC42G,EC46D,TC61A,MC62I",Human bone morphogenetic protein-2 (BMP-2),Human bone morphogenetic protein receptor type-1A (BMPR-1A),RC,Surface Plasmon Resonance,"10mM HEPES, 500mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"18160401 (Table 2, p. 5884)",4.90E-09,2.40E-09,2.80E+05,4.00E+05,1.11E-03,9.70E-04,-12.8,-0.42,,,,,
3856,2VLJ,AC:DE,DE32A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,7.40E-05,,,,,-7.21,1.57,,,,,
3857,2VLJ,AC:DE,DE56A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,6.50E-06,3.10E+04,3.80E+04,1.60E-01,2.50E-01,-7.21,0.13,-23,-24,-50.3,-57,
3858,2VLJ,AC:DE,IE53L,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,5.70E-05,3.10E+04,7.00E+03,1.60E-01,4.00E-01,-7.21,1.42,,,,,
3859,2VLJ,AC:DE,IE53V,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,7.30E-06,3.10E+04,1.71E+04,1.60E-01,1.30E-01,-7.21,0.2,-23,-22,-50.3,-50.3,
3860,2VLJ,AC:DE,NE55A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,3.50E-05,3.10E+04,1.80E+04,1.60E-01,6.30E-01,-7.21,1.13,-23,-18,-50.3,-40.2,
3861,2VLJ,AC:DE,NE55D,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,1.20E-05,3.10E+04,3.23E+04,1.60E-01,3.80E-01,-7.21,0.5,,,,,
3862,2VLJ,AC:DE,QD34A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,2.70E-05,3.10E+04,3.80E+04,1.60E-01,1.03E+00,-7.21,0.98,-23,-23,-50.3,-57,
3863,2VLJ,AC:DE,QE58A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,1.20E-05,3.10E+04,2.80E+04,1.60E-01,3.40E-01,-7.21,0.5,-23,-18,-50.3,-36.9,
3864,2VLJ,AC:DE,QE58E,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,5.20E-06,3.10E+04,5.00E+04,1.60E-01,2.60E-01,-7.21,0,-23,-20,-50.3,-43.6,
3865,2VLJ,AC:DE,SD31A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,1.50E-05,3.10E+04,1.30E+04,1.60E-01,2.00E-01,-7.21,0.63,,,,,
3866,2VLJ,AC:DE,SD32A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,3.00E-05,3.10E+04,1.50E+04,1.60E-01,4.60E-01,-7.21,1.04,-23,-24,-50.3,-60.4,
3867,2VLJ,AC:DE,SE99A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,4.90E-06,3.10E+04,5.90E+04,1.60E-01,2.90E-01,-7.21,-0.04,-23,-18,-50.3,-33.5,
3868,2VLJ,AC:DE,YE101A,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,7.70E-06,,,,,-7.21,0.23,-23,-29,-50.3,-73.8,
3869,2VLJ,AC:DE,YE101F,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",5.20E-06,1.20E-05,3.10E+04,1.80E+04,1.60E-01,2.10E-01,-7.21,0.5,-23,-20,-50.3,-43.6,
3870,2VLR,AC:DE,AE99S,Human MHCI-A2/Infuenza A virus matrix peptide complex,Human T-cell receptor JM22 V&beta;17,,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, and 0.005% Surfactant P20",298,7.4,SKEMPI,"18275829 (Table 2, p. 176, Table 3, p. 177)",4.90E-06,5.20E-06,5.90E+04,3.10E+04,2.90E-01,1.60E-01,-7.24,0.04,-18,-23,-33.5,-50.3,
3871,3BP8,A:C,AC63F,Escherichia coli PTS system glucose-specific EIICB component (EIICB-Glc),Escherichia coli making large colonies protein (mlc),,Surface Plasmon Resonance,"10mM Hepes, 200mM NaCl, 10mM KCl, 1mM MgCl2, 1mM DTT, 0.005% Tween 20",298,8,SKEMPI,"18319344 (Table 1, p. 3754)",4.14E-09,1.17E-08,9.95E+05,7.76E+05,3.85E-03,8.79E-03,-11.43,0.62,,,,,
3872,3BP8,A:C,FA136A,Escherichia coli PTS system glucose-specific EIICB component (EIICB-Glc),Escherichia coli making large colonies protein (mlc),,Surface Plasmon Resonance,"10mM Hepes, 200mM NaCl, 10mM KCl, 1mM MgCl2, 1mM DTT, 0.005% Tween 20",298,8,SKEMPI,"18319344 (Table 1, p. 3754)",4.14E-09,1.37E-08,9.95E+05,9.66E+05,3.85E-03,1.30E-02,-11.43,0.71,,,,,
3873,3BP8,A:C,"FA136A,AC63F",Escherichia coli PTS system glucose-specific EIICB component (EIICB-Glc),Escherichia coli making large colonies protein (mlc),,Surface Plasmon Resonance,"10mM Hepes, 200mM NaCl, 10mM KCl, 1mM MgCl2, 1mM DTT, 0.005% Tween 20",298,8,SKEMPI,"18319344 (Table 1, p. 3754)",4.14E-09,1.12E-09,9.95E+05,2.04E+06,3.85E-03,2.25E-03,-11.43,-0.77,,,,,
3874,1EMV,A:B,FB86A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.28E-11,7.24E+07,7.91E+07,2.36E-06,1.80E-03,-18.39,3.88,,,,,
3875,1EMV,A:B,"FB86A,LA33A",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.57E-09,7.24E+07,5.83E+07,2.36E-06,1.50E-01,-18.39,6.68,,,,,
3876,1EMV,A:B,"FB86A,VA34A",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,8.58E-11,7.24E+07,5.79E+07,2.36E-06,4.97E-03,-18.39,4.66,,,,,
3877,1EMV,A:B,"FB86A,VA37A",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,3.13E-11,7.24E+07,5.44E+07,2.36E-06,1.70E-03,-18.39,4.07,,,,,
3878,1EMV,A:B,"FB86A,YA54A",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,8.09E-08,7.24E+07,3.93E+07,2.36E-06,3.18E+00,-18.39,8.72,,,,,
3879,1EMV,A:B,"FB86A,YA55A",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,3.72E-08,7.24E+07,8.07E+07,2.36E-06,3.00E+00,-18.39,8.26,,,,,
3880,1EMV,A:B,KB97A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,8.92E-13,7.24E+07,3.42E+07,2.36E-06,3.05E-05,-18.39,1.96,,,,,
3881,1EMV,A:B,NB72A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.33E-13,7.24E+07,5.50E+07,2.36E-06,1.28E-05,-18.39,1.16,,,,,
3882,1EMV,A:B,NB75A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,1.68E-12,7.24E+07,1.00E+08,2.36E-06,1.68E-04,-18.39,2.33,,,,,
3883,1EMV,A:B,QB92A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.04E-14,7.24E+07,7.78E+07,2.36E-06,1.59E-06,-18.39,-0.28,,,,,
3884,1EMV,A:B,RB54A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,5.43E-13,7.24E+07,6.52E+07,2.36E-06,3.54E-05,-18.39,1.67,,,,,
3885,1EMV,A:B,SB74A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.17E-14,7.24E+07,8.05E+07,2.36E-06,1.75E-06,-18.39,-0.24,,,,,
3886,1EMV,A:B,SB77A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.20E-14,7.24E+07,7.18E+07,2.36E-06,1.58E-06,-18.39,-0.23,,,,,
3887,1EMV,A:B,SB78A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,1.31E-14,7.24E+07,7.76E+07,2.36E-06,1.02E-06,-18.39,-0.54,,,,,
3888,1EMV,A:B,SB84A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.71E-14,7.24E+07,6.91E+07,2.36E-06,1.87E-06,-18.39,-0.11,,,,,
3889,1EMV,A:B,TB87A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,4.26E-14,7.24E+07,5.73E+07,2.36E-06,2.44E-06,-18.39,0.16,,,,,
3890,1EMV,A:B,VB98A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",3.26E-14,2.05E-13,7.24E+07,7.09E+07,2.36E-06,1.45E-05,-18.39,1.09,,,,,
3891,2VLN,A:B,AB75N,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",1.68E-12,3.26E-14,1.00E+08,7.24E+07,1.68E-04,2.36E-06,-16.06,-2.33,,,,,
3892,2VLO,A:B,AB97K,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",8.92E-13,3.26E-14,3.42E+07,7.24E+07,3.05E-05,2.36E-06,-16.43,-1.96,,,,,
3893,2VLP,A:B,AB54R,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",5.43E-13,3.26E-14,6.52E+07,7.24E+07,3.54E-05,2.36E-06,-16.72,-1.67,,,,,
3894,2VLQ,A:B,AB86F,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 1, p. 748)",2.28E-11,3.26E-14,7.91E+07,7.24E+07,1.80E-03,2.36E-06,-14.51,-3.88,,,,,
3895,2WPT,A:B,FB86A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,9.37E-08,6.90E+07,5.86E+08,9.00E-01,5.49E+01,-10.75,1.17,,,,,
3896,2WPT,A:B,FB86A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,7.40E-07,,,,,-9.3,0.95,,,,,
3897,2WPT,A:B,KB97A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,3.01E-08,6.90E+07,2.26E+07,9.00E-01,6.80E-01,-10.75,0.5,,,,,
3898,2WPT,A:B,KB97A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,5.80E-07,,,,,-9.3,0.8,,,,,
3899,2WPT,A:B,NB72A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,6.12E-08,6.90E+07,1.77E+08,9.00E-01,1.08E+01,-10.75,0.92,,,,,
3900,2WPT,A:B,NB72A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,3.40E-07,,,,,-9.3,0.48,,,,,
3901,2WPT,A:B,NB75A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,1.05E-07,6.90E+07,3.58E+08,9.00E-01,3.76E+01,-10.75,1.24,,,,,
3902,2WPT,A:B,NB75A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,1.27E-06,,,,,-9.3,1.26,,,,,
3903,2WPT,A:B,QB92A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,5.94E-08,6.90E+07,6.90E+07,9.00E-01,4.10E-01,-10.75,0.9,,,,,
3904,2WPT,A:B,QB92A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,1.20E-07,,,,,-9.3,-0.13,,,,,
3905,2WPT,A:B,RB54A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,8.82E-08,6.90E+07,7.85E+07,9.00E-01,6.92E+00,-10.75,1.13,,,,,
3906,2WPT,A:B,RB54A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,4.20E-07,,,,,-9.3,0.61,,,,,
3907,2WPT,A:B,SB74A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,3.10E-09,6.90E+07,8.71E+07,9.00E-01,2.70E-01,-10.75,-0.85,,,,,
3908,2WPT,A:B,SB74A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,4.00E-07,,,,,-9.3,0.58,,,,,
3909,2WPT,A:B,SB77A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,4.63E-09,6.90E+07,7.13E+07,9.00E-01,3.30E-01,-10.75,-0.61,,,,,
3910,2WPT,A:B,SB77A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,9.00E-08,,,,,-9.3,-0.3,,,,,
3911,2WPT,A:B,SB78A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,1.01E-08,6.90E+07,6.41E+07,9.00E-01,6.50E-01,-10.75,-0.15,,,,,
3912,2WPT,A:B,SB78A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,1.40E-07,,,,,-9.3,-0.04,,,,,
3913,2WPT,A:B,SB84A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,1.11E-08,6.90E+07,7.18E+07,9.00E-01,8.00E-01,-10.75,-0.09,,,,,
3914,2WPT,A:B,SB84A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,1.40E-07,,,,,-9.3,-0.04,,,,,
3915,2WPT,A:B,TB87A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,3.16E-08,6.90E+07,3.26E+07,9.00E-01,1.03E+00,-10.75,0.53,,,,,
3916,2WPT,A:B,TB87A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,2.20E-07,,,,,-9.3,0.23,,,,,
3917,2WPT,A:B,VB98A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.30E-08,1.59E-08,6.90E+07,6.60E+07,9.00E-01,1.05E+00,-10.75,0.12,,,,,
3918,2WPT,A:B,VB98A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 2, p. 749)",1.50E-07,3.00E-07,,,,,-9.3,0.41,,,,,
3919,2WPT,A:B,"FB86A,DA33A",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 5, p. 755)",1.50E-07,1.20E-07,,,,,-9.3,-0.13,,,,,
3920,2WPT,A:B,"FB86A,NA34A",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 5, p. 755)",1.50E-07,1.47E-06,,,,,-9.3,1.35,,,,,
3921,2WPT,A:B,"FB86A,VA37A",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"18471830 (Table 5, p. 755)",1.50E-07,2.87E-05,,,,,-9.3,3.11,,,,,
3922,3BK3,A:C,AC36R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,2.27E-07,,,,,-10.44,1.38,,,,,
3923,3BK3,A:C,IC18A,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,5.00E-08,1.40E+06,8.80E+05,2.60E-02,4.40E-02,-10.44,0.49,,,,,
3924,3BK3,A:C,IC18R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,4.50E-08,1.40E+06,2.00E+06,2.60E-02,8.90E-02,-10.44,0.42,,,,,
3925,3BK3,A:C,IC21A,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,2.00E-07,,,,,-10.44,1.31,,,,,
3926,3BK3,A:C,IC21R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,7.90E-07,,,,,-10.44,2.12,,,,,
3927,3BK3,A:C,IC27A,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,1.85E-07,,,,,-10.44,1.26,,,,,
3928,3BK3,A:C,IC27R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,1.60E-07,,,,,-10.44,1.17,,,,,
3929,3BK3,A:C,IC2A,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,1.27E-07,,,,,-10.44,1.04,,,,,
3930,3BK3,A:C,IC2R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,6.60E-08,,,,,-10.44,0.65,,,,,
3931,3BK3,A:C,LC1A,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,2.20E-08,1.40E+06,1.30E+06,2.60E-02,2.80E-02,-10.44,0,,,,,
3932,3BK3,A:C,LC1R,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,2.30E-08,1.40E+06,1.20E+06,2.60E-02,2.80E-02,-10.44,0.03,,,,,
3933,3BK3,A:C,TC3P,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,5.00E-08,1.40E+06,9.50E+05,2.60E-02,4.80E-02,-10.44,0.49,,,,,
3934,3BK3,A:C,TC5P,Human bone morphogenetic protein-2 (BMP-2),Danio rerio crossveinless 2 (cv2),,Surface Plasmon Resonance,,298,,SKEMPI,"18477456 (Table 1, p. 745)",2.20E-08,4.17E-07,1.40E+06,1.80E+05,2.60E-02,7.50E-02,-10.44,1.74,,,,,
3935,,,M*743T,Human UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE),Human alpha-actinin 1,,Surface Plasmon Resonance,"20 mM Tris, 100-300 mM NaCl, 0.1 mM DTT, 2 mM CaCl2",298,7.5,Literature,"18560563 (Table 2, 5th page)",6.80E-08,8.20E-08,1.82E+04,1.23E+04,1.24E-03,1.01E-03,-13.05,0.15,,,,,
3936,,,M*743T,Human UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE),Human alpha-actinin 1,,Surface Plasmon Resonance,"20 mM Tris, 100-300 mM NaCl, 0.1 mM DTT, 2 mM EDTA",298,7.5,Literature,"18560563 (Table 2, 5th page)",2.56E-07,3.90E-07,,,,,-12,0.33,,,,,
3937,2OOB,A:B,"AA9S,KA10E",Human ubiquitin protein ligase Cbl-b,Human polyubiquitin-C,,Fluorescence titration,,298,,SKEMPI,"18596201 (Table 2, p. 1813)",5.31E-05,6.97E-05,,,,,-5.83,0.16,,,,,
3938,2OOB,A:B,GA16S,Human ubiquitin protein ligase Cbl-b,Human polyubiquitin-C,,Fluorescence titration,,298,,SKEMPI,"18596201 (Table 2, p. 1813)",5.31E-05,7.90E-05,,,,,-5.83,0.24,,,,,
3939,2OOB,A:B,"IA30E,IA41E",Human ubiquitin protein ligase Cbl-b,Human polyubiquitin-C,,Fluorescence titration,,298,,SKEMPI,"18596201 (Table 2, p. 1813)",5.31E-05,8.58E-05,,,,,-5.83,0.28,,,,,
3940,2OOB,A:B,KA10E,Human ubiquitin protein ligase Cbl-b,Human polyubiquitin-C,,Fluorescence titration,,298,,SKEMPI,"18596201 (Table 2, p. 1813)",5.31E-05,3.93E-05,,,,,-5.83,-0.18,,,,,
3941,2GOX,A:B,NB138A,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Surface Plasmon Resonance,"10 mM sodium phosphate, 150 mM sodium chloride, 0.005% Tween-20",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",1.40E-09,1.98E-08,4.04E+05,1.20E+04,5.63E-04,2.14E-02,-12.07,1.57,,,,,
3942,2GOX,A:B,NB138A,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",2.00E-09,1.90E-08,,,,,-11.86,1.33,,,,,
3943,2GOX,A:B,RB131A,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Surface Plasmon Resonance,"10 mM sodium phosphate, 150 mM sodium chloride, 0.005% Tween-20",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",1.40E-09,6.21E-08,4.04E+05,1.33E+04,5.63E-04,6.87E-02,-12.07,2.25,,,,,
3944,2GOX,A:B,RB131A,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",2.00E-09,2.60E-08,,,,,-11.86,1.52,,,,,
3945,3D5R,A:C,AC48N,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",1.98E-08,1.40E-09,1.20E+04,4.04E+05,2.14E-02,5.63E-04,-12.6,-1.57,,,,,
3946,3D5R,A:C,AC48N,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",1.90E-08,2.00E-09,,,,,-12.6,-1.33,-5.5,-8.5,16.8,11.4,
3947,3D5S,A:C,AC41R,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",6.21E-08,1.40E-09,1.33E+04,4.04E+05,6.87E-02,5.63E-04,-12.6,-2.25,,,,,
3948,3D5S,A:C,AC41R,Human complement C3,Staphylococcus aureus fibrinogen-binding protein efb,,Isothermal Titration Calorimetry,"20mM Tris, 200mM NaCl",298,8,SKEMPI,"18687868 (Table 2, p. 1899)",2.60E-08,2.00E-09,,,,,-12.6,-1.52,-3.9,-8.5,21.5,11.4,
3949,3C4P,A:B,EB73M,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,4.40E-09,,,,,,-3.53,,,,,
3950,3C4P,A:B,"EB73M,FB142W,YB143F",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,2.65E-07,,,,,,-1.11,,,,,
3951,3C4P,A:B,"EB73M,SB130K",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,1.50E-08,,,,,,-2.81,,,,,
3952,3C4P,A:B,"EB73M,SB130K,FB142W,YB143F",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,5.72E-08,,,,,,-2.01,,,,,
3953,3C4P,A:B,"EB73M,SB130K,FB142W,YB143F,SB146M",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,1.22E-08,,,,,,-2.93,,,,,
3954,3C4P,A:B,"EB73M,SB130K,SB146M",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,4.60E-09,,,,,,-3.51,,,,,
3955,3C4P,A:B,"EB73M,YB143F",Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,1.17E-07,,,,,,-1.59,,,,,
3956,3C4P,A:B,SB130K,Klebsiella pneumoniae beta-lactamase SHV-1,Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,,sodium PBS with 100 g/ml BSA,,,SKEMPI,"18775544 (Table 3, p. 1269)",1.72E-06,1.44E-07,,,,,,-1.47,,,,,
3957,1KTZ,A:B,RA25A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"19161338 (Table 1, p. 2150)",7.30E-08,8.90E-07,,,,,-9.73,1.48,,,,,
3958,1KTZ,A:B,RA25K,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"19161338 (Table 1, p. 2150)",7.30E-08,5.10E-07,7.40E+05,4.40E+05,5.40E-02,2.00E-01,-9.73,1.15,,,,,
3959,1KTZ,A:B,RA94A,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"19161338 (Table 1, p. 2150)",7.30E-08,9.50E-06,,,,,-9.73,2.88,,,,,
3960,1KTZ,A:B,RA94K,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"19161338 (Table 1, p. 2150)",7.30E-08,3.00E-06,,,,,-9.73,2.2,,,,,
3961,1KTZ,A:B,VA92I,Human transforming growth factor beta 3 (TGF-&beta;3),Human TGF-beta receptor type-2 (TGFR-2),RC,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"19161338 (Table 1, p. 2150)",7.30E-08,1.10E-07,7.40E+05,7.00E+05,5.40E-02,7.20E-02,-9.73,0.24,,,,,
3962,1SBN,E:I,RI45K,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hirudo medicinalis eglin c,EI,,,298,,SKEMPI,"1992167 (Table 1, p. 357)",5.40E-11,3.20E-11,,,,,-13.1,-0.31,,,,,
3963,1SIB,E:I,KI53R,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hirudo medicinalis eglin c,EI,,,298,,SKEMPI,"1992167 (Table 1, p. 357)",1.10E-10,3.20E-11,,,,,-13.1,-0.73,,,,,
3964,1A22,A:B,FA10A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.71E-09,,,,,-12.73,1.05,,,,,
3965,1A22,A:B,NA12A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,5.52E-10,,,,,-12.73,0.11,,,,,
3966,1A22,A:B,LA15A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,5.98E-10,,,,,-12.73,0.16,,,,,
3967,1A22,A:B,RA16A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,6.90E-10,,,,,-12.73,0.24,,,,,
3968,1A22,A:B,HA18A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,7.36E-10,,,,,-12.73,0.28,,,,,
3969,1A22,A:B,RA19A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.22E-10,,,,,-12.73,-0.21,,,,,
3970,1A22,A:B,HA21A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.52E-10,,,,,-12.73,-0.66,,,,,
3971,1A22,A:B,FA25A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.90E-10,,,,,-12.73,-0.27,,,,,
3972,1A22,A:B,DA26E,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.68E-10,,,,,-12.73,-0.13,,,,,
3973,1A22,A:B,FA54A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.02E-09,,,,,-12.73,0.88,,,,,
3974,1A22,A:B,SA55A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,5.52E-10,,,,,-12.73,0.11,,,,,
3975,1A22,A:B,EA56A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.89E-09,,,,,-12.73,0.84,,,,,
3976,1A22,A:B,SA57A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,6.44E-10,,,,,-12.73,0.2,,,,,
3977,1A22,A:B,IA58A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,7.82E-09,,,,,-12.73,1.68,,,,,
3978,1A22,A:B,PA59A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,8.74E-10,,,,,-12.73,0.38,,,,,
3979,1A22,A:B,SA62A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.29E-09,,,,,-12.73,0.61,,,,,
3980,1A22,A:B,NA63A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.52E-09,,,,,-12.73,0.71,,,,,
3981,1A22,A:B,RA64A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,9.66E-09,,,,,-12.73,1.8,,,,,
3982,1A22,A:B,EA65A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.71E-10,,,,,-12.73,-0.31,,,,,
3983,1A22,A:B,EA66A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,9.66E-10,,,,,-12.73,0.44,,,,,
3984,1A22,A:B,QA68A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.39E-09,,,,,-12.73,0.98,,,,,
3985,1A22,A:B,QA69A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,4.19E-10,,,,,-12.73,-0.06,,,,,
3986,1A22,A:B,KA70A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.10E-09,,,,,-12.73,0.52,,,,,
3987,1A22,A:B,SA71A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,9.20E-10,,,,,-12.73,0.41,,,,,
3988,1A22,A:B,LA73A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.27E-10,,,,,-12.73,-0.2,,,,,
3989,1A22,A:B,YA160A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,5.06E-10,,,,,-12.73,0.06,,,,,
3990,1A22,A:B,YA164A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.66E-09,,,,,-12.73,0.76,,,,,
3991,1A22,A:B,RA167A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.45E-10,,,,,-12.73,-0.17,,,,,
3992,1A22,A:B,KA168A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,5.06E-10,,,,,-12.73,0.06,,,,,
3993,1A22,A:B,DA171A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.27E-09,,,,,-12.73,1.16,,,,,
3994,1A22,A:B,KA172A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,6.44E-09,,,,,-12.73,1.56,,,,,
3995,1A22,A:B,EA174A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.01E-10,,,,,-12.73,-0.9,,,,,
3996,1A22,A:B,TA175S,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.61E-09,,,,,-12.73,0.74,,,,,
3997,1A22,A:B,FA176A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,7.36E-09,,,,,-12.73,1.64,,,,,
3998,1A22,A:B,RA178A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.67E-08,,,,,-12.73,2.4,,,,,
3999,1A22,A:B,IA179A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.24E-09,,,,,-12.73,0.59,,,,,
4000,1A22,A:B,IA179M,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,1.24E-09,,,,,-12.73,0.59,,,,,
4001,1A22,A:B,VA180A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,4.60E-10,,,,,-12.73,0,,,,,
4002,1A22,A:B,QA181A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,7.36E-10,,,,,-12.73,0.28,,,,,
4003,1A22,A:B,RA183A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,9.66E-10,,,,,-12.73,0.44,,,,,
4004,1A22,A:B,SA184A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,4.19E-10,,,,,-12.73,-0.06,,,,,
4005,1A22,A:B,VA185A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,2.07E-09,,,,,-12.73,0.89,,,,,
4006,1A22,A:B,EA186A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.63E-10,,,,,-12.73,-0.14,,,,,
4007,1A22,A:B,GA187A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,8.28E-10,,,,,-12.73,0.35,,,,,
4008,1A22,A:B,SA188A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>",298,7.4,PINT,"2014261 (Table 2, p. 3409)",4.60E-10,3.27E-10,,,,,-12.73,-0.2,,,,,
4009,1BP3,A:B,FA10A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4010,1BP3,A:B,NA12A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.00E-11,,,,,-14.29,-0.3,,,,,
4011,1BP3,A:B,LA15A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4012,1BP3,A:B,RA16A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4013,1BP3,A:B,HA18A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,4.50E-09,,,,,-14.29,2.91,,,,,
4014,1BP3,A:B,RA19A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4015,1BP3,A:B,HA21A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.00E-09,,,,,-14.29,2.67,,,,,
4016,1BP3,A:B,FA25A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.30E-10,,,,,-14.29,1.15,,,,,
4017,1BP3,A:B,DA26E,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.30E-11,,,,,-14.29,0.38,,,,,
4018,1BP3,A:B,FA54A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,4.70E-11,,,,,-14.29,0.21,,,,,
4019,1BP3,A:B,SA55A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,5.00E-11,,,,,-14.29,0.25,,,,,
4020,1BP3,A:B,EA56A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.70E-11,,,,,-14.29,-0.12,,,,,
4021,1BP3,A:B,SA57A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.50E-11,,,,,-14.29,0.03,,,,,
4022,1BP3,A:B,IA58A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.11E-10,,,,,-14.29,1.73,,,,,
4023,1BP3,A:B,PA59A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,4.30E-11,,,,,-14.29,0.16,,,,,
4024,1BP3,A:B,SA62A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.60E-10,,,,,-14.29,1.42,,,,,
4025,1BP3,A:B,NA63A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,1.40E-10,,,,,-14.29,0.86,,,,,
4026,1BP3,A:B,RA64A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.00E-11,,,,,-14.29,0.35,,,,,
4027,1BP3,A:B,EA65A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,8.30E-11,,,,,-14.29,0.55,,,,,
4028,1BP3,A:B,EA66A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.70E-11,,,,,-14.29,0.07,,,,,
4029,1BP3,A:B,QA68A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,4.00E-11,,,,,-14.29,0.11,,,,,
4030,1BP3,A:B,QA69A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.30E-11,,,,,-14.29,-0.21,,,,,
4031,1BP3,A:B,KA70A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,5.00E-11,,,,,-14.29,0.25,,,,,
4032,1BP3,A:B,SA71A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,9.30E-11,,,,,-14.29,0.61,,,,,
4033,1BP3,A:B,LA73A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.00E-11,,,,,-14.29,0.35,,,,,
4034,1BP3,A:B,YA160A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,4.70E-11,,,,,-14.29,0.21,,,,,
4035,1BP3,A:B,YA164A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,7.00E-11,,,,,-14.29,0.45,,,,,
4036,1BP3,A:B,RA167A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.50E-08,,,,,-14.29,3.93,,,,,
4037,1BP3,A:B,KA168A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.10E-10,,,,,-14.29,1.73,,,,,
4038,1BP3,A:B,DA171A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.70E-11,,,,,-14.29,0.07,,,,,
4039,1BP3,A:B,KA172A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,7.20E-09,,,,,-14.29,3.19,,,,,
4040,1BP3,A:B,EA174A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,1.20E-08,,,,,-14.29,3.49,,,,,
4041,1BP3,A:B,TA175S,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,7.60E-11,,,,,-14.29,0.49,,,,,
4042,1BP3,A:B,FA176A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,8.30E-10,,,,,-14.29,1.91,,,,,
4043,1BP3,A:B,RA178A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.30E-10,,,,,-14.29,1.15,,,,,
4044,1BP3,A:B,IA179A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,6.00E-11,,,,,-14.29,0.35,,,,,
4045,1BP3,A:B,IA179M,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.50E-11,,,,,-14.29,-0.16,,,,,
4046,1BP3,A:B,VA180A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.00E-11,,,,,-14.29,-0.3,,,,,
4047,1BP3,A:B,QA181A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4048,1BP3,A:B,RA183A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,8.60E-11,,,,,-14.29,0.57,,,,,
4049,1BP3,A:B,SA184A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.70E-11,,,,,-14.29,-0.12,,,,,
4050,1BP3,A:B,VA185A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,5.30E-11,,,,,-14.29,0.28,,,,,
4051,1BP3,A:B,EA186A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4052,1BP3,A:B,GA187A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,3.30E-11,,,,,-14.29,0,,,,,
4053,1BP3,A:B,SA188A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,PINT;ASEdb;,"2014261 (Table 2, p. 3409)",3.30E-11,2.00E-11,,,,,-14.29,-0.3,,,,,
4054,1BP3,A:B,HA18A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,3.70E-07,,,,,-8.96,0.19,,,,,
4055,1BP3,A:B,HA21A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,2.00E-07,,,,,-8.96,-0.18,,,,,
4056,1BP3,A:B,IA58A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,5.50E-06,,,,,-8.96,1.78,,,,,
4057,1BP3,A:B,RA167A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,9.70E-06,,,,,-8.96,2.12,,,,,
4058,1BP3,A:B,KA172A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,8.20E-06,,,,,-8.96,2.02,,,,,
4059,1BP3,A:B,EA174A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,3.60E-07,,,,,-8.96,0.17,,,,,
4060,1BP3,A:B,FA176A,Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 1 mM EDTA",298,7.4,PINT;ASEdb;,"2014261 (Table 3, p. 3409)",2.70E-07,7.20E-06,,,,,-8.96,1.94,,,,,
4061,1BP3,A:B,"KA168A,EA174A",Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",3.80E-11,3.50E-07,,,,,-14.21,5.41,,,,,
4062,1BP3,A:B,"RA64A,DA171A",Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",3.80E-11,7.20E-11,,,,,-14.21,0.38,,,,,
4063,1BP3,A:B,"KA172A,FA176A",Human growth hormone/somatotropin (hGH),Human prolactin receptor (hPRL-R),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",3.80E-11,3.20E-07,,,,,-14.21,5.35,,,,,
4064,1A22,A:B,"KA168A,EA174A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",4.40E-10,1.20E-10,,,,,-12.76,-0.77,,,,,
4065,1A22,A:B,"RA64A,DA171A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",4.40E-10,1.20E-07,,,,,-12.76,3.32,,,,,
4066,1A22,A:B,"KA172A,FA176A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 0.1% BSA, 0.02% NaN<sub>3</sub>, 50 &micro;M ZnCl<sub>2</sub>, 10 mM MgCl<sub>2</sub>",298,7.4,Literature,"2014261 (Table 4, p. 3409)",4.40E-10,2.60E-07,,,,,-12.76,3.78,,,,,
4067,1A22,A:B,"DB319A,EB320A,KB321A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.70E-10,,,,,-12.81,0.21,,,,,
4068,1A22,A:B,DB326A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.10E-09,,,,,-12.81,0.98,,,,,
4069,1A22,A:B,DB332A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.50E-09,,,,,-12.81,1.09,,,,,
4070,1A22,A:B,"DB352A,RB356A,EB358A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.80E-10,,,,,-12.81,0.31,,,,,
4071,1A22,A:B,DB405A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.70E-10,,,,,-12.81,-0.05,,,,,
4072,1A22,A:B,EB242A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.20E-09,,,,,-12.81,1.23,,,,,
4073,1A22,A:B,EB244A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.20E-09,,,,,-12.81,0.65,,,,,
4074,1A22,A:B,EB275A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.50E-10,,,,,-12.81,-0.08,,,,,
4075,1A22,A:B,EB279A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.50E-10,,,,,-12.81,-0.08,,,,,
4076,1A22,A:B,EB282A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.50E-09,,,,,-12.81,0.78,,,,,
4077,1A22,A:B,EB291A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.40E-10,,,,,-12.81,0.18,,,,,
4078,1A22,A:B,EB327A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,8.00E-10,,,,,-12.81,0.41,,,,,
4079,1A22,A:B,EB373A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.60E-10,,,,,-12.81,0.08,,,,,
4080,1A22,A:B,EB375A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.50E-10,,,,,-12.81,-0.08,,,,,
4081,1A22,A:B,EB380A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.60E-10,,,,,-12.81,0.2,,,,,
4082,1A22,A:B,"EB383A,KB385A,KB387A,DB390A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.90E-10,,,,,-12.81,0.12,,,,,
4083,1A22,A:B,EB407A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.50E-10,,,,,-12.81,-0.08,,,,,
4084,1A22,A:B,EB409A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.60E-10,,,,,-12.81,-0.06,,,,,
4085,1A22,A:B,EB424A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.80E-10,,,,,-12.81,0.11,,,,,
4086,1A22,A:B,FB296S,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.20E-10,,,,,-12.81,-0.13,,,,,
4087,1A22,A:B,FB300A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.90E-10,,,,,-12.81,-0.01,,,,,
4088,1A22,A:B,IB303A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,8.30E-10,,,,,-12.81,0.43,,,,,
4089,1A22,A:B,IB305A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.00E-10,,,,,-12.81,0.13,,,,,
4090,1A22,A:B,IB328A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.08E-09,,,,,-12.81,0.59,,,,,
4091,1A22,A:B,"KB234A,KB237A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.00E-10,,,,,-12.81,0.24,,,,,
4092,1A22,A:B,KB281A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.10E-10,,,,,-12.81,0.14,,,,,
4093,1A22,A:B,KB310A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.30E-10,,,,,-12.81,0.04,,,,,
4094,1A22,A:B,KB379A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.00E-10,,,,,-12.81,0,,,,,
4095,1A22,A:B,KB403A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.00E-10,,,,,-12.81,0.24,,,,,
4096,1A22,A:B,"KB403A,DB405A,KB406A,EB407A,EB409A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.65E-09,,,,,-12.81,1.12,,,,,
4097,1A22,A:B,KB406A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.60E-10,,,,,-12.81,0.2,,,,,
4098,1A22,A:B,KB415A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,9.30E-10,,,,,-12.81,0.5,,,,,
4099,1A22,A:B,NB272A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.90E-10,,,,,-12.81,-0.44,,,,,
4100,1A22,A:B,NB297A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.60E-10,,,,,-12.81,-0.26,,,,,
4101,1A22,A:B,PB241A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.20E-10,,,,,-12.81,0.26,,,,,
4102,1A22,A:B,PB306A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.37E-08,,,,,-12.81,2.63,,,,,
4103,1A22,A:B,QB274A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.50E-10,,,,,-12.81,-0.58,,,,,
4104,1A22,A:B,QB278A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.00E-10,,,,,-12.81,-0.41,,,,,
4105,1A22,A:B,QB330A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.80E-10,,,,,-12.81,-0.03,,,,,
4106,1A22,A:B,RB239A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.30E-10,,,,,-12.81,0.27,,,,,
4107,1A22,A:B,RB243A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,6.40E-10,,,,,-12.81,0.28,,,,,
4108,1A22,A:B,RB270A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,8.10E-10,,,,,-12.81,0.42,,,,,
4109,1A22,A:B,"RB270A,RB271A,EB275A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.03E-09,,,,,-12.81,0.96,,,,,
4110,1A22,A:B,RB271A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.10E-09,,,,,-12.81,0.6,,,,,
4111,1A22,A:B,"RB361A,DB364A,KB367A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.60E-10,,,,,-12.81,-0.06,,,,,
4112,1A22,A:B,RB411A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.40E-10,,,,,-12.81,0.06,,,,,
4113,1A22,A:B,RB413A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.90E-10,,,,,-12.81,-0.19,,,,,
4114,1A22,A:B,RB417A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,7.00E-10,,,,,-12.81,0.33,,,,,
4115,1A22,A:B,SB247A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.90E-10,,,,,-12.81,-0.01,,,,,
4116,1A22,A:B,SB298A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.30E-10,,,,,-12.81,-0.33,,,,,
4117,1A22,A:B,SB299A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.70E-10,,,,,-12.81,-0.51,,,,,
4118,1A22,A:B,SB302A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,8.80E-10,,,,,-12.81,0.47,,,,,
4119,1A22,A:B,TB251A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.50E-10,,,,,-12.81,0.07,,,,,
4120,1A22,A:B,TB273A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.90E-10,,,,,-12.81,-0.44,,,,,
4121,1A22,A:B,TB277A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.60E-10,,,,,-12.81,-0.26,,,,,
4122,1A22,A:B,TB301A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.50E-09,,,,,-12.81,1.09,,,,,
4123,1A22,A:B,VB325A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,2.75E-09,,,,,-12.81,1.14,,,,,
4124,1A22,A:B,VB329A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,3.70E-10,,,,,-12.81,-0.05,,,,,
4125,1A22,A:B,WB276A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,1.03E-09,,,,,-12.81,0.56,,,,,
4126,1A22,A:B,WB280A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.30E-10,,,,,-12.81,0.17,,,,,
4127,1A22,A:B,WB304F,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,4.40E-08,,,,,-12.81,2.78,,,,,
4128,1A22,A:B,YB295A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>I-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI,"2034689 (Table 1, p. 4499)",4.00E-10,5.60E-10,,,,,-12.81,0.2,,,,,
4129,2B5I,A:BD,FA42A,Human interleukin-2 (hIL-2),Human interleukin-2 receptor alpha-beta complex (hIL-2R/p55-p70),RC,Direct binding with radiolabeled Na<sup>125</sup>I,,,,Literature,"2052547 (Table 2, p. 4638)",5.40E-11,1.50E-09,,,,,,,,,,,
4130,2B5I,A:BD,RA38A,Human interleukin-2 (hIL-2),Human interleukin-2 receptor alpha-beta complex (hIL-2R/p55-p70),RC,Direct binding with radiolabeled Na<sup>125</sup>I,,,,Literature,"2052547 (Table 2, p. 4638)",5.40E-11,7.90E-10,,,,,,,,,,,
4131,2B5I,A:B,FA42A,Human interleukin-2 (hIL-2),Human interleukin-2 receptor beta (hIL-2Rb),RC,Direct binding with radiolabeled Na<sup>125</sup>I,,,,Literature,"2052547 (Table 2, p. 4638)",3.60E-10,1.90E-09,,,,,,,,,,,
4132,2B5I,A:B,RA38A,Human interleukin-2 (hIL-2),Human interleukin-2 receptor beta (hIL-2Rb),RC,Direct binding with radiolabeled Na<sup>125</sup>I,,,,Literature,"2052547 (Table 2, p. 4638)",3.60E-10,1.00E-09,,,,,,,,,,,
4133,3NGB,A:BC,TB33Y,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,6.64E-09,3.83E+04,4.24E+04,2.20E-04,2.81E-04,-12.33,0.08,,,,,
4134,3NGB,A:BC,GB54S,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,2.02E-08,3.83E+04,1.79E+04,2.20E-04,3.61E-04,-12.33,0.73,,,,,
4135,3NGB,A:BC,AB56G,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,5.24E-09,3.83E+04,6.62E+04,2.20E-04,3.47E-04,-12.33,-0.06,,,,,
4136,3NGB,A:BC,VB57T,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,7.27E-09,3.83E+04,2.70E+04,2.20E-04,1.96E-04,-12.33,0.14,,,,,
4137,3NGB,A:BC,PB62K,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,8.53E-09,3.83E+04,5.21E+04,2.20E-04,4.44E-04,-12.29,0.23,,,,,
4138,3NGB,A:BC,VB73T,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,7.61E-09,3.83E+04,4.98E+04,2.20E-04,3.79E-04,-12.29,0.16,,,,,
4139,3NGB,A:BC,YB74S,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,1.01E-08,3.83E+04,3.40E+04,2.20E-04,3.43E-04,-12.29,0.33,,,,,
4140,3NGB,A:BC,IB30T,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,6.52E-09,3.83E+04,4.79E+04,2.20E-04,3.12E-04,-12.29,0.07,,,,,
4141,3NGB,A:BC,KB52N,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,7.74E-09,3.83E+04,4.53E+04,2.20E-04,3.50E-04,-12.29,0.17,,,,,
4142,3NGB,A:BC,RB53N,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,6.23E-09,3.83E+04,7.06E+04,2.20E-04,4.40E-04,-12.29,0.05,,,,,
4143,3NGB,A:BC,RB61Q,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,6.78E-09,3.83E+04,4.30E+04,2.20E-04,2.92E-04,-12.29,0.09,,,,,
4144,3NGB,A:BC,YC30S,HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,1.73E-08,3.83E+04,4.73E+04,2.20E-04,8.20E-04,-12.29,0.64,,,,,
4145,3NGB,A:BC,"AB56G,VB57T,PB62K,VB73T",HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,9.72E-08,3.83E+04,7.23E+03,2.20E-04,7.02E-04,-12.29,1.65,,,,,
4146,3NGB,A:BC,"TB33Y,GB55S,AB56G,VB57T,PB62K,VB73T,YB74S",HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,1.52E-07,3.83E+04,3.73E+03,2.20E-04,5.67E-04,-12.29,1.91,,,,,
4147,3NGB,A:BC,"IB30T,KB52N,RB53N,GB54S,AB56G,VB57T,RB61Q,PB62K,VB73T,YB74S,YC28S",HIV-1 envelope glycoprotein gp160 subunit gp120,Human antibody IgG VRC01,Ag-Ab,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3mM EDTA, and 0.05% surfactant P-20",293,7.4,Ab-Bind,"20616231 (Supporting Online Material, Table S10a, p.41)",5.76E-09,2.47E-08,3.83E+04,6.32E+03,2.20E-04,1.56E-04,-12.29,0.85,,,,,
4148,1AO7,AC:DE,"GD28I,SD100A",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.10E-06,5.10E+04,4.60E+04,1.08E-01,5.20E-02,-7.74,-0.38,,,,,
4149,1AO7,AC:DE,"GD28I,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,4.60E-07,5.10E+04,2.20E+04,1.08E-01,1.00E-02,-7.74,-0.9,,,,,
4150,1AO7,AC:DE,"GD28L,SD100A",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,8.90E-07,5.10E+04,7.90E+04,1.08E-01,7.00E-02,-7.74,-0.51,,,,,
4151,1AO7,AC:DE,"GD28L,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,3.70E-07,5.10E+04,3.70E+04,1.08E-01,1.40E-02,-7.74,-1.03,,,,,
4152,1AO7,AC:DE,"GD28M,SD100A",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,5.40E-07,5.10E+04,8.00E+04,1.08E-01,4.30E-02,-7.74,-0.8,,,,,
4153,1AO7,AC:DE,"GD28M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.10E-07,5.10E+04,1.38E+05,1.08E-01,1.50E-02,-7.74,-1.75,,,,,
4154,1AO7,AC:DE,"GD28M,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,5.80E-08,5.10E+04,1.12E+05,1.08E-01,6.60E-03,-7.74,-2.13,,,,,
4155,1AO7,AC:DE,"GD28T,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.40E-07,5.10E+04,2.70E+04,1.08E-01,3.80E-03,-7.74,-1.6,,,,,
4156,1AO7,AC:DE,"RD27F,GD28M,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.00E-07,5.10E+04,1.06E+05,1.08E-01,1.10E-02,-7.74,-1.8,,,,,
4157,1AO7,AC:DE,"RD27F,GD28T,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.40E-07,5.10E+04,2.30E+04,1.08E-01,3.30E-03,-7.74,-1.6,,,,,
4158,1AO7,AC:DE,"DD26W,RD27F,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.10E-08,5.10E+04,6.30E+04,1.08E-01,1.40E-03,-7.74,-2.73,,,,,
4159,1AO7,AC:DE,"DD26W,GD28M,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,3.40E-07,5.10E+04,2.10E+04,1.08E-01,7.20E-03,-7.74,-1.08,,,,,
4160,1AO7,AC:DE,"DD26W,GD28T,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.60E-07,5.10E+04,1.10E+04,1.08E-01,3.00E-03,-7.74,-1.24,,,,,
4161,1AO7,AC:DE,"DD26W,RD27F,GD28T,SD51M,SD100T",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.40E-07,5.10E+04,2.00E+04,1.08E-01,4.80E-03,-7.74,-1.28,,,,,
4162,1AO7,AC:DE,"GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,1.50E-07,5.10E+04,2.10E+04,1.08E-01,3.20E-03,-7.74,-1.56,,,,,
4163,1AO7,AC:DE,"AE99M,GE100S",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,3.60E-07,5.10E+04,2.80E+04,1.08E-01,1.00E-02,-7.74,-1.04,,,,,
4164,1AO7,AC:DE,"AE99M,GE100S,GE101A",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,5.30E-09,5.10E+04,3.60E+04,1.08E-01,1.90E-04,-7.74,-3.54,,,,,
4165,1AO7,AC:DE,"AE99M,GE100S,GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.80E-09,5.10E+04,4.20E+04,1.08E-01,1.20E-04,-7.74,-3.92,,,,,
4166,1AO7,AC:DE,"GD28T,AE99M,GE100S,GE101A",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,3.10E-09,5.10E+04,3.20E+04,1.08E-01,1.00E-04,-7.74,-3.86,,,,,
4167,1AO7,AC:DE,"GD28T,AE99M,GE100S,GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.60E-09,5.10E+04,5.00E+04,1.08E-01,1.30E-04,-7.74,-3.96,,,,,
4168,1AO7,AC:DE,"DD26W,AE99M,GE100S,GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,2.30E-09,5.10E+04,1.90E+04,1.08E-01,4.50E-05,-7.74,-4.04,,,,,
4169,1AO7,AC:DE,"DD26W,RD27F,SD51M,AE99M,GE100S,GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,4.00E-09,5.10E+04,3.30E+04,1.08E-01,1.30E-04,-7.74,-3.71,,,,,
4170,1AO7,AC:DE,"DD26W,RD27F,SD51M,SD100T,AE99M,GE100S,GE101A,RE102Q",Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M HEPES, 0.15mM NaCl, 3mM EDTA, and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"20681514 (Table 1, p. 7052)",2.10E-06,6.20E-09,5.10E+04,1.90E+04,1.08E-01,1.10E-04,-7.74,-3.45,,,,,
4171,3BDY,V:LH,"RH50A,RH58A",Human bH1-44 antibody (anti-HER2/anti-VEGF dual-specific antibody),Human vascular endothelial growth factor A (VEGF A),Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,303,,Literature,21526167 (Fig.2A on 4th page),3.30E-09,3.00E-09,3.90E+05,3.50E+05,1.40E-03,1.00E-03,-11.76,-0.06,,,,,
4172,3BE1,A:LH,YL32A,Human bH1-44 antibody (anti-HER2/anti-VEGF dual-specific antibody),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,303,,Literature,21526167 (Fig.2A on 4th page),2.00E-10,1.00E-10,3.70E+05,6.20E+05,8.00E-05,4.00E-05,-13.45,-0.42,,,,,
4173,3BE1,A:LH,"IL29A,YL32A",Human bH1-44 antibody (anti-HER2/anti-VEGF dual-specific antibody),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,PBS with 0.05% Tween 20,303,,Literature,21526167 (Fig.2A on 4th page),2.00E-10,2.00E-10,3.70E+05,3.50E+05,8.00E-05,7.00E-05,-13.45,0,,,,,
4174,1FFW,A:B,CB213A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,2.40E-07,,,,,-9.23,0.2,,,,,
4175,1FFW,A:B,DB202A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,1.50E-07,,,,,-9.23,-0.07,,,,,
4176,1FFW,A:B,DB207A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,2.00E-07,,,,,-9.23,0.1,,,,,
4177,1FFW,A:B,EB171A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,5.70E-07,,,,,-9.23,0.72,,,,,
4178,1FFW,A:B,EB178A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,5.00E-07,,,,,-9.23,0.64,,,,,
4179,1FFW,A:B,FB214A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,8.00E-05,,,,,-9.23,3.64,,,,,
4180,1FFW,A:B,HB181A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,1.80E-07,,,,,-9.23,0.03,,,,,
4181,1FFW,A:B,IB216A,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence-monitored binding titrations,"50mM Tris, 50mM potassium glutamate, 25mM NaCl, 0.5mM DTT, 10% glycerol",281,7,SKEMPI,"21642453 (Table 1, p.3897)",1.70E-07,3.50E-07,,,,,-9.23,0.43,,,,,
4182,,,R*219H,Rattus norvegicus gap junction beta-1 protein/connexin-32 (Cx32),Bovine calmodulin (CaM),,Isothermal Titration Calorimetry,"25mM Tris-HCl, 100mM KCl, 1mM &beta;-ME, 5mM CaCl2",310,7,Literature,"22718765 (Table 1, p. 27778)",4.65E-06,1.04E-05,,,,,-7.56,0.5,,,,,
4183,,,R*230C,Rattus norvegicus gap junction beta-1 protein/connexin-32 (Cx32),Bovine calmodulin (CaM),,Isothermal Titration Calorimetry,"25mM Tris-HCl, 100mM KCl, 1mM &beta;-ME, 5mM CaCl2",310,7,Literature,"22718765 (Table 1, p. 27778)",4.65E-06,1.49E-05,,,,,-7.56,0.72,,,,,
4184,,,F*235C,Rattus norvegicus gap junction beta-1 protein/connexin-32 (Cx32),Bovine calmodulin (CaM),,Isothermal Titration Calorimetry,"25mM Tris-HCl, 100mM KCl, 1mM &beta;-ME, 5mM CaCl2",310,7,Literature,"22718765 (Table 1, p. 27778)",4.65E-06,3.85E-05,,,,,-7.56,1.3,,,,,
4185,1GC1,G:C,DC10A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.60E-09,,,,,,,,,,,
4186,1GC1,G:C,DC53A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,6.00E-09,,,,,,,,,,,
4187,1GC1,G:C,DC56A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.20E-09,,,,,,,,,,,
4188,1GC1,G:C,DC63A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.10E-09,,,,,,,,,,,
4189,1GC1,G:C,DC88A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.20E-09,,,,,,,,,,,
4190,1GC1,G:C,EC77A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,9.30E-09,,,,,,,,,,,
4191,1GC1,G:C,EC85A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.36E-08,,,,,,,,,,,
4192,1GC1,G:C,EC87A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,5.20E-09,,,,,,,,,,,
4193,1GC1,G:C,EC91A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.90E-09,,,,,,,,,,,
4194,1GC1,G:C,EC92A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.70E-09,,,,,,,,,,,
4195,1GC1,G:C,HC27A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,5.80E-09,,,,,,,,,,,
4196,1GC1,G:C,KC1A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.00E-09,,,,,,,,,,,
4197,1GC1,G:C,KC21A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.90E-09,,,,,,,,,,,
4198,1GC1,G:C,KC22A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,5.40E-09,,,,,,,,,,,
4199,1GC1,G:C,KC29A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,8.90E-09,,,,,,,,,,,
4200,1GC1,G:C,KC2A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.50E-09,,,,,,,,,,,
4201,1GC1,G:C,KC35A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,6.20E-09,,,,,,,,,,,
4202,1GC1,G:C,KC46A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.03E-08,,,,,,,,,,,
4203,1GC1,G:C,KC50A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.90E-09,,,,,,,,,,,
4204,1GC1,G:C,KC72A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.50E-09,,,,,,,,,,,
4205,1GC1,G:C,KC75A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.70E-09,,,,,,,,,,,
4206,1GC1,G:C,KC7A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,1.94E-08,,,,,,,,,,,
4207,1GC1,G:C,KC8A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.30E-09,,,,,,,,,,,
4208,1GC1,G:C,KC90A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.90E-09,,,,,,,,,,,
4209,1GC1,G:C,LC44A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.14E-08,,,,,,,,,,,
4210,1GC1,G:C,LC51A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.89E-08,,,,,,,,,,,
4211,1GC1,G:C,NC30A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.80E-09,,,,,,,,,,,
4212,1GC1,G:C,NC32A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.90E-09,,,,,,,,,,,
4213,1GC1,G:C,NC39A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,7.90E-09,,,,,,,,,,,
4214,1GC1,G:C,NC52A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,1.19E-08,,,,,,,,,,,
4215,1GC1,G:C,NC66A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.40E-09,,,,,,,,,,,
4216,1GC1,G:C,NC73A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.00E-09,,,,,,,,,,,
4217,1GC1,G:C,QC20A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.50E-09,,,,,,,,,,,
4218,1GC1,G:C,QC25A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.80E-09,,,,,,,,,,,
4219,1GC1,G:C,QC33A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.30E-09,,,,,,,,,,,
4220,1GC1,G:C,QC40A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,1.80E-09,,,,,,,,,,,
4221,1GC1,G:C,"QC40A,DC63A",HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,1.55E-09,,,,,,,,,,,
4222,1GC1,G:C,"QC40A,DC63A,QC89L",HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,8.60E-10,,,,,,,,,,,
4223,1GC1,G:C,QC64A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,7.60E-09,,,,,,,,,,,
4224,1GC1,G:C,QC89A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.80E-09,,,,,,,,,,,
4225,1GC1,G:C,QC89L,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.13E-09,,,,,,,,,,,
4226,1GC1,G:C,QC94A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.00E-09,,,,,,,,,,,
4227,1GC1,G:C,RC58A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.50E-09,,,,,,,,,,,
4228,1GC1,G:C,RC59A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.62E-08,,,,,,,,,,,
4229,1GC1,G:C,SC19A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.60E-09,,,,,,,,,,,
4230,1GC1,G:C,SC23A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,5.90E-09,,,,,,,,,,,
4231,1GC1,G:C,SC31A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,4.30E-09,,,,,,,,,,,
4232,1GC1,G:C,SC42A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.60E-09,,,,,,,,,,,
4233,1GC1,G:C,SC49A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,1.01E-08,,,,,,,,,,,
4234,1GC1,G:C,SC60A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.10E-09,,,,,,,,,,,
4235,1GC1,G:C,TC11A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.60E-09,,,,,,,,,,,
4236,1GC1,G:C,TC15A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,6.20E-09,,,,,,,,,,,
4237,1GC1,G:C,TC17A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.90E-09,,,,,,,,,,,
4238,1GC1,G:C,TC45A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,2.80E-09,,,,,,,,,,,
4239,1GC1,G:C,VC86A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.20E-09,,,,,,,,,,,
4240,1GC1,G:C,YC82A,HIV-1 envelope glycoprotein gp160 subunit gp120,Human T-cell surface glycoprotein CD4,,Binding with <sup>125</sup>I-labelled recombinant gp120,,,,SKEMPI,"2402498 (Table 1, p.7151)",3.60E-09,3.18E-08,,,,,,,,,,,
4241,1AO7,AC:DE,RD27P,Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 2, p.1591)",2.20E-06,3.70E-06,5.10E+04,4.40E+04,1.10E-01,1.60E-01,-7.71,0.31,,,,,
4242,1AO7,AC:DE,KD103P,Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 2, p.1591)",2.20E-06,1.40E-06,5.10E+04,1.40E+05,1.10E-01,1.91E-01,-7.71,-0.27,,,,,
4243,1AO7,AC:DE,AE52P,Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 2, p.1591)",2.20E-06,1.27E-06,5.10E+04,4.40E+04,1.10E-01,5.60E-02,-7.71,-0.33,,,,,
4244,1AO7,AC:DE,GE101P,Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 2, p.1591)",2.20E-06,4.70E-06,5.10E+04,3.90E+04,1.10E-01,1.80E-01,-7.71,0.45,,,,,
4245,1AO7,AC:DE,RE102P,Human T-cell receptor A6,"Human HLA class I histocompatibility antigen, A-2 alpha chain with protein TAX-1 (TAX-HLAA2)",Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 2, p.1591)",2.20E-06,8.30E-08,5.10E+04,1.57E+05,1.10E-01,1.30E-02,-7.71,-1.94,,,,,
4246,1YY9,A:CD,LD29P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.38E-09,1.46E+06,2.27E+06,1.91E-03,3.14E-03,-12.11,0.03,,,,,
4247,1YY9,A:CD,WD52P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.59E-08,1.46E+06,1.09E+06,1.91E-03,1.73E-02,-12.11,1.48,,,,,
4248,1YY9,A:CD,SD53P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,5.21E-09,1.46E+06,8.90E+05,1.91E-03,4.65E-03,-12.11,0.82,,,,,
4249,1YY9,A:CD,GD54P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,2.06E-09,1.46E+06,2.20E+06,1.91E-03,4.53E-03,-12.11,0.27,,,,,
4250,1YY9,A:CD,AD98P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,7.55E-09,1.46E+06,8.50E+05,1.91E-03,6.38E-03,-12.11,1.04,,,,,
4251,1YY9,A:CD,YD101P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,2.13E-08,1.46E+06,1.46E+06,1.91E-03,3.11E-02,-12.11,1.65,,,,,
4252,1YY9,A:CD,AC25P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.48E-09,1.46E+06,6.70E+05,1.91E-03,1.00E-03,-12.11,0.07,,,,,
4253,1YY9,A:CD,SC26P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.29E-09,1.46E+06,2.14E+06,1.91E-03,2.75E-03,-12.11,-0.01,,,,,
4254,1YY9,A:CD,SC28P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,9.00E-10,1.46E+06,2.36E+06,1.91E-03,2.13E-03,-12.11,-0.22,,,,,
4255,1YY9,A:CD,SC54P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.27E-09,1.46E+06,2.08E+06,1.91E-03,2.63E-03,-12.11,-0.02,,,,,
4256,1YY9,A:CD,TC96P,Human-mouse monoclonal antibody C225 gamma 1 Fab (cetuximab),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"0.01 M Hepes, 0.15mM NaCl, 3mM EDTA and 0.005% (v/v) Surfactant P20",298,7.4,Literature,"24380763 (Table 4, p. 1593)",1.31E-09,1.13E-06,1.46E+06,2.40E+04,1.91E-03,2.66E-02,-12.11,4,,,,,
4257,3VR6,AD:GH,"LA476A,VA477A",Enterococcus hirae V-type sodium ATPase catalytic subunits (A3B3),Enterococcus hirae V-type sodium ATPase catalytic subunits (DG),OE,Surface Plasmon Resonance,"20mM MES-Tris, 150mM NaCl, 50 &micro;M EDTA-Na, 0.005% Tween 20",298,6.5,Literature,"24404436 (Table 1, 3rd page)",1.60E-09,1.10E-09,,,,,-11.75,-0.22,,,,,
4258,3VR6,AD:GH,"LA476A,VA477A,LD398A",Enterococcus hirae V-type sodium ATPase catalytic subunits (A3B3),Enterococcus hirae V-type sodium ATPase catalytic subunits (DG),OE,Surface Plasmon Resonance,"20mM MES-Tris, 150mM NaCl, 50 &micro;M EDTA-Na, 0.005% Tween 20",298,6.5,Literature,"24404436 (Table 1, 3rd page)",1.60E-09,1.20E-09,,,,,-11.75,-0.17,,,,,
4259,3VR6,AD:GH,"LA476A,VA477A,RG165A,RG166A",Enterococcus hirae V-type sodium ATPase catalytic subunits (A3B3),Enterococcus hirae V-type sodium ATPase catalytic subunits (DG),OE,Surface Plasmon Resonance,"20mM MES-Tris, 150mM NaCl, 50 &micro;M EDTA-Na, 0.005% Tween 20",298,6.5,Literature,"24404436 (Table 1, 3rd page)",1.60E-09,5.09E-08,,,,,-11.75,2.05,,,,,
4260,3VR6,AD:GH,"LA476A,VA477A,LG170N",Enterococcus hirae V-type sodium ATPase catalytic subunits (A3B3),Enterococcus hirae V-type sodium ATPase catalytic subunits (DG),OE,Surface Plasmon Resonance,"20mM MES-Tris, 150mM NaCl, 50 &micro;M EDTA-Na, 0.005% Tween 20",298,6.5,Literature,"24404436 (Table 1, 3rd page)",1.60E-09,1.40E-09,,,,,-11.75,-0.08,,,,,
4261,2BDN,A:LH,LH27R,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,2.40E-09,1.40E+05,1.40E+05,1.00E-04,3.30E-04,-12.4,0.65,,,,,
4262,2BDN,A:LH,LH27K,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,3.50E-09,1.40E+05,1.10E+05,1.00E-04,3.90E-04,-12.4,0.87,,,,,
4263,2BDN,A:LH,NH28D,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,1.00E-09,1.40E+05,1.60E+04,1.00E-04,1.60E-04,-12.4,0.13,,,,,
4264,2BDN,A:LH,NH28Q,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,8.50E-09,1.40E+05,2.20E+05,1.00E-04,1.90E-03,-12.4,1.4,,,,,
4265,2BDN,A:LH,DH31E,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,5.00E-09,1.40E+05,3.00E+04,1.00E-04,1.50E-04,-12.4,1.09,,,,,
4266,2BDN,A:LH,YL30K,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,2.50E-09,1.40E+05,1.30E+05,1.00E-04,3.10E-04,-12.4,0.67,,,,,
4267,2BDN,A:LH,NL31R,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,1.70E-10,1.40E+05,1.30E+05,1.00E-04,2.20E-05,-12.4,-0.92,,,,,
4268,2BDN,A:LH,NL31K,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,2.90E-07,1.40E+05,3.40E+05,1.00E-04,9.80E-02,-12.4,3.49,,,,,
4269,2BDN,A:LH,SL53D,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,6.10E-10,1.40E+05,9.00E+04,1.00E-04,5.50E-05,-12.4,-0.16,,,,,
4270,2BDN,A:LH,SL53E,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,1.90E-10,1.40E+05,7.30E+04,1.00E-04,1.40E-05,-12.4,-0.85,,,,,
4271,2BDN,A:LH,TL56D,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,3.90E-10,1.40E+05,2.20E+05,1.00E-04,8.60E-05,-12.4,-0.43,,,,,
4272,2BDN,A:LH,TL56E,Mouse antibody 11K2 scFv,Human C-C motif chemokine 2/monocyte chemoattractant protein 1 (MCP-1),Ag-Ab,Surface Plasmon Resonance,PBS  0.005% (v/v) Tween20,298,,Literature,24475232 (Table 1 on 4th page),8.00E-10,2.50E-10,1.40E+05,1.00E+05,1.00E-04,2.60E-05,-12.4,-0.69,,,,,
4273,,,F*11A,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,1.70E-09,,,,,-12.53,0.57,,,,,mutation in eotaxin
4274,,,R*16A,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,3.10E-09,,,,,-12.53,0.93,,,,,mutation in eotaxin
4275,,,R*22A,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,1.30E-09,,,,,-12.53,0.41,,,,,mutation in eotaxin
4276,,,R*22E,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,2.20E-08,,,,,-12.53,2.09,,,,,mutation in eotaxin
4277,,,K*44A,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,9.70E-10,,,,,-12.53,0.24,,,,,mutation in eotaxin
4278,,,K*47A,Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,8.00E-11,,,,,-12.53,-1.24,,,,,mutation in eotaxin
4279,,,"R*16A,R*22A",Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,1.20E-08,,,,,-12.53,1.73,,,,,mutation in eotaxin
4280,,,"R*22A,K*44A",Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,3.10E-09,,,,,-12.53,0.93,,,,,mutation in eotaxin
4281,,,"R*16A,R*22E",Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,2.70E-08,,,,,-12.53,2.21,,,,,mutation in eotaxin
4282,,,"R*16A,R*22A,K*44A",Human C-C motif chemokine 11 (eotaxin-1),Rabbitpox viral CC chemokine inhibitor (35K),,Fluorescence Anisotropy/Polarization,"20 mM potassium phosphate, 100 mM NaCl",298,7,Literature,"24482230 (able 1, p. 6598)",6.50E-10,8.70E-08,,,,,-12.53,2.9,,,,,mutation in eotaxin
4283,1FSS,A:B,TB8V,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,6.90E-10,6.80E+07,5.17E+07,2.52E-02,3.57E-02,-12.86,0.37,,,,,
4284,1FSS,A:B,TB9I,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,2.50E-10,6.80E+07,3.18E+07,2.52E-02,7.96E-03,-12.86,-0.23,,,,,
4285,1FSS,A:B,TB9N,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,2.80E-09,6.80E+07,,2.52E-02,,-12.86,1.2,,,,,
4286,1FSS,A:B,"TB8V,TB9I",Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,7.80E-10,6.80E+07,8.60E+07,2.52E-02,6.71E-03,-12.86,0.44,,,,,
4287,1FSS,A:B,"TB8V,TB9N",Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,6.00E-10,6.80E+07,8.50E+07,2.52E-02,5.10E-02,-12.86,0.29,,,,,
4288,1FSS,A:B,RB11K,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,6.30E-10,6.80E+07,4.70E+07,2.52E-02,2.96E-02,-12.86,0.32,,,,,
4289,1FSS,A:B,AB12S,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,6.40E-10,6.80E+07,7.50E+07,2.52E-02,4.80E-02,-12.86,0.32,,,,,
4290,1FSS,A:B,RB27F,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,2.26E-08,6.80E+07,,2.52E-02,,-12.86,2.44,,,,,
4291,1FSS,A:B,RB27M,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,3.32E-08,6.80E+07,,2.52E-02,,-12.86,2.66,,,,,
4292,1FSS,A:B,RB27Y,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,3.13E-08,6.80E+07,,2.52E-02,,-12.86,2.63,,,,,
4293,1FSS,A:B,HB29K,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,1.30E-10,6.80E+07,1.96E+08,2.52E-02,2.55E-02,-12.86,-0.62,,,,,
4294,1FSS,A:B,HB29R,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,3.00E-11,6.80E+07,3.90E+08,2.52E-02,1.17E-02,-12.86,-1.49,,,,,
4295,1FSS,A:B,KB32R,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,2.30E-09,6.80E+07,3.50E+07,2.52E-02,8.05E-02,-12.86,1.08,,,,,
4296,1FSS,A:B,MB33F,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,1.80E-09,6.80E+07,6.18E+07,2.52E-02,1.11E-01,-12.86,0.94,,,,,
4297,1FSS,A:B,MB33L,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,1.88E-09,6.80E+07,1.97E+06,2.52E-02,3.70E-03,-12.86,0.96,,,,,
4298,1FSS,A:B,MB33Q,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,5.26E-09,6.80E+07,3.09E+06,2.52E-02,1.62E-02,-12.86,1.57,,,,,
4299,1FSS,A:B,MB33Y,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,3.90E-09,6.80E+07,4.63E+07,2.52E-02,1.81E-01,-12.86,1.39,,,,,
4300,1FSS,A:B,VB34T,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,5.38E-09,6.80E+07,3.33E+07,2.52E-02,1.79E-01,-12.86,1.59,,,,,
4301,1FSS,A:B,LB35W,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,4.29E-09,6.80E+07,1.92E+07,2.52E-02,8.24E-02,-12.86,1.45,,,,,
4302,1FSS,A:B,NB47F,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,8.50E-10,6.80E+07,1.55E+07,2.52E-02,1.34E-02,-12.86,0.49,,,,,
4303,1FSS,A:B,NB47W,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,4.50E-10,6.80E+07,1.19E+07,2.52E-02,5.70E-02,-12.86,0.12,,,,,
4304,1FSS,A:B,NB47R,Tetronarce californica acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",3.70E-10,1.50E-10,6.80E+07,6.75E+07,2.52E-02,1.03E-02,-12.86,-0.53,,,,,
4305,1B41,A:B,TB8V,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,6.40E-10,5.05E+06,2.20E+06,4.75E-04,1.43E-03,-13.67,1.14,,,,,
4306,1B41,A:B,TB9I,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,9.80E-11,5.05E+06,4.26E+06,4.75E-04,4.17E-04,-13.67,0.02,,,,,
4307,1B41,A:B,TB9N,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,4.17E-08,5.05E+06,3.98E+06,4.75E-04,1.66E-01,-13.67,3.61,,,,,
4308,1B41,A:B,"TB8V,TB9I",Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.83E-10,5.05E+06,2.00E+06,4.75E-04,3.66E-04,-13.67,0.39,,,,,
4309,1B41,A:B,"TB8V,TB9N",Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,5.66E-09,5.05E+06,5.83E+06,4.75E-04,3.30E-02,-13.67,2.43,,,,,
4310,1B41,A:B,RB11K,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,2.70E-10,5.05E+06,2.17E+06,4.75E-04,5.86E-04,-13.67,0.62,,,,,
4311,1B41,A:B,AB12S,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,3.10E-10,5.05E+06,7.10E+06,4.75E-04,2.20E-03,-13.67,0.71,,,,,
4312,1B41,A:B,RB27F,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,3.30E-09,5.05E+06,4.90E+06,4.75E-04,4.71E-02,-13.67,2.11,,,,,
4313,1B41,A:B,RB27M,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.15E-09,5.05E+06,3.02E+06,4.75E-04,3.47E-03,-13.67,1.48,,,,,
4314,1B41,A:B,RB27Y,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,5.37E-09,5.05E+06,3.34E+06,4.75E-04,1.79E-02,-13.67,2.4,,,,,
4315,1B41,A:B,HB29K,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,2.10E-11,5.05E+06,8.92E+06,4.75E-04,1.87E-04,-13.67,-0.89,,,,,
4316,1B41,A:B,HB29R,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,4.71E-11,5.05E+06,5.50E+06,4.75E-04,2.59E-04,-13.67,-0.41,,,,,
4317,1B41,A:B,KB32R,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.82E-10,5.05E+06,4.42E+06,4.75E-04,7.96E-04,-13.67,0.39,,,,,
4318,1B41,A:B,MB33F,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,3.50E-10,5.05E+06,2.45E+06,4.75E-04,8.58E-04,-13.67,0.78,,,,,
4319,1B41,A:B,MB33L,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.97E-09,5.05E+06,3.44E+06,4.75E-04,6.78E-03,-13.67,1.8,,,,,
4320,1B41,A:B,MB33Q,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.39E-09,5.05E+06,6.60E+05,4.75E-04,9.17E-04,-13.67,1.6,,,,,
4321,1B41,A:B,MB33Y,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,3.10E-10,5.05E+06,3.75E+06,4.75E-04,1.13E-03,-13.67,0.71,,,,,
4322,1B41,A:B,VB34T,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,7.30E-10,5.05E+06,1.46E+06,4.75E-04,1.06E-03,-13.67,1.21,,,,,
4323,1B41,A:B,LB35W,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,8.50E-10,5.05E+06,8.10E+06,4.75E-04,6.89E-03,-13.67,1.3,,,,,
4324,1B41,A:B,NB47F,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,7.40E-11,5.05E+06,4.60E+06,4.75E-04,3.45E-04,-13.67,-0.14,,,,,
4325,1B41,A:B,NB47W,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,1.00E-10,5.05E+06,3.30E+06,4.75E-04,3.55E-04,-13.67,0.04,,,,,
4326,1B41,A:B,NB47R,Human acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Enzyme activity assay using the colorimetric detection of AChE product,"50 mM phosphate buffer, 0.1 mg/ml BSA, 0.025% NaN3 (0.15 M) ",298,8,Literature,"24613488 (Table 1, p. 639-40)",9.40E-11,8.93E-11,5.05E+06,4.27E+06,4.75E-04,3.80E-04,-13.67,-0.03,,,,,
4327,1A22,A:B,PA2A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.10E-10,,,,,-12.91,-0.05,,,,,
4328,1A22,A:B,TA3A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.10E-10,,,,,-12.91,-0.05,,,,,
4329,1A22,A:B,IA4A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,6.80E-10,,,,,-12.91,0.41,,,,,
4330,1A22,A:B,PA5A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.10E-10,,,,,-12.91,0.44,,,,,
4331,1A22,A:B,LA6A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,9.50E-10,,,,,-12.91,0.61,,,,,
4332,1A22,A:B,SA7A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,6.10E-10,,,,,-12.91,0.35,,,,,
4333,1A22,A:B,RA8A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.80E-10,,,,,-12.91,0.2,,,,,
4334,1A22,A:B,LA9A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.20E-10,,,,,-12.91,-0.04,,,,,
4335,1A22,A:B,FA10A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.00E-09,,,,,-12.91,1.05,,,,,
4336,1A22,A:B,NA12A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.00E-10,,,,,-12.91,0.1,,,,,
4337,1A22,A:B,MA14A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.50E-10,,,,,-12.91,0.47,,,,,
4338,1A22,A:B,LA15A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.40E-10,,,,,-12.91,0.15,,,,,
4339,1A22,A:B,RA16A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,5.10E-10,,,,,-12.91,0.24,,,,,
4340,1A22,A:B,HA18A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.40E-10,,,,,-12.91,-0.21,,,,,
4341,1A22,A:B,RA19A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.70E-10,,,,,-12.91,0.05,,,,,
4342,1A22,A:B,FA54A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.50E-09,,,,,-12.91,0.88,,,,,
4343,1A22,A:B,SA55A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.10E-10,,,,,-12.91,0.11,,,,,
4344,1A22,A:B,EA56A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.40E-09,,,,,-12.91,0.84,,,,,
4345,1A22,A:B,SA57A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.80E-10,,,,,-12.91,0.2,,,,,
4346,1A22,A:B,IA58A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,5.60E-09,,,,,-12.91,1.66,,,,,
4347,1A22,A:B,PA59A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,6.50E-10,,,,,-12.91,0.38,,,,,
4348,1A22,A:B,SA62A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,9.50E-10,,,,,-12.91,0.61,,,,,
4349,1A22,A:B,NA63A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.12E-09,,,,,-12.91,0.71,,,,,
4350,1A22,A:B,RA64A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.11E-09,,,,,-12.91,1.8,,,,,
4351,1A22,A:B,EA65A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.00E-10,,,,,-12.91,-0.31,,,,,
4352,1A22,A:B,EA66A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.10E-10,,,,,-12.91,0.44,,,,,
4353,1A22,A:B,QA68A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.80E-09,,,,,-12.91,0.99,,,,,
4354,1A22,A:B,QA69A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.10E-10,,,,,-12.91,-0.05,,,,,
4355,1A22,A:B,KA70A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,8.20E-10,,,,,-12.91,0.52,,,,,
4356,1A22,A:B,SA71A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,6.80E-10,,,,,-12.91,0.41,,,,,
4357,1A22,A:B,LA73A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.40E-10,,,,,-12.91,-0.21,,,,,
4358,1A22,A:B,RA167A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.60E-10,,,,,-12.91,-0.16,,,,,
4359,1A22,A:B,KA168A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.70E-10,,,,,-12.91,0.05,,,,,
4360,1A22,A:B,DA171A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.40E-09,,,,,-12.91,1.16,,,,,
4361,1A22,A:B,KA172A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.60E-09,,,,,-12.91,1.54,,,,,
4362,1A22,A:B,EA174A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.50E-11,,,,,-12.91,-0.9,,,,,
4363,1A22,A:B,TA175S,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,5.90E-09,,,,,-12.91,1.69,,,,,
4364,1A22,A:B,FA176A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,5.40E-09,,,,,-12.91,1.64,,,,,
4365,1A22,A:B,RA178N,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.90E-09,,,,,-12.91,1.27,,,,,
4366,1A22,A:B,IA179A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,9.20E-10,,,,,-12.91,0.59,,,,,
4367,1A22,A:B,VA180A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.40E-10,,,,,-12.91,0,,,,,
4368,1A22,A:B,QA181A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,5.40E-10,,,,,-12.91,0.27,,,,,
4369,1A22,A:B,CA182A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.90E-09,,,,,-12.91,1.02,,,,,
4370,1A22,A:B,RA183A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,7.10E-10,,,,,-12.91,0.44,,,,,
4371,1A22,A:B,SA184A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,3.10E-10,,,,,-12.91,-0.05,,,,,
4372,1A22,A:B,VA185A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,1.50E-09,,,,,-12.91,0.88,,,,,
4373,1A22,A:B,EA186A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.70E-10,,,,,-12.91,-0.14,,,,,
4374,1A22,A:B,GA187A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,6.10E-10,,,,,-12.91,0.35,,,,,
4375,1A22,A:B,SA188A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,2.40E-10,,,,,-12.91,-0.21,,,,,
4376,1A22,A:B,FA191A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive displacement of <sup>125</sup>1-labeled hGH,"50 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 1 g/L BSA, 0.2 g/L NaN<sub>3</sub>",298,7.4,SKEMPI;ASEdb;PINT;,"2471267 (Table 1, p. 1082)",3.40E-10,4.70E-10,,,,,-12.91,0.19,,,,,
4377,,,Q*223R,Human leptin,Human leptin receptor,HR,Surface Plasmon Resonance,"0.01 M HEPES, 0.15 M NaCl, 3 mM EDTA, 0.005% v/v Surfactant P20",298,7.4,Literature,"24743494 (Table 1, p. 4)",6.47E-11,8.43E-11,1.76E+06,1.75E+06,1.21E-04,1.47E-04,-13.89,0.16,,,,,mutation in leptin receptor
4378,1A4Y,A:B,HB114A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT",298,6,SKEMPI;ASEdb;,"2479414 (Interaction of H13A- and H114A-Angiogenin with Placental Ribonuclease Inhibitor, p. 7404)",3.30E-16,1.00E-15,4.00E+08,2.20E+08,1.50E-07,2.20E-07,-21.11,0.66,,,,,
4379,1A4Y,A:B,HB13A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT",298,6,SKEMPI;ASEdb;,"2479414 (Interaction of H13A- and H114A-Angiogenin with Placental Ribonuclease Inhibitor, p. 7404)",3.30E-16,2.00E-16,4.00E+08,4.10E+08,1.50E-07,8.10E-08,-21.11,-0.3,,,,,
4380,4OZ1,AB:C,"WC218A,WC232A,WC254A,WC293A,WC310A,WC338A",Human RNA-binding protein 39 (CAPER-&alpha;),Human splicing factor 3B subunit 1 (SF3b155),,Isothermal Titration Calorimetry,"50 mM NaCl, 25 mM HEPES, 0.2 mM TCEP",303,7.4,Literature,"24795046 (Table 2, p.17330)",5.80E-08,2.30E-06,,,,,-10.03,2.22,,,,,
4381,4OZ1,AB:C,"WC200A,WC218A,WC232A,WC254A,WC310A,WC338A",Human RNA-binding protein 39 (CAPER-&alpha;),Human splicing factor 3B subunit 1 (SF3b155),,Isothermal Titration Calorimetry,"50 mM NaCl, 25 mM HEPES, 0.2 mM TCEP",303,7.4,Literature,"24795046 (Table 2, p.17330)",5.80E-08,6.80E-05,,,,,-10.03,4.26,,,,,
4382,4OZ1,AB:C,"WC200A,WC218A,WC232A,WC254A,WC293A,WC310A",Human RNA-binding protein 39 (CAPER-&alpha;),Human splicing factor 3B subunit 1 (SF3b155),,Isothermal Titration Calorimetry,"50 mM NaCl, 25 mM HEPES, 0.2 mM TCEP",303,7.4,Literature,"24795046 (Table 2, p.17330)",5.80E-08,1.40E-05,,,,,-10.03,3.3,,,,,
4383,1JTG,A:B,QA97A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,6.22E-10,1.08E+05,8.00E+04,2.48E-05,4.98E-05,-13.05,0.59,,,,,
4384,1JTG,A:B,NA98A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,1.90E-11,1.08E+05,6.70E+04,2.48E-05,1.30E-06,-13.05,-1.47,,,,,
4385,1JTG,A:B,LA100A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,9.80E-10,1.08E+05,4.50E+04,2.48E-05,4.41E-05,-13.05,0.85,,,,,
4386,1JTG,A:B,EA102A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,2.52E-08,1.08E+05,7.50E+04,2.48E-05,1.89E-03,-13.05,2.76,,,,,
4387,1JTG,A:B,YA103A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,1.96E-10,1.08E+05,2.80E+04,2.48E-05,5.50E-06,-13.05,-0.09,,,,,
4388,1JTG,A:B,PA105A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,3.43E-10,1.08E+05,7.50E+04,2.48E-05,2.57E-05,-13.05,0.24,,,,,
4389,1JTG,A:B,EA108A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,2.50E-11,1.08E+05,1.01E+05,2.48E-05,2.50E-06,-13.05,-1.31,,,,,
4390,1JTG,A:B,KA109A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,5.40E-11,1.08E+05,8.50E+04,2.48E-05,4.60E-06,-13.05,-0.85,,,,,
4391,1JTG,A:B,MA127A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,2.94E-09,1.08E+05,7.80E+04,2.48E-05,2.29E-04,-13.05,1.5,,,,,
4392,1JTG,A:B,VA214A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,8.60E-11,1.08E+05,8.90E+04,2.48E-05,7.70E-06,-13.05,-0.58,,,,,
4393,1JTG,A:B,MA272A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",2.30E-10,2.11E-10,1.08E+05,2.18E+05,2.48E-05,4.60E-05,-13.05,-0.05,,,,,
4394,1JTD,A:B,QA97A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,3.60E-12,1.90E+06,2.50E+06,2.90E-06,8.80E-06,-16.01,0.51,,,,,
4395,1JTD,A:B,NA98A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,5.80E-12,1.90E+06,1.70E+06,2.90E-06,9.70E-06,-16.01,0.8,,,,,
4396,1JTD,A:B,LA100A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,2.80E-11,1.90E+06,4.60E+06,2.90E-06,1.27E-04,-16.01,1.72,,,,,
4397,1JTD,A:B,EA102A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,6.20E-12,1.90E+06,6.30E+06,2.90E-06,3.89E-05,-16.01,0.83,,,,,
4398,1JTD,A:B,YA103A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,6.70E-11,1.90E+06,1.30E+06,2.90E-06,8.66E-05,-16.01,2.23,,,,,
4399,1JTD,A:B,PA105A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,2.80E-11,1.90E+06,2.90E+06,2.90E-06,8.01E-05,-16.01,1.72,,,,,
4400,1JTD,A:B,EA108A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,1.60E-12,1.90E+06,2.70E+06,2.90E-06,4.20E-06,-16.01,0.04,,,,,
4401,1JTD,A:B,KA109A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,5.60E-11,1.90E+06,1.20E+06,2.90E-06,6.97E-05,-16.01,2.13,,,,,
4402,1JTD,A:B,MA127A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,1.06E-10,1.90E+06,1.80E+06,2.90E-06,1.89E-04,-16.01,2.5,,,,,
4403,1JTD,A:B,VA214A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,1.60E-12,1.90E+06,1.30E+06,2.90E-06,2.10E-06,-16.01,0.04,,,,,
4404,1JTD,A:B,MA272A,Escherichia coli beta-lactamase (TEM-1),Streptomyces exfoliatus beta-lactamase inhibitory protein II (BLIP II),EI,Stopped-flow tryptophan fluorescence spectrometry and competitive displacement assay,"10mM Tris, 150mM NaCl",296,7,Literature,"24947275 (Table 3, p. 1239)",1.50E-12,2.40E-12,1.90E+06,1.40E+06,2.90E-06,3.40E-06,-16.01,0.28,,,,,
4405,2DVW,A:B,RB342A,Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,2.17E-07,,,,,-9.78,0.69,-28.7,-22,-0.06,-0.04,
4406,2DVW,A:B,"RB338A,RB342A",Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,2.55E-06,,,,,-9.78,2.15,-28.7,-6.1,-0.06,0.01,
4407,2DVW,A:B,"RB338A,RB339A,RB342A",Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,7.47E-06,,,,,-9.78,2.79,-28.7,-2.2,-0.06,0.02,
4408,2DVW,A:B,"EB356A,EB357A",Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,7.18E-08,,,,,-9.78,0.04,-28.7,-27.3,-0.06,-0.06,
4409,2DVW,A:B,KB397E,Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,9.52E-08,,,,,-9.78,0.21,-28.7,-25.6,-0.06,-0.05,
4410,2DVW,A:B,RA41A,Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,3.13E-07,,,,,-9.78,0.91,-28.7,-17.1,-0.06,-0.03,
4411,2DVW,A:B,KA116A,Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,7.13E-08,,,,,-9.78,0.03,-28.7,-24,-0.06,-0.05,
4412,2DVW,A:B,"DA39A,DA71A",Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,9.30E-08,,,,,-9.78,0.19,-28.7,-25,-0.06,-0.05,
4413,2DVW,A:B,"RA41A,KA116A",Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,3.63E-06,,,,,-9.78,2.36,-28.7,-4.9,-0.06,0.01,
4414,2DVW,A:B,EA182A,Mouse 26S proteasome non-ATPase regulatory subunit 10 (gankyrin),Human 26S protease regulatory subunit 6B,OE,Isothermal Titration Calorimetry,"20 mM sodium phosphate, 150 mM NaCl, 2.5 mM 2-mercaptoethanol",298,7.4,Literature,"25343477 (Table 1, p. 6858)",6.73E-08,1.41E-07,,,,,-9.78,0.44,-28.7,-28.2,-0.06,-0.06,
4415,3WWN,A:B,RA227E,Thermus thermophilus LysW (TtLysW),Thermus thermophilus LysZ  (TtLysZ),,Isothermal Titration Calorimetry,"20mM HEPES-NaOH, 150mM NaCl",333,8,Literature,"25392000 (Table 2, p. 444)",6.62E-06,3.75E-06,,,,,-7.89,-0.38,-6.36,-6.03,,,
4416,3WWN,A:B,RA230E,Thermus thermophilus LysW (TtLysW),Thermus thermophilus LysZ  (TtLysZ),,Isothermal Titration Calorimetry,"20mM HEPES-NaOH, 150mM NaCl",333,8,Literature,"25392000 (Table 2, p. 444)",6.62E-06,5.88E-05,,,,,-7.89,1.45,-6.36,-6.7,,,
4417,3WWN,A:B,KA231E,Thermus thermophilus LysW (TtLysW),Thermus thermophilus LysZ  (TtLysZ),,Isothermal Titration Calorimetry,"20mM HEPES-NaOH, 150mM NaCl",333,8,Literature,"25392000 (Table 2, p. 444)",6.62E-06,8.62E-06,,,,,-7.89,0.17,-6.36,-5.46,,,
4418,2KWI,A:B,"LA14A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.00E-07,,,,,,,,,,,Q72L RalB is the wild-type
4419,2KWI,A:B,"YA36A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.04E-06,,,,,,,,,,,Q72L RalB is the wild-type
4420,2KWI,A:B,"YA36F,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.35E-07,,,,,,,,,,,Q72L RalB is the wild-type
4421,2KWI,A:B,"EA38A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,1.39E-06,,,,,,,,,,,Q72L RalB is the wild-type
4422,2KWI,A:B,"EA38Q,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,1.05E-06,,,,,,,,,,,Q72L RalB is the wild-type
4423,2KWI,A:B,"TA46S,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,4.13E-06,,,,,,,,,,,Q72L RalB is the wild-type
4424,2KWI,A:B,"KA47A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.39E-07,,,,,,,,,,,Q72L RalB is the wild-type
4425,2KWI,A:B,"AA48G,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,9.45E-07,,,,,,,,,,,Q72L RalB is the wild-type
4426,2KWI,A:B,"DA49A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,2.33E-06,,,,,,,,,,,Q72L RalB is the wild-type
4427,2KWI,A:B,"DA49E,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.69E-07,,,,,,,,,,,Q72L RalB is the wild-type
4428,2KWI,A:B,"SA50A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,1.40E-07,,,,,,,,,,,Q72L RalB is the wild-type
4429,2KWI,A:B,"RA52A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,6.82E-07,,,,,,,,,,,Q72L RalB is the wild-type
4430,2KWI,A:B,"LA67A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,2.68E-06,,,,,,,,,,,Q72L RalB is the wild-type
4431,2KWI,A:B,"EA73A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,1.09E-06,,,,,,,,,,,Q72L RalB is the wild-type
4432,2KWI,A:B,"DA74A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,3.26E-07,,,,,,,,,,,Q72L RalB is the wild-type
4433,2KWI,A:B,"YA75A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,5.44E-07,,,,,,,,,,,Q72L RalB is the wild-type
4434,2KWI,A:B,"AA77R,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,5.85E-07,,,,,,,,,,,Q72L RalB is the wild-type
4435,2KWI,A:B,"IA78A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,7.24E-07,,,,,,,,,,,Q72L RalB is the wild-type
4436,2KWI,A:B,"NA81A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,6.96E-07,,,,,,,,,,,Q72L RalB is the wild-type
4437,2KWI,A:B,"YA82A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,1.21E-05,,,,,,,,,,,Q72L RalB is the wild-type
4438,2KWI,A:B,"RA84A,QA72L",Human ras-related protein Ral-B,Human ralA-binding protein 1 (RalBP1),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.16E-07,2.32E-06,,,,,,,,,,,Q72L RalB is the wild-type
4439,,,"L*14A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,1.59E-06,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4440,,,"Y*36F,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,7.30E-06,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4441,,,"E*38Q,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,4.46E-06,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4442,,,"K*47A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,7.63E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4443,,,"A*48G,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,2.97E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4444,,,"D*49A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,1.75E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4445,,,"S*50A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,9.90E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4446,,,"R*52A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,3.71E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4447,,,"L*67A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,1.04E-06,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4448,,,"E*73A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,6.97E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4449,,,"D*74A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,3.11E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4450,,,"Y*75A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,4.13E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4451,,,"A*77R,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,2.03E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4452,,,"I*78A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,2.06E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4453,,,"N*81A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,4.91E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4454,,,"Y*82A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,2.30E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4455,,,"R*84A,Q*72L",Human ras-related protein Ral-B,Human exocyst complex component 2 (Sec5),GC,Scintillation Proximity Assay,"20 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 1 mM DTT, 0.2 mg/mL BSA",,7.5,Literature,"25621740 (Table 3, p. 1385)",2.38E-07,5.01E-07,,,,,,,,,,,Q72L RalB is the wild-type; double mutant ralB
4456,3F1S,A:B,MA71A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,1.70E-08,,,,,-11.83,1.24,,,,,
4457,3F1S,A:B,DA74A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,8.40E-08,,,,,-11.83,2.18,,,,,
4458,3F1S,A:B,DA238A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,4.20E-09,,,,,-11.83,0.41,,,,,
4459,3F1S,A:B,KA239A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,1.00E-10,,,,,-11.83,-1.8,,,,,
4460,3F1S,A:B,KA239C,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,1.00E-10,,,,,-11.83,-1.8,,,,,
4461,3F1S,A:B,YA240A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,3.30E-07,,,,,-11.83,2.99,,,,,
4462,3F1S,A:B,DA293A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.1 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",2.10E-09,1.20E-06,,,,,-11.83,3.76,,,,,
4463,3F1S,A:B,DA238A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.25 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",1.60E-08,5.20E-08,,,,,-10.63,0.7,,,,,
4464,3F1S,A:B,KA239A,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.25 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",1.60E-08,3.00E-10,,,,,-10.63,-2.35,,,,,
4465,3F1S,A:B,KA239C,Human vitamin-K dependent protein Z,Human protein Z-dependent protease inhibitor (ZPI/serpin A10),EI,Competitive binding titrations,"Tris buffer, 0.25 M NaCl",298,7.1,Literature,"25713144 (Table 2, p. 9911)",1.60E-08,1.10E-09,,,,,-10.63,-1.59,,,,,
4466,1KNE,A:P,AA25F,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.40E-05,,,,,-6.5,-0.11,,,,,
4467,1KNE,A:P,AA25K,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,7.70E-05,,,,,-6.5,0.89,,,,,
4468,1KNE,A:P,AA25L,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.70E-05,,,,,-6.5,0,,,,,
4469,1KNE,A:P,AA25T,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,9.00E-06,,,,,-6.5,-0.38,,,,,
4470,1KNE,A:P,DA62F,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,6.00E-06,,,,,-6.5,-0.62,,,,,
4471,1KNE,A:P,DA62I,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,3.70E-05,,,,,-6.5,0.46,,,,,
4472,1KNE,A:P,DA62K,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,9.00E-06,,,,,-6.5,-0.38,,,,,
4473,1KNE,A:P,DA62T,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,3.90E-05,,,,,-6.5,0.49,,,,,
4474,1KNE,A:P,TP6K,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.00E-05,,,,,-6.5,-0.31,,,,,
4475,1KNE,A:P,"AA25F,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.60E-05,,,,,-6.5,-0.04,,,,,
4476,1KNE,A:P,"AA25K,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.53E-04,,,,,-6.5,1.6,,,,,
4477,1KNE,A:P,"AA25L,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.30E-05,,,,,-6.5,-0.16,,,,,
4478,1KNE,A:P,"AA25T,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.00E-05,,,,,-6.5,-0.31,,,,,
4479,1KNE,A:P,"DA62F,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.20E-05,,,,,-6.5,-0.21,,,,,
4480,1KNE,A:P,"DA62I,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.60E-05,,,,,-6.5,0.59,,,,,
4481,1KNE,A:P,"DA62K,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,3.00E-05,,,,,-6.5,0.34,,,,,
4482,1KNE,A:P,"DA62T,TP6K",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,5.80E-05,,,,,-6.5,0.73,,,,,
4483,1KNE,A:P,TP6I,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.70E-05,,,,,-6.5,0.27,,,,,
4484,1KNE,A:P,"AA25F,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.60E-05,,,,,-6.5,0.59,,,,,
4485,1KNE,A:P,"AA25K,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.80E-04,,,,,-6.5,1.4,,,,,
4486,1KNE,A:P,"AA25L,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.90E-05,,,,,-6.5,0.07,,,,,
4487,1KNE,A:P,"AA25T,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.70E-05,,,,,-6.5,0.6,,,,,
4488,1KNE,A:P,"DA62F,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.40E-05,,,,,-6.5,0.2,,,,,
4489,1KNE,A:P,"DA62I,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.80E-05,,,,,-6.5,0.61,,,,,
4490,1KNE,A:P,"DA62K,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.70E-05,,,,,-6.5,0,,,,,
4491,1KNE,A:P,"DA62T,TP6I",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,7.60E-05,,,,,-6.5,0.89,,,,,
4492,1KNE,A:P,TP6F,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.00E-05,,,,,-6.5,0.1,,,,,
4493,1KNE,A:P,"AA25F,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,6.60E-05,,,,,-6.5,0.8,,,,,
4494,1KNE,A:P,"AA25K,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.03E-04,,,,,-6.5,1.47,,,,,
4495,1KNE,A:P,"AA25L,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.60E-05,,,,,-6.5,0.25,,,,,
4496,1KNE,A:P,"AA25T,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,6.40E-05,,,,,-6.5,0.79,,,,,
4497,1KNE,A:P,"DA62F,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.30E-05,,,,,-6.5,-0.16,,,,,
4498,1KNE,A:P,"DA62I,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.08E-04,,,,,-6.5,1.09,,,,,
4499,1KNE,A:P,"DA62K,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.60E-05,,,,,-6.5,-0.04,,,,,
4500,1KNE,A:P,"DA62T,TP6F",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.38E-04,,,,,-6.5,1.24,,,,,
4501,1KNE,A:P,TP6L,Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.40E-05,,,,,-6.5,0.2,,,,,
4502,1KNE,A:P,"AA25F,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,3.30E-05,,,,,-6.5,0.39,,,,,
4503,1KNE,A:P,"AA25K,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,3.76E-04,,,,,-6.5,1.83,,,,,
4504,1KNE,A:P,"AA25L,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.60E-05,,,,,-6.5,0.25,,,,,
4505,1KNE,A:P,"AA25T,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.40E-05,,,,,-6.5,0.56,,,,,
4506,1KNE,A:P,"DA62F,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.80E-05,,,,,-6.5,0.3,,,,,
4507,1KNE,A:P,"DA62I,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,4.50E-05,,,,,-6.5,0.58,,,,,
4508,1KNE,A:P,"DA62K,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,1.00E-05,,,,,-6.5,-0.31,,,,,
4509,1KNE,A:P,"DA62T,TP6L",Drosophila melanogaster heterochromatin protein 1 (HP1),Drosophila melanogaster Histone H3,,Fluorescence Anisotropy/Polarization,"50 mM potassium phosphate buffer, 25 mM NaCl, 4 mM DTT",298,8,Literature,"25790265 (Table 1, p. 2316)",1.70E-05,2.60E-05,,,,,-6.5,0.25,,,,,
4510,,,Y*507A,Escherichia coli colicin-E3,Escherichia coli colicin-E3 immunity protein (ImmE3),EI,Isothermal Titration Calorimetry; Fluorescence Anisotropy/Polarization,"50mM MOPS-NaOH, 200mM NaCl",298,7,Literature,"25856265 (Table 1, p. 5253)",1.20E-12,2.80E-08,1.10E+08,4.40E+05,1.50E-04,3.10E-04,-16.25,5.96,,,,,mutation in E3
4511,,,Y*537S,Human prohibitin-2 (PHB2/REA),Human estrogen receptor alpha (ER-&alpha;),RC,Isothermal Titration Calorimetry,"20 mM HEPES-NaOH, 150 mM NaCl, 5% glycerol, 0.5 mM TCEP",298,8,Literature,"26049107 (Table 1, p. 729)",1.30E-06,1.90E-06,,,,,-8.03,0.22,13.8,4.1,0.02,0.01,
4512,,,D*538G,Human prohibitin-2 (PHB2/REA),Human estrogen receptor alpha (ER-&alpha;),RC,Isothermal Titration Calorimetry,"20 mM HEPES-NaOH, 150 mM NaCl, 5% glycerol, 0.5 mM TCEP",298,8,Literature,"26049107 (Table 1, p. 729)",1.30E-06,6.40E-06,,,,,-8.03,0.94,13.8,6,0.02,0,
4513,4E6K,A:G,EA81A,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,2.59E-04,,,,,-7.4,2.56,,,,,
4514,4E6K,A:G,LA68A,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,2.99E-04,,,,,-7.4,2.64,,,,,
4515,4E6K,A:G,EA85A,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,5.90E-06,,,,,-7.4,0.34,,,,,
4516,4E6K,A:G,YG2F,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,1.07E-07,,,,,-7.4,-2.01,,,,,
4517,4E6K,A:G,KG40A,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,7.70E-08,,,,,-7.4,-2.2,,,,,
4518,4E6K,A:G,LG5A,Pseudomonas aeruginosa bacterioferritin/ferroxidase (bfrB),Pseudomonas aeruginosa bacterioferritin-associated ferredoxin,OE,Surface Plasmon Resonance,PBS with 1.5 mM TCEP,295,7.4,Literature,"26368531 (Table 2, p. 6169)",3.30E-06,8.20E-07,,,,,-7.4,-0.82,,,,,
4519,,,M*743T,Human UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE),Human alpha-actinin 2,,Surface Plasmon Resonance,"20mM Tri, 250mM NaCl, 0.1mM DTT, 2mM CaCl2",298,7.5,Literature,27023225 (Figure 2 on the 5th page),9.37E-09,6.49E-09,,,,,-14.62,-0.29,,,,,
4520,,,T*58A,Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,3.36E-08,3.30E+05,1.00E+04,,3.80E-04,-12.33,2.14,,,,,mutation in TG2
4521,,,E*120A,Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,1.15E-08,3.30E+05,7.00E+04,,8.50E-04,-12.33,1.51,,,,,mutation in TG2
4522,,,S*129A,Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,1.90E-09,3.30E+05,3.60E+05,,6.60E-04,-12.33,0.44,,,,,mutation in TG2
4523,,,D*187A,Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,1.30E-09,3.30E+05,1.90E+05,,2.50E-04,-12.33,0.22,,,,,mutation in TG2
4524,,,D*198A,Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,7.82E-08,3.30E+05,5.00E+03,,3.70E-04,-12.33,2.64,,,,,mutation in TG2
4525,,,"R*116A,H*134A",Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,4.51E-07,3.30E+05,,,,-12.33,3.68,,,,,mutations in TG2
4526,,,"K*30E,R*116A,H*134A",Human protein-glutamine gamma-glutamyltransferase 2/transglutaminase-2 (TG2),Human fibronectin (FN),,Surface Plasmon Resonance,"0.01 M Hepes, 0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20",298,7.4,Literature,27394141 (Table I on the 8th page),9.00E-10,2.17E-06,3.30E+05,,,,-12.33,4.61,,,,,mutations in TG2
4527,1A4Y,A:B,KB40Q,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times,"0.1 M Mes, 0.1 M NaCl, 1mM EDTA",298,6,SKEMPI;ASEdb;,"2742853 (Table I, p.3558)",7.10E-16,9.30E-13,1.80E+08,6.10E+09,1.30E-07,5.70E-09,-20.66,4.25,,,,,
4528,1A22,A:B,TA175A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,2.25E-08,3.00E+05,3.00E+05,2.70E-04,6.75E-03,-12.33,1.91,,,,,
4529,1A22,A:B,RA178A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,5.40E-08,3.00E+05,1.20E+05,2.70E-04,6.48E-03,-12.33,2.42,,,,,
4530,1A22,A:B,FA176A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.80E-09,3.00E+05,2.73E+05,2.70E-04,5.94E-03,-12.33,0.41,,,,,
4531,1A22,A:B,KA172A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,2.70E-08,3.00E+05,2.00E+05,2.70E-04,5.40E-03,-12.33,2.01,,,,,
4532,1A22,A:B,RA64A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.44E-08,3.00E+05,1.43E+05,2.70E-04,2.13E-03,-12.33,1.64,,,,,
4533,1A22,A:B,PA61A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,6.93E-09,3.00E+05,2.73E+05,2.70E-04,1.94E-03,-12.33,1.21,,,,,
4534,1A22,A:B,DA171A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,3.42E-09,3.00E+05,3.61E+05,2.70E-04,1.24E-03,-12.33,0.79,,,,,
4535,1A22,A:B,LA45A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,7.11E-09,3.00E+05,1.67E+05,2.70E-04,1.16E-03,-12.33,1.22,,,,,
4536,1A22,A:B,QA68A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,2.43E-09,3.00E+05,3.75E+05,2.70E-04,8.91E-04,-12.33,0.59,,,,,
4537,1A22,A:B,IA179A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,3.51E-09,3.00E+05,2.31E+05,2.70E-04,7.83E-04,-12.33,0.81,,,,,
4538,1A22,A:B,YA164A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.62E-09,3.00E+05,3.33E+05,2.70E-04,5.67E-04,-12.33,0.35,,,,,
4539,1A22,A:B,EA56A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.80E-09,3.00E+05,3.09E+05,2.70E-04,5.67E-04,-12.33,0.41,,,,,
4540,1A22,A:B,SA62A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.17E-09,3.00E+05,3.75E+05,2.70E-04,4.32E-04,-12.33,0.16,,,,,
4541,1A22,A:B,RA183A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,2.25E-09,3.00E+05,1.67E+05,2.70E-04,3.78E-04,-12.33,0.54,,,,,
4542,1A22,A:B,HA21A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.17E-09,3.00E+05,3.00E+05,2.70E-04,3.51E-04,-12.33,0.16,,,,,
4543,1A22,A:B,MA14A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,9.00E-10,3.00E+05,3.00E+05,2.70E-04,3.24E-04,-12.33,0,,,,,
4544,1A22,A:B,YA42A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.26E-09,3.00E+05,2.50E+05,2.70E-04,3.24E-04,-12.33,0.2,,,,,
4545,1A22,A:B,SA51A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.62E-09,3.00E+05,2.14E+05,2.70E-04,3.24E-04,-12.33,0.35,,,,,
4546,1A22,A:B,NA63A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.53E-09,3.00E+05,2.14E+05,2.70E-04,3.24E-04,-12.33,0.31,,,,,
4547,1A22,A:B,PA48A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.80E-09,3.00E+05,1.76E+05,2.70E-04,3.24E-04,-12.33,0.41,,,,,
4548,1A22,A:B,EA186A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,8.82E-10,3.00E+05,3.00E+05,2.70E-04,2.62E-04,-12.33,-0.01,,,,,
4549,1A22,A:B,QA46A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.08E-09,3.00E+05,2.14E+05,2.70E-04,2.43E-04,-12.33,0.11,,,,,
4550,1A22,A:B,DA26A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,6.30E-10,3.00E+05,3.37E+05,2.70E-04,2.13E-04,-12.33,-0.21,,,,,
4551,1A22,A:B,EA65A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,4.05E-10,3.00E+05,4.55E+05,2.70E-04,1.86E-04,-12.33,-0.47,,,,,
4552,1A22,A:B,KA168A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,6.93E-10,3.00E+05,2.50E+05,2.70E-04,1.73E-04,-12.33,-0.15,,,,,
4553,1A22,A:B,QA22A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,6.21E-10,3.00E+05,2.73E+05,2.70E-04,1.67E-04,-12.33,-0.22,,,,,
4554,1A22,A:B,RA167A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.44E-09,3.00E+05,9.09E+04,2.70E-04,1.32E-04,-12.33,0.28,,,,,
4555,1A22,A:B,FA25A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,4.23E-10,3.00E+05,3.00E+05,2.70E-04,1.27E-04,-12.33,-0.45,,,,,
4556,1A22,A:B,HA18A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,3.96E-10,3.00E+05,2.73E+05,2.70E-04,1.11E-04,-12.33,-0.49,,,,,
4557,1A22,A:B,QA29A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,3.33E-10,3.00E+05,3.09E+05,2.70E-04,1.03E-04,-12.33,-0.59,,,,,
4558,1A22,A:B,EA174A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"150 mM NaCl, 10 mM sodium phosphate, 0.02% Tween 20",298,7.4,SKEMPI;ASEdb;,"7504735 (Tables 1 and 2, pp. 556-7)",9.00E-10,1.89E-10,3.00E+05,4.92E+05,2.70E-04,8.91E-05,-12.33,-0.92,,,,,
4559,1A22,A:B,CB308A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4560,1A22,A:B,CB322A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4561,1A22,A:B,DB326A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,5.21E-09,,,,,-12.29,1,,,,,
4562,1A22,A:B,DB364A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.43E-08,,,,,-12.29,1.6,,,,,
4563,1A22,A:B,EB244A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,2.01E-08,,,,,-12.29,1.8,,,,,
4564,1A22,A:B,EB275A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,8.13E-10,,,,,-12.29,-0.1,,,,,
4565,1A22,A:B,EB320A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,6.87E-10,,,,,-12.29,-0.2,,,,,
4566,1A22,A:B,EB327A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,5.21E-09,,,,,-12.29,1,,,,,
4567,1A22,A:B,IB303A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,2.01E-08,,,,,-12.29,1.8,,,,,
4568,1A22,A:B,IB305A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,2.82E-08,,,,,-12.29,2,,,,,
4569,1A22,A:B,IB365A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,3.95E-08,,,,,-12.29,2.2,,,,,
4570,1A22,A:B,KB321A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.14E-09,,,,,-12.29,0.1,,,,,
4571,1A22,A:B,KB367A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4572,1A22,A:B,NB272A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.35E-09,,,,,-12.29,0.2,,,,,
4573,1A22,A:B,NB418A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.60E-09,,,,,-12.29,0.3,,,,,
4574,1A22,A:B,QB274A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4575,1A22,A:B,QB366A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4576,1A22,A:B,QB416A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,4.40E-09,,,,,-12.29,0.9,,,,,
4577,1A22,A:B,RB243A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,3.95E-08,,,,,-12.29,2.2,,,,,
4578,1A22,A:B,RB417A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.35E-09,,,,,-12.29,0.2,,,,,
4579,1A22,A:B,SB298A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,8.13E-10,,,,,-12.29,-0.1,,,,,
4580,1A22,A:B,SB302A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,6.87E-10,,,,,-12.29,-0.2,,,,,
4581,1A22,A:B,SB324A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.35E-09,,,,,-12.29,0.2,,,,,
4582,1A22,A:B,TB273A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.14E-09,,,,,-12.29,0.1,,,,,
4583,1A22,A:B,TB394A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,1.35E-09,,,,,-12.29,0.2,,,,,
4584,1A22,A:B,TB395A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,8.13E-10,,,,,-12.29,-0.1,,,,,
4585,1A22,A:B,VB371A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,2.95E-10,,,,,-12.29,-0.7,,,,,
4586,1A22,A:B,WB276A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,2.65E-09,,,,,-12.29,0.6,,,,,
4587,1A22,A:B,WB280A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Competitive Binding,"50mM Tris-HCl, 10mM CaCl2, 1g/L bovine albumin, 0.2 g/L NaN3",298,7.4,SKEMPI;Asedb;,"7529940 (Figure 2, p. 384)",9.63E-10,9.63E-10,,,,,-12.29,0,,,,,
4588,1FFG,A:B,AA103V,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Isothermal Titration Calorimetry,"20mM sodium phosphate, 20mM NaCl, 1mM EDTA, 1mM PMSF, 10% (v/v) glycerol",301,7.4,PINT,"7578071 (Table 1, p. 14629)",1.50E-06,1.45E-05,,,,,-6.7,1.3,-8.8,,,,
4589,1FFG,A:B,YA51C,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Isothermal Titration Calorimetry,"20mM sodium phosphate, 20mM NaCl, 1mM EDTA, 1mM PMSF, 10% (v/v) glycerol",301,7.4,PINT,"7578071 (Table 1, p. 14629)",1.35E-06,2.08E-06,,,,,-7.8,0.3,-14.7,,,,
4590,1FFW,A:B,DA13K,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,1.30E-06,,,,,-8.07,0.05,,,,,
4591,1FFW,A:B,TA87I,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,7.00E-07,,,,,-8.07,-0.32,,,,,
4592,1FFW,A:B,AA90V,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,1.40E-06,,,,,-8.07,0.09,,,,,
4593,1FFW,A:B,EA93K,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,4.80E-06,,,,,-8.07,0.82,,,,,
4594,1FFW,A:B,YA106W,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,4.00E-06,,,,,-8.07,0.71,,,,,
4595,1FFW,A:B,VA108M,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,8.10E-06,,,,,-8.07,1.13,,,,,
4596,1FFW,A:B,FA111V,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,1.00E-05,,,,,-8.07,1.26,,,,,
4597,1FFW,A:B,TA112I,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,3.10E-06,,,,,-8.07,0.56,,,,,
4598,1FFW,A:B,EA117K,Escherichia coli chemotaxis protein CheA,Escherichia coli chemotaxis protein CheY,OE,Fluorescence Quenching,"50 mM sodium phosphate, 5 mM MgCl<sub>2</sub>",298,6.5,SKEMPI,"7592655 (Table II, p.24417)",1.20E-06,4.00E-06,,,,,-8.07,0.71,,,,,
4599,3HFM,Y:LH,YH33F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,1.41E-08,,,,,-11.96,1.07,-21.9,-17.5,-32.6,-21.8,
4600,3HFM,Y:LH,YH33L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,6.67E-08,,,,,-11.96,2.01,-21.9,-16.1,-32.6,-20.4,
4601,3HFM,Y:LH,YH33W,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,4.35E-08,,,,,-11.96,1.75,-21.9,-15.7,-32.6,-18.1,
4602,3HFM,Y:LH,YH50F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,3.45E-08,,,,,-11.96,1.61,-21.9,-14.3,-32.6,-13.2,
4603,3HFM,Y:LH,YH50L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,2.70E-07,,,,,-11.96,2.85,-21.9,-12.9,-32.6,-12.5,
4604,3HFM,Y:LH,YH53A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,5.26E-07,,,,,-11.96,3.25,-21.9,-14.4,-32.6,-18.8,
4605,3HFM,Y:LH,YH53F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,6.67E-09,,,,,-11.96,0.62,-21.9,-20.2,-32.6,-29.3,
4606,3HFM,Y:LH,YH53L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,9.09E-09,,,,,-11.96,0.81,-21.9,-19.6,-32.6,-27.9,
4607,3HFM,Y:LH,YH53W,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,7.69E-09,,,,,-11.96,0.71,-21.9,-23.6,-32.6,-40.8,
4608,3HFM,Y:LH,YH58A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,3.85E-08,,,,,-11.96,1.68,-21.9,-17.3,-32.6,-23,
4609,3HFM,Y:LH,YH58F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,4.35E-09,,,,,-11.96,0.36,-21.9,-20.4,-32.6,-29,
4610,3HFM,Y:LH,YH58L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,50mM phosphate buffer with 0.2 M NaCl,303,7.2,SKEMPI,"7629185 (Table III, p.18555)",2.38E-09,2.94E-08,,,,,-11.96,1.51,-21.9,-14.9,-32.6,-14.8,
4611,1DAN,TU:LH,KU159A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC1<sub>2</sub>",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.72E-09,3.40E+05,2.72E+05,2.10E-03,2.10E-03,-11.2,0.13,,,,,
4612,1DAN,TU:LH,DT44A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,2.13E-08,3.40E+05,2.65E+05,2.10E-03,5.77E-03,-11.2,0.73,,,,,
4613,1DAN,TU:LH,"DT54A,ET56A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.28E-08,3.40E+05,2.99E+05,2.10E-03,3.95E-03,-11.2,0.43,,,,,
4614,1DAN,TU:LH,DT58A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.77E-07,3.40E+05,2.65E+05,2.10E-03,4.97E-02,-11.2,1.99,,,,,
4615,1DAN,TU:LH,DU129A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.89E-09,3.40E+05,3.63E+05,2.10E-03,2.18E-03,-11.2,-0.03,,,,,
4616,1DAN,TU:LH,"DT61A,ET62A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.03E-08,3.40E+05,1.75E+05,2.10E-03,2.05E-03,-11.2,0.3,,,,,
4617,1DAN,TU:LH,DU145A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.05E-09,3.40E+05,2.25E+05,2.10E-03,1.37E-03,-11.2,-0.01,,,,,
4618,1DAN,TU:LH,ET24A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.87E-08,3.40E+05,2.92E+05,2.10E-03,5.51E-03,-11.2,0.66,,,,,
4619,1DAN,TU:LH,ET26A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.31E-09,3.40E+05,2.80E+05,2.10E-03,2.09E-03,-11.2,0.1,,,,,
4620,1DAN,TU:LH,EU128A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.12E-09,3.40E+05,2.94E+05,2.10E-03,2.15E-03,-11.2,0.09,,,,,
4621,1DAN,TU:LH,EU208A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.11E-09,3.40E+05,2.95E+05,2.10E-03,1.82E-03,-11.2,0,,,,,
4622,1DAN,TU:LH,"EU130A,RU131F",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.94E-09,3.40E+05,3.42E+05,2.10E-03,2.08E-03,-11.2,-0.02,,,,,
4623,1DAN,TU:LH,"EU183A,NU184A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.26E-09,3.40E+05,4.02E+05,2.10E-03,2.14E-03,-11.2,-0.09,,,,,
4624,1DAN,TU:LH,EU99A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.58E-09,3.40E+05,4.48E+05,2.10E-03,2.07E-03,-11.2,-0.18,,,,,
4625,1DAN,TU:LH,FT50A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.29E-08,3.40E+05,3.02E+05,2.10E-03,3.99E-03,-11.2,0.44,,,,,
4626,1DAN,TU:LH,FU140A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.36E-08,3.40E+05,3.34E+05,2.10E-03,1.86E-02,-11.2,1.28,,,,,
4627,1DAN,TU:LH,IT22A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.83E-08,3.40E+05,3.46E+05,2.10E-03,6.53E-03,-11.2,0.64,,,,,
4628,1DAN,TU:LH,IU152A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.33E-09,3.40E+05,3.06E+05,2.10E-03,2.58E-03,-11.2,0.18,,,,,
4629,1DAN,TU:LH,KT15A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,3.15E-09,3.40E+05,3.89E+05,2.10E-03,1.25E-03,-11.2,-0.4,,,,,
4630,1DAN,TU:LH,KT20A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.86E-07,3.40E+05,2.70E+04,2.10E-03,1.30E-02,-11.2,2.59,,,,,
4631,1DAN,TU:LH,KT28A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.50E-09,3.40E+05,2.73E+05,2.10E-03,2.08E-03,-11.2,0.12,,,,,
4632,1DAN,TU:LH,KT41A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.06E-08,3.40E+05,2.76E+05,2.10E-03,3.01E-03,-11.2,0.32,,,,,
4633,1DAN,TU:LH,KT46A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,9.11E-09,3.40E+05,2.33E+05,2.10E-03,2.16E-03,-11.2,0.23,,,,,
4634,1DAN,TU:LH,KT48A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.24E-08,3.40E+05,2.11E+05,2.10E-03,2.70E-03,-11.2,0.41,,,,,
4635,1DAN,TU:LH,KT68A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.47E-09,3.40E+05,4.39E+05,2.10E-03,2.42E-03,-11.2,-0.07,,,,,
4636,1DAN,TU:LH,"KT41A,DT44A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.74E-08,3.40E+05,4.79E+05,2.10E-03,5.25E-02,-11.2,1.57,,,,,
4637,1DAN,TU:LH,KU122A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.02E-09,3.40E+05,4.09E+05,2.10E-03,2.07E-03,-11.2,-0.12,,,,,
4638,1DAN,TU:LH,"KT46A,KT48A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.19E-08,3.40E+05,3.22E+05,2.10E-03,1.51E-02,-11.2,1.14,,,,,
4639,1DAN,TU:LH,KU169A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.50E-09,3.40E+05,2.61E+05,2.10E-03,2.00E-03,-11.2,0.12,,,,,
4640,1DAN,TU:LH,"KT65A,DT66A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,2.63E-09,3.40E+05,2.56E+05,2.10E-03,6.85E-04,-11.2,-0.5,,,,,
4641,1DAN,TU:LH,DT58E,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.33E-08,3.40E+05,4.79E+05,2.10E-03,3.08E-02,-11.2,1.38,,,,,
4642,1DAN,TU:LH,"KT68A,QT69A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.35E-09,3.40E+05,4.30E+05,2.10E-03,1.88E-03,-11.2,-0.21,,,,,
4643,1DAN,TU:LH,KU181A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.34E-09,3.40E+05,3.76E+05,2.10E-03,2.42E-03,-11.2,0.02,,,,,
4644,1DAN,TU:LH,"KU149A,DU150A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.19E-09,3.40E+05,3.09E+05,2.10E-03,1.63E-03,-11.2,-0.1,,,,,
4645,1DAN,TU:LH,"KU165A,KU166A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.11E-09,3.40E+05,3.52E+05,2.10E-03,1.69E-03,-11.2,-0.24,,,,,
4646,1DAN,TU:LH,"KU201A,DU204A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.62E-09,3.40E+05,3.25E+05,2.10E-03,2.18E-03,-11.2,0.04,,,,,
4647,1DAN,TU:LH,LU133A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.88E-09,3.40E+05,2.79E+05,2.10E-03,1.68E-03,-11.2,-0.03,,,,,
4648,1DAN,TU:LH,LU176A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.05E-09,3.40E+05,2.82E+05,2.10E-03,2.01E-03,-11.2,0.08,,,,,
4649,1DAN,TU:LH,"LU104A,EU105A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,2.82E-09,3.40E+05,6.66E+05,2.10E-03,1.88E-03,-11.2,-0.46,,,,,
4650,1DAN,TU:LH,NT18A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.35E-09,3.40E+05,2.11E+05,2.10E-03,1.76E-03,-11.2,0.18,,,,,
4651,1DAN,TU:LH,QT37A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.55E-08,3.40E+05,2.88E+05,2.10E-03,4.56E-03,-11.2,0.55,,,,,
4652,1DAN,TU:LH,"NU107A,QU110A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.24E-08,3.40E+05,3.76E+05,2.10E-03,4.55E-03,-11.2,0.41,,,,,
4653,1DAN,TU:LH,"NU173A,EU174A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.91E-09,3.40E+05,4.04E+05,2.10E-03,2.40E-03,-11.2,-0.02,,,,,
4654,1DAN,TU:LH,"NU199A,RU200A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.21E-08,3.40E+05,2.34E+05,2.10E-03,2.86E-03,-11.2,0.4,,,,,
4655,1DAN,TU:LH,GU164R,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.68E-09,3.40E+05,4.39E+05,2.10E-03,2.07E-03,-11.2,-0.16,,,,,
4656,1DAN,TU:LH,"QU114A,EU117A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.52E-09,3.40E+05,2.60E+05,2.10E-03,1.74E-03,-11.2,0.03,,,,,
4657,1DAN,TU:LH,RU135A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.48E-08,3.40E+05,2.01E+05,2.10E-03,3.11E-03,-11.2,0.52,,,,,
4658,1DAN,TU:LH,RU144A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.13E-09,3.40E+05,3.37E+05,2.10E-03,2.14E-03,-11.2,0,,,,,
4659,1DAN,TU:LH,"RU136A,NU137A,NU138A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.73E-09,3.40E+05,1.96E+05,2.10E-03,1.73E-03,-11.2,0.21,,,,,
4660,1DAN,TU:LH,KT20R,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.06E-07,3.40E+05,3.94E+05,2.10E-03,4.23E-02,-11.2,1.68,,,,,
4661,1DAN,TU:LH,ST42A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.48E-09,3.40E+05,3.52E+05,2.10E-03,1.95E-03,-11.2,-0.07,,,,,
4662,1DAN,TU:LH,ST47A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.63E-09,3.40E+05,3.14E+05,2.10E-03,2.07E-03,-11.2,0.04,,,,,
4663,1DAN,TU:LH,SU163A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.40E-09,3.40E+05,3.00E+05,2.10E-03,1.93E-03,-11.2,0.02,,,,,
4664,1DAN,TU:LH,SU195A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,6.13E-09,3.40E+05,3.40E+05,2.10E-03,2.11E-03,-11.2,0,,,,,
4665,1DAN,TU:LH,"SU195A,RU196A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.81E-08,3.40E+05,1.84E+05,2.10E-03,3.37E-03,-11.2,0.64,,,,,
4666,1DAN,TU:LH,TT17A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.55E-09,3.40E+05,3.37E+05,2.10E-03,2.55E-03,-11.2,0.12,,,,,
4667,1DAN,TU:LH,TT21A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.71E-09,3.40E+05,4.38E+05,2.10E-03,2.06E-03,-11.2,-0.16,,,,,
4668,1DAN,TU:LH,TT52A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.22E-08,3.40E+05,1.73E+05,2.10E-03,2.07E-03,-11.2,0.4,,,,,
4669,1DAN,TU:LH,TU139A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.99E-09,3.40E+05,3.42E+05,2.10E-03,2.09E-03,-11.2,-0.02,,,,,
4670,1DAN,TU:LH,TU167A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.81E-09,3.40E+05,3.11E+05,2.10E-03,2.71E-03,-11.2,0.21,,,,,
4671,1DAN,TU:LH,TU172A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.90E-09,3.40E+05,3.18E+05,2.10E-03,1.90E-03,-11.2,-0.03,,,,,
4672,1DAN,TU:LH,"TU197A,VU198A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.79E-09,3.40E+05,4.34E+05,2.10E-03,2.07E-03,-11.2,-0.15,,,,,
4673,1DAN,TU:LH,TU203A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.74E-09,3.40E+05,2.56E+05,2.10E-03,1.98E-03,-11.2,0.14,,,,,
4674,1DAN,TU:LH,VU207A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,4.48E-09,3.40E+05,3.96E+05,2.10E-03,1.76E-03,-11.2,-0.19,,,,,
4675,1DAN,TU:LH,WT14F,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.98E-08,3.40E+05,6.39E+04,2.10E-03,1.24E-03,-11.2,0.69,,,,,
4676,1DAN,TU:LH,WT25F,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,1.74E-08,3.40E+05,5.03E+04,2.10E-03,8.93E-04,-11.2,0.61,,,,,
4677,1DAN,TU:LH,WT45F,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,5.26E-08,3.40E+05,5.60E+05,2.10E-03,5.45E-02,-11.2,1.27,,,,,
4678,1DAN,TU:LH,WU158F,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,7.58E-09,3.40E+05,2.24E+05,2.10E-03,1.70E-03,-11.2,0.12,,,,,
4679,1DAN,TU:LH,YU156L,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,8.03E-09,3.40E+05,2.39E+05,2.10E-03,1.95E-03,-11.2,0.16,,,,,
4680,1DAN,TU:LH,YU185A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,3.53E-09,3.40E+05,4.99E+05,2.10E-03,1.78E-03,-11.2,-0.33,,,,,
4681,1DAN,TU:LH,YU94A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"20mM Tris-HCl, 100mM NaCl, 5mM CaC12",298,7.5,SKEMPI,"7654692 (Figure 4, pp. 10387)",6.16E-09,3.47E-08,3.40E+05,1.71E+05,2.10E-03,6.00E-03,-11.2,1.02,,,,,
4682,3HFM,Y:LH,DY101A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition Enzyme Assay,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,1.00E-09,,,,,-13.48,1.21,,,,,
4683,3HFM,Y:LH,DY101E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,3.64E-09,,,,,-13.48,1.97,,,,,
4684,3HFM,Y:LH,DY101F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,5.07E-09,,,,,-13.48,2.17,,,,,
4685,3HFM,Y:LH,DY101G,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,1.82E-10,,,,,-13.48,0.2,,,,,
4686,3HFM,Y:LH,DY101K,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,3.64E-09,,,,,-13.48,1.97,,,,,
4687,3HFM,Y:LH,DY101N,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,1.25E-09,,,,,-13.48,1.34,,,,,
4688,3HFM,Y:LH,DY101Q,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,3.38E-09,,,,,-13.48,1.93,,,,,
4689,3HFM,Y:LH,DY101R,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,4.68E-09,,,,,-13.48,2.12,,,,,
4690,3HFM,Y:LH,DY101S,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 1, p.3960)",1.30E-10,2.34E-09,,,,,-13.48,1.71,,,,,
4691,3HFM,Y:LH,GY102V,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,1.95E-10,,,,,-13.48,0.24,,,,,
4692,3HFM,Y:LH,NY19D,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,2.60E-10,,,,,-13.48,0.41,,,,,
4693,3HFM,Y:LH,NY19K,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,1.95E-10,,,,,-13.48,0.24,,,,,
4694,3HFM,Y:LH,NY19Q,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,1.21E-10,,,,,-13.48,-0.04,,,,,
4695,3HFM,Y:LH,RY21E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,6.24E-09,,,,,-13.48,2.29,,,,,
4696,3HFM,Y:LH,RY21G,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,5.98E-09,,,,,-13.48,2.27,,,,,
4697,3HFM,Y:LH,RY21H,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,3.90E-09,,,,,-13.48,2.01,,,,,
4698,3HFM,Y:LH,RY21K,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,1.95E-09,,,,,-13.48,1.6,,,,,
4699,3HFM,Y:LH,RY21N,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,5.07E-09,,,,,-13.48,2.17,,,,,
4700,3HFM,Y:LH,RY21Q,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,5.72E-09,,,,,-13.48,2.24,,,,,
4701,3HFM,Y:LH,RY21W,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,"0.1% BSA, 66mM potassium phosphate",298,6.24,SKEMPI,"7683415 (Table 3, p.3960)",1.30E-10,3.64E-09,,,,,-13.48,1.97,,,,,
4702,,,DL28N,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.70E-10,6.40E+04,7.50E+04,1.70E-05,1.30E-05,-13.05,-0.27,,,,,Mutation in hu4D5 Fab
4703,,,NL30A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.75E-09,6.40E+04,4.10E+04,1.70E-05,7.20E-05,-13.05,1.11,,,,,Mutation in hu4D5 Fab
4704,,,TL31A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.04E-09,6.40E+04,6.50E+04,1.70E-05,6.70E-05,-13.05,0.8,,,,,Mutation in hu4D5 Fab
4705,,,YL49A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.60E-09,6.40E+04,5.90E+04,1.70E-05,9.70E-05,-13.05,1.05,,,,,Mutation in hu4D5 Fab
4706,,,SL50A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.40E-10,6.40E+04,7.30E+04,1.70E-05,1.70E-05,-13.05,-0.07,,,,,Mutation in hu4D5 Fab
4707,,,SL52A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.60E-10,6.40E+04,1.04E+05,1.70E-05,1.60E-05,-13.05,-0.31,,,,,Mutation in hu4D5 Fab
4708,,,FL53N,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.02E-09,6.40E+04,3.20E+04,1.70E-05,6.50E-05,-13.05,1.19,,,,,Mutation in hu4D5 Fab
4709,,,EL55Y,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.00E-10,6.40E+04,7.40E+04,1.70E-05,1.50E-05,-13.05,-0.18,,,,,Mutation in hu4D5 Fab
4710,,,RL66G,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,3.90E-10,6.40E+04,6.50E+04,1.70E-05,2.50E-05,-13.05,0.22,,,,,Mutation in hu4D5 Fab
4711,,,HL91A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,5.50E-08,6.40E+04,3.20E+04,1.70E-05,1.70E-03,-13.05,3.15,,,,,Mutation in hu4D5 Fab
4712,,,HL91F,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.30E-10,6.40E+04,6.70E+04,1.70E-05,9.00E-06,-13.05,-0.43,,,,,Mutation in hu4D5 Fab
4713,,,YL92A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.70E-09,6.40E+04,4.10E+04,1.70E-05,1.10E-04,-13.05,1.36,,,,,Mutation in hu4D5 Fab
4714,,,YL92F,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.90E-10,6.40E+04,7.50E+04,1.70E-05,1.40E-05,-13.05,-0.21,,,,,Mutation in hu4D5 Fab
4715,,,TL93A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.10E-09,6.40E+04,4.30E+04,1.70E-05,4.70E-05,-13.05,0.83,,,,,Mutation in hu4D5 Fab
4716,,,TL94A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.20E-10,6.40E+04,6.60E+04,1.70E-05,1.50E-05,-13.05,-0.12,,,,,Mutation in hu4D5 Fab
4717,,,KH30A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,7.40E-10,6.40E+04,2.90E+04,1.70E-05,2.10E-05,-13.05,0.6,,,,,Mutation in hu4D5 Fab
4718,,,DH31A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,4.10E-10,6.40E+04,3.60E+04,1.70E-05,1.50E-05,-13.05,0.25,,,,,Mutation in hu4D5 Fab
4719,,,TH32A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,5.10E-10,6.40E+04,3.80E+04,1.70E-05,1.90E-05,-13.05,0.38,,,,,Mutation in hu4D5 Fab
4720,,,YH33A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.30E-10,6.40E+04,8.00E+04,1.70E-05,1.80E-05,-13.05,-0.09,,,,,Mutation in hu4D5 Fab
4721,,,RH50A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,6.10E-07,6.40E+04,3.50E+04,1.70E-05,2.10E-02,-13.05,4.57,,,,,Mutation in hu4D5 Fab
4722,,,YH52A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,4.00E-10,6.40E+04,4.30E+04,1.70E-05,1.70E-05,-13.05,0.23,,,,,Mutation in hu4D5 Fab
4723,,,TH53A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,3.10E-10,6.40E+04,4.90E+04,1.70E-05,1.50E-05,-13.05,0.08,,,,,Mutation in hu4D5 Fab
4724,,,NH54A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.10E-10,6.40E+04,8.60E+04,1.70E-05,1.80E-05,-13.05,-0.15,,,,,Mutation in hu4D5 Fab
4725,,,YH56A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.18E-09,6.40E+04,4.10E+04,1.70E-05,4.90E-05,-13.05,0.87,,,,,Mutation in hu4D5 Fab
4726,,,WH95A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,5.00E-06,6.40E+04,3.90E+04,1.70E-05,1.90E-01,-13.05,5.82,,,,,Mutation in hu4D5 Fab
4727,,,DH98A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.15E-09,6.40E+04,2.00E+04,1.70E-05,4.30E-05,-13.05,1.23,,,,,Mutation in hu4D5 Fab
4728,,,FH100A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,1.90E-09,6.40E+04,4.70E+04,1.70E-05,9.00E-05,-13.05,1.16,,,,,Mutation in hu4D5 Fab
4729,,,YH100A,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,3.40E-06,6.40E+04,5.70E+04,1.70E-05,1.90E-01,-13.05,5.59,,,,,Mutation in hu4D5 Fab
4730,,,YH100F,Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,2.50E-10,6.40E+04,1.61E+05,1.70E-05,3.90E-05,-13.05,-0.05,,,,,Mutation in hu4D5 Fab
4731,,,"HL91A,YH100A",Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,8.80E-06,6.40E+04,6.00E+02,1.70E-05,4.90E-03,-13.05,6.15,,,,,Mutation in hu4D5 Fab
4732,,,"WH95A,YH100A",Humanized mouse monoclonal antibody Fab (mAb hu4D5-5),Human epidermal growth factor receptor 2 (EGFR-2/HER2),Ag-Ab,Surface Plasmon Resonance,"20mM sodium phosphate, 0.1 M NaCl, 0.05% Tween 20",298,7.5,PINT,"7687461 (Table 1, p.6831)",2.70E-10,6.30E-06,6.40E+04,3.00E+02,1.70E-05,1.85E-03,-13.05,5.96,,,,,Mutation in hu4D5 Fab
4733,1FC2,C:D,FC149W,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,,,298,,SKEMPI,"7716157 (Table II, p. 1468)",1.50E-08,1.50E-08,,,,,-14.2,0,,,,,
4734,1FC2,C:D,IC135W,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,,,298,,SKEMPI,"7716157 (Table II, p. 1468)",1.50E-08,3.00E-06,,,,,-14.2,3.14,,,,,
4735,1FC2,C:D,LC163W,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,,,298,,SKEMPI,"7716157 (Table II, p. 1468)",1.50E-08,1.50E-08,,,,,-14.2,0,,,,,
4736,1FC2,C:D,YC133W,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,,,298,,SKEMPI,"7716157 (Table II, p. 1468)",1.50E-08,3.00E-08,,,,,-14.2,0.41,,,,,
4737,1B2S,A:D,AA27K,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.57E-10,2.30E-13,4.30E+07,3.20E+08,6.80E-03,7.20E-05,-16.15,-3.86,,,,,
4738,1B2S,A:D,"AA27K,AD43T",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,1.00E-14,3.70E+07,3.70E+08,6.80E-03,3.70E-06,-16.15,-9.54,,,,,
4739,1B2S,A:D,AD43T,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,8.80E-11,3.70E+07,5.10E+07,6.80E-03,4.50E-03,-16.15,-4.17,,,,,
4740,1B2U,A:D,AA27K,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,2.00E-11,3.70E+07,1.90E+08,3.60E+00,3.80E-03,-16.15,-5.04,,,,,
4741,1B2U,A:D,"AA27K,AD36D",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,1.00E-14,3.70E+07,3.70E+08,3.60E+00,3.70E-06,-16.15,-9.54,,,,,
4742,1B2U,A:D,AD36D,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,8.80E-11,3.70E+07,5.10E+07,3.60E+00,4.50E-03,-16.15,-4.17,,,,,
4743,1B3S,A:D,AA102H,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.17E-10,8.00E-15,3.90E+08,3.00E+08,4.50E-02,2.40E-06,-16.15,-5.68,,,,,
4744,1B3S,A:D,"AA102H,FD30Y",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-07,1.00E-14,3.70E+07,3.70E+08,4.50E-02,3.70E-06,-16.15,-9.54,,,,,
4745,1B3S,A:D,FD30Y,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.17E-10,3.20E-10,3.90E+08,4.00E+08,4.50E-02,1.29E-01,-16.15,0.6,,,,,
4746,1BRS,A:D,DD35A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,2.00E-11,3.70E+08,1.90E+08,3.73E-06,3.80E-03,-15.17,4.5,-19.3,-14.4,-1.01,0.34,
4747,1BRS,A:D,DD39A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.06E-09,3.70E+08,1.90E+08,3.73E-06,9.00E-01,-15.17,7.65,-19.3,-7.4,-1.01,13.1,
4748,1BRS,A:D,ED76A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.00E-13,3.70E+08,2.00E+08,3.73E-06,2.10E-05,-15.17,1.36,-19.3,-17.8,-1.01,-0.34,
4749,1BRS,A:D,ED80A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,2.50E-14,3.70E+08,2.10E+08,3.73E-06,5.20E-06,-15.17,0.54,,,,,
4750,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.20E-10,3.70E+08,4.00E+08,3.73E-06,1.29E-01,-15.17,6.14,-19.3,-10.9,-1.01,6.71,
4751,1BRS,A:D,"HA102A,DD39A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.90E-08,3.70E+08,4.40E+08,3.73E-06,1.70E+01,-15.17,8.99,-19.3,-2.4,-1.01,25.8,
4752,1BRS,A:D,"HA102A,ED76A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.50E-09,3.70E+08,1.70E+08,3.73E-06,5.90E-01,-15.17,7.56,,,,,
4753,1BRS,A:D,"HA102A,ED80A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.80E-10,3.70E+08,2.00E+08,3.73E-06,1.80E-01,-15.17,6.74,,,,,
4754,1BRS,A:D,"HA102A,TD42A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,9.20E-09,3.70E+08,2.70E+08,3.73E-06,2.40E+00,-15.17,8.13,,,,,
4755,1BRS,A:D,"HA102A,WD38F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.00E-09,3.70E+08,3.20E+08,3.73E-06,1.28E+00,-15.17,7.64,,,,,
4756,1BRS,A:D,"HA102A,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.20E-10,3.70E+08,3.60E+08,3.73E-06,1.50E-01,-15.17,6.3,-19.3,-13.3,-1.01,-2.01,
4757,1BRS,A:D,"HA102A,YD29F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.17E-10,3.70E+08,3.90E+08,3.73E-06,4.50E-02,-15.17,5.55,-19.3,-12,-1.01,5.03,
4758,1BRS,A:D,KA27A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.80E-11,3.70E+08,5.10E+07,3.73E-06,4.50E-03,-15.17,5.38,-19.3,-13.1,-1.01,1.68,
4759,1BRS,A:D,"KA27A,DD35A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.00E-07,3.70E+08,3.70E+07,3.73E-06,3.60E+00,-15.17,9.54,,,,,
4760,1BRS,A:D,"KA27A,DD39A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.17E-08,3.70E+08,5.80E+07,3.73E-06,6.80E-01,-15.17,8.27,-19.3,-10.6,-1.01,0.67,
4761,1BRS,A:D,"KA27A,ED76A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.10E-10,3.70E+08,1.60E+07,3.73E-06,1.30E-02,-15.17,6.69,,,,,
4762,1BRS,A:D,"KA27A,ED80A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.10E-10,3.70E+08,3.20E+07,3.73E-06,3.50E-03,-15.17,5.51,,,,,
4763,1BRS,A:D,"KA27A,TD42A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.57E-10,3.70E+08,4.30E+07,3.73E-06,6.80E-03,-15.17,5.72,,,,,
4764,1BRS,A:D,"KA27A,WD38F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,5.60E-11,3.70E+08,3.80E+07,3.73E-06,2.10E-02,-15.17,5.11,,,,,
4765,1BRS,A:D,"KA27A,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,2.10E-08,3.70E+08,4.60E+07,3.73E-06,9.70E-01,-15.17,8.62,,,,,
4766,1BRS,A:D,RA59A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,7.00E-11,3.70E+08,3.40E+07,3.73E-06,2.40E-03,-15.17,5.24,-19.3,-11.9,-1.01,6.37,
4767,1BRS,A:D,"RA59A,DD35A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.40E-10,3.70E+08,3.10E+07,3.73E-06,1.40E-02,-15.17,6.33,,,,,
4768,1BRS,A:D,"RA59A,ED76A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.40E-11,3.70E+08,3.60E+07,3.73E-06,1.60E-03,-15.17,4.97,,,,,
4769,1BRS,A:D,"RA59A,ED80A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,6.50E-11,3.70E+08,3.10E+07,3.73E-06,2.00E-03,-15.17,5.2,,,,,
4770,1BRS,A:D,"RA59A,TD42A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.00E-09,3.70E+08,2.10E+07,3.73E-06,2.30E-02,-15.17,6.82,,,,,
4771,1BRS,A:D,"RA59A,WD38F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,4.00E-10,3.70E+08,3.30E+07,3.73E-06,1.30E-02,-15.17,6.28,,,,,
4772,1BRS,A:D,"RA59A,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,9.00E-09,3.70E+08,2.80E+07,3.73E-06,2.50E-01,-15.17,8.12,,,,,
4773,1BRS,A:D,RA83Q,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,9.40E-11,3.70E+08,1.10E+08,3.73E-06,1.00E-02,-15.17,5.42,,,,,
4774,1BRS,A:D,"RA83Q,DD35A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.10E-07,3.70E+08,6.30E+07,3.73E-06,7.10E+00,-15.17,9.6,,,,,
4775,1BRS,A:D,"RA83Q,DD39A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,5.25E-10,3.70E+08,1.00E+08,3.73E-06,5.30E-02,-15.17,6.44,,,,,
4776,1BRS,A:D,"RA83Q,ED76A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.45E-10,3.70E+08,4.00E+07,3.73E-06,3.40E-02,-15.17,6.72,,,,,
4777,1BRS,A:D,"RA83Q,ED80A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.68E-10,3.70E+08,6.30E+07,3.73E-06,1.10E-02,-15.17,5.76,,,,,
4778,1BRS,A:D,"RA83Q,TD42A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.00E-10,3.70E+08,1.20E+08,3.73E-06,3.50E-02,-15.17,6.1,,,,,
4779,1BRS,A:D,"RA83Q,WD38F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,9.00E-10,3.70E+08,1.00E+08,3.73E-06,9.10E-02,-15.17,6.76,,,,,
4780,1BRS,A:D,"RA83Q,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.20E-08,3.70E+08,9.30E+07,3.73E-06,1.10E+00,-15.17,8.29,,,,,
4781,1BRS,A:D,RA87A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.20E-10,3.70E+08,1.40E+08,3.73E-06,1.70E-02,-15.17,5.56,-19.3,-17.3,-1.01,-12.7,
4782,1BRS,A:D,"RA87A,DD39A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.85E-09,3.70E+08,1.60E+08,3.73E-06,3.00E-01,-15.17,7.18,-19.3,-13.4,-1.01,-5.03,
4783,1BRS,A:D,"RA87A,ED76A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.08E-09,3.70E+08,6.90E+07,3.73E-06,7.40E-02,-15.17,6.86,,,,,
4784,1BRS,A:D,"RA87A,ED80A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.10E-10,3.70E+08,7.60E+07,3.73E-06,2.40E-02,-15.17,6.12,,,,,
4785,1BRS,A:D,"RA87A,TD42A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.40E-09,3.70E+08,1.10E+08,3.73E-06,3.10E-01,-15.17,7.02,,,,,
4786,1BRS,A:D,"RA87A,WD38F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.45E-09,3.70E+08,1.90E+08,3.73E-06,2.75E-01,-15.17,7.04,,,,,
4787,1BRS,A:D,"RA87A,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.00E-09,3.70E+08,1.60E+08,3.73E-06,1.30E+00,-15.17,8.05,,,,,
4788,1BRS,A:D,TD42A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,2.30E-13,3.70E+08,3.20E+08,3.73E-06,7.20E-05,-15.17,1.86,,,,,
4789,1BRS,A:D,WD38F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.60E-13,3.70E+08,4.30E+08,3.73E-06,7.00E-05,-15.17,1.64,,,,,
4790,1BRS,A:D,WD44F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,1.10E-14,3.70E+08,3.10E+08,3.73E-06,3.40E-06,-15.17,0.06,,,,,
4791,1BRS,A:D,YD29A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,3.50E-12,3.70E+08,2.90E+08,3.73E-06,1.00E-03,-15.17,3.47,-19.3,-14.2,-1.01,4.7,
4792,1BRS,A:D,YD29F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Stopped-flow Fluorescence,50mM Tris-HCl,298,8,SKEMPI,"7739054 (Table 1, p. 481)",1.00E-14,8.00E-15,3.70E+08,3.00E+08,3.73E-06,2.40E-06,-15.17,-0.13,-19.3,-18.8,-1.01,1.01,
4793,1DAN,TU:LH,"CT49S,CT57S",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.50E-12,,,,,-16.43,-0.34,,,,,
4794,1DAN,TU:LH,DT44A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.67E-11,,,,,-16.43,1.43,,,,,
4795,1DAN,TU:LH,"DT44A,DT58A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.75E-09,,,,,-16.43,4.01,,,,,
4796,1DAN,TU:LH,"DT44A,FU140A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,5.51E-10,,,,,-16.43,3.3,,,,,
4797,1DAN,TU:LH,"DT44A,KT20A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.21E-09,,,,,-16.43,4.16,,,,,
4798,1DAN,TU:LH,"DT44A,KT20A,FU140A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,4.16E-08,,,,,-16.43,5.96,,,,,
4799,1DAN,TU:LH,"DT44A,TT60A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.91E-09,,,,,-16.43,4.32,,,,,
4800,1DAN,TU:LH,"DT44A,WT45A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,3.31E-11,,,,,-16.43,1.57,,,,,
4801,1DAN,TU:LH,FT76A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.68E-11,,,,,-16.43,1.15,,,,,
4802,1DAN,TU:LH,GT43A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.90E-12,,,,,-16.43,0.07,,,,,
4803,1DAN,TU:LH,IT38A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.10E-12,,,,,-16.43,-0.13,,,,,
4804,1DAN,TU:LH,KT48A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.23E-11,,,,,-16.43,0.96,,,,,
4805,1DAN,TU:LH,PU92A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.90E-12,,,,,-16.43,-0.19,,,,,
4806,1DAN,TU:LH,QT37A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,8.90E-12,,,,,-16.43,0.76,,,,,
4807,1DAN,TU:LH,ST47A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.10E-12,,,,,-16.43,-0.13,,,,,
4808,1DAN,TU:LH,TT60A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.11E-10,,,,,-16.43,2.31,,,,,
4809,1DAN,TU:LH,"TT60A,FU140A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,3.85E-09,,,,,-16.43,4.5,,,,,
4810,1DAN,TU:LH,"TT60A,KT20A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,4.51E-10,,,,,-16.43,3.18,,,,,
4811,1DAN,TU:LH,VT33A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,1.90E-12,,,,,-16.43,-0.19,,,,,
4812,1DAN,TU:LH,VT36A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.10E-12,,,,,-16.43,-0.13,,,,,
4813,1DAN,TU:LH,WT45A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,3.27E-11,,,,,-16.43,1.56,,,,,
4814,1DAN,TU:LH,"WT45R,ST47G",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,3.17E-11,,,,,-16.43,1.54,,,,,
4815,1DAN,TU:LH,YT51A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,2.10E-12,,,,,-16.43,-0.13,,,,,
4816,1DAN,TU:LH,YT78A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,7.50E-12,,,,,-16.43,0.65,,,,,
4817,1DAN,TU:LH,YU94A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Enzyme-Linked Functional Assay,"20mM HEPES, 130mM NaCl, 5mM CaC12, 0.5% BSA",310,7.4,SKEMPI,"7756258 (Table 2, p.6312)",2.60E-12,4.40E-12,,,,,-16.43,0.32,,,,,
4818,4OGA,AB:E,DE12A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,9.12E-09,,,,,-11.22,1.03,,,,,
4819,4OGA,AB:E,DE45A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,7.40E-10,,,,,-11.22,-0.35,,,,,
4820,4OGA,AB:E,DE59A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,9.10E-10,,,,,-11.22,-0.24,,,,,
4821,4OGA,AB:E,DE74A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.41E-09,,,,,-11.22,0,,,,,
4822,4OGA,AB:E,EE24A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,9.30E-10,,,,,-11.22,-0.23,,,,,
4823,4OGA,AB:E,EE30A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.08E-09,,,,,-11.22,-0.15,,,,,
4824,4OGA,AB:E,EE44A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,4.84E-09,,,,,-11.22,0.68,,,,,
4825,4OGA,AB:E,EE6A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.44E-09,,,,,-11.22,0.01,,,,,
4826,4OGA,AB:E,EE70A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.54E-09,,,,,-11.22,0.05,,,,,
4827,4OGA,AB:E,FE39A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,3.57E-08,,,,,-11.22,1.78,,,,,
4828,4OGA,AB:E,FE46A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,2.24E-09,,,,,-11.22,0.25,,,,,
4829,4OGA,AB:E,FE88A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,2.31E-09,,,,,-11.22,0.27,,,,,
4830,4OGA,AB:E,FE89A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,5.17E-09,,,,,-11.22,0.72,,,,,
4831,4OGA,AB:E,HE32A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,2.06E-09,,,,,-11.22,0.21,,,,,
4832,4OGA,AB:E,IE13A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.63E-08,,,,,-11.22,1.35,,,,,
4833,4OGA,AB:E,KE40A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.60E-09,,,,,-11.22,0.07,,,,,
4834,4OGA,AB:E,KE53A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.49E-09,,,,,-11.22,0.03,,,,,
4835,4OGA,AB:E,KE73A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,7.50E-10,,,,,-11.22,-0.35,,,,,
4836,4OGA,AB:E,LE17A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,4.90E-10,,,,,-11.22,-0.58,,,,,
4837,4OGA,AB:E,LE36A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.41E-08,,,,,-11.22,1.27,,,,,
4838,4OGA,AB:E,LE61A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.68E-09,,,,,-11.22,0.1,,,,,
4839,4OGA,AB:E,LE69A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,8.90E-10,,,,,-11.22,-0.25,,,,,
4840,4OGA,AB:E,LE93A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.93E-09,,,,,-11.22,0.17,,,,,
4841,4OGA,AB:E,ME11A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.66E-09,,,,,-11.22,0.09,,,,,
4842,4OGA,AB:E,ME38A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,4.43E-09,,,,,-11.22,0.63,,,,,
4843,4OGA,AB:E,NE15A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,3.53E-07,,,,,-11.22,3.04,,,,,
4844,4OGA,AB:E,NE90A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,8.83E-09,,,,,-11.22,1.01,,,,,
4845,4OGA,AB:E,QE34A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.81E-08,,,,,-11.22,1.4,,,,,
4846,4OGA,AB:E,RE114A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,4.80E-10,,,,,-11.22,-0.59,,,,,
4847,4OGA,AB:E,RE19A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.46E-09,,,,,-11.22,0.02,,,,,
4848,4OGA,AB:E,RE42A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.62E-09,,,,,-11.22,0.08,,,,,
4849,4OGA,AB:E,RE65A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.07E-09,,,,,-11.22,-0.15,,,,,
4850,4OGA,AB:E,RE83A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,8.30E-10,,,,,-11.22,-0.29,,,,,
4851,4OGA,AB:E,TE41A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.05E-09,,,,,-11.22,-0.16,,,,,
4852,4OGA,AB:E,VE66A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.09E-09,,,,,-11.22,-0.14,,,,,
4853,4OGA,AB:E,YE67A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,3.22E-09,,,,,-11.22,0.45,,,,,
4854,4OGA,AB:E,YE91A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,3.85E-09,,,,,-11.22,0.55,,,,,
4855,4OGA,AB:E,"RE47A,DE48A","Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,2.43E-09,,,,,-11.22,0.3,,,,,
4856,4OGA,AB:E,"KE73A,DE74A","Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,2.18E-09,,,,,-11.22,0.24,,,,,
4857,4OGA,AB:E,"KE102A,EE103A","Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.94E-09,,,,,-11.22,0.18,,,,,
4858,4OGA,AB:E,"YE107A,NE108A","Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.73E-09,,,,,-11.22,0.11,,,,,
4859,4OGA,AB:E,"SE85A,RE86A","Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,,277,,ASEdb,"7852381 (Table I, p.3014)",1.41E-09,1.55E-09,,,,,-11.22,0.05,,,,,
4860,1TM1,E:I,EI60A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,9.75E-11,,,,,-16.57,2.92,,,,,
4861,1TM1,E:I,TI58A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,5.38E-11,5.50E+06,3.80E+06,3.90E-06,2.06E-04,-16.57,2.57,,,,,
4862,1TM1,E:I,"TI58A,EI60A",Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,2.14E-10,,,3.90E-06,3.50E-04,-16.57,3.39,,,,,
4863,1TM1,E:I,TI58D,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,2.42E-11,5.50E+06,1.40E+06,3.90E-06,3.40E-05,-16.57,2.1,,,,,
4864,1TM1,E:I,"TI58D,EI60A",Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,2.50E-12,5.50E+06,4.30E+06,3.90E-06,1.07E-05,-16.57,0.75,,,,,
4865,1TM1,E:I,VI70A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Hordeum vulgare chymotrypsin inhibitor 2 (CI2),EI,Spectrophotometry,,298,,SKEMPI,"7947796 (Table 3, p. 13883)",7.00E-13,7.30E-13,5.50E+06,4.60E+06,3.90E-06,3.40E-06,-16.57,0.02,,,,,
4866,1DAN,TU:LH,DT44A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,2.98E-07,,,,,-10.49,2.22,,,,,
4867,1DAN,TU:LH,FU140A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,2.23E-07,,,,,-10.49,2.06,,,,,
4868,1DAN,TU:LH,KT20A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,3.25E-07,,,,,-10.49,2.27,,,,,
4869,1DAN,TU:LH,KT46A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,2.40E-08,,,,,-10.49,0.83,,,,,
4870,1DAN,TU:LH,QU110A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI;ASEdb;,"7947809 (Table 3, p. 14008)",5.30E-09,4.80E-08,,,,,-10.49,1.21,,,,,
4871,1DAN,TU:LH,RU135A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,2.80E-08,,,,,-10.49,0.92,,,,,
4872,1DAN,TU:LH,VU207A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,7.50E-08,,,,,-10.49,1.46,,,,,
4873,1DAN,TU:LH,WT45A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,ELISA,,277,,SKEMPI,"7947809 (Table 3, p. 14008)",5.30E-09,2.90E-07,,,,,-10.49,2.2,,,,,
4874,1ILQ,AB:C,"SC2A,NC3A,IC4A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.19E-09,,,,,-10.8,0.03,,,,,
4875,1ILQ,AB:C,"TC5A,PC7A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.62E-09,,,,,-10.8,-0.34,,,,,
4876,1ILQ,AB:C,"QC8A,MC9A,VC10A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.57E-09,,,,,-10.8,0.09,,,,,
4877,1ILQ,AB:C,FC12A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,4.82E-09,,,,,-10.8,0.26,,,,,
4878,1ILQ,AB:C,"LC15A,NC16A,FC17A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,4.70E-09,,,,,-10.8,0.24,,,,,
4879,1ILQ,AB:C,"SC28A,PC29A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,2.51E-09,,,,,-10.8,-0.1,,,,,
4880,1ILQ,AB:C,"MC31A,LC32A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.40E-09,,,,,-10.8,0.06,,,,,
4881,1ILQ,AB:C,TC34A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,4.98E-09,,,,,-10.8,0.27,,,,,
4882,1ILQ,AB:C,TC36A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.19E-09,,,,,-10.8,0.03,,,,,
4883,1ILQ,AB:C,"LC37A,NC38A,KC39A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.24E-09,,,,,-10.8,0.04,,,,,
4884,1ILQ,AB:C,"KC99A,VC100A,NC101A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,2.94E-09,,,,,-10.8,-0.02,,,,,
4885,1ILQ,AB:C,"FC108A,LC109A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.87E-09,,,,,-10.8,-0.27,,,,,
4886,1ILQ,AB:C,KC11A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.99E-09,,,,,-10.8,-0.23,,,,,
4887,1ILQ,AB:C,"RC175A,QC176A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.03E-08,,,,,-10.8,0.67,,,,,
4888,1ILQ,AB:C,"NC181A,NC182A,SC183A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,2.71E-09,,,,,-10.8,-0.06,,,,,
4889,1ILQ,AB:C,"SC184A,PC185A,VC186A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,8.10E-10,,,,,-10.8,-0.73,,,,,
4890,1ILQ,AB:C,"NC193A,TC195A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,5.84E-09,,,,,-10.8,0.36,,,,,
4891,1ILQ,AB:C,"KC197A,WC198A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,5.66E-09,,,,,-10.8,0.34,,,,,
4892,1ILQ,AB:C,"NC281A,NC282A,IC283A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.39E-09,,,,,-10.8,-0.43,,,,,
4893,1ILQ,AB:C,"GC284A,RC285A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,1.92E-09,,,,,-10.8,-0.25,,,,,
4894,1ILQ,AB:C,LC287A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,3.92E-09,,,,,-10.8,0.14,,,,,
4895,1ILQ,AB:C,TC290A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,"25mM Hepes, 0.5% BSA, HBSS without Mg2+ or Ca2+",277,7.2,ASEdb,"8034699 (Table I, p. 19344)",3.03E-09,2.40E-09,,,,,-10.8,-0.13,,,,,
4896,4CPA,A:I,VI38A,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,,,,,SKEMPI,"8063780 (Table I, p. 21468)",1.50E-09,7.60E-08,,,,,,,,,,,
4897,4CPA,A:I,VI38F,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,,,,,SKEMPI,"8063780 (Table I, p. 21468)",1.50E-09,1.50E-09,,,,,,,,,,,
4898,4CPA,A:I,VI38I,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,,,,,SKEMPI,"8063780 (Table I, p. 21468)",1.50E-09,2.10E-09,,,,,,,,,,,
4899,4CPA,A:I,VI38L,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,,,,,SKEMPI,"8063780 (Table I, p. 21468)",1.50E-09,1.30E-08,,,,,,,,,,,
4900,4CPA,A:I,VI38G,Bovine carboxypeptidase A1 (CPA),Solanum tuberosum metallocarboxypeptidase inhibitor (CPI),EI,,,,,SKEMPI,"8063780 (Table I, p. 21468)",1.50E-09,8.20E-10,,,,,,,,,,,
4901,1ILQ,AB:C,DC11E,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,1.20E-09,,,,,-11.42,0.12,,,,,
4902,1ILQ,AB:C,DC11K,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,2.90E-09,,,,,-11.42,0.6,,,,,
4903,1ILQ,AB:C,KC117A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,1.30E-09,,,,,-11.42,0.16,,,,,
4904,1ILQ,AB:C,EC118A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,4.10E-09,,,,,-11.42,0.79,,,,,
4905,1ILQ,AB:C,EC278A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,3.60E-09,,,,,-11.42,0.72,,,,,
4906,1ILQ,AB:C,RC279A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table 2, p. 18551)",9.70E-10,1.25E-09,,,,,-11.42,0.14,,,,,
4907,1ILQ,AB:C,DC6A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,8.90E-10,,,,,-11.42,-0.05,,,,,
4908,1ILQ,AB:C,"DC13A,DC14A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.30E-09,,,,,-11.42,0.16,,,,,
4909,1ILQ,AB:C,"DC24A,EC25A,DC26A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,8.30E-10,,,,,-11.42,-0.09,,,,,
4910,1ILQ,AB:C,"EC33A,EC35A",Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.10E-09,,,,,-11.42,0.07,,,,,
4911,1ILQ,AB:C,EC189A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.45E-09,,,,,-11.42,0.22,,,,,
4912,1ILQ,AB:C,DC194A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.25E-09,,,,,-11.42,0.14,,,,,
4913,1ILQ,AB:C,DC265A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,2.50E-09,,,,,-11.42,0.52,,,,,
4914,1ILQ,AB:C,DC288A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.07E-09,,,,,-11.42,0.05,,,,,
4915,1ILQ,AB:C,EC291A,Human interleukin-8 (hIL-8),Human interleukin-8 receptor (hIL-8R),RC,Binding measured using <sup>125</sup>I-IL-8,,277,,ASEdb,"8103045 (Table I, p. 18550)",9.70E-10,1.20E-09,,,,,-11.42,0.12,,,,,
4916,1N8O,ABC:E,ME84K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,SKEMPI,"8143850 (Table 1, p.59)",4.00E-12,4.70E-11,,,,,-15.33,1.44,,,,,
4917,1N8O,ABC:E,ME84L,Bovine alpha-chymotrypsin/chymotrypsinogen A,Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,SKEMPI,"8143850 (Table 1, p.59)",4.00E-12,3.60E-12,,,,,-15.33,-0.06,,,,,
4918,1N8O,ABC:E,ME84R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,SKEMPI,"8143850 (Table 1, p.59)",4.00E-12,3.90E-11,,,,,-15.33,1.33,,,,,
4919,,,M*84K,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,Literature,"8143850 (Table 1, p.59)",1.30E-09,7.00E-08,,,,,-11.95,2.33,,,,,
4920,,,M*84L,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,Literature,"8143850 (Table 1, p.59)",1.30E-09,2.30E-09,,,,,-11.95,0.33,,,,,
4921,,,M*84R,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Escherichia coli ecotin,EI,Fluorescence,"50mM Tris-HCl, 20mM CaCl2, 0.005% (w/v) Triton X-100",294,8.3,Literature,"8143850 (Table 1, p.59)",1.30E-09,1.00E-07,,,,,-11.95,2.54,,,,,
4922,1KU6,A:B,YA72N,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,7.80E-09,,,,,-16.51,5.01,,,,,
4923,1KU6,A:B,WA286R,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,2.10E-06,,,,,-16.51,8.45,,,,,
4924,1KU6,A:B,"YA72N,YA124Q",Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,7.20E-08,,,,,-16.51,6.38,,,,,
4925,1KU6,A:B,"YA124Q,WA286R",Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,8.50E-06,,,,,-16.51,9.32,,,,,
4926,1KU6,A:B,"YA72N,WA286R",Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,1.70E-04,,,,,-16.51,11.16,,,,,
4927,1KU6,A:B,"YA72N,YA124Q,WA286R",Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235)",2.30E-12,2.35E-04,,,,,-16.51,11.36,,,,,
4928,1KU6,A:B,YA337A,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,4.20E-12,7.00E+08,6.90E+08,4.40E-03,6.80E-03,-16.51,0.37,,,,,
4929,1KU6,A:B,FA338G,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,7.90E-12,7.00E+08,,4.40E-03,,-16.51,0.76,,,,,
4930,1KU6,A:B,FA295L,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,1.60E-11,7.00E+08,5.00E+08,4.40E-03,3.70E-03,-16.51,1.19,,,,,
4931,1KU6,A:B,FA297I,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,5.70E-11,7.00E+08,3.30E+08,4.40E-03,6.00E-03,-16.51,1.98,,,,,
4932,1KU6,A:B,FA297Y,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,7.90E-12,7.00E+08,4.70E+08,4.40E-03,3.10E-03,-16.51,0.76,,,,,
4933,1KU6,A:B,DA74N,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,4.30E-11,7.00E+08,4.80E+08,4.40E-03,4.00E-02,-16.51,1.8,,,,,
4934,1KU6,A:B,YA124Q,Mouse acetylcholinesterase (AChE),Dendroaspis angusticeps fasciculin-2 (fas-2),EI,Measure of substrate hydrolysis after attaining equilibrium,"0.1 M NaPO4  buffer, with 0.01%  BSA",310,7,SKEMPI,"8157652 (Table 1, p. 11235, Table 2, p. 11236)",2.30E-12,2.48E-10,7.00E+08,4.90E+08,4.40E-03,2.90E-01,-16.51,2.88,,,,,
4935,,,Q*141K,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",2.50E-10,2.50E-10,,,,,-13.62,0,,,,,mutation in mIL-2
4936,,,N*99K,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",2.50E-10,2.08E-11,,,,,-13.62,-1.53,,,,,mutation in mIL-2
4937,,,N*103G,Mouse interleukin-2 (mIL-2),"Mouse high affinity interleukin-2 receptor (alpha/beta subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",2.50E-10,1.25E-11,,,,,-13.62,-1.85,,,,,mutation in mIL-2
4938,,,V*83A,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,ASEdb,"8262055 (Table II, p. 5115)",3.20E-09,1.14E-11,,,,,-12.05,-3.47,,,,,mutation in mIL-2
4939,,,N*44S,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,4.57E-09,,,,,-12.05,0.22,,,,,mutation in mIL-2
4940,,,L*86R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,7.27E-12,,,,,-12.05,-3.75,,,,,mutation in mIL-2
4941,,,N*44R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.29E-11,,,,,-12.05,-3.04,,,,,mutation in mIL-2
4942,,,T*87R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,4.00E-10,,,,,-12.05,-1.28,,,,,mutation in mIL-2
4943,,,R*46G,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.67E-10,,,,,-12.05,-1.53,,,,,mutation in mIL-2
4944,,,Q*88I,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.28E-10,,,,,-12.05,-1.98,,,,,mutation in mIL-2
4945,,,N*47G,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.56E-11,,,,,-12.05,-2.97,,,,,mutation in mIL-2
4946,,,S*89D,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,3.20E-10,,,,,-12.05,-1.42,,,,,mutation in mIL-2
4947,,,K*49E,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,7.11E-11,,,,,-12.05,-2.35,,,,,mutation in mIL-2
4948,,,K*90D,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,3.20E-09,,,,,-12.05,0,,,,,mutation in mIL-2
4949,,,L*50A,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,ASEdb,"8262055 (Table II, p. 5115)",3.20E-09,1.78E-10,,,,,-12.05,-1.78,,,,,mutation in mIL-2
4950,,,F*92R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.33E-10,,,,,-12.05,-1.1,,,,,mutation in mIL-2
4951,,,R*52M,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,4.57E-09,,,,,-12.05,0.22,,,,,mutation in mIL-2
4952,,,L*94A,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,ASEdb,"8262055 (Table II, p. 5115)",3.20E-09,2.00E-10,,,,,-12.05,-1.71,,,,,mutation in mIL-2
4953,,,R*52Q,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.91E-11,,,,,-12.05,-2.9,,,,,mutation in mIL-2
4954,,,D*96A,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,ASEdb,"8262055 (Table II, p. 5115)",3.20E-09,1.60E-09,,,,,-12.05,-0.43,,,,,mutation in mIL-2
4955,,,M*53W,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.33E-11,,,,,-12.05,-2.52,,,,,mutation in mIL-2
4956,,,N*99K,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.33E-09,,,,,-12.05,0.31,,,,,mutation in mIL-2
4957,,,L*54K,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.07E-09,,,,,-12.05,-0.67,,,,,mutation in mIL-2
4958,,,N*103G,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.60E-09,,,,,-12.05,-0.43,,,,,mutation in mIL-2
4959,,,L*54G,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.00E-11,,,,,-12.05,-3.13,,,,,mutation in mIL-2
4960,,,K*112S,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.07E-09,,,,,-12.05,-0.67,,,,,mutation in mIL-2
4961,,,F*56V,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,4.44E-12,,,,,-12.05,-4.05,,,,,mutation in mIL-2
4962,,,D*123R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,8.00E-10,,,,,-12.05,-0.85,,,,,mutation in mIL-2
4963,,,K*57D,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,8.00E-10,,,,,-12.05,-0.85,,,,,mutation in mIL-2
4964,,,D*124R,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.07E-10,,,,,-12.05,-2.09,,,,,mutation in mIL-2
4965,,,K*57E,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.56E-12,,,,,-12.05,-4.39,,,,,mutation in mIL-2
4966,,,E*125K,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.33E-10,,,,,-12.05,-1.1,,,,,mutation in mIL-2
4967,,,F*58L,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,2.00E-11,,,,,-12.05,-3.13,,,,,mutation in mIL-2
4968,,,T*128E,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.33E-11,,,,,-12.05,-2.52,,,,,mutation in mIL-2
4969,,,Y*59A,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,ASEdb,"8262055 (Table II, p. 5115)",3.20E-09,8.42E-12,,,,,-12.05,-3.66,,,,,mutation in mIL-2
4970,,,V*129T,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.68E-10,,,,,-12.05,-1.82,,,,,mutation in mIL-2
4971,,,Y*59S,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,3.40E-12,,,,,-12.05,-4.22,,,,,mutation in mIL-2
4972,,,V*130E,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,8.00E-11,,,,,-12.05,-2.27,,,,,mutation in mIL-2
4973,,,D*75K,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,4.92E-11,,,,,-12.05,-2.57,,,,,mutation in mIL-2
4974,,,V*130D,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,3.37E-11,,,,,-12.05,-2.81,,,,,mutation in mIL-2
4975,,,E*76K,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,5.71E-13,,,,,-12.05,-5.32,,,,,mutation in mIL-2
4976,,,D*34S,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.60E-09,,,,,-12.05,-0.43,,,,,mutation in mIL-2
4977,,,P*79S,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,9.70E-12,,,,,-12.05,-3.57,,,,,mutation in mIL-2
4978,,,D*34G,Mouse interleukin-2 (mIL-2),"Mouse low affinity interleukin-2 receptor (alpha subunit, mIL-2R)",RC,Competitive Binding,"100 &micro;L HBSS, 0.1% BSA, 0.1% sodium azide",310,,Literature,"8262055 (Table II, p. 5115)",3.20E-09,1.60E-09,,,,,-12.05,-0.43,,,,,mutation in mIL-2
4979,2SIC,E:I,MI73A,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,2.60E-11,6.50E+06,3.70E+06,9.00E-05,1.40E-04,-14.65,0.22,,,,,
4980,2SIC,E:I,MI73D,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,6.40E-11,6.50E+06,1.80E+06,9.00E-05,2.60E-04,-14.65,0.75,,,,,
4981,2SIC,E:I,MI73E,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,6.90E-11,6.50E+06,1.90E+06,9.00E-05,1.10E-04,-14.65,0.8,,,,,
4982,2SIC,E:I,MI73G,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,2.30E-11,6.50E+06,4.50E+06,9.00E-05,1.30E-04,-14.65,0.15,,,,,
4983,2SIC,E:I,MI73H,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,2.60E-11,6.50E+06,4.40E+06,9.00E-05,4.10E-04,-14.65,0.22,,,,,
4984,2SIC,E:I,MI73I,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,2.70E-10,6.50E+06,6.20E+06,9.00E-05,1.70E-03,-14.65,1.6,,,,,
4985,2SIC,E:I,MI73K,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,1.80E-11,,,,,-14.65,0,,,,,
4986,2SIC,E:I,MI73L,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,1.20E-11,6.50E+06,4.20E+06,9.00E-05,2.10E-04,-14.65,-0.24,,,,,
4987,2SIC,E:I,MI73R,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,1.80E-11,,,,,-14.65,0,,,,,
4988,2SIC,E:I,MI73V,Bacillus amyloliquefaciens subtilisin BPN'/subtilisin novo,Streptomyces albogriseolus subtilisin inhibitor,EI,Spectroscopy,5mM phosphate buffer with 0.005% (w/v) Triton X-100,298,7,SKEMPI,"8276767 (Table 1, p. 555)",1.80E-11,6.00E-11,6.50E+06,5.40E+06,9.00E-05,3.50E-04,-14.65,0.71,,,,,
4989,1DAN,TU:LH,KT15A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,2.05E-12,,,,,-16.15,-0.43,,,,,
4990,1DAN,TU:LH,ST16A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,2.05E-12,,,,,-16.15,-0.43,,,,,
4991,1DAN,TU:LH,TT17A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
4992,1DAN,TU:LH,NT18A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
4993,1DAN,TU:LH,KT20A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,1.44E-10,,,,,-16.15,2.19,,,,,
4994,1DAN,TU:LH,TT21A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
4995,1DAN,TU:LH,IT22A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-11,,,,,-16.15,1.53,,,,,
4996,1DAN,TU:LH,"ET24A,ET26A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,1.64E-11,,,,,-16.15,0.85,,,,,
4997,1DAN,TU:LH,KT28A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
4998,1DAN,TU:LH,"VT30A,QT32A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
4999,1DAN,TU:LH,"ST39A,TT40A,ST42A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5000,1DAN,TU:LH,"KT41A,KT46A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,8.20E-12,,,,,-16.15,0.43,,,,,
5001,1DAN,TU:LH,FT49A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5002,1DAN,TU:LH,"TT53A,TT55A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5003,1DAN,TU:LH,"DT54A,ET56A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5004,1DAN,TU:LH,DT58A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,1.68E-10,,,,,-16.15,2.29,,,,,
5005,1DAN,TU:LH,LT59A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5006,1DAN,TU:LH,DT61A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5007,1DAN,TU:LH,ET62A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5008,1DAN,TU:LH,IT63A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5009,1DAN,TU:LH,VT64A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5010,1DAN,TU:LH,"KT65A,DT66A,KT68A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5011,1DAN,TU:LH,VT67A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5012,1DAN,TU:LH,QT69A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5013,1DAN,TU:LH,LT72A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5014,1DAN,TU:LH,YT78A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,8.20E-12,,,,,-16.15,0.43,,,,,
5015,1DAN,TU:LH,"ET84A,ST85A,TT86A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5016,1DAN,TU:LH,"EU91A,EU95A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,9.02E-12,,,,,-16.15,0.49,,,,,
5017,1DAN,TU:LH,"SU97A,TU100A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5018,1DAN,TU:LH,EU98A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5019,1DAN,TU:LH,"YU103A,LU104A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5020,1DAN,TU:LH,EU105A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5021,1DAN,TU:LH,TU106A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5022,1DAN,TU:LH,NU107A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5023,1DAN,TU:LH,"PU116A,EU117A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5024,1DAN,TU:LH,"QU118A,VH119A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5025,1DAN,TU:LH,"TU121A,KU122A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5026,1DAN,TU:LH,"EU128A,EU130A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,8.20E-12,,,,,-16.15,0.43,,,,,
5027,1DAN,TU:LH,RU131A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5028,1DAN,TU:LH,TU132A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5029,1DAN,TU:LH,"LU133A,VU134A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,8.20E-12,,,,,-16.15,0.43,,,,,
5030,1DAN,TU:LH,RU135A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,2.87E-11,,,,,-16.15,1.2,,,,,
5031,1DAN,TU:LH,RU136A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5032,1DAN,TU:LH,NU138A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5033,1DAN,TU:LH,"TU139A,SU142A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5034,1DAN,TU:LH,FU140A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,7.38E-11,,,,,-16.15,1.78,,,,,
5035,1DAN,TU:LH,"LU141A,LU143A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5036,1DAN,TU:LH,DU145A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5037,1DAN,TU:LH,VU146A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5038,1DAN,TU:LH,FU147A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5039,1DAN,TU:LH,YU157A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5040,1DAN,TU:LH,"KU165A,KU166A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.10E-12,,,,,-16.15,0,,,,,
5041,1DAN,TU:LH,LU176A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,8.20E-12,,,,,-16.15,0.43,,,,,
5042,1DAN,TU:LH,VU179A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5043,1DAN,TU:LH,"KU181A,EU183A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,4.92E-12,,,,,-16.15,0.11,,,,,
5044,1DAN,TU:LH,RU196A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,1.23E-11,,,,,-16.15,0.68,,,,,
5045,1DAN,TU:LH,TU197A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,7.38E-12,,,,,-16.15,0.36,,,,,
5046,1DAN,TU:LH,VU198A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5047,1DAN,TU:LH,NU199A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,6.15E-12,,,,,-16.15,0.25,,,,,
5048,1DAN,TU:LH,"RU200A,KU201A",Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Linked Chromogenic Assay,5mM Ca2+,310,,SKEMPI;ASEdb;,"8312277 (Figure 3, p.1569)",4.10E-12,7.38E-12,,,,,-16.15,0.36,,,,,
5049,1FC2,C:D,FC149A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Competitive binding assay,PBS with 0.5% gelatin,298,,SKEMPI,"8332602 (Table II, p. 446)",6.25E-08,5.88E-08,,,,,-14.2,-0.04,,,,,
5050,1FC2,C:D,IC150A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Competitive binding assay,PBS with 0.5% gelatin,298,,SKEMPI,"8332602 (Table II, p. 446)",6.25E-08,2.50E-06,,,,,-14.2,2.18,,,,,
5051,1FC2,C:D,KC154A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Competitive binding assay,PBS with 0.5% gelatin,298,,SKEMPI,"8332602 (Table II, p. 446)",6.25E-08,5.00E-07,,,,,-14.2,1.23,,,,,
5052,1FC2,C:D,LC136D,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Competitive binding assay,PBS with 0.5% gelatin,298,,SKEMPI,"8332602 (Table II, p. 446)",6.25E-08,2.50E-07,,,,,-14.2,0.82,,,,,
5053,1FC2,C:D,NC147A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Competitive binding assay,PBS with 0.5% gelatin,298,,SKEMPI,"8332602 (Table II, p. 446)",6.25E-08,1.67E-07,,,,,-14.2,0.58,,,,,
5054,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM acetate buffer",298,4.5,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",9.35E-11,2.79E-08,1.07E+08,4.30E+07,1.00E-02,1.20E+00,-13.68,3.37,,,,,
5055,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM acetate buffer",298,5,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",1.56E-11,6.55E-09,7.70E+07,5.80E+07,1.20E-03,3.80E-01,-14.74,3.58,,,,,
5056,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM MES",298,5.5,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",4.50E-12,,1.00E+08,,4.50E-04,2.90E-01,-15.47,,,,,,
5057,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM MES",298,6,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",1.15E-12,3.15E-09,1.22E+08,7.30E+07,1.40E-04,2.30E-01,-16.28,4.69,,,,,
5058,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM MOPS",298,7,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",1.48E-13,2.56E-09,1.35E+08,7.80E+07,2.00E-05,2.00E-01,-17.49,5.78,,,,,
5059,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM Trizma base",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",1.30E-13,2.50E-09,1.17E+08,9.30E+07,1.50E-05,2.30E-01,-17.58,5.84,,,,,
5060,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"100mM NaCl, 10mM Trizma base",298,9,SKEMPI;ASEdb;PINT;,"8494892 (Table I, p. 5148)",1.83E-13,,8.20E+07,7.90E+07,1.50E-05,,-17.37,,,,,,
5061,1BRS,A:D,DA54A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,2.90E-15,6.00E+08,1.80E+09,8.00E-06,5.30E-06,-18.93,-0.89,,,,,
5062,1BRS,A:D,EA60A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,7.50E-15,6.00E+08,4.50E+09,8.00E-06,3.40E-05,-18.93,-0.33,,,,,
5063,1BRS,A:D,EA73A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,3.20E-13,6.00E+08,2.30E+09,8.00E-06,7.40E-04,-18.93,1.9,,,,,
5064,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,5.00E-10,6.00E+08,4.40E+08,8.00E-06,2.20E-01,-18.93,6.25,,,,,
5065,1BRS,A:D,KA27A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,1.20E-10,6.00E+08,5.50E+07,8.00E-06,6.60E-03,-18.93,5.41,,,,,
5066,1BRS,A:D,NA58A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,2.30E-12,6.00E+08,2.80E+08,8.00E-06,6.40E-04,-18.93,3.06,,,,,
5067,1BRS,A:D,RA59A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,8.20E-11,6.00E+08,4.50E+07,8.00E-06,3.70E-03,-18.93,5.18,,,,,
5068,1BRS,A:D,RA87A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,3.00E-10,6.00E+08,2.30E+08,8.00E-06,6.70E-02,-18.93,5.95,,,,,
5069,1BRS,A:D,WA35F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,50mM Tris buffer,298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table II, p. 5148)",1.30E-14,1.40E-13,6.00E+08,5.60E+08,8.00E-06,8.00E-05,-18.93,1.41,,,,,
5070,1BRS,A:D,DA54A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,9.80E-14,1.20E+08,1.80E+08,1.50E-05,1.80E-05,-17.57,-0.17,,,,,
5071,1BRS,A:D,EA60A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,3.10E-13,1.20E+08,4.20E+08,1.50E-05,1.30E-04,-17.57,0.51,,,,,
5072,1BRS,A:D,EA73A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,1.50E-11,1.20E+08,1.80E+08,1.50E-05,2.60E-03,-17.57,2.81,,,,,
5073,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,3.70E-09,1.20E+08,9.40E+07,1.50E-05,3.50E-01,-17.57,6.07,,,,,
5074,1BRS,A:D,KA27A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,3.00E-10,1.20E+08,2.00E+07,1.50E-05,6.10E-03,-17.57,4.59,,,,,
5075,1BRS,A:D,NA58A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,2.50E-11,1.20E+08,3.60E+07,1.50E-05,9.10E-04,-17.57,3.11,,,,,
5076,1BRS,A:D,RA59A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,5.00E-10,1.20E+08,1.30E+07,1.50E-05,6.50E-03,-17.57,4.89,,,,,
5077,1BRS,A:D,WA35F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Competitive binding with [<sup>3</sup>H] Barstar or Stopped-flow spectrophotometry,"50mM Tris buffer, 100mM NaCl",298,8,SKEMPI;ASEdb;PINT;,"8494892 (Table III, p. 5149)",1.30E-13,8.50E-13,1.20E+08,1.10E+08,1.50E-05,9.60E-05,-17.57,1.11,,,,,
5078,1BRS,A:D,"CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,2.00E-13,,,,,-18.03,0.71,,,,,
5079,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,4.00E-12,,,,,-18.03,2.49,,,,,
5080,1BRS,A:D,HA102D,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,2.50E-12,,,,,-18.03,2.21,,,,,
5081,1BRS,A:D,HA102G,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,1.50E-10,,,,,-18.03,4.63,,,,,
5082,1BRS,A:D,HA102L,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,1.70E-10,,,,,-18.03,4.71,,,,,
5083,1BRS,A:D,HA102Q,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,1.30E-10,,,,,-18.03,4.55,,,,,
5084,1BRS,A:D,"HA102Q,CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,1.70E-09,,,,,-18.03,6.07,,,,,
5085,1BRS,A:D,"HA102Q,RA59A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,1.30E-10,,,,,-18.03,4.55,,,,,
5086,1BRS,A:D,"HA102Q,RA59K",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,6.00E-09,,,,,-18.03,6.82,,,,,
5087,1BRS,A:D,RA59A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,7.00E-09,,,,,-18.03,6.91,,,,,
5088,1BRS,A:D,"RA59A,CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,2.50E-08,,,,,-18.03,7.66,,,,,
5089,1BRS,A:D,RA59K,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,7.00E-09,,,,,-18.03,6.91,,,,,
5090,1BRS,A:D,"RA59K,CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Titration and competition assays,,298,,SKEMPI,"8507637 (Table V, p. 5983)",6.00E-14,4.00E-07,,,,,-18.03,9.3,,,,,
5091,4OGA,AB:E,DF707A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,2.80E-11,,,,,-11.73,-1.65,,,,,
5092,4OGA,AB:E,FF714A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,8.15E-09,,,,,-11.73,1.47,,,,,
5093,4OGA,AB:E,LF709A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,8.44E-09,,,,,-11.73,1.49,,,,,
5094,4OGA,AB:E,NF711A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,3.69E-09,,,,,-11.73,1.04,,,,,
5095,4OGA,AB:E,PF716A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,3.70E-11,,,,,-11.73,-1.5,,,,,
5096,4OGA,AB:E,RF717A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,1.00E-10,,,,,-11.73,-0.95,,,,,
5097,4OGA,AB:E,VF712A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,3.10E-11,,,,,-11.73,-1.59,,,,,
5098,4OGA,AB:E,VF715A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,6.13E-10,,,,,-11.73,0.05,,,,,
5099,4OGA,AB:E,YF708A,"Human insulin receptor, soluble (sHIR)",Human insulin,HR,Microtiter Plate Antibody Capture Assay,"137.5mM NaCl, 10mM magnesium sulfate, 20 mM Hepes, 0.5% BSA (w/v), 0.025% Triton X-100 (v/v), and 0.02% sodium azide (w/v)",277,7.8,ASEdb,"8576204 (Table I, p. 2441)",5.60E-10,1.04E-08,,,,,-11.73,1.61,,,,,
5100,1FC2,C:D,FC149A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Surface Plasmon Resonance,"137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.05% Surfactant P20",298,7.3,SKEMPI,"8588944 (Table 2, p. 275)",1.68E-08,1.87E-08,1.90E+05,2.30E+05,3.20E-03,4.30E-03,-10.6,0.06,,,,,
5101,1FC2,C:D,IC150A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Surface Plasmon Resonance,"137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.05% Surfactant P20",298,7.3,SKEMPI,"8588944 (Table 2, p. 275)",1.68E-08,1.24E-04,1.90E+05,5.00E+01,3.20E-03,6.20E-03,-10.6,5.27,,,,,
5102,1FC2,C:D,KC154A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Surface Plasmon Resonance,"137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.05% Surfactant P20",298,7.3,SKEMPI,"8588944 (Table 2, p. 275)",1.68E-08,2.21E-07,1.90E+05,1.40E+05,3.20E-03,3.10E-02,-10.6,1.53,,,,,
5103,1FC2,C:D,LC136D,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Surface Plasmon Resonance,"137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.05% Surfactant P20",298,7.3,SKEMPI,"8588944 (Table 2, p. 275)",1.68E-08,1.89E-07,1.90E+05,1.90E+04,3.20E-03,3.60E-03,-10.6,1.43,,,,,
5104,1FC2,C:D,NC147A,Staphylococcus aureus IgG-binding protein A,Human IgG Fc fragment,Ag-Ab,Surface Plasmon Resonance,"137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 0.05% Surfactant P20",298,7.3,SKEMPI,"8588944 (Table 2, p. 275)",1.68E-08,4.67E-08,1.90E+05,1.80E+05,3.20E-03,8.40E-03,-10.6,0.61,,,,,
5105,1BRS,A:D,"HA18R,RA59A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,1.50E-10,,,,,-18.03,4.63,,,,,
5106,1BRS,A:D,"HA18R,RA59A,CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,1.70E-10,,,,,-18.03,4.71,,,,,
5107,1BRS,A:D,"HA102K,CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,2.00E-05,,,,,-18.03,11.62,,,,,
5108,1BRS,A:D,"CD40A,CD82A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,2.00E-13,,,,,-18.03,0.71,,,,,
5109,1BRS,A:D,"HA18R,RA59A,CD40A,CD82A,YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,1.00E-09,,,,,-18.03,5.76,,,,,
5110,1BRS,A:D,"HA102K,CD40A,CD82A,YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,3.00E-09,,,,,-18.03,6.41,,,,,
5111,1BRS,A:D,"CD40A,CD82A,YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,1.00E-10,,,,,-18.03,4.39,,,,,
5112,1BRS,A:D,"HA18R,RA59A,YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,5.00E-09,,,,,-18.03,6.71,,,,,
5113,1BRS,A:D,"HA102K,YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,2.00E-09,,,,,-18.03,6.17,,,,,
5114,1BRS,A:D,"YD29D,YD30W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Fluorescence,,298,,Literature,"8637875 (Table 1, p. 2346)",6.00E-14,8.00E-11,,,,,-18.03,4.26,,,,,
5115,1DVF,AB:CD,DB100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.20E-06,9.30E+07,8.30E+05,,,-10.86,2.79,,,,,
5116,1DVF,AB:CD,DB54A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.49E-05,9.30E+07,6.70E+04,,,-10.86,4.28,,,,,
5117,1DVF,AB:CD,DB58A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.61E-07,9.30E+07,6.20E+07,,,-10.86,1.6,,,,,
5118,1DVF,AB:CD,EB98A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.27E-05,9.30E+07,7.90E+06,,,-10.86,4.19,,,,,
5119,1DVF,AB:CD,HA30A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.75E-07,9.30E+07,5.70E+06,,,-10.86,1.65,,,,,
5120,1DVF,AB:CD,NB56A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,7.69E-08,9.30E+07,1.30E+04,,,-10.86,1.16,,,,,
5121,1DVF,AB:CD,RB99A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,2.56E-07,9.30E+07,3.90E+06,,,-10.86,1.87,,,,,
5122,1DVF,AB:CD,SA93A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,7.69E-08,9.30E+07,1.30E+07,,,-10.86,1.16,,,,,
5123,1DVF,AB:CD,TB30A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,5.00E-08,9.30E+07,2.00E+07,,,-10.86,0.91,,,,,
5124,1DVF,AB:CD,WA92A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.92E-08,9.30E+07,5.20E+07,,,-10.86,0.34,,,,,
5125,1DVF,AB:CD,WB52A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.16E-05,9.30E+07,8.60E+06,,,-10.86,4.13,,,,,
5126,1DVF,AB:CD,YA32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,3.33E-07,9.30E+07,4.20E+07,,,-10.86,2.03,,,,,
5127,1DVF,AB:CD,YA49A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,1.69E-07,9.30E+07,5.00E+06,,,-10.86,1.63,,,,,
5128,1DVF,AB:CD,YA50A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,3.45E-08,9.30E+07,2.90E+07,,,-10.86,0.69,,,,,
5129,1DVF,AB:CD,YB101F,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,3.23E-07,9.30E+07,3.10E+06,,,-10.86,2.01,,,,,
5130,1DVF,AB:CD,YB32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",1.08E-08,2.38E-07,9.30E+07,3.00E+06,,,-10.86,1.83,,,,,
5131,1VFB,AB:C,DB100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,3.57E-06,5.00E+07,2.80E+05,,,-10.5,3.07,,,,,
5132,1VFB,AB:C,DB54A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,5.88E-08,5.00E+07,1.70E+07,,,-10.5,0.64,,,,,
5133,1VFB,AB:C,DB58A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.41E-08,5.00E+07,7.10E+07,,,-10.5,-0.21,,,,,
5134,1VFB,AB:C,EB98A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.41E-07,5.00E+07,7.70E+06,,,-10.5,1.16,,,,,
5135,1VFB,AB:C,HA30A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,8.33E-08,5.00E+07,1.20E+07,,,-10.5,0.84,,,,,
5136,1VFB,AB:C,NB56A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,2.70E-08,5.00E+07,3.70E+07,,,-10.5,0.18,,,,,
5137,1VFB,AB:C,RB99A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.69E-08,5.00E+07,5.90E+07,,,-10.5,-0.1,,,,,
5138,1VFB,AB:C,SA93A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,3.57E-08,5.00E+07,2.80E+07,,,-10.5,0.34,,,,,
5139,1VFB,AB:C,TB30A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.82E-08,5.00E+07,5.50E+07,,,-10.5,-0.06,,,,,
5140,1VFB,AB:C,WA92A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,2.00E-06,5.00E+07,5.00E+05,,,-10.5,2.73,,,,,
5141,1VFB,AB:C,WB52A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,3.70E-08,5.00E+07,2.70E+07,,,-10.5,0.36,,,,,
5142,1VFB,AB:C,YA32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.92E-07,5.00E+07,2.30E+07,,,-10.5,1.34,,,,,
5143,1VFB,AB:C,YA49A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,7.69E-08,5.00E+07,1.30E+07,,,-10.5,0.8,,,,,
5144,1VFB,AB:C,YA50A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,3.85E-08,5.00E+07,2.60E+07,,,-10.5,0.39,,,,,
5145,1VFB,AB:C,YB101F,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,1.00E-07,5.00E+07,1.00E+07,,,-10.5,0.95,,,,,
5146,1VFB,AB:C,YB32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 10mM Hepes",298,7.5,SKEMPI;ASEdb;,"8703938 (Table 1, p. 9672)",2.00E-08,4.35E-08,5.00E+07,5.20E+06,,,-10.5,0.46,,,,,
5147,1A22,A:B,FA25A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"PBS with 10mM sodium phosphate, 137mM NaCl, 2.7mM KCl, 0.05% Tween 20",298,7.2,SKEMPI,"8756685 (Table 2, p. 10303)",2.90E-09,1.40E-09,1.70E+05,1.90E+05,4.90E-04,2.80E-04,-11.64,-0.43,-9.4,-12.2,7.7,-0.3,
5148,1A22,A:B,"FA25A,YA42A,QA46A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"PBS with 10mM sodium phosphate, 137mM NaCl, 2.7mM KCl, 0.05% Tween 20",298,7.2,SKEMPI,"8756685 (Table 2, p. 10303)",2.90E-09,4.00E-09,1.70E+05,1.20E+05,4.90E-04,5.00E-04,-11.64,0.19,-9.4,-12.2,7.7,-2.3,
5149,1A22,A:B,"YA42A,QA46A",Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,Surface Plasmon Resonance,"PBS with 10mM sodium phosphate, 137mM NaCl, 2.7mM KCl, 0.05% Tween 20",298,7.2,SKEMPI,"8756685 (Table 2, p. 10303)",2.90E-09,4.60E-09,1.70E+05,1.80E+05,4.90E-04,8.50E-04,-11.64,0.27,-9.4,-9.8,7.7,5.3,
5150,1T7C,A:B,TB11A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.60E-08,1.70E+05,1.40E+05,1.80E-03,2.30E-03,-10.74,0.22,,,,,
5151,1T7C,A:B,GB12A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,3.50E-08,1.70E+05,5.80E+04,1.80E-03,2.00E-03,-10.74,0.68,,,,,
5152,1T7C,A:B,PB13A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.00E-08,1.70E+05,2.30E+05,1.80E-03,2.30E-03,-10.74,-0.06,,,,,
5153,1T7C,A:B,KB15A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,3.30E-07,1.70E+05,6.00E+04,1.80E-03,2.00E-02,-10.74,1.99,,,,,
5154,1T7C,A:B,RB17A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,2.80E-08,1.70E+05,1.80E+05,1.80E-03,4.90E-03,-10.74,0.55,,,,,
5155,1T7C,A:B,IB18A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.20E-07,1.70E+05,1.50E+05,1.80E-03,1.70E-02,-10.74,1.4,,,,,
5156,1T7C,A:B,IB19A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.40E-08,1.70E+05,1.80E+05,1.80E-03,2.50E-03,-10.74,0.14,,,,,
5157,1T7C,A:B,RB20A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,2.00E-08,1.70E+05,2.00E+05,1.80E-03,3.90E-03,-10.74,0.35,,,,,
5158,1T7C,A:B,FB33A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.40E-08,1.70E+05,1.80E+05,1.80E-03,2.40E-03,-10.74,0.14,,,,,
5159,1T7C,A:B,VB34A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.20E-08,1.70E+05,2.40E+05,1.80E-03,2.80E-03,-10.74,0.05,,,,,
5160,1T7C,A:B,YB35A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,4.90E-08,1.70E+05,1.80E+05,1.80E-03,8.90E-03,-10.74,0.88,,,,,
5161,1T7C,A:B,GB36A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,5.60E-08,1.70E+05,1.00E+05,1.80E-03,5.60E-03,-10.74,0.95,,,,,
5162,1T7C,A:B,GB37A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,4.40E-08,1.70E+05,1.10E+05,1.80E-03,5.00E-03,-10.74,0.81,,,,,
5163,1T7C,A:B,RB39A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.60E-08,1.70E+05,4.50E+05,1.80E-03,6.90E-03,-10.74,0.22,,,,,
5164,1T7C,A:B,KB46A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",1.10E-08,1.40E-08,1.70E+05,1.20E+05,1.80E-03,1.20E-03,-10.74,0.14,,,,,
5165,4Y0Y,E:I,TI11A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,3.50E+05,5.00E-08,,-17.95,,,,,,
5166,4Y0Y,E:I,GI12A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,8.30E-11,9.90E+05,2.30E+05,5.00E-08,1.90E-05,-17.95,4.35,,,,,
5167,4Y0Y,E:I,PI13A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,6.80E+05,5.00E-08,,-17.95,,,,,,
5168,4Y0Y,E:I,KI15A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,1.40E-06,9.90E+05,4.30E+03,5.00E-08,4.20E-05,-17.95,10.05,,,,,
5169,4Y0Y,E:I,RI17A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,1.10E+06,5.00E-08,,-17.95,,,,,,
5170,4Y0Y,E:I,II18A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,2.40E-10,9.90E+05,3.90E+05,5.00E-08,9.20E-05,-17.95,4.97,,,,,
5171,4Y0Y,E:I,II19A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,5.50E+05,5.00E-08,,-17.95,,,,,,
5172,4Y0Y,E:I,RI20A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,1.10E+06,5.00E-08,,-17.95,,,,,,
5173,4Y0Y,E:I,FI33A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,4.70E+05,5.00E-08,,-17.95,,,,,,
5174,4Y0Y,E:I,VI34A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,7.00E+05,5.00E-08,,-17.95,,,,,,
5175,4Y0Y,E:I,YI35A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,5.10E+05,5.00E-08,,-17.95,,,,,,
5176,4Y0Y,E:I,GI36A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,2.10E-10,9.90E+05,5.10E+05,5.00E-08,1.10E-04,-17.95,4.89,,,,,
5177,4Y0Y,E:I,GI37A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,7.00E+05,5.00E-08,,-17.95,,,,,,
5178,4Y0Y,E:I,RI39A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,6.30E+05,5.00E-08,,-17.95,,,,,,
5179,4Y0Y,E:I,KI46A,Bovine cationic trypsin/beta-trypsin,Bovine pancreatic trypsin inhibitor (BPTI),EI,monitoring the release of p-nitroanilide using spectrophotometry,"50mM Tris-HCl, 20mM CaCl2, 0.005% Triton X-100",295,8.2,SKEMPI;ASEdb;PINT;,"8784199 (Table 1, p. 11439)",5.00E-14,,9.90E+05,5.50E+05,5.00E-08,,-17.95,,,,,,
5180,1KIP,AB:C,AB32Y,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,"0.15 M NaCl, 0.01 M Tris-HCl",298,7.2,SKEMPI,"8952503 (Table 3, p. 15498)",1.43E-08,3.70E-09,,,,,-10.7,-0.8,,,,,
5181,1KIQ,AB:C,FB101Y,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,"0.15 M NaCl, 0.01 M Tris-HCl",298,7.2,SKEMPI,"8952503 (Table 3, p. 15498)",2.50E-07,3.70E-09,,,,,-9,-2.49,,,,,
5182,1KIR,AB:C,SA50Y,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Isothermal Titration Calorimetry,"0.15 M NaCl, 0.01 M Tris-HCl",298,7.2,SKEMPI,"8952503 (Table 3, p. 15498)",3.85E-08,3.70E-09,,,,,-10.11,-1.39,,,,,
5183,1DAN,TU:LH,KH192A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 5mM CaCl2, 1mM CHAPS, 0.005% surfactant P20",295,7.4,SKEMPI;ASEdb;,"8962059 (Table 1, p. 14382)",3.70E-09,2.70E-09,1.60E+05,1.50E+05,5.70E-04,3.90E-04,-11.38,-0.18,,,,,
5184,1DAN,TU:LH,LH144A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 5mM CaCl2, 1mM CHAPS, 0.005% surfactant P20",295,7.4,SKEMPI;ASEdb;,"8962059 (Table 1, p. 14382)",3.70E-09,3.80E-09,1.60E+05,1.50E+05,5.70E-04,5.70E-04,-11.38,0.02,,,,,
5185,1DAN,TU:LH,MH164A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 5mM CaCl2, 1mM CHAPS, 0.005% surfactant P20",295,7.4,SKEMPI;ASEdb;,"8962059 (Table 1, p. 14382)",3.70E-09,1.30E-08,1.60E+05,1.20E+05,5.70E-04,1.50E-03,-11.38,0.74,,,,,
5186,1DAN,TU:LH,RH134A,Human plasma coagulation factor VIIa,Human tissue factor/thromboplastin,OE,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 5mM CaCl2, 1mM CHAPS, 0.005% surfactant P20",295,7.4,SKEMPI;ASEdb;,"8962059 (Table 1, p. 14382)",3.70E-09,1.31E-08,1.60E+05,1.40E+05,5.70E-04,1.80E-03,-11.38,0.74,,,,,
5187,1DVF,AB:CD,DB100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.20E-06,,,,,-10.86,2.79,,,,,
5188,1DVF,AB:CD,"DB100A,DD52A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.59E-05,,,,,-10.86,4.32,,,,,
5189,1DVF,AB:CD,"DB100A,HD33A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.19E-05,,,,,-10.86,4.15,,,,,
5190,1DVF,AB:CD,"DB100A,ND54A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.08E-05,,,,,-10.86,4.09,,,,,
5191,1DVF,AB:CD,DB54A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.49E-05,,,,,-10.86,4.28,,,,,
5192,1DVF,AB:CD,"DB54A,YC49A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.13E-05,,,,,-10.86,4.49,,,,,
5193,1DVF,AB:CD,DB58A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.61E-07,,,,,-10.86,1.6,,,,,
5194,1DVF,AB:CD,"DB58A,QD100A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.28E-07,,,,,-10.86,1.46,,,,,
5195,1DVF,AB:CD,DD52A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.85E-07,,,,,-10.86,1.68,,,,,
5196,1DVF,AB:CD,EB98A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.27E-05,,,,,-10.86,4.19,,,,,
5197,1DVF,AB:CD,"EB98A,YD98A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.70E-05,,,,,-10.86,4.63,,,,,
5198,1DVF,AB:CD,HD33A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.50E-07,,,,,-10.86,1.86,,,,,
5199,1DVF,AB:CD,ID97A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.00E-06,,,,,-10.86,2.68,,,,,
5200,1DVF,AB:CD,KD30A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,5.88E-08,,,,,-10.86,1,,,,,
5201,1DVF,AB:CD,NB56A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,7.69E-08,,,,,-10.86,1.16,,,,,
5202,1DVF,AB:CD,"NB56A,HD33A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,7.69E-07,,,,,-10.86,2.53,,,,,
5203,1DVF,AB:CD,"NB56A,ND54A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,5.26E-07,,,,,-10.86,2.3,,,,,
5204,1DVF,AB:CD,"NB56A,QD100A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.33E-07,,,,,-10.86,1.49,,,,,
5205,1DVF,AB:CD,ND54A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.50E-07,,,,,-10.86,1.86,,,,,
5206,1DVF,AB:CD,QD100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.69E-07,,,,,-10.86,1.63,,,,,
5207,1DVF,AB:CD,RD100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.08E-05,,,,,-10.86,4.09,,,,,
5208,1DVF,AB:CD,WB52A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.16E-05,,,,,-10.86,4.13,,,,,
5209,1DVF,AB:CD,"WB52A,QD100A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,1.22E-05,,,,,-10.86,4.16,,,,,
5210,1DVF,AB:CD,YA32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,3.33E-07,,,,,-10.86,2.03,,,,,
5211,1DVF,AB:CD,"YA32A,RD100A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.78E-05,,,,,-10.86,4.65,,,,,
5212,1DVF,AB:CD,YA49A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.00E-07,,,,,-10.86,1.73,,,,,
5213,1DVF,AB:CD,"YA49A,HD33A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,9.09E-07,,,,,-10.86,2.63,,,,,
5214,1DVF,AB:CD,"YA49A,ND54A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,3.33E-07,,,,,-10.86,2.03,,,,,
5215,1DVF,AB:CD,YC49A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,2.50E-07,,,,,-10.86,1.86,,,,,
5216,1DVF,AB:CD,YD98A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Mouse antibody E5.2,Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"8993317 (Table 1, p. 52)",1.08E-08,3.23E-05,,,,,-10.86,4.74,,,,,
5217,1CHO,EFG:I,LI18G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.52E-07,,,,,-15.17,6,,,,,
5218,1CHO,EFG:I,LI18A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.64E-08,,,,,-15.17,4.7,,,,,
5219,1CHO,EFG:I,LI18S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,2.38E-08,,,,,-15.17,4.92,,,,,
5220,1CHO,EFG:I,LI18C,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,4.55E-10,,,,,-15.17,2.61,,,,,
5221,1CHO,EFG:I,LI18V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,7.14E-09,,,,,-15.17,4.21,,,,,
5222,1CHO,EFG:I,LI18T,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.02E-08,,,,,-15.17,4.42,,,,,
5223,1CHO,EFG:I,LI18P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.49E-05,,,,,-15.17,8.68,,,,,
5224,1CHO,EFG:I,LI18I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.01E-08,,,,,-15.17,4.42,,,,,
5225,1CHO,EFG:I,LI18M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.00E-11,,,,,-15.17,0.38,,,,,
5226,1CHO,EFG:I,LI18N,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.52E-09,,,,,-15.17,3.31,,,,,
5227,1CHO,EFG:I,LI18D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.00E-06,,,,,-15.17,7.1,,,,,
5228,1CHO,EFG:I,LI18K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.00E-08,,,,,-15.17,4.41,,,,,
5229,1CHO,EFG:I,LI18Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,7.69E-10,,,,,-15.17,2.91,,,,,
5230,1CHO,EFG:I,LI18E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,4.00E-07,,,,,-15.17,6.57,,,,,
5231,1CHO,EFG:I,LI18H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,8.33E-10,,,,,-15.17,2.96,,,,,
5232,1CHO,EFG:I,LI18F,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,4.17E-13,,,,,-15.17,-1.48,,,,,
5233,1CHO,EFG:I,LI18R,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,4.55E-09,,,,,-15.17,3.95,,,,,
5234,1CHO,EFG:I,LI18Y,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,1.23E-13,,,,,-15.17,-2.19,,,,,
5235,1CHO,EFG:I,LI18W,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",5.26E-12,3.03E-13,,,,,-15.17,-1.67,,,,,
5236,1PPF,E:I,LI18G,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,4.55E-08,,,,,-13.16,3.29,,,,,
5237,1PPF,E:I,LI18A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.00E-09,,,,,-13.16,1.06,,,,,
5238,1PPF,E:I,LI18S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,3.03E-08,,,,,-13.16,3.05,,,,,
5239,1PPF,E:I,LI18C,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.41E-10,,,,,-13.16,-0.09,,,,,
5240,1PPF,E:I,LI18V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,7.14E-11,,,,,-13.16,-0.49,,,,,
5241,1PPF,E:I,LI18T,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,7.69E-10,,,,,-13.16,0.9,,,,,
5242,1PPF,E:I,LI18P,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,5.26E-06,,,,,-13.16,6.06,,,,,
5243,1PPF,E:I,LI18I,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,4.76E-11,,,,,-13.16,-0.72,,,,,
5244,1PPF,E:I,LI18M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.37E-09,,,,,-13.16,1.24,,,,,
5245,1PPF,E:I,LI18N,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.11E-06,,,,,-13.16,5.15,,,,,
5246,1PPF,E:I,LI18D,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,6.25E-05,,,,,-13.16,7.51,,,,,
5247,1PPF,E:I,LI18K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,2.63E-06,,,,,-13.16,5.66,,,,,
5248,1PPF,E:I,LI18Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,4.35E-08,,,,,-13.16,3.26,,,,,
5249,1PPF,E:I,LI18E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,2.44E-05,,,,,-13.16,6.96,,,,,
5250,1PPF,E:I,LI18H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,9.09E-06,,,,,-13.16,6.38,,,,,
5251,1PPF,E:I,LI18F,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.01E-06,,,,,-13.16,5.1,,,,,
5252,1PPF,E:I,LI18R,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,3.03E-05,,,,,-13.16,7.08,,,,,
5253,1PPF,E:I,LI18Y,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,1.20E-05,,,,,-13.16,6.54,,,,,
5254,1PPF,E:I,LI18W,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.64E-10,5.56E-05,,,,,-13.16,7.44,,,,,
5255,1R0R,E:I,LI18G,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,1.56E-09,,,,,-14.17,2.32,,,,,
5256,1R0R,E:I,LI18A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,5.00E-11,,,,,-14.17,0.31,,,,,
5257,1R0R,E:I,LI18S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,4.17E-10,,,,,-14.17,1.55,,,,,
5258,1R0R,E:I,LI18C,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,3.03E-12,,,,,-14.17,-1.33,,,,,
5259,1R0R,E:I,LI18V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,1.12E-09,,,,,-14.17,2.13,,,,,
5260,1R0R,E:I,LI18T,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,3.85E-11,,,,,-14.17,0.16,,,,,
5261,1R0R,E:I,LI18P,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,1.27E-05,,,,,-14.17,7.58,,,,,
5262,1R0R,E:I,LI18I,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,7.14E-09,,,,,-14.17,3.21,,,,,
5263,1R0R,E:I,LI18M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,1.23E-11,,,,,-14.17,-0.51,,,,,
5264,1R0R,E:I,LI18N,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,3.70E-10,,,,,-14.17,1.48,,,,,
5265,1R0R,E:I,LI18D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,6.25E-08,,,,,-14.17,4.48,,,,,
5266,1R0R,E:I,LI18K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,8.33E-09,,,,,-14.17,3.3,,,,,
5267,1R0R,E:I,LI18Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
5268,1R0R,E:I,LI18E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,1.16E-09,,,,,-14.17,2.15,,,,,
5269,1R0R,E:I,LI18H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,7.69E-11,,,,,-14.17,0.56,,,,,
5270,1R0R,E:I,LI18F,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,8.33E-11,,,,,-14.17,0.61,,,,,
5271,1R0R,E:I,LI18R,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,4.17E-09,,,,,-14.17,2.89,,,,,
5272,1R0R,E:I,LI18Y,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,6.25E-11,,,,,-14.17,0.44,,,,,
5273,1R0R,E:I,LI18W,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",2.94E-11,3.85E-10,,,,,-14.17,1.5,,,,,
5274,2NU0,E:I,LI18G,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,8.33E-08,,,,,-14.46,4.93,,,,,
5275,2NU0,E:I,LI18A,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,2.78E-09,,,,,-14.46,2.95,,,,,
5276,2NU0,E:I,LI18S,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,2.00E-08,,,,,-14.46,4.1,,,,,
5277,2NU0,E:I,LI18C,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,1.75E-11,,,,,-14.46,-0.01,,,,,
5278,2NU0,E:I,LI18V,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.03E-09,,,,,-14.46,3,,,,,
5279,2NU0,E:I,LI18T,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,4.00E-09,,,,,-14.46,3.16,,,,,
5280,2NU0,E:I,LI18P,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,2.78E-05,,,,,-14.46,8.33,,,,,
5281,2NU0,E:I,LI18I,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.45E-08,,,,,-14.46,4.42,,,,,
5282,2NU0,E:I,LI18M,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.70E-11,,,,,-14.46,0.42,,,,,
5283,2NU0,E:I,LI18N,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,5.56E-09,,,,,-14.46,3.35,,,,,
5284,2NU0,E:I,LI18D,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,2.56E-07,,,,,-14.46,5.59,,,,,
5285,2NU0,E:I,LI18K,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.85E-09,,,,,-14.46,3.14,,,,,
5286,2NU0,E:I,LI18Q,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,1.45E-09,,,,,-14.46,2.57,,,,,
5287,2NU0,E:I,LI18E,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,4.35E-07,,,,,-14.46,5.9,,,,,
5288,2NU0,E:I,LI18H,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.23E-10,,,,,-14.46,1.69,,,,,
5289,2NU0,E:I,LI18F,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,1.82E-10,,,,,-14.46,1.35,,,,,
5290,2NU0,E:I,LI18R,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,5.26E-09,,,,,-14.46,3.32,,,,,
5291,2NU0,E:I,LI18Y,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,3.03E-10,,,,,-14.46,1.65,,,,,
5292,2NU0,E:I,LI18W,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9047374 (Table 1, p. 443)",1.79E-11,4.17E-10,,,,,-14.46,1.84,,,,,
5293,,,L*18G,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,2.22E-08,,,,,-15.44,5.14,,,,,mutation in OMTKY3
5294,,,L*18A,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,5.26E-10,,,,,-15.44,2.96,,,,,mutation in OMTKY3
5295,,,L*18S,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,6.25E-09,,,,,-15.44,4.4,,,,,mutation in OMTKY3
5296,,,L*18C,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,3.03E-12,,,,,-15.44,-0.06,,,,,mutation in OMTKY3
5297,,,L*18V,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,4.76E-10,,,,,-15.44,2.9,,,,,mutation in OMTKY3
5298,,,L*18T,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,5.00E-10,,,,,-15.44,2.93,,,,,mutation in OMTKY3
5299,,,L*18P,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,2.17E-05,,,,,-15.44,9.17,,,,,mutation in OMTKY3
5300,,,L*18I,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,6.67E-09,,,,,-15.44,4.44,,,,,mutation in OMTKY3
5301,,,L*18M,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,3.85E-12,,,,,-15.44,0.08,,,,,mutation in OMTKY3
5302,,,L*18N,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,3.85E-09,,,,,-15.44,4.12,,,,,mutation in OMTKY3
5303,,,L*18D,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.96E-07,,,,,-15.44,6.42,,,,,mutation in OMTKY3
5304,,,L*18K,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.79E-08,,,,,-15.44,5.02,,,,,mutation in OMTKY3
5305,,,L*18Q,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,8.33E-10,,,,,-15.44,3.23,,,,,mutation in OMTKY3
5306,,,L*18E,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.27E-07,,,,,-15.44,6.16,,,,,mutation in OMTKY3
5307,,,L*18H,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,3.85E-10,,,,,-15.44,2.78,,,,,mutation in OMTKY3
5308,,,L*18F,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,5.56E-12,,,,,-15.44,0.3,,,,,mutation in OMTKY3
5309,,,L*18R,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.22E-08,,,,,-15.44,4.79,,,,,mutation in OMTKY3
5310,,,L*18Y,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.00E-11,,,,,-15.44,0.64,,,,,mutation in OMTKY3
5311,,,L*18W,Streptomyces griseus streptogrisin-A/serine protease A (SGPA),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",3.33E-12,1.12E-10,,,,,-15.44,2.05,,,,,mutation in OMTKY3
5312,,,L*18G,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.11E-09,,,,,-14.29,2.24,,,,,mutation in OMTKY3
5313,,,L*18A,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.38E-11,,,,,-14.29,0,,,,,mutation in OMTKY3
5314,,,L*18S,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.16E-09,,,,,-14.29,2.27,,,,,mutation in OMTKY3
5315,,,L*18C,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,4.00E-11,,,,,-14.29,0.3,,,,,mutation in OMTKY3
5316,,,L*18V,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.14E-10,,,,,-14.29,0.92,,,,,mutation in OMTKY3
5317,,,L*18T,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,3.45E-11,,,,,-14.29,0.22,,,,,mutation in OMTKY3
5318,,,L*18P,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.69E-06,,,,,-14.29,6.53,,,,,mutation in OMTKY3
5319,,,L*18I,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.69E-10,,,,,-14.29,1.15,,,,,mutation in OMTKY3
5320,,,L*18M,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,7.69E-11,,,,,-14.29,0.69,,,,,mutation in OMTKY3
5321,,,L*18N,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.45E-08,,,,,-14.29,3.75,,,,,mutation in OMTKY3
5322,,,L*18D,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.37E-05,,,,,-14.29,7.75,,,,,mutation in OMTKY3
5323,,,L*18K,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.17E-05,,,,,-14.29,8.02,,,,,mutation in OMTKY3
5324,,,L*18Q,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.33E-08,,,,,-14.29,4.02,,,,,mutation in OMTKY3
5325,,,L*18E,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,,,,,,-14.29,,,,,,mutation in OMTKY3
5326,,,L*18H,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.70E-05,,,,,-14.29,8.15,,,,,mutation in OMTKY3
5327,,,L*18F,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.04E-05,,,,,-14.29,7.98,,,,,mutation in OMTKY3
5328,,,L*18R,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,2.08E-04,,,,,-14.29,9.34,,,,,mutation in OMTKY3
5329,,,L*18Y,"Sus scrofa chymotrypsin-like elastase family member 1, pancreatic/elastase-1",Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,Titration,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,Literature,"9047374 (Table 1, p. 443)",2.38E-11,1.33E-04,,,,,-14.29,9.08,,,,,mutation in OMTKY3
5330,1ACB,E:I,LI45D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,1.61E-07,,,,,-15.91,6.77,,,,,
5331,1ACB,E:I,LI45E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,1.11E-07,,,,,-15.91,6.55,,,,,
5332,1ACB,E:I,LI45G,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,4.55E-08,,,,,-15.91,6.03,,,,,
5333,1ACB,E:I,LI45I,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,2.08E-09,,,,,-15.91,4.23,,,,,
5334,1ACB,E:I,LI45P,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,1.85E-07,,,,,-15.91,6.85,,,,,
5335,1ACB,E:I,LI45S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.49E-12,7.14E-09,,,,,-15.91,4.95,,,,,
5336,1CSE,E:I,LI45D,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,1.92E-09,,,,,-16.08,4.35,,,,,
5337,1CSE,E:I,LI45E,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,6.25E-11,,,,,-16.08,2.35,,,,,
5338,1CSE,E:I,LI45G,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,5.26E-11,,,,,-16.08,2.25,,,,,
5339,1CSE,E:I,LI45I,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,1.72E-10,,,,,-16.08,2.94,,,,,
5340,1CSE,E:I,LI45P,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,1.02E-07,,,,,-16.08,6.67,,,,,
5341,1CSE,E:I,LI45S,Bacillus licheniformis subtilisin carlsberg,Hirudo medicinalis eglin c,EI,Spectroscopy,"0.1 M Tris-HCI, 0.005% Triton X-100, 0.02 M CaCl2",294,8.3,SKEMPI,"9048543 (Table 1, p. 1602)",1.12E-12,8.33E-12,,,,,-16.08,1.17,,,,,
5342,1IAR,A:B,EA19A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,9.44E-11,1.30E+07,1.80E+07,2.10E-03,1.70E-03,-13.35,-0.32,,,,,
5343,1IAR,A:B,EA19R,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.33E-10,1.30E+07,1.20E+07,2.10E-03,1.60E-03,-13.35,-0.12,,,,,
5344,1IAR,A:B,EA9Q,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,3.10E-08,1.30E+07,8.70E+06,2.10E-03,2.70E-01,-13.35,3.11,,,,,
5345,1IAR,A:B,FA82A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.40E-10,1.30E+07,1.50E+07,2.10E-03,2.10E-03,-13.35,-0.09,,,,,
5346,1IAR,A:B,FA82D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,6.08E-11,1.30E+07,1.20E+07,2.10E-03,7.30E-04,-13.35,-0.58,,,,,
5347,1IAR,A:B,IA11A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.82E-10,1.30E+07,1.10E+07,2.10E-03,2.00E-03,-13.35,0.07,,,,,
5348,1IAR,A:B,IA5A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.17E-09,1.30E+07,1.20E+07,2.10E-03,1.40E-02,-13.35,1.17,,,,,
5349,1IAR,A:B,IA5R,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,6.21E-10,1.30E+07,1.40E+07,2.10E-03,8.70E-03,-13.35,0.8,,,,,
5350,1IAR,A:B,KA12E,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.05E-10,1.30E+07,7.30E+06,2.10E-03,1.50E-03,-13.35,0.14,,,,,
5351,1IAR,A:B,KA12S,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.58E-10,1.30E+07,1.20E+07,2.10E-03,1.90E-03,-13.35,-0.01,,,,,
5352,1IAR,A:B,KA77A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.10E-10,1.30E+07,1.00E+07,2.10E-03,2.10E-03,-13.35,0.15,,,,,
5353,1IAR,A:B,KA77E,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,4.55E-10,1.30E+07,4.40E+06,2.10E-03,2.00E-03,-13.35,0.61,,,,,
5354,1IAR,A:B,KA84A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.90E-10,1.30E+07,1.00E+07,2.10E-03,2.90E-03,-13.35,0.34,,,,,
5355,1IAR,A:B,KA84D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,3.87E-09,1.30E+07,2.40E+06,2.10E-03,9.30E-03,-13.35,1.88,,,,,
5356,1IAR,A:B,NA15A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.53E-10,1.30E+07,1.50E+07,2.10E-03,2.30E-03,-13.35,-0.03,,,,,
5357,1IAR,A:B,NA15D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.42E-10,1.30E+07,1.20E+07,2.10E-03,1.70E-03,-13.35,-0.08,,,,,
5358,1IAR,A:B,NA89A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.25E-09,1.30E+07,1.20E+07,2.10E-03,2.70E-02,-13.35,1.56,,,,,
5359,1IAR,A:B,QA78A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.00E-10,1.30E+07,1.10E+07,2.10E-03,2.20E-03,-13.35,0.12,,,,,
5360,1IAR,A:B,QA78E,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,2.45E-10,1.30E+07,1.10E+07,2.10E-03,2.70E-03,-13.35,0.24,,,,,
5361,1IAR,A:B,QA8A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.56E-10,1.30E+07,1.60E+07,2.10E-03,2.50E-03,-13.35,-0.02,,,,,
5362,1IAR,A:B,QA8R,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.73E-10,1.30E+07,1.10E+07,2.10E-03,1.90E-03,-13.35,0.04,,,,,
5363,1IAR,A:B,RA53Q,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,6.64E-10,1.30E+07,1.10E+07,2.10E-03,7.30E-03,-13.35,0.84,,,,,
5364,1IAR,A:B,RA81A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,3.64E-10,1.30E+07,7.70E+06,2.10E-03,2.80E-03,-13.35,0.48,,,,,
5365,1IAR,A:B,RA81E,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.91E-09,1.30E+07,3.20E+06,2.10E-03,6.10E-03,-13.35,1.46,,,,,
5366,1IAR,A:B,RA85A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,3.33E-10,1.30E+07,8.10E+06,2.10E-03,2.70E-03,-13.35,0.43,,,,,
5367,1IAR,A:B,RA85E,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.28E-09,1.30E+07,3.60E+06,2.10E-03,4.60E-03,-13.35,1.22,,,,,
5368,1IAR,A:B,RA88A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,9.16E-08,1.30E+07,8.30E+06,2.10E-03,7.60E-01,-13.35,3.75,,,,,
5369,1IAR,A:B,RA88Q,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.92E-08,1.30E+07,7.30E+06,2.10E-03,1.40E-01,-13.35,2.83,,,,,
5370,1IAR,A:B,SA16A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.19E-10,1.30E+07,1.60E+07,2.10E-03,1.90E-03,-13.35,-0.18,,,,,
5371,1IAR,A:B,SA16D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.36E-10,1.30E+07,1.10E+07,2.10E-03,1.50E-03,-13.35,-0.1,,,,,
5372,1IAR,A:B,TA13A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,8.45E-10,1.30E+07,8.40E+06,2.10E-03,7.10E-03,-13.35,0.98,,,,,
5373,1IAR,A:B,TA13D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.12E-10,1.30E+07,7.60E+06,2.10E-03,8.50E-04,-13.35,-0.22,,,,,
5374,1IAR,A:B,TA6A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.36E-10,1.30E+07,1.40E+07,2.10E-03,1.90E-03,-13.35,-0.1,,,,,
5375,1IAR,A:B,TA6D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.70E-09,1.30E+07,8.80E+06,2.10E-03,1.50E-02,-13.35,1.39,,,,,
5376,1IAR,A:B,WA91A,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,5.55E-10,1.30E+07,1.10E+07,2.10E-03,6.10E-03,-13.35,0.73,,,,,
5377,1IAR,A:B,WA91D,Human interleukin-4 (hIL-4),Human interleukin-4 receptor alpha (hIL-4Ra),RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI;ASEdb;PINT;,"9050834 (Table 1, p. 1658)",1.62E-10,1.47E-09,1.30E+07,5.80E+06,2.10E-03,8.50E-03,-13.35,1.31,,,,,
5378,1A4Y,A:B,HB8A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 1, p. 1762)",5.00E-16,2.30E-15,2.80E+08,2.00E+08,1.40E-07,4.50E-07,-20.86,0.9,,,,,
5379,1A4Y,A:B,QB12A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 1, p. 1762)",5.00E-16,8.30E-16,2.80E+08,2.40E+08,1.40E-07,2.00E-07,-20.86,0.3,,,,,
5380,1A4Y,A:B,NB68A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 1, p. 1762)",5.00E-16,6.10E-16,2.80E+08,3.80E+08,1.40E-07,2.30E-07,-20.86,0.12,,,,,
5381,1A4Y,A:B,EB108A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 1, p. 1762)",5.00E-16,2.90E-16,2.80E+08,5.50E+08,1.40E-07,1.60E-07,-20.86,-0.32,,,,,
5382,1Z7X,W:X,YW434A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Assay of enzymatic activity of free RNase A at various times,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 5 mM DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.10E-14,7.20E-10,3.80E+08,,1.20E-05,,-18.42,5.95,,,,,
5383,1Z7X,W:X,DW435A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Assay of enzymatic activity of free RNase A at various times,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 5 mM DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.10E-14,1.50E-11,3.80E+08,,1.20E-05,,-18.42,3.66,,,,,
5384,1Z7X,W:X,YW437A,Human angiogenin,"Human ribonuclease inhibitor, placental (hRI)",EI,Assay of enzymatic activity of free RNase A at various times,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 5 mM DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.10E-14,2.60E-12,3.80E+08,2.80E+08,1.20E-05,7.40E-04,-18.42,2.62,,,,,
5385,1A4Y,A:B,YA434A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.90E-16,9.60E-14,2.80E+08,7.60E+07,1.10E-07,7.30E-06,-21.01,3.26,,,,,
5386,1A4Y,A:B,DA435A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.90E-16,1.40E-13,2.80E+08,1.00E+08,1.10E-07,1.40E-05,-21.01,3.48,,,,,
5387,1A4Y,A:B,YA437A,"Bovine ribonuclease A, pancreatic (RNase A)","Human ribonuclease inhibitor, placental (hRI)",EI,HPLC quantitation of free angiogenin at various times for complexes with native hRI; Scintillation counting of free and bound radiolabeled [<sup>14</sup>C]Ang for hRI mutants,"0.1 M Mes, containing 0.1 M NaCl, 1 mM EDTA, 120 &micro;M DTT, 100 &micro;g/mL BSA",298,6,SKEMPI;ASEdb;,"9050852 (Table 4, p. 1765)",3.90E-16,1.60E-15,2.80E+08,2.00E+08,1.10E-07,3.10E-07,-21.01,0.84,,,,,
5388,4NFG,A:B,AA193F,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,3.45E-05,1.00E+05,2.90E+04,,,-6.82,0.73,2.25,1.91,30.8,26.8,
5389,4NFG,A:B,DA34N,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,4.00E-05,1.00E+05,2.50E+04,,,-6.82,0.82,2.25,2.51,30.8,28.4,
5390,4NFG,A:B,EA290N,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,4.35E-05,1.00E+05,2.30E+04,,,-6.82,0.87,2.25,2.06,30.8,27,
5391,4NFG,A:B,EA291Q,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,9.09E-06,1.00E+05,1.10E+05,,,-6.82,-0.06,2.25,2.13,30.8,30.1,
5392,4NFG,A:B,EA32Q,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,2.78E-05,1.00E+05,3.60E+04,,,-6.82,0.61,2.25,2.25,30.8,29.2,
5393,4NFG,A:B,EA35Q,"Saccharomyces cerevisiae cytochrome c peroxidase, mitochondrial (CcP)",Equus caballus cytochrome c,OE,Isothermal Titration Calorimetry,"0.010 M potassium phosphate buffer, 0.050 M KNO3",298,6,SKEMPI;PINT;,"9092837 (Table 1, p. 4056 and Table 2, p. 4059)",1.00E-05,3.13E-05,1.00E+05,3.20E+04,,,-6.82,0.68,2.25,1.05,30.8,24.4,
5394,1BRS,A:D,DD39A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,7.69E-09,,,,,-19.09,8.03,-19.3,-7.45,,,
5395,1BRS,A:D,"DD39A,KA27A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,2.70E-08,,,,,-19.09,8.77,-19.3,-10.6,,,
5396,1BRS,A:D,"DD39A,RA59A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,2.13E-06,,,,,-19.09,11.36,-19.3,-1.7,,,
5397,1BRS,A:D,HA102A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,,,,,,-19.09,,-19.3,-11,,,
5398,1BRS,A:D,"HA102A,DD39A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,7.69E-07,,,,,-19.09,10.75,-19.3,-2.45,,,
5399,1BRS,A:D,"HA102A,YD29A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,,,,,,-19.09,,-19.3,-13.3,,,
5400,1BRS,A:D,"HA102A,YD29F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,,,,,,-19.09,,-19.3,-11.95,,,
5401,1BRS,A:D,YD29A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,,,,,,-19.09,,-19.3,-14.2,,,
5402,1BRS,A:D,YD29F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"24mM Hepes, 1mM DTT",298,8,SKEMPI,"9126847 (Table 2, p. 699)",1.00E-14,,,,,,-19.09,,-19.3,-18.8,,,
5403,1BRS,A:D,DD35A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,2.00E-11,,,,,-19.09,4.5,-18.94,-14.4,,,
5404,1BRS,A:D,"DD35A,EA73A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,5.26E-10,,,,,-19.09,6.44,-18.94,-3,,,
5405,1BRS,A:D,"DD35A,EA73F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,5.00E-10,,,,,-19.09,6.41,-18.94,-3.7,,,
5406,1BRS,A:D,"DD35A,EA73W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.54E-10,,,,,-19.09,5.71,-18.94,-4.7,,,
5407,1BRS,A:D,DD39A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,4.76E-09,,,,,-19.09,7.74,-18.94,-7,,,
5408,1BRS,A:D,"DD39A,EA73A",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.85E-09,,,,,-19.09,7.18,-18.94,-11.9,,,
5409,1BRS,A:D,"DD39A,EA73F",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,3.03E-09,,,,,-19.09,7.47,-18.94,-9,,,
5410,1BRS,A:D,"DD39A,EA73Q",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.92E-09,,,,,-19.09,7.2,-18.94,-6.3,,,
5411,1BRS,A:D,"DD39A,EA73W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,7.69E-10,,,,,-19.09,6.66,-18.94,-7.9,,,
5412,1BRS,A:D,EA73A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,5.26E-13,,,,,-19.09,2.35,-18.94,-7.25,,,
5413,1BRS,A:D,EA73C,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,7.14E-13,,,,,-19.09,2.53,-18.94,-8.9,,,
5414,1BRS,A:D,EA73F,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,4.35E-13,,,,,-19.09,2.23,-18.94,-9.1,,,
5415,1BRS,A:D,EA73Q,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"35mM Tes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,,,,,,-19.09,1.45,-18.94,-9.95,,,
5416,1BRS,A:D,EA73Q,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.16E-13,,,,,-19.09,,-19.5,-10.7,,,
5417,1BRS,A:D,EA73S,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.61E-12,,,,,-19.09,3.01,-18.94,-7.7,,,
5418,1BRS,A:D,EA73W,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"35mM Tes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,,,,,,-19.09,1.66,-18.94,-8.5,,,
5419,1BRS,A:D,EA73W,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.64E-13,,,,,-19.09,,-19.5,-8.9,,,
5420,1BRS,A:D,EA73Y,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,5.88E-13,,,,,-19.09,2.41,-18.94,-10.7,,,
5421,1BRS,A:D,ED76A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,1.05E-13,,,,,-19.09,1.39,-18.94,-17.8,,,
5422,1BRS,A:D,"ED76A,EA73Q",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,3.85E-12,,,,,-19.09,3.53,-18.94,-8.1,,,
5423,1BRS,A:D,"ED76A,EA73W",Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Isothermal Titration Calorimetry,"39mM Hepes, 1 mM DTT",298,8,SKEMPI,"9126847 (Table 3, p. 700)",1.00E-14,4.00E-12,,,,,-19.09,3.55,-18.94,-6.5,,,
5424,,,D*63A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.41,,,,,mutation in VEGF
5425,,,D*19A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.3,,,,,mutation in VEGF
5426,,,D*41A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.24,,,,,mutation in VEGF
5427,,,E*67A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.71,,,,,mutation in VEGF
5428,,,E*38A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.41,,,,,mutation in VEGF
5429,,,E*93A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.41,,,,,mutation in VEGF
5430,,,E*42A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.21,,,,,mutation in VEGF
5431,,,E*44A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.21,,,,,mutation in VEGF
5432,,,E*13A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.13,,,,,mutation in VEGF
5433,,,E*103A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.06,,,,,mutation in VEGF
5434,,,E*64A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,2.77,,,,,mutation in VEGF
5435,,,F*36A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.31,,,,,mutation in VEGF
5436,,,F*47A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,1.3,,,,,mutation in VEGF
5437,,,F*17A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,2.66,,,,,mutation in VEGF
5438,,,G*88A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0,,,,,mutation in VEGF
5439,,,G*92A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.11,,,,,mutation in VEGF
5440,,,G*65A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.15,,,,,mutation in VEGF
5441,,,H*86A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.15,,,,,mutation in VEGF
5442,,,H*90A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.31,,,,,mutation in VEGF
5443,,,H*12A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.35,,,,,mutation in VEGF
5444,,,H*11A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.54,,,,,mutation in VEGF
5445,,,I*91A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0,,,,,mutation in VEGF
5446,,,I*43A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,1.74,,,,,mutation in VEGF
5447,,,I*83A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,3.26,,,,,mutation in VEGF
5448,,,I*46A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,3.42,,,,,mutation in VEGF
5449,,,K*48A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.21,,,,,mutation in VEGF
5450,,,K*16A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.06,,,,,mutation in VEGF
5451,,,K*84A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.47,,,,,mutation in VEGF
5452,,,L*66A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.71,,,,,mutation in VEGF
5453,,,M*81A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.41,,,,,mutation in VEGF
5454,,,M*94A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.61,,,,,mutation in VEGF
5455,,,M*18A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.7,,,,,mutation in VEGF
5456,,,N*62A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.41,,,,,mutation in VEGF
5457,,,P*40A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.3,,,,,mutation in VEGF
5458,,,P*85A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,2.1,,,,,mutation in VEGF
5459,,,Q*37A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.24,,,,,mutation in VEGF
5460,,,Q*87A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.35,,,,,mutation in VEGF
5461,,,Q*22A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.47,,,,,mutation in VEGF
5462,,,Q*89A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.54,,,,,mutation in VEGF
5463,,,Q*79A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,2.65,,,,,mutation in VEGF
5464,,,R*82A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.3,,,,,mutation in VEGF
5465,,,R*105A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.13,,,,,mutation in VEGF
5466,,,R*23A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.24,,,,,mutation in VEGF
5467,,,V*69A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.3,,,,,mutation in VEGF
5468,,,V*15A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,-0.13,,,,,mutation in VEGF
5469,,,V*14A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.35,,,,,mutation in VEGF
5470,,,Y*39A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.15,,,,,mutation in VEGF
5471,,,Y*45A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.28,,,,,mutation in VEGF
5472,,,Y*25A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.31,,,,,mutation in VEGF
5473,,,Y*21A,Human vascular endothelial growth factor A (VEGF A),Human vascular endothelial growth factor receptor 2 (VEGFR-2)/kinase insert domain receptor (KDR),Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-14.7,0.61,,,,,mutation in VEGF
5474,,,D*19A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,-0.21,,,,,mutation in VEGF
5475,,,D*41A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.38,,,,,mutation in VEGF
5476,,,D*63A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,-0.06,,,,,mutation in VEGF
5477,,,E*103A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.49,,,,,mutation in VEGF
5478,,,E*13A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.15,,,,,mutation in VEGF
5479,,,E*38A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,-0.21,,,,,mutation in VEGF
5480,,,E*42A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.2,,,,,mutation in VEGF
5481,,,E*44A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.15,,,,,mutation in VEGF
5482,,,E*64A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.31,,,,,mutation in VEGF
5483,,,E*67A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.28,,,,,mutation in VEGF
5484,,,E*93A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.93,,,,,mutation in VEGF
5485,,,F*17A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.51,,,,,mutation in VEGF
5486,,,F*36A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.11,,,,,mutation in VEGF
5487,,,F*47A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0,,,,,mutation in VEGF
5488,,,G*65A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.31,,,,,mutation in VEGF
5489,,,G*88A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,2.15,,,,,mutation in VEGF
5490,,,G*92A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,2.72,,,,,mutation in VEGF
5491,,,H*11A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.31,,,,,mutation in VEGF
5492,,,H*12A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.06,,,,,mutation in VEGF
5493,,,H*86A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.48,,,,,mutation in VEGF
5494,,,H*90A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.31,,,,,mutation in VEGF
5495,,,I*43A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.11,,,,,mutation in VEGF
5496,,,I*46A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.44,,,,,mutation in VEGF
5497,,,I*83A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,2.06,,,,,mutation in VEGF
5498,,,I*91A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.73,,,,,mutation in VEGF
5499,,,K*16A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.11,,,,,mutation in VEGF
5500,,,K*48A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.46,,,,,mutation in VEGF
5501,,,K*84A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,1.2,,,,,mutation in VEGF
5502,,,L*66A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.28,,,,,mutation in VEGF
5503,,,M*18A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.11,,,,,mutation in VEGF
5504,,,M*81A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,2.5,,,,,mutation in VEGF
5505,,,M*94A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.94,,,,,mutation in VEGF
5506,,,N*62A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.47,,,,,mutation in VEGF
5507,,,P*40A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.41,,,,,mutation in VEGF
5508,,,P*85A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0,,,,,mutation in VEGF
5509,,,Q*22A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.2,,,,,mutation in VEGF
5510,,,Q*37A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0,,,,,mutation in VEGF
5511,,,Q*79A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,1,,,,,mutation in VEGF
5512,,,Q*87A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.2,,,,,mutation in VEGF
5513,,,Q*89A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,2.69,,,,,mutation in VEGF
5514,,,R*105A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.2,,,,,mutation in VEGF
5515,,,R*23A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.15,,,,,mutation in VEGF
5516,,,R*82A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,1.8,,,,,mutation in VEGF
5517,,,V*14A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.24,,,,,mutation in VEGF
5518,,,V*15A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.06,,,,,mutation in VEGF
5519,,,V*69A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.2,,,,,mutation in VEGF
5520,,,Y*21A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.54,,,,,mutation in VEGF
5521,,,Y*25A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.11,,,,,mutation in VEGF
5522,,,Y*39A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.24,,,,,mutation in VEGF
5523,,,Y*45A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",,,,,,,-11.4,0.88,,,,,mutation in VEGF
5524,1BJ1,W:LH,DW19A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5525,1BJ1,W:LH,DW41A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5526,1BJ1,W:LH,DW63A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5527,1BJ1,W:LH,EW103A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5528,1BJ1,W:LH,EW13A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5529,1BJ1,W:LH,EW38A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5530,1BJ1,W:LH,EW42A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5531,1BJ1,W:LH,EW44A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5532,1BJ1,W:LH,EW64A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5533,1BJ1,W:LH,EW67A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5534,1BJ1,W:LH,FW36A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5535,1BJ1,W:LH,GW65A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5536,1BJ1,W:LH,HW11A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5537,1BJ1,W:LH,HW12A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5538,1BJ1,W:LH,IW43A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5539,1BJ1,W:LH,IW46A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5540,1BJ1,W:LH,KW16A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5541,1BJ1,W:LH,LW66A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.15,,,,,,
5542,1BJ1,W:LH,MW18A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5543,1BJ1,W:LH,NW62A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5544,1BJ1,W:LH,PW40A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5545,1BJ1,W:LH,PW85A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5546,1BJ1,W:LH,QW22A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5547,1BJ1,W:LH,QW37A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.08,,,,,,
5548,1BJ1,W:LH,RW105A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.06,,,,,,
5549,1BJ1,W:LH,RW23A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5550,1BJ1,W:LH,VW14A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5551,1BJ1,W:LH,VW15A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5552,1BJ1,W:LH,VW69A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5553,1BJ1,W:LH,YW25A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5554,1BJ1,W:LH,YW39A,Human vascular endothelial growth factor A (VEGF A),Humanized mouse antibody mAb A4.6.1,Ag-Ab,Radioimmunoassay,"PBS, 0.5% BSA, 0.1% Tween 20",,,ASEdb,"9207067 (Tables 2 and 3, p. 7195)",3.41E-09,,4.10E+04,,1.40E-04,,-16.01,,,,,,
5555,1AK4,A:D,AD488G,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,1.06E-03,,,,,-7.94,3.95,,,,,
5556,1AK4,A:D,AD488V,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,4.40E-05,,,,,-7.94,2.1,,,,,
5557,1AK4,A:D,AD492G,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,3.20E-05,,,,,-7.94,1.91,,,,,
5558,1AK4,A:D,AD492V,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,2.20E-05,,,,,-7.94,1.69,,,,,
5559,1AK4,A:D,GD489A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,4.00E-04,,,,,-7.94,3.38,,,,,
5560,1AK4,A:D,GD489V,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,2.00E-03,,,,,-7.94,4.32,,,,,
5561,1AK4,A:D,HD487A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,6.60E-05,,,,,-7.94,2.33,,,,,
5562,1AK4,A:D,HD487Q,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,6.20E-05,,,,,-7.94,2.3,,,,,
5563,1AK4,A:D,HD487R,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,1.93E-04,,,,,-7.94,2.96,,,,,
5564,1AK4,A:D,ID491A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,1.80E-05,,,,,-7.94,1.58,,,,,
5565,1AK4,A:D,ID491V,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,1.20E-05,,,,,-7.94,1.34,,,,,
5566,1AK4,A:D,PD485A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,7.50E-05,,,,,-7.94,2.41,,,,,
5567,1AK4,A:D,PD490A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,4.70E-04,,,,,-7.94,3.48,,,,,
5568,1AK4,A:D,PD493A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,3.80E-05,,,,,-7.94,2.01,,,,,
5569,1AK4,A:D,VD486A,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",1.20E-06,6.40E-05,,,,,-7.94,2.32,,,,,
5570,1M9E,A:D,AD87H,Human peptidyl-prolyl cis-trans isomerase A/cyclophilin  A (CypA),HIV-1 gag-pol polyprotein/capsid protein (CA),,Surface Plasmon Resonance,"100mM NaCl, 25mM potassium phosphate, 1mM &beta;-mercaptoethanol, 0.005% (v/v) P20",293,6.5,SKEMPI,"9223641 ( Table 2, p. 787)",6.60E-05,1.20E-06,,,,,-5.6,-2.33,,,,,
5571,1E96,A:B,DA38N,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,5.10E-06,,,,,-9.26,2.16,,,,,
5572,1E96,A:B,IA33N,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,3.90E-06,,,,,-9.26,2.01,,,,,
5573,1E96,A:B,KA132E,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,9.00E-08,,,,,-9.26,-0.19,,,,,
5574,1E96,A:B,LA134R,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,1.00E-07,,,,,-9.26,-0.13,,,,,
5575,1E96,A:B,MA45T,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,2.30E-07,,,,,-9.26,0.36,,,,,
5576,1E96,A:B,NA26H,Human ras-related C3 botulinum toxin substrate 1 (Rac-1),"Human neutrophil cytosol factor 2 (p67phox, NCF2)",,Fluorescence spectrophotometric assay,"20mM Tris acetate buffer with 3mM NaCl, 50mM KCl, 0.1 &micro;m MgCl2",293,7.45,SKEMPI,"9228059 (Table 1, p. 18837)",1.24E-07,8.00E-07,,,,,-9.26,1.09,,,,,
5577,2J0T,A:D,"CD1S,FD12Y",Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,1.80E-06,,,,,-12.52,4.37,,,,,
5578,2J0T,A:D,CD70S,Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,2.16E-06,,,,,-12.52,4.48,,,,,
5579,2J0T,A:D,MD66A,Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,2.40E-08,,,,,-12.52,1.71,,,,,
5580,2J0T,A:D,TD2A,Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,2.09E-06,,,,,-12.52,4.46,,,,,
5581,2J0T,A:D,"VD69A,AD103V",Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,4.90E-09,,,,,-12.52,0.73,,,,,
5582,2J0T,A:D,VD69I,Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,5.70E-09,,,,,-12.52,0.82,,,,,
5583,2J0T,A:D,VD69T,Human nterstitial collagenase/matrix metalloproteinase-1 (MMP-1),Human metalloproteinase inhibitor 1/tissue inhibitor of metalloproteinases 1 (TIMP-1),EI,activity measured by following release of fluorogenic product with time,"50mM Tris-HCl, 0.15 M NaCl, 10mM CaCl2, 0.02% Brij 35",310,7.5,SKEMPI,"9268350 (Table II, p. 22089)",1.50E-09,1.32E-09,,,,,-12.52,-0.08,,,,,
5584,1EMV,A:B,"EA32D,LA33D,VA34N,TA38R,HA39E,EA42R,MA43L,SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,1.31E-08,,,,,-18.74,7.99,,,,,
5585,1EMV,A:B,"QA17E,LA18F,SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,1.28E-14,,,,,-18.74,-0.21,,,,,
5586,1EMV,A:B,"QA17E,LA18F,TA20K,TA21K,NA24R,DA26E,TA27G,SA28A,SA29T,EA32D,LA33D,VA34N,TA38R,HA39E,EA42R,MA43L,SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,1.47E-08,,,,,-18.74,8.05,,,,,
5587,1EMV,A:B,"QA17E,LA18F,TA20K,TA21K,NA24R,DA26E,TA27G,SA28A,SA29T,SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,3.23E-13,,,,,-18.74,1.7,,,,,
5588,1EMV,A:B,"QA17E,LA18F,TA20K,TA21K,NA24R,DA26E,TA27G,SA28A,SA29T,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,2.26E-12,,,,,-18.74,2.86,,,,,
5589,1EMV,A:B,"QA17E,LA18F,TA20K,TA21K,NA24R,SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,2.01E-13,,,,,-18.74,1.42,,,,,
5590,1EMV,A:B,"SA48D,KA57R,EA58D,GA59D,DA60R,DA61E,SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,7.60E-15,,,,,-18.74,-0.52,,,,,
5591,1EMV,A:B,"SA65E,NA69K,TA70E,VA71I,QA73E",Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.82E-14,2.08E-14,,,,,-18.74,0.08,,,,,
5592,2WPT,A:B,"DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,3.23E-13,,,,,-10.68,-6.35,,,,,
5593,2WPT,A:B,"DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M,DA48S,RA57K,DA58E,DA59G,RA60D,EA61D",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,2.26E-12,,,,,-10.68,-5.2,,,,,
5594,2WPT,A:B,"EA17Q,FA18L,KA20T,KA21T,RA24N,EA26D,GA27T,AA28S,TA29S",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,1.31E-08,,,,,-10.68,-0.07,,,,,
5595,2WPT,A:B,"EA17Q,FA18L,KA20T,KA21T,RA24N,EA26D,GA27T,AA28S,TA29S,DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,7.60E-15,,,,,-10.68,-8.57,,,,,
5596,2WPT,A:B,"EA17Q,FA18L,KA20T,KA21T,RA24N,EA26D,GA27T,AA28S,TA29S,DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M,DA48S,RA57K,DA58E,DA59G,RA60D,EA61D",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,2.08E-14,,,,,-10.68,-7.98,,,,,
5597,2WPT,A:B,"EA17Q,FA18L,KA20T,KA21T,RA24N,EA26D,GA27T,AA28S,TA29S,DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M,DA48S,RA57K,DA58E,DA59G,RA60D,EA61D,EA65S,KA69N,EA70T,IA71V,EA73Q",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,1.82E-14,,,,,-10.68,-8.05,,,,,
5598,2WPT,A:B,"EA26D,GA27T,AA28S,TA29S,DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,2.01E-13,,,,,-10.68,-6.63,,,,,
5599,2WPT,A:B,"KA20T,KA21T,RA24N,EA26D,GA27T,AA28S,TA29S,DA32E,DA33L,NA34V,RA38T,EA39H,RA42E,LA43M",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI,"9268373 (Table 1, 22256)",1.47E-08,1.28E-14,,,,,-10.68,-8.26,,,,,
5600,1JRH,LH:I,"AI103L,VI104M",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,4.14E-08,,,,,-10.7,0.63,,,,,
5601,1JRH,LH:I,"AI59S,II61T,HI65D",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.60E-08,,,,,-10.7,0.07,,,,,
5602,1JRH,LH:I,"AI95D,KI98R,EI100K",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.31E-08,,,,,-10.7,-0.05,,,,,
5603,1JRH,LH:I,EI45Q,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.68E-08,,,,,-10.7,0.1,,,,,
5604,1JRH,LH:I,"II35N,PI37S,VI39T,VI41I",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.81E-08,,,,,-10.7,0.14,,,,,
5605,1JRH,LH:I,"MI25L,II28V",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,9.90E-09,,,,,-10.7,-0.21,,,,,
5606,1JRH,LH:I,"SI71Y,DI72E,HI73Q,VI74I,GI75M,DI76Y,SI78D,NI79V,LI81A",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,2.10E-06,,,,,-10.7,2.96,,,,,
5607,1JRH,LH:I,TI14V,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.36E-08,,,,,-10.7,-0.03,,,,,
5608,1JRH,LH:I,"TI19L,EI21K",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,1.36E-08,,,,,-10.7,-0.03,,,,,
5609,1JRH,LH:I,"VI83A,RI88K",Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005% (v/v) Surfactant-p20",298,7.2,SKEMPI,"9367779 (Table 1, p. 885)",1.42E-08,9.90E-09,,,,,-10.7,-0.21,,,,,
5610,1EMV,A:B,CA23A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,7.68E-14,1.13E+08,7.93E+07,1.83E-06,6.09E-06,-18.8,0.92,,,,,
5611,1EMV,A:B,DA26A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.86E-14,1.13E+08,1.03E+08,1.83E-06,2.95E-06,-18.8,0.34,,,,,
5612,1EMV,A:B,DA51A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,3.53E-10,1.13E+08,1.73E+07,1.83E-06,6.11E-03,-18.8,5.92,,,,,
5613,1EMV,A:B,DA60A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,3.84E-14,1.13E+08,7.01E+07,1.83E-06,2.69E-06,-18.8,0.51,,,,,
5614,1EMV,A:B,EA30A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,1.77E-13,1.13E+08,8.36E+07,1.83E-06,1.48E-05,-18.8,1.42,,,,,
5615,1EMV,A:B,EA31A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.72E-14,1.13E+08,8.05E+07,1.83E-06,2.19E-06,-18.8,0.31,,,,,
5616,1EMV,A:B,EA32A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.35E-14,1.13E+08,1.04E+08,1.83E-06,2.44E-06,-18.8,0.22,,,,,
5617,1EMV,A:B,EA41A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,5.46E-13,1.13E+08,2.60E+07,1.83E-06,1.42E-05,-18.8,2.08,,,,,
5618,1EMV,A:B,EA42A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,4.92E-14,1.13E+08,6.61E+07,1.83E-06,3.25E-06,-18.8,0.66,,,,,
5619,1EMV,A:B,EA45A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.32E-14,1.13E+08,8.79E+07,1.83E-06,2.04E-06,-18.8,0.21,,,,,
5620,1EMV,A:B,GA49A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,1.99E-13,1.13E+08,6.13E+07,1.83E-06,1.22E-05,-18.8,1.49,,,,,
5621,1EMV,A:B,HA46A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,6.60E-14,1.13E+08,6.03E+07,1.83E-06,3.98E-06,-18.8,0.83,,,,,
5622,1EMV,A:B,IA53A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,6.78E-14,1.13E+08,8.94E+07,1.83E-06,6.06E-06,-18.8,0.85,,,,,
5623,1EMV,A:B,KA35A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.24E-14,1.13E+08,9.82E+07,1.83E-06,2.20E-06,-18.8,0.19,,,,,
5624,1EMV,A:B,LA33A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,5.20E-12,1.13E+08,7.69E+07,1.83E-06,4.00E-04,-18.8,3.42,,,,,
5625,1EMV,A:B,LA36A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,7.49E-14,1.13E+08,6.34E+07,1.83E-06,4.75E-06,-18.8,0.91,,,,,
5626,1EMV,A:B,LA52A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,4.47E-14,1.13E+08,6.42E+07,1.83E-06,2.87E-06,-18.8,0.6,,,,,
5627,1EMV,A:B,NA24A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.05E-14,1.13E+08,9.66E+07,1.83E-06,1.98E-06,-18.8,0.14,,,,,
5628,1EMV,A:B,NA69A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.59E-14,1.13E+08,9.50E+07,1.83E-06,2.46E-06,-18.8,0.28,,,,,
5629,1EMV,A:B,PA47A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,3.39E-14,1.13E+08,6.67E+07,1.83E-06,2.26E-06,-18.8,0.44,,,,,
5630,1EMV,A:B,PA56A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,1.32E-13,1.13E+08,9.85E+07,1.83E-06,1.30E-05,-18.8,1.24,,,,,
5631,1EMV,A:B,SA28A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.17E-14,1.13E+08,8.80E+07,1.83E-06,1.91E-06,-18.8,0.17,,,,,
5632,1EMV,A:B,SA29A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,8.14E-14,1.13E+08,8.76E+07,1.83E-06,7.13E-06,-18.8,0.96,,,,,
5633,1EMV,A:B,SA48A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,1.64E-14,1.13E+08,1.08E+08,1.83E-06,1.77E-06,-18.8,0.01,,,,,
5634,1EMV,A:B,SA50A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,6.51E-13,1.13E+08,7.90E+07,1.83E-06,5.14E-05,-18.8,2.19,,,,,
5635,1EMV,A:B,SA63A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,7.04E-14,1.13E+08,6.45E+07,1.83E-06,4.54E-06,-18.8,0.87,,,,,
5636,1EMV,A:B,TA27A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,5.54E-14,1.13E+08,6.08E+07,1.83E-06,3.37E-06,-18.8,0.73,,,,,
5637,1EMV,A:B,TA38A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,7.40E-14,1.13E+08,6.93E+07,1.83E-06,5.13E-06,-18.8,0.9,,,,,
5638,1EMV,A:B,TA44A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.71E-14,1.13E+08,9.96E+07,1.83E-06,2.70E-06,-18.8,0.3,,,,,
5639,1EMV,A:B,VA34A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,1.26E-12,1.13E+08,7.57E+07,1.83E-06,9.54E-05,-18.8,2.58,,,,,
5640,1EMV,A:B,VA37A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,2.69E-13,1.13E+08,7.77E+07,1.83E-06,2.09E-05,-18.8,1.66,,,,,
5641,1EMV,A:B,VA68A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,3.72E-13,1.13E+08,4.27E+07,1.83E-06,1.59E-05,-18.8,1.86,,,,,
5642,1EMV,A:B,YA54A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,5.69E-11,1.13E+08,4.48E+07,1.83E-06,2.55E-03,-18.8,4.83,,,,,
5643,1EMV,A:B,YA55A,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",1.62E-14,4.06E-11,1.13E+08,6.77E+07,1.83E-06,2.75E-03,-18.8,4.63,,,,,
5644,1FR2,A:B,AA41E,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",5.46E-13,1.62E-14,2.60E+07,1.13E+08,1.42E-05,1.83E-06,-16.72,-2.08,,,,,
5645,2GYK,A:B,AA51D,Escherichia coli colicin-E9,Escherichia coli colicin-E9 immunity protein (ImmE9),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM dithiothretol (DTT)",298,7,SKEMPI;ASEdb;PINT;,"9425068 (Table 1, p. 480)",3.53E-10,1.62E-14,1.73E+07,1.13E+08,6.11E-03,1.83E-06,-12.89,-5.92,,,,,
5646,1AHW,AB:C,DC178A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,1.50E-09,,,,,-11.55,-0.48,,,,,
5647,1AHW,AB:C,"KC149A,DC150A",Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI,"9480775 (Table 4, p. 883)",3.40E-09,2.50E-08,,,,,-11.55,1.18,,,,,
5648,1AHW,AB:C,"KC165A,KC166A",Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI,"9480775 (Table 4, p. 883)",3.40E-09,3.60E-10,,,,,-11.55,-1.33,,,,,
5649,1AHW,AB:C,LC176A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,1.80E-08,,,,,-11.55,0.99,,,,,
5650,1AHW,AB:C,NC199A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,2.10E-08,,,,,-11.55,1.08,,,,,
5651,1AHW,AB:C,TC167A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,3.00E-09,,,,,-11.55,-0.07,,,,,
5652,1AHW,AB:C,TC170A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,2.20E-08,,,,,-11.55,1.11,,,,,
5653,1AHW,AB:C,TC197A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,3.30E-08,,,,,-11.55,1.35,,,,,
5654,1AHW,AB:C,VC198A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,2.00E-09,,,,,-11.55,-0.31,,,,,
5655,1AHW,AB:C,YC157A,Mouse Ig 5G9 Fab,Human tissue factor/thromboplastin,Ag-Ab,Competition assay,5mM CaCl2,298,,SKEMPI;ASEdb;,"9480775 (Table 4, p. 883)",3.40E-09,1.40E-10,,,,,-11.55,-1.89,,,,,
5656,1JCK,AC:BD,GB102A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",4.50E-06,4.60E-06,,,,,-7.29,0.01,,,,,
5657,1JCK,AC:BD,KB103A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,9.40E-06,,,,,-7.53,0.68,,,,,
5658,1JCK,AC:BD,NB60A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,4.80E-05,,,,,-7.53,1.64,,,,,
5659,1JCK,AC:BD,TB20A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,4.90E-05,,,,,-7.53,1.65,,,,,
5660,1JCK,AC:BD,VB91A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,1.30E-04,,,,,-7.53,2.23,,,,,
5661,1JCK,AC:BD,YB26A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,6.00E-05,,,,,-7.53,1.77,,,,,
5662,1JCK,AC:BD,YB90A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,2.40E-04,,,,,-7.53,2.59,,,,,
5663,1JCK,AC:BD,FB176A,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type C-3 (SEC3),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI;ASEdb;,"9500785 (Table 1, p. 826)",3.00E-06,1.10E-04,,,,,-7.53,2.13,,,,,
5664,1SBB,A:B,LB20T,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type B (SEB),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI,"9500785 (Table 1, p. 826)",1.40E-04,1.20E-04,,,,,-5.25,-0.09,,,,,
5665,1SBB,A:B,VB26Y,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type B (SEB),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI,"9500785 (Table 1, p. 826)",1.40E-04,1.20E-05,,,,,-5.25,-1.45,,,,,
5666,1SBB,A:B,YB91V,Mouse 14.3.D T-cell antigen receptor,Staphylococcus aureus enterotoxin type B (SEB),,Sedimentation equilibrium using analytical centrifugation or surface plasmon resonance,50 mM Tris-HCl,298,7.5,SKEMPI,"9500785 (Table 1, p. 826)",1.40E-04,1.60E-04,,,,,-5.25,0.08,,,,,
5667,1A22,A:B,DB326A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.82E-09,1.50E+05,2.70E+05,5.10E-05,4.91E-04,-12.91,0.99,,,,,
5668,1A22,A:B,DB364A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,4.18E-09,1.50E+05,1.46E+05,5.10E-05,6.08E-04,-12.91,1.49,,,,,
5669,1A22,A:B,EB242A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,4.60E-10,,,,,-12.91,0.18,,,,,
5670,1A22,A:B,EB244A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.92E-09,1.50E+05,2.40E+05,5.10E-05,1.42E-03,-12.91,1.69,,,,,
5671,1A22,A:B,EB275A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,2.90E-10,,,,,-12.91,-0.09,,,,,
5672,1A22,A:B,EB320A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,2.50E-10,1.50E+05,1.77E+05,5.10E-05,4.42E-05,-12.91,-0.18,,,,,
5673,1A22,A:B,EB327A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.75E-09,1.50E+05,1.64E+05,5.10E-05,2.86E-04,-12.91,0.97,,,,,
5674,1A22,A:B,FB296S,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.70E-10,,,,,-12.91,0.05,,,,,
5675,1A22,A:B,IB303A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.13E-09,1.50E+05,2.24E+05,5.10E-05,1.15E-03,-12.91,1.61,,,,,
5676,1A22,A:B,IB305A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,9.01E-09,1.50E+05,1.20E+05,5.10E-05,1.08E-03,-12.91,1.94,,,,,
5677,1A22,A:B,IB365A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.24E-08,1.50E+05,1.34E+05,5.10E-05,1.66E-03,-12.91,2.13,,,,,
5678,1A22,A:B,KB321A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.90E-10,1.50E+05,1.12E+05,5.10E-05,4.39E-05,-12.91,0.08,,,,,
5679,1A22,A:B,KB367A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.30E-10,,,,,-12.91,-0.02,,,,,
5680,1A22,A:B,KB415A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.28E-09,1.50E+05,1.58E+05,5.10E-05,2.02E-04,-12.91,0.79,,,,,
5681,1A22,A:B,NB272A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.40E-10,1.50E+05,1.29E+05,5.10E-05,6.97E-05,-12.91,0.27,,,,,
5682,1A22,A:B,NB418A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.60E-10,1.50E+05,1.54E+05,5.10E-05,8.65E-05,-12.91,0.3,,,,,
5683,1A22,A:B,PB306A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,9.01E-08,1.50E+05,5.70E+03,5.10E-05,5.14E-04,-12.91,3.3,,,,,
5684,1A22,A:B,QB274A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.40E-10,,,,,-12.91,0,,,,,
5685,1A22,A:B,QB366A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.50E-10,1.50E+05,1.11E+05,5.10E-05,3.89E-05,-12.91,0.02,,,,,
5686,1A22,A:B,QB416A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.53E-09,1.50E+05,1.22E+05,5.10E-05,1.86E-04,-12.91,0.89,,,,,
5687,1A22,A:B,RB243A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.21E-08,1.50E+05,1.05E+05,5.10E-05,1.27E-03,-12.91,2.12,,,,,
5688,1A22,A:B,RB243L,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,8.20E-10,,,,,-12.91,0.52,,,,,
5689,1A22,A:B,RB243M,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.84E-09,,,,,-12.91,1,,,,,
5690,1A22,A:B,RB270A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.09E-09,1.50E+05,1.58E+05,5.10E-05,1.72E-04,-12.91,0.69,,,,,
5691,1A22,A:B,RB271A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,8.40E-10,,,,,-12.91,0.54,,,,,
5692,1A22,A:B,RB417A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.40E-10,1.50E+05,1.30E+05,5.10E-05,7.05E-05,-12.91,0.27,,,,,
5693,1A22,A:B,SB298A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.10E-10,1.50E+05,1.10E+05,5.10E-05,3.39E-05,-12.91,-0.05,,,,,
5694,1A22,A:B,SB302A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,2.50E-10,1.50E+05,1.12E+05,5.10E-05,2.81E-05,-12.91,-0.18,,,,,
5695,1A22,A:B,SB324A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,5.40E-10,,,,,-12.91,0.27,,,,,
5696,1A22,A:B,SB419A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.60E-10,1.50E+05,1.12E+05,5.10E-05,4.05E-05,-12.91,0.03,,,,,
5697,1A22,A:B,TB273A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,4.10E-10,,,,,-12.91,0.11,,,,,
5698,1A22,A:B,TB277A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,4.80E-10,1.50E+05,1.34E+05,5.10E-05,6.41E-05,-12.91,0.2,,,,,
5699,1A22,A:B,TB301A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,6.65E-09,,,,,-12.91,1.76,,,,,
5700,1A22,A:B,TB394A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,4.80E-10,,,,,-12.91,0.2,,,,,
5701,1A22,A:B,TB395A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,2.90E-10,,,,,-12.91,-0.09,,,,,
5702,1A22,A:B,VB371A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,1.20E-10,1.50E+05,1.28E+05,5.10E-05,1.53E-05,-12.91,-0.62,,,,,
5703,1A22,A:B,WB276A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,8.10E-10,1.50E+05,9.45E+04,5.10E-05,7.65E-05,-12.91,0.51,,,,,
5704,1A22,A:B,WB280A,Human growth hormone/somatotropin (hGH),Human growth hormone receptor (hGHR),HR,"competitive displacement of hGH from hGHbp, using <sup>125</sup>I-labeled hGH as a tracer",PBS with 0.02% (v/v) Tween 20,298,,SKEMPI,"9571026 (Table 1, p. 1118)",3.40E-10,3.30E-10,,,,,-12.91,-0.02,,,,,
5705,,,D*26K,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,6.40E-05,,,,,-5.59,-0.13,,,,,mutation in CD2
5706,,,R*34D,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,3.20E-05,,,,,-5.59,-0.54,,,,,mutation in CD2
5707,,,S*36E,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,9.60E-05,,,,,-5.59,0.11,,,,,mutation in CD2
5708,,,T*37K,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,4.00E-05,,,,,-5.59,-0.41,,,,,mutation in CD2
5709,,,K*45E,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,4.00E-05,,,,,-5.59,-0.41,,,,,mutation in CD2
5710,,,M*46Y,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,6.40E-05,,,,,-5.59,-0.13,,,,,mutation in CD2
5711,,,K*47D,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,8.80E-05,,,,,-5.59,0.06,,,,,mutation in CD2
5712,,,K*51E,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,2.32E-04,,,,,-5.59,0.63,,,,,mutation in CD2
5713,,,S*52E,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,1.76E-04,,,,,-5.59,0.47,,,,,mutation in CD2
5714,,,E*56R,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,9.60E-05,,,,,-5.59,0.11,,,,,mutation in CD2
5715,,,T*79E,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,1.84E-04,,,,,-5.59,0.49,,,,,mutation in CD2
5716,,,T*83D,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,1.68E-04,,,,,-5.59,0.44,,,,,mutation in CD2
5717,,,N*90K,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,1.92E-04,,,,,-5.59,0.52,,,,,mutation in CD2
5718,,,D*94K,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT,"9576909 (Table 1, p. 5491)",8.00E-05,1.52E-04,,,,,-5.59,0.38,,,,,mutation in CD2
5719,,,E*33A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,1.20E-04,,,,,-5.59,0.24,,,,,mutation in CD2
5720,,,R*34A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,7.20E-05,,,,,-5.59,-0.06,,,,,mutation in CD2
5721,,,E*41A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,8.80E-05,,,,,-5.59,0.06,,,,,mutation in CD2
5722,,,K*43A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,1.60E-04,,,,,-5.59,0.41,,,,,mutation in CD2
5723,,,K*51A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,1.04E-04,,,,,-5.59,0.16,,,,,mutation in CD2
5724,,,E*56A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,9.60E-05,,,,,-5.59,0.11,,,,,mutation in CD2
5725,,,T*86A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,5.60E-05,,,,,-5.59,-0.21,,,,,mutation in CD2
5726,,,R*87A,Rattus norvegicus T-cell surface antigen CD2,Rattus norvegicus CD48 antigen,,Surface Plasmon Resonance,"150mM NaCl, 1mM CaCl2, 1mM MgCl2, 10mM Hepes, 0.005% Surfactant P-20",298,7.4,PINT;ASEdb;,"9576909 (Table 1, p. 5491)",8.00E-05,1.60E-05,,,,,-5.59,-0.95,,,,,mutation in CD2
5727,1NMB,N:LH,DH56E,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,6.67E-06,,,,,-10.01,2.95,,,,,
5728,1NMB,N:LH,DH56N,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,6.67E-06,1.61E+05,8.00E+02,5.20E-03,2.90E-03,-10.01,2.95,,,,,
5729,1NMB,N:LH,LL94V,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,2.08E-07,1.61E+05,8.00E+04,5.20E-03,1.11E-02,-10.01,0.9,,,,,
5730,1NMB,N:LH,TL93F,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,4.37E-08,1.61E+05,1.22E+05,5.20E-03,4.30E-03,-10.01,-0.02,,,,,
5731,1NMB,N:LH,TL93W,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,6.21E-08,1.61E+05,1.30E+05,5.20E-03,6.30E-03,-10.01,0.18,,,,,
5732,1NMB,N:LH,YH100aF,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,5.00E-07,1.61E+05,8.80E+04,5.20E-03,5.60E-03,-10.01,1.42,,,,,
5733,1NMB,N:LH,YH99A,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,1.69E-06,1.61E+05,1.49E+05,5.20E-03,5.88E-02,-10.01,2.14,,,,,
5734,1NMB,N:LH,YL32F,Influenza A virus neuraminidase subtype N9,Mouse antibody NC10 Fab,Ag-Ab,Surface Plasmon Resonance,"10mM  HEPES, 0.15 M NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,SKEMPI,"9579662 (Table IV, p. 71)",4.55E-08,1.00E-07,1.61E+05,1.18E+05,5.20E-03,6.60E-02,-10.01,0.47,,,,,
5735,1VFB,AB:C,"DB100A,SC24A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,3.70E-06,,,,,-10.78,3.37,,,,,
5736,1VFB,AB:C,"DB54A,TC118A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.04E-07,,,,,-10.78,1.25,,,,,
5737,1VFB,AB:C,DB100A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.79E-06,,,,,-10.78,2.94,,,,,
5738,1VFB,AB:C,DB54A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,6.67E-08,,,,,-10.78,0.99,,,,,
5739,1VFB,AB:C,DC119A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,6.25E-08,,,,,-10.78,0.95,,,,,
5740,1VFB,AB:C,DC18A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,2.22E-08,,,,,-10.78,0.34,,,,,
5741,1VFB,AB:C,IC124A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.00E-07,,,,,-10.78,1.23,,,,,
5742,1VFB,AB:C,KC116A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,4.17E-08,,,,,-10.78,0.71,,,,,
5743,1VFB,AB:C,LC129A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.67E-08,,,,,-10.78,0.17,,,,,
5744,1VFB,AB:C,NC19A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,2.44E-08,,,,,-10.78,0.4,,,,,
5745,1VFB,AB:C,"WA92A,IC124A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,8.33E-06,,,,,-10.78,3.85,,,,,
5746,1VFB,AB:C,"WA92A,LC129A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,3.33E-06,,,,,-10.78,3.31,,,,,
5747,1VFB,AB:C,"WA92A,QC121A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,4.76E-06,,,,,-10.78,3.52,,,,,
5748,1VFB,AB:C,"WA92A,RC125A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,3.85E-06,,,,,-10.78,3.39,,,,,
5749,1VFB,AB:C,QC121A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.61E-06,,,,,-10.78,2.88,,,,,
5750,1VFB,AB:C,RC125A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,2.78E-07,,,,,-10.78,1.84,,,,,
5751,1VFB,AB:C,"WB52A,DC119A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,5.56E-07,,,,,-10.78,2.25,,,,,
5752,1VFB,AB:C,SC24A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,5.26E-08,,,,,-10.78,0.85,,,,,
5753,1VFB,AB:C,TC118A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,4.55E-08,,,,,-10.78,0.77,,,,,
5754,1VFB,AB:C,"YA32A,IC124A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.69E-06,,,,,-10.78,2.91,,,,,
5755,1VFB,AB:C,"YA32A,QC121A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.82E-07,,,,,-10.78,1.59,,,,,
5756,1VFB,AB:C,VC120A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,5.88E-08,,,,,-10.78,0.92,,,,,
5757,1VFB,AB:C,WA92A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,3.57E-06,,,,,-10.78,3.35,,,,,
5758,1VFB,AB:C,WB52A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,5.88E-08,,,,,-10.78,0.92,,,,,
5759,1VFB,AB:C,"YA50A,DC119A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.00E-07,,,,,-10.78,1.23,,,,,
5760,1VFB,AB:C,"YA50A,DC18A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.06E-07,,,,,-10.78,1.27,,,,,
5761,1VFB,AB:C,YA32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,2.27E-07,,,,,-10.78,1.72,,,,,
5762,1VFB,AB:C,YA50A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,3.03E-08,,,,,-10.78,0.52,,,,,
5763,1VFB,AB:C,"YB101F,DC119A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.27E-06,,,,,-10.78,2.74,,,,,
5764,1VFB,AB:C,"YB101F,VC120A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,9.09E-07,,,,,-10.78,2.54,,,,,
5765,1VFB,AB:C,YB101F,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.82E-07,,,,,-10.78,1.59,,,,,
5766,1VFB,AB:C,YB32A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,8.33E-08,,,,,-10.78,1.12,,,,,
5767,1VFB,AB:C,"YB32A,KC116A",Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,1.82E-07,,,,,-10.78,1.59,,,,,
5768,1VFB,AB:C,YC23A,Mouse anti-hen egg white lysozyme monoclonal antibody D1.3,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Surface Plasmon Resonance,"150mM NaCl, 0.005% Surfactant P-20, 3.4mM EDTA, 10mM Hepes",298,7.5,SKEMPI;ASEdb;PINT;,"9609690 (Table II, p. 7985)",1.25E-08,2.50E-08,,,,,-10.78,0.41,,,,,
5769,1GRN,A:B,DA38E,Human cell division control protein 42 homolog (CDC42),Human Rho GTPase-activating protein 1/CDC42 GTPase-activating protein (p50-RhoGAP),GC,monitoring the nucleotide-sensitive fluorescence from Trp97 of Cdc42Hs,"20mM Hepes-NaOH, 5mM MgCl2, 100mM NaCl",298,7.5,SKEMPI,"9632678 (Table 1, p. 16212)",2.90E-06,5.60E-06,,,,,-7.55,0.39,,,,,
5770,1NCA,N:LH,DH97K,Influenza A virus neuraminidase subtype N9,Mouse Ig gamma-2A chain C region/antibody NC41 scFv,Ag-Ab,,PBS,298,7.2,SKEMPI,"9692956 (Table 2, p. 10667)",5.00E-08,1.67E-07,,,,,-9.96,0.71,,,,,
5771,1NCA,N:LH,EH96D,Influenza A virus neuraminidase subtype N9,Mouse Ig gamma-2A chain C region/antibody NC41 scFv,Ag-Ab,Fluorescence Quenching Assay,PBS,298,7.2,SKEMPI,"9692956 (Table 2, p. 10667)",5.00E-08,1.00E-07,,,,,-9.96,0.41,,,,,
5772,1NCA,N:LH,NH31Q,Influenza A virus neuraminidase subtype N9,Mouse Ig gamma-2A chain C region/antibody NC41 scFv,Ag-Ab,Fluorescence Quenching Assay,PBS,298,7.2,SKEMPI,"9692956 (Table 2, p. 10667)",5.00E-08,5.00E-08,,,,,-9.96,0,,,,,
5773,1NCA,N:LH,NH98Q,Influenza A virus neuraminidase subtype N9,Mouse Ig gamma-2A chain C region/antibody NC41 scFv,Ag-Ab,Fluorescence Quenching Assay,PBS,298,7.2,SKEMPI,"9692956 (Table 2, p. 10667)",5.00E-08,1.25E-07,,,,,-9.96,0.54,,,,,
5774,2WPT,A:B,DA33L,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,4.80E-11,5.00E+07,7.90E+07,7.30E-01,3.80E-03,-10.67,-3.4,,,,,
5775,2WPT,A:B,"DA33L,NA34V,RA38T",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,3.40E-13,5.00E+07,1.15E+08,7.30E-01,3.70E-05,-10.67,-6.33,,,,,
5776,2WPT,A:B,EA39H,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,1.60E-08,5.00E+07,5.60E+07,7.30E-01,8.80E-01,-10.67,0.04,,,,,
5777,2WPT,A:B,NA34V,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,3.30E-09,5.00E+07,5.10E+07,7.30E-01,1.60E-01,-10.67,-0.9,,,,,
5778,2WPT,A:B,"NA34V,RA38T",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,1.90E-10,5.00E+07,9.80E+07,7.30E-01,1.80E-02,-10.67,-2.59,,,,,
5779,2WPT,A:B,"NA34V,RA38T,EA39H,RA42E",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,9.50E-11,5.00E+07,1.45E+08,7.30E-01,1.30E-02,-10.67,-3,,,,,
5780,2WPT,A:B,"NA34V,RA38T,RA42E",Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,6.40E-11,5.00E+07,1.83E+08,7.30E-01,1.20E-02,-10.67,-3.23,,,,,
5781,2WPT,A:B,RA38T,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,2.60E-09,5.00E+07,1.10E+08,7.30E-01,2.90E-01,-10.67,-1.04,,,,,
5782,2WPT,A:B,RA42E,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 1, p. 11774)",1.50E-08,8.00E-09,5.00E+07,6.30E+07,7.30E-01,5.00E-01,-10.67,-0.37,,,,,
5783,2WPT,A:B,DA33A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,1.20E-08,5.00E+07,5.00E+07,7.30E-01,1.20E-08,-10.67,-0.13,,,,,
5784,2WPT,A:B,EA30A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,2.80E-07,5.00E+07,3.30E+07,7.30E-01,2.80E-07,-10.67,1.73,,,,,
5785,2WPT,A:B,EA41A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,3.00E-05,5.00E+07,4.00E+06,7.30E-01,3.00E-05,-10.67,4.5,,,,,
5786,2WPT,A:B,NA34A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,7.90E-09,5.00E+07,8.90E+07,7.30E-01,7.90E-09,-10.67,-0.38,,,,,
5787,2WPT,A:B,PA56A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,2.10E-06,5.00E+07,1.30E+07,7.30E-01,2.10E-06,-10.67,2.93,,,,,
5788,2WPT,A:B,RA38A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,2.30E-09,5.00E+07,1.02E+08,7.30E-01,2.30E-09,-10.67,-1.11,,,,,
5789,2WPT,A:B,RA42A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,1.00E-08,5.00E+07,6.00E+07,7.30E-01,1.00E-08,-10.67,-0.24,,,,,
5790,2WPT,A:B,SA50A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,9.00E-07,5.00E+07,3.90E+07,7.30E-01,9.00E-07,-10.67,2.42,,,,,
5791,2WPT,A:B,VA37A,Escherichia coli colicin-E9,Escherichia coli colicin-E2 immunity protein (ImmE2),EI,Stopped-flow Fluorescence,"50mM Mops buffer, 200mM NaCl, 1mM DTT",298,7,SKEMPI;ASEdb;PINT;,"9718299 (Table 2, p. 11776)",1.50E-08,9.30E-06,5.00E+07,1.10E+07,7.30E-01,9.30E-06,-10.67,3.81,,,,,
5792,1WQJ,I:B,RI21A,Human insulin-like growth factor I (IGF-I),Human insulin-like growth factor-binding protein-1 (IGFBP-1),,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",4.14E-10,4.59E-10,6.71E+05,6.75E+05,2.78E-04,3.10E-04,-12.79,0.06,,,,,
5793,1WQJ,I:B,"RI36A,RI37A",Human insulin-like growth factor I (IGF-I),Human insulin-like growth factor-binding protein-1 (IGFBP-1),,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,Literature,"9733769 (Table II, p. 24704)",4.14E-10,6.84E-10,6.71E+05,5.07E+05,2.78E-04,3.47E-04,-12.79,0.3,,,,,
5794,1WQJ,I:B,RI50A,Human insulin-like growth factor I (IGF-I),Human insulin-like growth factor-binding protein-1 (IGFBP-1),,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",4.14E-10,1.16E-09,6.71E+05,3.12E+05,2.78E-04,3.61E-04,-12.79,0.61,,,,,
5795,1WQJ,I:B,RI55A,Human insulin-like growth factor I (IGF-I),Human insulin-like growth factor-binding protein-1 (IGFBP-1),,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",4.14E-10,3.57E-10,6.71E+05,8.34E+05,2.78E-04,2.98E-04,-12.79,-0.09,,,,,
5796,1WQJ,I:B,RI56A,Human insulin-like growth factor I (IGF-I),Human insulin-like growth factor-binding protein-1 (IGFBP-1),,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",4.14E-10,4.81E-10,6.71E+05,6.84E+05,2.78E-04,3.29E-04,-12.79,0.09,,,,,
5797,4XSS,B:E,RB21A,Human insulin-like growth factor I (IGF-I),Human insulin receptor (IR),HR,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",5.78E-09,1.82E-08,4.83E+05,3.35E+05,2.79E-03,6.10E-03,-11.23,0.68,,,,,
5798,4XSS,B:E,"RB36A,RB37A",Human insulin-like growth factor I (IGF-I),Human insulin receptor (IR),HR,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,Literature,"9733769 (Table II, p. 24704)",5.78E-09,3.28E-08,4.83E+05,1.64E+05,2.79E-03,5.38E-03,-11.23,1.03,,,,,
5799,4XSS,B:E,RB50A,Human insulin-like growth factor I (IGF-I),Human insulin receptor (IR),HR,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",5.78E-09,9.09E-09,4.83E+05,3.42E+05,2.79E-03,3.11E-03,-11.23,0.27,,,,,
5800,4XSS,B:E,RB55A,Human insulin-like growth factor I (IGF-I),Human insulin receptor (IR),HR,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",5.78E-09,6.39E-09,4.83E+05,4.15E+05,2.79E-03,2.65E-03,-11.23,0.06,,,,,
5801,4XSS,B:E,RB56A,Human insulin-like growth factor I (IGF-I),Human insulin receptor (IR),HR,Surface Plasmon Resonance,"10mM HEPES, 150mM NaCl, 3.4mM EDTA, 0.05% P20",298,7.4,ASEdb,"9733769 (Table II, p. 24704)",5.78E-09,1.14E-08,4.83E+05,4.16E+05,2.79E-03,4.73E-03,-11.23,0.4,,,,,
5802,2LHI,A,FA12A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,3.60E-08,,,,,-9.88,-0.27,,,,,
5803,2LHI,A,FA141A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,8.20E-07,,,,,-9.88,1.58,,,,,
5804,2LHI,A,FA16A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,9.40E-08,,,,,-9.88,0.3,,,,,
5805,2LHI,A,FA19A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,1.70E-07,,,,,-9.88,0.65,,,,,
5806,2LHI,A,FA89A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,1.90E-07,,,,,-9.88,0.71,,,,,
5807,2LHI,A,FA92A,Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,ASEdb,"9756868 (Table II, p. 23679)",5.70E-08,3.10E-07,,,,,-9.88,1,,,,,
5808,2LHI,A,"FA16A,FA19A",Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,Literature,"9756868 (Table II, p. 23679)",5.70E-08,7.90E-07,,,,,-9.88,1.56,,,,,
5809,2LHI,A,"FA65A,FA68A",Saccharomyces cerevisiae calmodulin (yCaM),Saccharomyces cerevisiae calcineurin,,Surface Plasmon Resonance,"20mM Tris/HCl with 1mM CaCl2, 250mM NaCl, 0.005% Tween 20",298,7.5,Literature,"9756868 (Table II, p. 23679)",5.70E-08,6.50E-08,,,,,-9.88,0.08,,,,,
5810,3HFM,Y:LH,DY101A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,9.80E-10,1.49E+06,6.30E+05,1.12E-04,6.00E-04,-13.81,1.52,,,,,
5811,3HFM,Y:LH,DY101E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.60E-09,1.49E+06,1.02E+06,1.12E-04,3.60E-03,-13.81,2.29,,,,,
5812,3HFM,Y:LH,DY101F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,5.00E-09,1.49E+06,1.80E+05,1.12E-04,9.00E-04,-13.81,2.49,,,,,
5813,3HFM,Y:LH,DY101G,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,1.80E-10,1.49E+06,5.90E+05,1.12E-04,1.10E-04,-13.81,0.52,,,,,
5814,3HFM,Y:LH,DY101K,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.50E-09,1.49E+06,3.20E+05,1.12E-04,1.10E-03,-13.81,2.28,,,,,
5815,3HFM,Y:LH,DY101N,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,1.20E-09,1.49E+06,5.00E+05,1.12E-04,6.00E-04,-13.81,1.64,,,,,
5816,3HFM,Y:LH,DY101Q,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.30E-09,1.49E+06,5.60E+05,1.12E-04,1.80E-03,-13.81,2.24,,,,,
5817,3HFM,Y:LH,DY101R,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,4.60E-09,1.49E+06,2.70E+05,1.12E-04,1.30E-03,-13.81,2.44,,,,,
5818,3HFM,Y:LH,DY101S,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,2.30E-09,1.49E+06,4.30E+05,1.12E-04,1.00E-03,-13.81,2.03,,,,,
5819,3HFM,Y:LH,GY102V,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,1.90E-10,1.49E+06,5.40E+05,1.12E-04,1.00E-04,-13.81,0.55,,,,,
5820,3HFM,Y:LH,KY96M,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,7.00E-06,,,,,-13.81,6.78,,,,,
5821,3HFM,Y:LH,KY97A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,8.90E-07,,,,,-13.81,5.56,,,,,
5822,3HFM,Y:LH,KY97D,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,6.90E-06,,,,,-13.81,6.77,,,,,
5823,3HFM,Y:LH,KY97E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.30E-08,1.49E+06,4.50E+05,1.12E-04,1.50E-02,-13.81,3.6,,,,,
5824,3HFM,Y:LH,KY97G,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.90E-06,,,,,-13.81,6.43,,,,,
5825,3HFM,Y:LH,KY97M,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,2.90E-10,1.49E+06,5.70E+05,1.12E-04,1.70E-04,-13.81,0.8,,,,,
5826,3HFM,Y:LH,KY97R,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,1.30E-08,1.49E+06,6.20E+05,1.12E-04,8.20E-03,-13.81,3.05,,,,,
5827,3HFM,Y:LH,RY21A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.00E-10,1.49E+06,1.47E+06,1.12E-04,4.40E-04,-13.81,0.82,,,,,
5828,3HFM,Y:LH,RY21E,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,6.20E-09,1.49E+06,2.90E+05,1.12E-04,1.80E-03,-13.81,2.61,,,,,
5829,3HFM,Y:LH,RY21G,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,5.80E-09,1.49E+06,1.00E+06,1.12E-04,5.80E-03,-13.81,2.57,,,,,
5830,3HFM,Y:LH,RY21H,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.80E-09,1.49E+06,1.14E+06,1.12E-04,4.40E-03,-13.81,2.32,,,,,
5831,3HFM,Y:LH,RY21K,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,1.90E-09,1.49E+06,7.90E+05,1.12E-04,1.50E-03,-13.81,1.91,,,,,
5832,3HFM,Y:LH,RY21M,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,2.39E-09,1.49E+06,6.00E+05,1.12E-04,1.43E-03,-13.81,2.05,,,,,
5833,3HFM,Y:LH,RY21N,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,5.00E-09,1.49E+06,9.20E+05,1.12E-04,4.50E-03,-13.81,2.49,,,,,
5834,3HFM,Y:LH,RY21Q,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,5.60E-09,1.49E+06,1.02E+06,1.12E-04,5.80E-03,-13.81,2.55,,,,,
5835,3HFM,Y:LH,RY21W,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.60E-09,1.49E+06,5.60E+05,1.12E-04,2.00E-03,-13.81,2.29,,,,,
5836,3HFM,Y:LH,YY20F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761467 (Table I, p. 1859)",7.50E-11,3.20E-11,1.49E+06,1.92E+06,1.12E-04,6.10E-05,-13.81,-0.5,,,,,
5837,3HFM,Y:LH,DY101A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,3.50E-10,1.43E+06,8.30E+05,1.00E-04,2.90E-04,-13.85,0.95,,,,,
5838,3HFM,Y:LH,HY15A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,3.30E-11,1.43E+06,1.89E+06,1.00E-04,6.30E-05,-13.85,-0.45,,,,,
5839,3HFM,Y:LH,IY98A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,7.00E-11,1.43E+06,1.38E+06,1.00E-04,9.10E-05,-13.85,0,,,,,
5840,3HFM,Y:LH,KY96R,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,5.90E-07,,,,,-13.85,5.35,,,,,
5841,3HFM,Y:LH,LY75A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,2.30E-10,1.43E+06,7.00E+05,1.00E-04,1.64E-04,-13.85,0.7,,,,,
5842,3HFM,Y:LH,NY93A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,1.00E-10,1.43E+06,1.43E+06,1.00E-04,1.50E-04,-13.85,0.21,,,,,
5843,3HFM,Y:LH,RY21A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,3.00E-10,1.43E+06,1.47E+06,1.00E-04,4.40E-04,-13.85,0.86,,,,,
5844,3HFM,Y:LH,RY73A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,4.00E-11,1.43E+06,1.75E+06,1.00E-04,6.20E-05,-13.85,-0.33,,,,,
5845,3HFM,Y:LH,SY100A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,1.10E-10,1.43E+06,1.43E+06,1.00E-04,1.60E-04,-13.85,0.27,,,,,
5846,3HFM,Y:LH,TY89A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,7.00E-11,1.43E+06,1.58E+06,1.00E-04,1.13E-04,-13.85,0,,,,,
5847,3HFM,Y:LH,WY63A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,1.20E-10,1.43E+06,1.48E+06,1.00E-04,1.77E-04,-13.85,0.32,,,,,
5848,3HFM,Y:LH,YY20A,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI;ASEdb;,"9761468 (Table 1, p. 1870)",7.00E-11,9.50E-08,,,,,-13.85,4.27,,,,,
5849,3HFM,Y:LH,YY20F,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761468 (Table 2, p. 1871)",7.00E-11,3.20E-11,,,,,-13.85,-0.46,,,,,
5850,3HFM,Y:LH,YY20L,Mouse anti-lysozyme HyHEL-10 antibody IgG1 Fab,Gallus gallus egg-white lysozyme C (HEL/HEWL),Ag-Ab,Competitive Inhibition,66mM potassium phosphate ,298,6.24,SKEMPI,"9761468 (Table 2, p. 1871)",7.00E-11,2.80E-09,,,,,-13.85,2.18,,,,,
5851,,,D*116A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 0.1 M NaCl, 0.005% Surfactant P20",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,6.90E-07,,,,,-8.54,0.13,,,,,mutation in TN
5852,,,E*120A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,4.00E-07,,,,,-8.54,-0.19,,,,,mutation in TN
5853,,,K*134A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,5.30E-07,,,,,-8.54,-0.02,,,,,mutation in TN
5854,,,I*140A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,8.50E-07,,,,,-8.54,0.26,,,,,mutation in TN
5855,,,Q*143A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,4.80E-07,,,,,-8.54,-0.08,,,,,mutation in TN
5856,,,D*145A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,3.10E-07,,,,,-8.54,-0.34,,,,,mutation in TN
5857,,,K*148A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,3.70E-06,,,,,-8.54,1.13,,,,,mutation in TN
5858,,,E*150A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,2.00E-06,,,,,-8.54,0.76,,,,,mutation in TN
5859,,,N*151A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,4.00E-07,,,,,-8.54,-0.19,,,,,mutation in TN
5860,,,K*162A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,4.40E-07,,,,,-8.54,-0.13,,,,,mutation in TN
5861,,,F*164L,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,5.60E-07,,,,,-8.54,0.01,,,,,mutation in TN
5862,,,D*165A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,2.70E-06,,,,,-8.54,0.94,,,,,mutation in TN
5863,,,K*166A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,1.00E-06,,,,,-8.54,0.35,,,,,mutation in TN
5864,,,R*167A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,1.30E-06,,,,,-8.54,0.51,,,,,mutation in TN
5865,,,R*169A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",5.50E-07,5.10E-07,,,,,-8.54,-0.04,,,,,mutation in TN
5866,,,D*116A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,6.70E-07,,,,,-9.2,0.78,,,,,mutation in TN
5867,,,E*120A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,1.00E-07,,,,,-9.2,-0.35,,,,,mutation in TN
5868,,,K*134A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,2.00E-07,,,,,-9.2,0.06,,,,,mutation in TN
5869,,,I*140A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,5.50E-07,,,,,-9.2,0.66,,,,,mutation in TN
5870,,,Q*143A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,1.30E-07,,,,,-9.2,-0.19,,,,,mutation in TN
5871,,,D*145A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,5.60E-08,,,,,-9.2,-0.69,,,,,mutation in TN
5872,,,E*150A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",2.00E-07,1.10E-05,,,,,-9.13,2.37,,,,,mutation in TN
5873,,,N*151A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,2.60E-08,,,,,-9.2,-1.15,,,,,mutation in TN
5874,,,K*162A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,5.60E-08,,,,,-9.2,-0.69,,,,,mutation in TN
5875,,,F*164L,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,2.50E-07,,,,,-9.2,0.19,,,,,mutation in TN
5876,,,D*165A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",2.00E-07,1.50E-05,,,,,-9.13,2.56,,,,,mutation in TN
5877,,,K*166A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,3.50E-07,,,,,-9.2,0.39,,,,,mutation in TN
5878,,,R*167A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,1.40E-06,,,,,-9.2,1.21,,,,,mutation in TN
5879,,,R*169A,Human tetranectin (TN),Human plasminogen (kringle 4 protein domain),,Surface Plasmon Resonance,"50mM Tris-HCl, 500mMNaCl",298,8,PINT,"9786936 (Table II, p. 29244)",1.80E-07,2.20E-07,,,,,-9.2,0.12,,,,,mutation in TN
5880,2BTF,A:P,FP59A,"Bovine actin, cytoplasmic 1",Bovine profilin-1,,High Shear Viscometry,"0.01 M imidazole, 0.15mM CaCl2, 1.5mM DTE,  1mM ATP",298,7,SKEMPI;ASEdb;,"9788869 (Figure 4, p. 3267)",2.30E-06,3.40E-05,,,,,-7.69,1.6,,,,,
5881,2BTF,A:P,GP120F,"Bovine actin, cytoplasmic 1",Bovine profilin-1,,High Shear Viscometry,"0.01 M imidazole, 0.15mM CaCl2, 1.5mM DTE,  1mM ATP",298,7,SKEMPI,"9788869 (Figure 4, p. 3267)",2.30E-06,4.20E-05,,,,,-7.69,1.72,,,,,
5882,2BTF,A:P,KP125A,"Bovine actin, cytoplasmic 1",Bovine profilin-1,,High Shear Viscometry,"0.01 M imidazole, 0.15mM CaCl2, 1.5mM DTE,  1mM ATP",298,7,SKEMPI;ASEdb;,"9788869 (Figure 4, p. 3267)",2.30E-06,5.00E-06,,,,,-7.69,0.46,,,,,
5883,2BTF,A:P,VP60E,"Bovine actin, cytoplasmic 1",Bovine profilin-1,,High Shear Viscometry,"0.01 M imidazole, 0.15mM CaCl2, 1.5mM DTE,  1mM ATP",298,7,SKEMPI,"9788869 (Figure 4, p. 3267)",2.30E-06,1.20E-05,,,,,-7.69,0.98,,,,,
5884,3BPL,AB:C,KA123A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,,3.20E+04,,1.10E-01,,-7.45,,,,,,
5885,3BPL,AB:C,YA124A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,,3.20E+04,,1.10E-01,9.13E-01,-7.45,,,,,,
5886,3BPL,AB:C,EA114A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,7.86E-06,3.20E+04,2.24E+04,1.10E-01,1.76E-01,-7.45,0.49,,,,,
5887,3BPL,AB:C,EA122A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,8.25E-06,3.20E+04,3.20E+04,1.10E-01,2.64E-01,-7.45,0.52,,,,,
5888,3BPL,AB:C,EA19A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.09E-06,3.20E+04,3.20E+04,1.10E-01,9.90E-02,-7.45,-0.06,,,,,
5889,3BPL,AB:C,IA11A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.49E-05,3.20E+04,2.24E+04,1.10E-01,7.81E-01,-7.45,1.37,,,,,
5890,3BPL,AB:C,IA5A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.44E-06,3.20E+04,3.84E+04,1.10E-01,1.32E-01,-7.45,0,,,,,
5891,3BPL,AB:C,KA117A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,6.11E-06,3.20E+04,2.88E+04,1.10E-01,1.76E-01,-7.45,0.34,,,,,
5892,3BPL,AB:C,LA7A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,2.31E-05,3.20E+04,2.24E+04,1.10E-01,5.17E-01,-7.45,1.13,,,,,
5893,3BPL,AB:C,NA15A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,1.80E-05,3.20E+04,2.56E+04,1.10E-01,4.62E-01,-7.45,0.98,,,,,
5894,3BPL,AB:C,QA8A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,4.58E-06,3.20E+04,2.88E+04,1.10E-01,1.32E-01,-7.45,0.17,,,,,
5895,3BPL,AB:C,RA115A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.82E-06,3.20E+04,2.88E+04,1.10E-01,1.10E-01,-7.45,0.06,,,,,
5896,3BPL,AB:C,RA121A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,1.03E-05,3.20E+04,3.52E+04,1.10E-01,3.63E-01,-7.45,0.65,,,,,
5897,3BPL,AB:C,SA125A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,8.40E-06,3.20E+04,2.88E+04,1.10E-01,2.42E-01,-7.45,0.53,,,,,
5898,3BPL,AB:C,SA16A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.44E-06,3.20E+04,3.52E+04,1.10E-01,1.21E-01,-7.45,0,,,,,
5899,3BPL,AB:C,TA118A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,6.88E-06,3.20E+04,2.88E+04,1.10E-01,1.98E-01,-7.45,0.41,,,,,
5900,3BPL,AB:C,TA13A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.82E-06,3.20E+04,2.88E+04,1.10E-01,1.10E-01,-7.45,0.06,,,,,
5901,3BPL,AB:C,TA6A,Human interleukin-4 (IL-4) with interleukin-4 receptor (IL-4R),Cytokine receptor common subunit gamma,RC,Surface Plasmon Resonance,"10mM Hepes, 150mM NaCl, 3.4mM EDTA, 0.005% surfactant P20",298,7.4,ASEdb,"9799097 (Table 1, p. 15)",3.44E-06,3.09E-06,3.20E+04,3.20E+04,1.10E-01,9.90E-02,-7.45,-0.06,,,,,
5902,1JRH,LH:I,EI55A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,6.91E-09,6.09E+05,6.15E+05,8.75E-03,4.29E-03,-10.69,-0.43,,,,,
5903,1JRH,LH:I,GI50A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,3.00E-05,,,,,-10.69,4.53,,,,,
5904,1JRH,LH:I,KI47A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,6.05E-06,,,,,-10.69,3.58,,,,,
5905,1JRH,LH:I,KI47M,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,3.74E-06,,,,,-10.69,3.29,,,,,
5906,1JRH,LH:I,KI52A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,2.22E-06,6.09E+05,1.52E+03,8.75E-03,3.32E-03,-10.69,2.98,,,,,
5907,1JRH,LH:I,KI52M,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,5.76E-05,,,,,-10.69,4.91,,,,,
5908,1JRH,LH:I,KI98A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,1.34E-08,6.09E+05,8.04E+05,8.75E-03,1.08E-02,-10.69,-0.04,,,,,
5909,1JRH,LH:I,NI48A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,8.78E-09,6.09E+05,5.60E+05,8.75E-03,4.81E-03,-10.69,-0.29,,,,,
5910,1JRH,LH:I,NI48Q,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,2.66E-08,6.09E+05,3.53E+05,8.75E-03,9.62E-03,-10.69,0.36,,,,,
5911,1JRH,LH:I,NI53A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,1.03E-05,6.09E+05,7.31E+02,8.75E-03,7.61E-03,-10.69,3.89,,,,,
5912,1JRH,LH:I,NI79A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,7.34E-09,6.09E+05,6.27E+05,8.75E-03,4.64E-03,-10.69,-0.4,,,,,
5913,1JRH,LH:I,RI84A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,9.50E-09,6.09E+05,6.09E+05,8.75E-03,5.34E-03,-10.69,-0.25,,,,,
5914,1JRH,LH:I,SI54A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,2.38E-08,6.09E+05,5.60E+05,8.75E-03,1.29E-02,-10.69,0.3,,,,,
5915,1JRH,LH:I,VI51A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,3.46E-07,6.09E+05,6.03E+05,8.75E-03,2.06E-01,-10.69,1.88,,,,,
5916,1JRH,LH:I,WI56F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,4.75E-09,6.09E+05,7.25E+05,8.75E-03,3.50E-03,-10.69,-0.66,,,,,
5917,1JRH,LH:I,WI56Y,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,1.48E-08,6.09E+05,5.05E+05,8.75E-03,7.52E-03,-10.69,0.02,,,,,
5918,1JRH,LH:I,WI82A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,3.01E-05,,,,,-10.69,4.53,,,,,
5919,1JRH,LH:I,WI82F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,9.36E-08,6.09E+05,6.82E+05,8.75E-03,6.37E-02,-10.69,1.11,,,,,
5920,1JRH,LH:I,WI82Y,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,9.79E-08,6.09E+05,5.05E+05,8.75E-03,5.01E-02,-10.69,1.14,,,,,
5921,1JRH,LH:I,YI49A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,4.48E-06,,,,,-10.69,3.4,,,,,
5922,1JRH,LH:I,YI49F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Surface Plasmon Resonance,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 1, p. 808)",1.44E-08,5.47E-08,6.09E+05,7.06E+05,8.75E-03,3.88E-02,-10.69,0.79,,,,,
5923,1JRH,LH:I,EI55A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,7.40E-10,,,,,-11.75,-0.7,,,,,
5924,1JRH,LH:I,GI50A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,3.88E-06,,,,,-11.75,4.38,,,,,
5925,1JRH,LH:I,KI47A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.60E-06,,,,,-11.75,3.85,,,,,
5926,1JRH,LH:I,KI52A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.44E-06,,,,,-11.75,3.79,,,,,
5927,1JRH,LH:I,KI98A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,7.40E-09,,,,,-11.75,0.67,,,,,
5928,1JRH,LH:I,NI48A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,7.00E-09,,,,,-11.75,0.63,,,,,
5929,1JRH,LH:I,NI48Q,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,7.90E-09,,,,,-11.75,0.71,,,,,
5930,1JRH,LH:I,NI53A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,6.80E-06,,,,,-11.75,4.71,,,,,
5931,1JRH,LH:I,NI79A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,2.40E-09,,,,,-11.75,0,,,,,
5932,1JRH,LH:I,RI84A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.37E-08,,,,,-11.75,1.03,,,,,
5933,1JRH,LH:I,SI54A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,5.20E-09,,,,,-11.75,0.46,,,,,
5934,1JRH,LH:I,VI51A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,2.90E-08,,,,,-11.75,1.48,,,,,
5935,1JRH,LH:I,WI56F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,3.10E-09,,,,,-11.75,0.15,,,,,
5936,1JRH,LH:I,WI56Y,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,6.40E-09,,,,,-11.75,0.58,,,,,
5937,1JRH,LH:I,WI82A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,3.60E-06,,,,,-11.75,4.33,,,,,
5938,1JRH,LH:I,WI82F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.53E-08,,,,,-11.75,1.1,,,,,
5939,1JRH,LH:I,WI82Y,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.95E-08,,,,,-11.75,1.24,,,,,
5940,1JRH,LH:I,YI49A,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.15E-06,,,,,-11.75,3.66,,,,,
5941,1JRH,LH:I,YI49F,Mouse Ig kappa chain C region (mAb A6),Human interferon gamma receptor (IFN-&gamma;-R1),Ag-Ab,Competition ELISA,"50mM sodium phosphate buffer, 150mM NaCl, 0.005 % (v/v) Surfactant p20",298,7.2,SKEMPI,"9878445 (Table 3, p. 809)",2.40E-09,1.36E-08,,,,,-11.75,1.03,,,,,
5942,1JTG,A:B,DB49A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,8.30E-09,,,,,-13.58,2.56,,,,,
5943,1JTG,A:B,EA104K,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,1.40E-07,,,,,-13.58,4.23,,,,,
5944,1JTG,A:B,"EA104K,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,1.50E-06,,,,,-13.58,5.64,,,,,
5945,1JTG,A:B,"EA104K,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,2.40E-07,,,,,-13.58,4.55,,,,,
5946,1JTG,A:B,FB142A,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,3.30E-08,,,,,-13.58,3.38,,,,,
5947,1JTG,A:B,GA238S,Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,7.00E-12,,,,,-13.58,-1.63,,,,,
5948,1JTG,A:B,"GA238S,DB49A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,9.40E-09,,,,,-13.58,2.63,,,,,
5949,1JTG,A:B,"GA238S,FB142A",Escherichia coli beta-lactamase (TEM-1),Streptomyces clavuligerus beta-lactamase inhibitor protein (BLIP),EI,Spectrophotometric monitoring of cephaloridine hydrolysis,"0.05 M phosphate buffer, 1 mg/ml BSA",298,7,SKEMPI,"9891008 (Table 1, p. 2397)",1.10E-10,5.50E-08,,,,,-13.58,3.68,,,,,
5950,1CHO,EFG:I,"AI15D,GI32A",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.22E-12,,,,,-15.17,-0.85,,,,,
5951,1CHO,EFG:I,"AI15D,GI32A,NI33S",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.00E-12,,,,,-15.17,-0.03,,,,,
5952,1CHO,EFG:I,"AI15D,LI18A",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.82E-08,,,,,-15.17,4.76,,,,,
5953,1CHO,EFG:I,"AI15D,LI18A,YI20D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.26E-04,,,,,-15.17,10.76,,,,,
5954,1CHO,EFG:I,"AI15G,LI18M,LI23V,KI29I,EI43K",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.45E-11,,,,,-15.17,1.1,,,,,
5955,1CHO,EFG:I,"AI15G,TI17M,LI18M,YI20R,RI21L,GI32N,NI33D,SI51N,KI55E",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.94E-05,,,,,-15.17,9.08,,,,,
5956,1CHO,EFG:I,"AI15R,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.08E-08,,,,,-15.17,4.84,,,,,
5957,1CHO,EFG:I,"AI15R,TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.57E-06,,,,,-15.17,7.85,,,,,
5958,1CHO,EFG:I,"AI15R,TI17P,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.72E-05,,,,,-15.17,8.76,,,,,
5959,1CHO,EFG:I,"AI15T,LI18M",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.50E-11,,,,,-15.17,0.91,,,,,
5960,1CHO,EFG:I,AI15V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.50E-11,,,,,-15.17,0.91,,,,,
5961,1CHO,EFG:I,"AI15V,TI17S",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.33E-09,,,,,-15.17,3.56,,,,,
5962,1CHO,EFG:I,"AI15V,TI17S,RI21M,NI28S,KI29Q,GI32S,KI34E,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.85E-07,,,,,-15.17,6.54,,,,,
5963,1CHO,EFG:I,"DI7N,EI10D,AI15V,TI17S,EI19L,RI21M,VI42A,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.86E-07,,,,,-15.17,6.37,,,,,
5964,1CHO,EFG:I,"DI7N,EI10G,LI18M,RI21M,EI43D,KI55E",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.33E-10,,,,,-15.17,1.89,,,,,
5965,1CHO,EFG:I,"EI10D,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.88E-08,,,,,-15.17,5.45,,,,,
5966,1CHO,EFG:I,"EI10D,AI15V,EI19D,RI21M,KI29T,GI32S,EI43D,LI48I",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.69E-08,,,,,-15.17,5.6,,,,,
5967,1CHO,EFG:I,"EI10D,AI15V,TI17P,EI19D,RI21M,NI28S,GI32S,NI45S,SI51R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.25E-06,,,,,-15.17,7.23,,,,,
5968,1CHO,EFG:I,"EI10D,AI15V,TI17S,EI19D,RI21M,KI29T,GI32N,NI36I,EI43D,LI48I",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.00E-06,,,,,-15.17,7.51,,,,,
5969,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32N,NI36D,SI51G",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,8.33E-09,,,,,-15.17,4.3,,,,,
5970,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.26E-08,,,,,-15.17,5.38,,,,,
5971,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,9.09E-09,,,,,-15.17,4.36,,,,,
5972,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D,TI49N",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.14E-09,,,,,-15.17,4.21,,,,,
5973,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,VI41F,EI43D,TI49S",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,6.67E-09,,,,,-15.17,4.17,,,,,
5974,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,VI42A,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.38E-08,,,,,-15.17,4.92,,,,,
5975,1CHO,EFG:I,"EI10D,AI15V,TI17S,RI21M,VI42A,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.70E-08,,,,,-15.17,5.18,,,,,
5976,1CHO,EFG:I,"EI10D,AI15V,YI20E,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.86E-06,,,,,-15.17,7.72,,,,,
5977,1CHO,EFG:I,"EI10D,KI13M,LI18M,LI23V",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.28E-11,,,,,-15.17,0.52,,,,,
5978,1CHO,EFG:I,"EI10D,KI13R,AI15D,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.13E-10,,,,,-15.17,2.39,,,,,
5979,1CHO,EFG:I,"EI10D,KI13R,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.56E-08,,,,,-15.17,4.96,,,,,
5980,1CHO,EFG:I,"EI10D,LI18F,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.03E-11,,,,,-15.17,1.02,,,,,
5981,1CHO,EFG:I,"EI10D,LI18M,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.26E-10,,,,,-15.17,2.69,,,,,
5982,1CHO,EFG:I,"EI10D,LI18M,RI21M,GI32D,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.14E-08,,,,,-15.17,5.56,,,,,
5983,1CHO,EFG:I,"EI10D,LI18V,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.70E-07,,,,,-15.17,6.52,,,,,
5984,1CHO,EFG:I,"EI10D,LI18V,RI21M,GI32D,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.00E-05,,,,,-15.17,9.39,,,,,
5985,1CHO,EFG:I,"EI10D,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.85E-10,,,,,-15.17,2.51,,,,,
5986,1CHO,EFG:I,"EI10D,RI21M,KI29Q,GI32S,NI36S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,4.76E-11,,,,,-15.17,1.29,,,,,
5987,1CHO,EFG:I,"EI10D,RI21M,KI34R,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.33E-10,,,,,-15.17,2.42,,,,,
5988,1CHO,EFG:I,"EI10D,RI21M,LI23F,NI28S,GI32S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,4.76E-10,,,,,-15.17,2.63,,,,,
5989,1CHO,EFG:I,"EI10D,TI17L,RI21M,GI32D,NI36S,EI43D,TI49S",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.03E-05,,,,,-15.17,9.09,,,,,
5990,1CHO,EFG:I,"EI10D,TI17R,LI18M,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.23E-07,,,,,-15.17,6.44,,,,,
5991,1CHO,EFG:I,"EI10D,TI17S,EI19D,RI21M,NI28S,GI32S,EI43D,GI54E",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.17E-06,,,,,-15.17,7.55,,,,,
5992,1CHO,EFG:I,"EI10D,YI11H,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.96E-08,,,,,-15.17,4.8,,,,,
5993,1CHO,EFG:I,"EI10D,YI11H,TI17L,LI18Q,YI20Q,RI21K,GI32D,NI36S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.69E-04,,,,,-15.17,10.98,,,,,
5994,1CHO,EFG:I,"EI10D,YI11H,TI17L,LI18Q,YI20Q,RI21K,LI23I,GI32D,NI36S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,6.67E-04,,,,,-15.17,10.9,,,,,
5995,1CHO,EFG:I,"EI10G,KI13Q,PI14S,TI17P,LI18Q,EI19D,RI21V,LI23F,GI32S,VI42A,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.67E-06,,,,,-15.17,7.4,,,,,
5996,1CHO,EFG:I,"EI10G,KI13Q,TI17S,RI21V,LI23F,GI32S,NI36D,VI42A,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,8.33E-11,,,,,-15.17,1.61,,,,,
5997,1CHO,EFG:I,"EI10G,LI18M,RI21M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.00E-10,,,,,-15.17,2.66,,,,,
5998,1CHO,EFG:I,"EI10G,LI18M,RI21M,EI43D,KI55E",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.28E-10,,,,,-15.17,1.86,,,,,
5999,1CHO,EFG:I,"EI10G,LI18M,YI20S,LI23I,KI29T,GI32S,HI52Y,FI53P,KI55V",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.88E-10,,,,,-15.17,2.76,,,,,
6000,1CHO,EFG:I,GI32A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.43E-12,,,,,-15.17,-0.76,,,,,
6001,1CHO,EFG:I,GI32V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.43E-11,,,,,-15.17,0.58,,,,,
6002,1CHO,EFG:I,LI18A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.17E-08,,,,,-15.17,4.86,,,,,
6003,1CHO,EFG:I,LI18E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.56E-07,,,,,-15.17,6.76,,,,,
6004,1CHO,EFG:I,LI18K,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.14E-09,,,,,-15.17,4.21,,,,,
6005,1CHO,EFG:I,LI18M,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,9.09E-12,,,,,-15.17,0.32,,,,,
6006,1CHO,EFG:I,"LI18M,GI32D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.69E-09,,,,,-15.17,3.37,,,,,
6007,1CHO,EFG:I,"LI18M,HI52R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,6.67E-12,,,,,-15.17,0.14,,,,,
6008,1CHO,EFG:I,"LI18M,HI52R,KI55E",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.50E-12,,,,,-15.17,-0.43,,,,,
6009,1CHO,EFG:I,"LI18M,LI23V,KI29I,EI43K",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,3.03E-11,,,,,-15.17,1.02,,,,,
6010,1CHO,EFG:I,"LI18M,NI36D,SI51N",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.33E-12,,,,,-15.17,-0.48,,,,,
6011,1CHO,EFG:I,"LI18M,SI51N",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.00E-11,,,,,-15.17,0.38,,,,,
6012,1CHO,EFG:I,"LI18M,SI51N,HI52R,KI55Q",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,8.33E-12,,,,,-15.17,0.27,,,,,
6013,1CHO,EFG:I,"LI18M,TI30S,GI32D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.22E-09,,,,,-15.17,3.53,,,,,
6014,1CHO,EFG:I,"LI18M,TI49N,KI55T",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.59E-11,,,,,-15.17,0.65,,,,,
6015,1CHO,EFG:I,"LI18M,YI20H,KI29Q,GI32D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,6.67E-09,,,,,-15.17,4.17,,,,,
6016,1CHO,EFG:I,"LI18M,YI20Q",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.04E-09,,,,,-15.17,3.48,,,,,
6017,1CHO,EFG:I,LI18Q,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.13E-09,,,,,-15.17,3.51,,,,,
6018,1CHO,EFG:I,"LI18S,RI21V,LI23I",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.04E-06,,,,,-15.17,7.12,,,,,
6019,1CHO,EFG:I,NI28S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.26E-12,,,,,-15.17,0,,,,,
6020,1CHO,EFG:I,"NI28S,GI32A",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.23E-12,,,,,-15.17,-0.85,,,,,
6021,1CHO,EFG:I,"PI14S,AI15R,TI17P,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,8.33E-06,,,,,-15.17,8.34,,,,,
6022,1CHO,EFG:I,"RI21M,KI29Q,GI32S,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,8.33E-10,,,,,-15.17,2.96,,,,,
6023,1CHO,EFG:I,"RI21V,LI23I",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.04E-10,,,,,-15.17,2.14,,,,,
6024,1CHO,EFG:I,TI17A,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.69E-09,,,,,-15.17,4.26,,,,,
6025,1CHO,EFG:I,TI17E,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.04E-08,,,,,-15.17,4.83,,,,,
6026,1CHO,EFG:I,"TI17K,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.25E-06,,,,,-15.17,7.23,,,,,
6027,1CHO,EFG:I,"TI17M,LI18S,GI32V",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.04E-05,,,,,-15.17,8.86,,,,,
6028,1CHO,EFG:I,"TI17P,LI18K",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.14E-06,,,,,-15.17,8.25,,,,,
6029,1CHO,EFG:I,"TI17P,LI18K,EI19D,LI23V,GI32S,SI51N",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.72E-06,,,,,-15.17,7.42,,,,,
6030,1CHO,EFG:I,"TI17P,LI18K,EI19D,LI23V,SI51N",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,9.09E-07,,,,,-15.17,7.05,,,,,
6031,1CHO,EFG:I,"TI17P,LI18K,EI19D,LI23V,SI51N,HI52R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,7.14E-07,,,,,-15.17,6.9,,,,,
6032,1CHO,EFG:I,"TI17P,LI18K,GI32D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.00E-04,,,,,-15.17,9.79,,,,,
6033,1CHO,EFG:I,"TI17R,LI18R",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.00E-06,,,,,-15.17,7.1,,,,,
6034,1CHO,EFG:I,TI17S,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,2.78E-10,,,,,-15.17,2.32,,,,,
6035,1CHO,EFG:I,TI17V,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.32E-09,,,,,-15.17,3.23,,,,,
6036,1CHO,EFG:I,"VI6I,EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D,TI49I",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.00E-08,,,,,-15.17,5.35,,,,,
6037,1CHO,EFG:I,"YI11H,EI19D,LI23I,NI28S,GI32S,NI36D,VI42M,EI43D",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,6.67E-12,,,,,-15.17,0.14,,,,,
6038,1CHO,EFG:I,"YI11H,YI20D,TI30I,GI32S,NI36D,VI42L",Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.88E-07,,,,,-15.17,6.79,,,,,
6039,1CHO,EFG:I,YI20D,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,1.59E-07,,,,,-15.17,6.03,,,,,
6040,1CHO,EFG:I,YI20H,Bovine alpha-chymotrypsin/chymotrypsinogen A,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",5.26E-12,5.88E-11,,,,,-15.17,1.41,,,,,
6041,1PPF,E:I,"AI15D,GI32A",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.16E-09,,,,,-13.16,1.14,,,,,
6042,1PPF,E:I,"AI15D,LI18A,YI20D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.17E-04,,,,,-13.16,8.62,,,,,
6043,1PPF,E:I,"AI15G,LI18M,LI23V,KI29I,EI43K",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,7.69E-09,,,,,-13.16,2.25,,,,,
6044,1PPF,E:I,"AI15T,LI18M",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.32E-11,,,,,-13.16,-1.47,,,,,
6045,1PPF,E:I,AI15V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.27E-10,,,,,-13.16,0.19,,,,,
6046,1PPF,E:I,"AI15V,TI17S",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.23E-09,,,,,-13.16,1.74,,,,,
6047,1PPF,E:I,"AI15V,TI17S,LI18P,RI21M,NI28S,GI32N,NI36D,NI39S,SI51G",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.17E-05,,,,,-13.16,7.27,,,,,
6048,1PPF,E:I,"AI15V,TI17S,RI21M,NI28S,KI29Q,GI32S,KI34E,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.35E-09,,,,,-13.16,1.92,,,,,
6049,1PPF,E:I,"DI7N,EI10D,AI15V,TI17S,EI19L,RI21M,VI42A,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.75E-09,,,,,-13.16,1.38,,,,,
6050,1PPF,E:I,"DI7N,EI10G,LI18M,RI21M,EI43D,KI55E",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.75E-10,,,,,-13.16,0.04,,,,,
6051,1PPF,E:I,"EI10D,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.09E-08,,,,,-13.16,2.45,,,,,
6052,1PPF,E:I,"EI10D,AI15V,EI19D,RI21M,KI29T,GI32S,EI43D,LI48I",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.17E-09,,,,,-13.16,1.89,,,,,
6053,1PPF,E:I,"EI10D,AI15V,TI17P,EI19D,RI21M,NI28S,GI32S,NI45S,SI51R",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.55E-08,,,,,-13.16,3.29,,,,,
6054,1PPF,E:I,"EI10D,AI15V,TI17S,EI19D,RI21M,KI29T,GI32N,NI36I,EI43D,LI48I",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.85E-07,,,,,-13.16,4.53,,,,,
6055,1PPF,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32N,NI36D,SI51G",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,9.09E-10,,,,,-13.16,1,,,,,
6056,1PPF,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,5.56E-09,,,,,-13.16,2.06,,,,,
6057,1PPF,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.56E-10,,,,,-13.16,-0.03,,,,,
6058,1PPF,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,VI42A,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.50E-09,,,,,-13.16,1.59,,,,,
6059,1PPF,E:I,"EI10D,AI15V,TI17S,RI21M,VI42A,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.30E-09,,,,,-13.16,1.21,,,,,
6060,1PPF,E:I,"EI10D,AI15V,TI17S,YI20D,RI21M,NI28S,GI32S,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,5.00E-05,,,,,-13.16,7.38,,,,,
6061,1PPF,E:I,"EI10D,AI15V,YI20D,RI21M,KI29I,GI32H,NI36Y,VI42A,EI43H,LI50F",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,6.67E-07,,,,,-13.16,4.86,,,,,
6062,1PPF,E:I,"EI10D,AI15V,YI20E,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.00E-05,,,,,-13.16,6.44,,,,,
6063,1PPF,E:I,"EI10D,KI13M,LI18M,LI23V",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.56E-09,,,,,-13.16,1.61,,,,,
6064,1PPF,E:I,"EI10D,KI13R,AI15D,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.04E-10,,,,,-13.16,0.13,,,,,
6065,1PPF,E:I,"EI10D,KI13R,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,8.33E-09,,,,,-13.16,2.29,,,,,
6066,1PPF,E:I,"EI10D,LI18F,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.57E-07,,,,,-13.16,4.49,,,,,
6067,1PPF,E:I,"EI10D,LI18M,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,6.67E-10,,,,,-13.16,0.82,,,,,
6068,1PPF,E:I,"EI10D,LI18V,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.75E-10,,,,,-13.16,0.04,,,,,
6069,1PPF,E:I,"EI10D,LI18V,RI21M,GI32D,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.75E-09,,,,,-13.16,1.38,,,,,
6070,1PPF,E:I,"EI10D,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.55E-11,,,,,-13.16,-0.75,,,,,
6071,1PPF,E:I,"EI10D,RI21M,KI29Q,GI32S,NI36S,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,7.69E-11,,,,,-13.16,-0.44,,,,,
6072,1PPF,E:I,"EI10D,RI21M,LI23F,NI28S,GI32S,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.57E-10,,,,,-13.16,0.45,,,,,
6073,1PPF,E:I,"EI10D,TI17L,RI21M,GI32D,NI36S,EI43D,TI49S",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.63E-07,,,,,-13.16,4.31,,,,,
6074,1PPF,E:I,"EI10D,TI17R,LI18M,RI21M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.00E-07,,,,,-13.16,4.56,,,,,
6075,1PPF,E:I,"EI10D,TI17S,EI19D,RI21M,NI28S,GI32S,EI43D,GI54E",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.17E-08,,,,,-13.16,3.24,,,,,
6076,1PPF,E:I,"EI10D,YI11H,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.70E-10,,,,,-13.16,0.29,,,,,
6077,1PPF,E:I,"EI10G,KI13Q,PI14S,TI17P,LI18Q,EI19D,RI21V,LI23F,GI32S,VI42A,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.35E-06,,,,,-13.16,5.95,,,,,
6078,1PPF,E:I,"EI10G,KI13Q,TI17S,RI21V,LI23F,GI32S,NI36D,VI42A,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.85E-10,,,,,-13.16,0.5,,,,,
6079,1PPF,E:I,"EI10G,LI18M,RI21M,EI43D,KI55E",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.61E-10,,,,,-13.16,-0.01,,,,,
6080,1PPF,E:I,"EI10G,LI18M,YI20S,LI23I,KI29T,GI32S,HI52Y,FI53P,KI55V",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.17E-06,,,,,-13.16,5.54,,,,,
6081,1PPF,E:I,GI32A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.63E-10,,,,,-13.16,0.28,,,,,
6082,1PPF,E:I,GI32V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.20E-08,,,,,-13.16,2.51,,,,,
6083,1PPF,E:I,LI18A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,8.33E-10,,,,,-13.16,0.95,,,,,
6084,1PPF,E:I,LI18E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.50E-05,,,,,-13.16,6.97,,,,,
6085,1PPF,E:I,"LI18I,GI32D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.16E-08,,,,,-13.16,2.49,,,,,
6086,1PPF,E:I,LI18K,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.27E-06,,,,,-13.16,5.57,,,,,
6087,1PPF,E:I,LI18M,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.30E-09,,,,,-13.16,1.21,,,,,
6088,1PPF,E:I,"LI18M,GI32D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.37E-07,,,,,-13.16,3.93,,,,,
6089,1PPF,E:I,"LI18M,HI52R",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.00E-09,,,,,-13.16,1.46,,,,,
6090,1PPF,E:I,"LI18M,LI23V,KI29I,EI43K",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.72E-09,,,,,-13.16,1.37,,,,,
6091,1PPF,E:I,"LI18M,NI36D,SI51N",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.85E-11,,,,,-13.16,-0.85,,,,,
6092,1PPF,E:I,"LI18M,SI51N",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.37E-09,,,,,-13.16,1.24,,,,,
6093,1PPF,E:I,"LI18M,TI30S,GI32D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.89E-07,,,,,-13.16,4.12,,,,,
6094,1PPF,E:I,"LI18M,YI20Q",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,3.13E-06,,,,,-13.16,5.76,,,,,
6095,1PPF,E:I,LI18Q,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,5.00E-08,,,,,-13.16,3.34,,,,,
6096,1PPF,E:I,"RI21M,KI29Q,GI32S,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.85E-10,,,,,-13.16,0.07,,,,,
6097,1PPF,E:I,"RI21V,LI23I",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.00E-10,,,,,-13.16,-0.29,,,,,
6098,1PPF,E:I,TI17A,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.17E-08,,,,,-13.16,2.85,,,,,
6099,1PPF,E:I,TI17E,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.94E-08,,,,,-13.16,3.03,,,,,
6100,1PPF,E:I,TI17S,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.27E-09,,,,,-13.16,1.54,,,,,
6101,1PPF,E:I,TI17V,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.22E-09,,,,,-13.16,1.52,,,,,
6102,1PPF,E:I,"VI6I,EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D,TI49I",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,4.55E-09,,,,,-13.16,1.94,,,,,
6103,1PPF,E:I,"YI11H,EI19D,LI23I,NI28S,GI32S,NI36D,VI42M,EI43D",Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,2.86E-10,,,,,-13.16,0.32,,,,,
6104,1PPF,E:I,YI20H,Human neutrophil elastase (elastase-2/HLE),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.64E-10,1.03E-08,,,,,-13.16,2.42,,,,,
6105,1R0R,E:I,"AI15D,GI32A",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,6.25E-07,,,,,-14.17,5.82,,,,,
6106,1R0R,E:I,"AI15D,GI32A,NI33S",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.56E-07,,,,,-14.17,5.75,,,,,
6107,1R0R,E:I,"AI15D,LI18A",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.33E-07,,,,,-14.17,5.45,,,,,
6108,1R0R,E:I,"AI15D,LI18A,YI20D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.06E-04,,,,,-14.17,8.82,,,,,
6109,1R0R,E:I,"AI15G,LI18M,LI23V,KI29I,EI43K",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.69E-10,,,,,-14.17,1.02,,,,,
6110,1R0R,E:I,"AI15R,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.35E-05,,,,,-14.17,7.62,,,,,
6111,1R0R,E:I,"AI15R,TI17K,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.89E-04,,,,,-14.17,9.16,,,,,
6112,1R0R,E:I,"AI15T,LI18M",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.55E-11,,,,,-14.17,0.26,,,,,
6113,1R0R,E:I,AI15V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.56E-12,,,,,-14.17,-0.97,,,,,
6114,1R0R,E:I,"AI15V,TI17S",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.45E-11,,,,,-14.17,0.09,,,,,
6115,1R0R,E:I,"AI15V,TI17S,LI18P,RI21M,NI28S,GI32N,NI36D,NI39S,SI51G",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.72E-04,,,,,-14.17,9.1,,,,,
6116,1R0R,E:I,"AI15V,TI17S,RI21M,NI28S,KI29Q,GI32S,KI34E,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.13E-10,,,,,-14.17,1.38,,,,,
6117,1R0R,E:I,"DI7N,EI10D,AI15V,TI17S,EI19L,RI21M,VI42A,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,6.25E-12,,,,,-14.17,-0.9,,,,,
6118,1R0R,E:I,"DI7N,EI10G,LI18M,RI21M,EI43D,KI55E",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.00E-12,,,,,-14.17,-1.04,,,,,
6119,1R0R,E:I,"EI10D,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.96E-11,,,,,-14.17,-0.24,,,,,
6120,1R0R,E:I,"EI10D,AI15V,EI19D,RI21M,KI29T,GI32S,EI43D,LI48I",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.17E-11,,,,,-14.17,-0.18,,,,,
6121,1R0R,E:I,"EI10D,AI15V,TI17P,EI19D,RI21M,NI28S,GI32S,NI45S,SI51R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.23E-07,,,,,-14.17,4.87,,,,,
6122,1R0R,E:I,"EI10D,AI15V,TI17S,EI19D,RI21M,KI29T,GI32N,NI36I,EI43D,LI48I",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.88E-10,,,,,-14.17,1.75,,,,,
6123,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32N,NI36D,SI51G",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,6.67E-11,,,,,-14.17,0.48,,,,,
6124,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.17E-11,,,,,-14.17,0.2,,,,,
6125,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.57E-11,,,,,-14.17,0.11,,,,,
6126,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D,TI49N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.33E-11,,,,,-14.17,0.07,,,,,
6127,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,VI41F,EI43D,TI49S",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.13E-11,,,,,-14.17,0.04,,,,,
6128,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,VI42A,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.70E-11,,,,,-14.17,-0.05,,,,,
6129,1R0R,E:I,"EI10D,AI15V,TI17S,RI21M,VI42A,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.17E-12,,,,,-14.17,-1.14,,,,,
6130,1R0R,E:I,"EI10D,AI15V,TI17S,YI20D,RI21M,NI28S,GI32S,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.38E-07,,,,,-14.17,5.26,,,,,
6131,1R0R,E:I,"EI10D,AI15V,YI20D,RI21M,KI29I,GI32H,NI36Y,VI42A,EI43H,LI50F",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.35E-07,,,,,-14.17,5.61,,,,,
6132,1R0R,E:I,"EI10D,AI15V,YI20E,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.70E-09,,,,,-14.17,2.82,,,,,
6133,1R0R,E:I,"EI10D,KI13M,LI18M,LI23V",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.52E-12,,,,,-14.17,-1.73,,,,,
6134,1R0R,E:I,"EI10D,KI13Q,AI15V,TI17M,LI18G,EI19D,RI21M,NI28S,GI32S,EI43D,SI51N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.56E-09,,,,,-14.17,3.06,,,,,
6135,1R0R,E:I,"EI10D,KI13R,AI15D,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.00E-07,,,,,-14.17,5.69,,,,,
6136,1R0R,E:I,"EI10D,KI13R,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.47E-11,,,,,-14.17,-0.4,,,,,
6137,1R0R,E:I,"EI10D,LI18F,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.00E-10,,,,,-14.17,1.12,,,,,
6138,1R0R,E:I,"EI10D,LI18M,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.96E-11,,,,,-14.17,-0.24,,,,,
6139,1R0R,E:I,"EI10D,LI18M,RI21M,GI32D,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,9.09E-10,,,,,-14.17,2,,,,,
6140,1R0R,E:I,"EI10D,LI18V,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.64E-09,,,,,-14.17,2.35,,,,,
6141,1R0R,E:I,"EI10D,LI18V,RI21M,GI32D,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,7.69E-08,,,,,-14.17,4.6,,,,,
6142,1R0R,E:I,"EI10D,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.88E-11,,,,,-14.17,0.4,,,,,
6143,1R0R,E:I,"EI10D,RI21M,KI29Q,GI32S,NI36S,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,9.09E-11,,,,,-14.17,0.66,,,,,
6144,1R0R,E:I,"EI10D,RI21M,KI34R,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.56E-11,,,,,-14.17,-0.08,,,,,
6145,1R0R,E:I,"EI10D,RI21M,LI23F,NI28S,GI32S,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.63E-10,,,,,-14.17,1.28,,,,,
6146,1R0R,E:I,"EI10D,TI17L,RI21M,GI32D,NI36S,EI43D,TI49S",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.85E-08,,,,,-14.17,3.77,,,,,
6147,1R0R,E:I,"EI10D,TI17R,LI18M,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,9.09E-09,,,,,-14.17,3.35,,,,,
6148,1R0R,E:I,"EI10D,TI17S,EI19D,RI21M,NI28S,GI32S,EI43D,GI54E",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.63E-10,,,,,-14.17,1.28,,,,,
6149,1R0R,E:I,"EI10D,YI11H,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.26E-11,,,,,-14.17,0.34,,,,,
6150,1R0R,E:I,"EI10G,KI13Q,PI14S,TI17P,LI18Q,EI19D,RI21V,LI23F,GI32S,VI42A,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.22E-08,,,,,-14.17,3.52,,,,,
6151,1R0R,E:I,"EI10G,KI13Q,TI17S,RI21V,LI23F,GI32S,NI36D,VI42A,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.94E-11,,,,,-14.17,0,,,,,
6152,1R0R,E:I,"EI10G,LI18M,RI21M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.96E-11,,,,,-14.17,-0.24,,,,,
6153,1R0R,E:I,"EI10G,LI18M,RI21M,EI43D,KI55E",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,9.09E-12,,,,,-14.17,-0.69,,,,,
6154,1R0R,E:I,"EI10G,LI18M,YI20S,LI23I,KI29T,GI32S,HI52Y,FI53P,KI55V",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,8.33E-09,,,,,-14.17,3.3,,,,,
6155,1R0R,E:I,GI32A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.78E-10,,,,,-14.17,1.31,,,,,
6156,1R0R,E:I,GI32V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,8.33E-10,,,,,-14.17,1.95,,,,,
6157,1R0R,E:I,LI18A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,7.14E-11,,,,,-14.17,0.52,,,,,
6158,1R0R,E:I,LI18E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.06E-09,,,,,-14.17,2.09,,,,,
6159,1R0R,E:I,"LI18I,GI32D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.27E-07,,,,,-14.17,5.23,,,,,
6160,1R0R,E:I,LI18K,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.57E-09,,,,,-14.17,2.8,,,,,
6161,1R0R,E:I,LI18M,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.23E-11,,,,,-14.17,-0.51,,,,,
6162,1R0R,E:I,"LI18M,GI32D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.67E-09,,,,,-14.17,2.36,,,,,
6163,1R0R,E:I,"LI18M,HI52R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.72E-11,,,,,-14.17,-0.31,,,,,
6164,1R0R,E:I,"LI18M,HI52R,KI55E",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,6.25E-12,,,,,-14.17,-0.9,,,,,
6165,1R0R,E:I,"LI18M,LI23V,KI29I,EI43K",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,7.14E-12,,,,,-14.17,-0.83,,,,,
6166,1R0R,E:I,"LI18M,NI36D,SI51N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.75E-11,,,,,-14.17,-0.3,,,,,
6167,1R0R,E:I,"LI18M,SI51N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.27E-11,,,,,-14.17,-0.49,,,,,
6168,1R0R,E:I,"LI18M,SI51N,HI52R,KI55Q",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.00E-11,,,,,-14.17,-0.63,,,,,
6169,1R0R,E:I,"LI18M,TI30S,GI32D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.10E-09,,,,,-14.17,2.12,,,,,
6170,1R0R,E:I,"LI18M,TI49N,KI55T",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,7.14E-12,,,,,-14.17,-0.83,,,,,
6171,1R0R,E:I,"LI18M,YI20Q",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.37E-08,,,,,-14.17,3.59,,,,,
6172,1R0R,E:I,LI18Q,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,8.33E-11,,,,,-14.17,0.61,,,,,
6173,1R0R,E:I,"LI18S,RI21V,LI23I",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,7.14E-10,,,,,-14.17,1.86,,,,,
6174,1R0R,E:I,NI28S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.63E-11,,,,,-14.17,-0.07,,,,,
6175,1R0R,E:I,"NI28S,GI32A",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.44E-10,,,,,-14.17,1.24,,,,,
6176,1R0R,E:I,"RI21M,KI29Q,GI32S,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.92E-10,,,,,-14.17,1.1,,,,,
6177,1R0R,E:I,"RI21V,LI23I",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,2.86E-11,,,,,-14.17,-0.02,,,,,
6178,1R0R,E:I,TI17A,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.11E-10,,,,,-14.17,0.78,,,,,
6179,1R0R,E:I,TI17E,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.45E-09,,,,,-14.17,2.78,,,,,
6180,1R0R,E:I,"TI17M,LI18S,GI32V",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.76E-09,,,,,-14.17,2.97,,,,,
6181,1R0R,E:I,"TI17P,LI18K,EI19D,LI23V,GI32S,SI51N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.25E-05,,,,,-14.17,7.57,,,,,
6182,1R0R,E:I,"TI17P,LI18K,EI19D,LI23V,SI51N",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.00E-05,,,,,-14.17,7.44,,,,,
6183,1R0R,E:I,"TI17R,LI18R",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.67E-06,,,,,-14.17,6.4,,,,,
6184,1R0R,E:I,TI17S,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.19E-10,,,,,-14.17,0.82,,,,,
6185,1R0R,E:I,TI17V,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.82E-10,,,,,-14.17,1.07,,,,,
6186,1R0R,E:I,"VI6I,EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D,TI49I",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,4.76E-11,,,,,-14.17,0.28,,,,,
6187,1R0R,E:I,"YI11H,EI19D,LI23I,NI28S,GI32S,NI36D,VI42M,EI43D",Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,1.10E-10,,,,,-14.17,0.77,,,,,
6188,1R0R,E:I,YI20D,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,3.03E-07,,,,,-14.17,5.4,,,,,
6189,1R0R,E:I,YI20H,Bacillus licheniformis subtilisin carlsberg,Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",2.94E-11,5.00E-09,,,,,-14.17,3,,,,,
6190,3SGB,E:I,"AI15D,GI32A",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.11E-10,,,,,-14.46,1.07,,,,,
6191,3SGB,E:I,"AI15D,GI32A,NI33S",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,7.14E-10,,,,,-14.46,2.15,,,,,
6192,3SGB,E:I,"AI15D,LI18A",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.49E-09,,,,,-14.46,2.58,,,,,
6193,3SGB,E:I,"AI15D,LI18A,YI20D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.03E-07,,,,,-14.46,5.69,,,,,
6194,3SGB,E:I,"AI15G,LI18M,LI23V,KI29I,EI43K",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.17E-09,,,,,-14.46,3.18,,,,,
6195,3SGB,E:I,"AI15G,TI17M,LI18M,YI20R,RI21L,GI32N,NI33D,SI51N,KI55E",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.33E-05,,,,,-14.46,7.9,,,,,
6196,3SGB,E:I,"AI15R,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.05E-07,,,,,-14.46,5.07,,,,,
6197,3SGB,E:I,"AI15R,TI17P,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.33E-05,,,,,-14.46,8.43,,,,,
6198,3SGB,E:I,"AI15T,LI18M",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.00E-11,,,,,-14.46,0.47,,,,,
6199,3SGB,E:I,AI15V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.88E-12,,,,,-14.46,-0.65,,,,,
6200,3SGB,E:I,"AI15V,TI17S",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.70E-10,,,,,-14.46,1.59,,,,,
6201,3SGB,E:I,"AI15V,TI17S,RI21M,NI28S,KI29Q,GI32S,KI34E,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.45E-08,,,,,-14.46,4.42,,,,,
6202,3SGB,E:I,"DI7N,EI10D,AI15V,TI17S,EI19L,RI21M,VI42A,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.54E-09,,,,,-14.46,2.6,,,,,
6203,3SGB,E:I,"DI7N,EI10G,LI18M,RI21M,EI43D,KI55E",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.85E-11,,,,,-14.46,0.02,,,,,
6204,3SGB,E:I,"EI10D,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.12E-10,,,,,-14.46,1.07,,,,,
6205,3SGB,E:I,"EI10D,AI15V,EI19D,RI21M,KI29T,GI32S,EI43D,LI48I",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.35E-10,,,,,-14.46,1.18,,,,,
6206,3SGB,E:I,"EI10D,AI15V,TI17P,EI19D,RI21M,NI28S,GI32S,NI45S,SI51R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.30E-09,,,,,-14.46,2.5,,,,,
6207,3SGB,E:I,"EI10D,AI15V,TI17S,EI19D,RI21M,KI29T,GI32N,NI36I,EI43D,LI48I",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.38E-08,,,,,-14.46,4.2,,,,,
6208,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32N,NI36D,SI51G",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.28E-08,,,,,-14.46,3.84,,,,,
6209,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.00E-09,,,,,-14.46,3.16,,,,,
6210,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,EI43D,TI49I",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.86E-09,,,,,-14.46,2.96,,,,,
6211,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.26E-09,,,,,-14.46,3.32,,,,,
6212,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,EI43D,TI49N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.00E-09,,,,,-14.46,3.29,,,,,
6213,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D,VI41F,EI43D,TI49S",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.76E-09,,,,,-14.46,3.26,,,,,
6214,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,NI28S,GI32S,VI42A,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.49E-09,,,,,-14.46,2.58,,,,,
6215,3SGB,E:I,"EI10D,AI15V,TI17S,RI21M,VI42A,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.27E-10,,,,,-14.46,1.48,,,,,
6216,3SGB,E:I,"EI10D,AI15V,TI17S,YI20D,RI21M,NI28S,GI32S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,6.67E-08,,,,,-14.46,4.8,,,,,
6217,3SGB,E:I,"EI10D,AI15V,YI20D,RI21M,KI29I,GI32H,NI36Y,VI42A,EI43H,LI50F",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,9.09E-10,,,,,-14.46,2.29,,,,,
6218,3SGB,E:I,"EI10D,AI15V,YI20E,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.23E-10,,,,,-14.46,1.69,,,,,
6219,3SGB,E:I,"EI10D,KI13M,LI18M,LI23V",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.04E-11,,,,,-14.46,0.08,,,,,
6220,3SGB,E:I,"EI10D,KI13Q,AI15V,TI17M,LI18G,EI19D,RI21M,NI28S,GI32S,EI43D,SI51N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.33E-07,,,,,-14.46,5.74,,,,,
6221,3SGB,E:I,"EI10D,KI13R,AI15D,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.10E-11,,,,,-14.46,-0.28,,,,,
6222,3SGB,E:I,"EI10D,KI13R,AI15V,EI19D,RI21M,GI32S,EI43D,LI48I,KI55R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.56E-11,,,,,-14.46,-0.08,,,,,
6223,3SGB,E:I,"EI10D,LI18F,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,6.67E-11,,,,,-14.46,0.77,,,,,
6224,3SGB,E:I,"EI10D,LI18M,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.00E-11,,,,,-14.46,0.47,,,,,
6225,3SGB,E:I,"EI10D,LI18M,RI21M,GI32D,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.00E-10,,,,,-14.46,1.95,,,,,
6226,3SGB,E:I,"EI10D,LI18V,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.03E-09,,,,,-14.46,3,,,,,
6227,3SGB,E:I,"EI10D,LI18V,RI21M,GI32D,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.61E-08,,,,,-14.46,3.97,,,,,
6228,3SGB,E:I,"EI10D,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.04E-11,,,,,-14.46,0.08,,,,,
6229,3SGB,E:I,"EI10D,RI21M,KI29Q,GI32S,NI36S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.13E-10,,,,,-14.46,1.67,,,,,
6230,3SGB,E:I,"EI10D,RI21M,KI34R,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.41E-11,,,,,-14.46,-0.14,,,,,
6231,3SGB,E:I,"EI10D,RI21M,LI23F,NI28S,GI32S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.70E-10,,,,,-14.46,1.59,,,,,
6232,3SGB,E:I,"EI10D,TI17L,RI21M,GI32D,NI36S,EI43D,TI49S",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.04E-08,,,,,-14.46,3.72,,,,,
6233,3SGB,E:I,"EI10D,TI17R,LI18M,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.03E-09,,,,,-14.46,2.37,,,,,
6234,3SGB,E:I,"EI10D,TI17S,EI19D,RI21M,NI28S,GI32S,EI43D,GI54E",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.76E-08,,,,,-14.46,4.61,,,,,
6235,3SGB,E:I,"EI10D,YI11H,AI15V,TI17S,RI21M,NI28S,GI32S,NI36D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.56E-08,,,,,-14.46,3.96,,,,,
6236,3SGB,E:I,"EI10D,YI11H,TI17L,LI18Q,YI20Q,RI21K,GI32D,NI36S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.26E-06,,,,,-14.46,7.36,,,,,
6237,3SGB,E:I,"EI10D,YI11H,TI17L,LI18Q,YI20Q,RI21K,LI23I,GI32D,NI36S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.00E-06,,,,,-14.46,7.33,,,,,
6238,3SGB,E:I,"EI10G,KI13Q,PI14S,TI17P,LI18Q,EI19D,RI21V,LI23F,GI32S,VI42A,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.27E-08,,,,,-14.46,4.17,,,,,
6239,3SGB,E:I,"EI10G,KI13Q,TI17S,RI21V,LI23F,GI32S,NI36D,VI42A,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.85E-09,,,,,-14.46,3.14,,,,,
6240,3SGB,E:I,"EI10G,LI18M,RI21M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,8.33E-11,,,,,-14.46,0.9,,,,,
6241,3SGB,E:I,"EI10G,LI18M,RI21M,EI43D,KI55E",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.44E-11,,,,,-14.46,0.18,,,,,
6242,3SGB,E:I,"EI10G,LI18M,YI20S,LI23I,KI29T,GI32S,HI52Y,FI53P,KI55V",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,9.09E-09,,,,,-14.46,3.64,,,,,
6243,3SGB,E:I,GI32A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.79E-10,,,,,-14.46,1.35,,,,,
6244,3SGB,E:I,GI32V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.50E-09,,,,,-14.46,2.89,,,,,
6245,3SGB,E:I,LI18A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.63E-09,,,,,-14.46,2.92,,,,,
6246,3SGB,E:I,LI18E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,8.33E-07,,,,,-14.46,6.28,,,,,
6247,3SGB,E:I,"LI18I,GI32D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.45E-07,,,,,-14.46,5.76,,,,,
6248,3SGB,E:I,LI18M,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.00E-11,,,,,-14.46,0.47,,,,,
6249,3SGB,E:I,"LI18M,GI32D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,8.33E-10,,,,,-14.46,2.24,,,,,
6250,3SGB,E:I,"LI18M,HI52R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.17E-11,,,,,-14.46,0.49,,,,,
6251,3SGB,E:I,"LI18M,HI52R,KI55E",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.47E-11,,,,,-14.46,-0.12,,,,,
6252,3SGB,E:I,"LI18M,LI23V,KI29I,EI43K",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,7.14E-11,,,,,-14.46,0.81,,,,,
6253,3SGB,E:I,"LI18M,NI36D,SI51N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.14E-10,,,,,-14.46,1.08,,,,,
6254,3SGB,E:I,"LI18M,SI51N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.85E-11,,,,,-14.46,0.45,,,,,
6255,3SGB,E:I,"LI18M,SI51N,HI52R,KI55Q",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.63E-11,,,,,-14.46,0.22,,,,,
6256,3SGB,E:I,"LI18M,TI30S,GI32D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,9.09E-10,,,,,-14.46,2.29,,,,,
6257,3SGB,E:I,"LI18M,TI49N,KI55T",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.86E-11,,,,,-14.46,0.27,,,,,
6258,3SGB,E:I,"LI18M,YI20Q",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.05E-08,,,,,-14.46,3.72,,,,,
6259,3SGB,E:I,LI18Q,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.19E-09,,,,,-14.46,2.45,,,,,
6260,3SGB,E:I,"LI18S,RI21V,LI23I",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.45E-08,,,,,-14.46,4.42,,,,,
6261,3SGB,E:I,NI28S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.82E-11,,,,,-14.46,0.01,,,,,
6262,3SGB,E:I,"NI28S,GI32A",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.69E-10,,,,,-14.46,1.31,,,,,
6263,3SGB,E:I,"PI14S,AI15R,TI17P,LI18R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.85E-05,,,,,-14.46,8.09,,,,,
6264,3SGB,E:I,"RI21M,KI29Q,GI32S,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,6.25E-10,,,,,-14.46,2.08,,,,,
6265,3SGB,E:I,"RI21V,LI23I",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.38E-11,,,,,-14.46,0.17,,,,,
6266,3SGB,E:I,TI17A,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,4.17E-09,,,,,-14.46,3.18,,,,,
6267,3SGB,E:I,TI17E,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,3.33E-08,,,,,-14.46,4.4,,,,,
6268,3SGB,E:I,"TI17M,LI18S,GI32V",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.08E-06,,,,,-14.46,6.81,,,,,
6269,3SGB,E:I,"TI17P,LI18K",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,7.69E-07,,,,,-14.46,6.23,,,,,
6270,3SGB,E:I,"TI17P,LI18K,EI19D,LI23V,GI32S,SI51N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,9.09E-08,,,,,-14.46,4.99,,,,,
6271,3SGB,E:I,"TI17P,LI18K,EI19D,LI23V,SI51N",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,7.14E-08,,,,,-14.46,4.84,,,,,
6272,3SGB,E:I,"TI17P,LI18K,EI19D,LI23V,SI51N,HI52R",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,6.25E-08,,,,,-14.46,4.77,,,,,
6273,3SGB,E:I,"TI17P,LI18K,GI32D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.12E-06,,,,,-14.46,6.45,,,,,
6274,3SGB,E:I,TI17S,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.30E-09,,,,,-14.46,2.5,,,,,
6275,3SGB,E:I,TI17V,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,5.00E-10,,,,,-14.46,1.95,,,,,
6276,3SGB,E:I,"YI11H,EI19D,LI23I,NI28S,GI32S,NI36D,VI42M,EI43D",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,9.09E-10,,,,,-14.46,2.29,,,,,
6277,3SGB,E:I,"YI11H,YI20D,TI30I,GI32S,NI36D,VI42L",Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.33E-07,,,,,-14.46,5.54,,,,,
6278,3SGB,E:I,YI20D,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,2.08E-09,,,,,-14.46,2.78,,,,,
6279,3SGB,E:I,YI20H,Streptomyces griseus streptogrisin-B/serine protease B (SGPB),Meleagris gallopavo (turkey) ovomucoid (OMTKY3),EI,,,294,,SKEMPI,"Stephen Ming-teh Lu, PhD Thesis, Purdue University, 2000 (See <a href=""https://life.bsc.es/pid/mutation_database/datatable.html"">SKEMPI</a> for data source)",1.79E-11,1.92E-10,,,,,-14.46,1.39,,,,,
6280,1BRS,A:D,DD39A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",1.32E-10,2.96E-06,8.74E+05,1.55E+05,1.15E-04,4.57E-01,-13.47,5.93,,,,,
6281,1X1U,A:D,DD35A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",1.32E-10,1.27E-07,8.74E+05,2.14E+05,1.15E-04,2.73E-02,-13.47,4.07,,,,,
6282,1X1W,A:D,ED80A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",1.32E-10,2.64E-10,8.74E+05,8.62E+05,1.15E-04,2.28E-04,-13.47,0.41,,,,,
6283,1X1W,A:D,AD80E,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",2.64E-10,1.32E-10,8.62E+05,8.74E+05,2.28E-04,1.15E-04,-13.06,-0.41,,,,,
6284,1X1X,A:D,ED76A,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",1.32E-10,5.30E-10,8.74E+05,8.97E+05,1.15E-04,4.75E-04,-13.47,0.82,,,,,
6285,1X1X,A:D,AD76E,Bacillus amyloliquefaciens barnase/ribonuclease,Bacillus amyloliquefaciens barstar,EI,Surface Plasmon Resonance,"Hepes buffer with 150mM NaCl, 3mM EDTA, 0.005% Tween 20",298,7.4,SKEMPI,"Water-mediated interaction at a protein-protein interface, Chemical Physics, Volume 307, Issues 2-3, 2004 (Table I, p. 113)",5.30E-10,1.32E-10,8.97E+05,8.74E+05,4.75E-04,1.15E-04,-12.65,-0.82,,,,,
6286,1OHZ,A:B,LA83A,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,3,,,,,
6287,1OHZ,A:B,LA83S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,3.4,,,,,
6288,1OHZ,A:B,NA37A,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,0,,,,,
6289,1OHZ,A:B,NA37D,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,2.5,,,,,
6290,1OHZ,A:B,EA131A,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,1.8,,,,,
6291,1OHZ,A:B,"NA37A,EA120A",Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,1.2,,,,,
6292,1OHZ,A:B,"NA37A,EA131A",Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,1,,,,,
6293,1OHZ,A:B,VA41Y,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,0.7,,,,,
6294,1OHZ,A:B,DA70S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,-0.1,,,,,
6295,,,D*39S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,1.20E-09,,,,,-12.93,0.54,-3.33,-0.44,,,
6296,,,Y*74A,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,4.35E-10,,,,,-12.93,-0.09,-3.33,-1.72,,,
6297,1OHZ,A:B,VA81S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,1.9,,,,,
6298,1OHZ,A:B,AA85L,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,iELISA,"TBS,10mM CaCl<sub>2</sub>,0.05% Tween 20,2% BSA",310,,Literature,"25833947 (Table 1, p. 13660)",,,,,,,,-0.1,,,,,
6299,,,E*86S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,9.09E-10,,,,,-12.93,0.38,-3.33,-3.91,,,
6300,,,"D*39S,Y*74A",Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,2.94E-09,,,,,-12.93,1.06,-3.33,1.52,,,
6301,,,"D*39S,Y*74A,E*86S",Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,5.00E-08,,,,,-12.93,2.77,-3.33,0.38,,,
6302,,,A*94L,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,1.25E-09,,,,,-12.93,0.55,-3.33,-5.72,,,
6303,,,G*97S,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),Clostridium thermocellum dockerin (Endoglucanase D CelD),,Isothermal Titration Calorimetry,"20mM Tris-HCl,0.125M NaCl,5mM CaCl<sub>2</sub>",301.7,7.4,Literature,"11841201 (Table 1, p. 2117)",5.00E-10,5.88E-10,,,,,-12.93,0.1,-3.33,-3.19,,,
6304,1CF4,A:B,LA174A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,4.80E-07,,,,,-9.92,1.45,-13,-13,-10,-15,
6305,1CF4,A:B,LB449A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,3.60E-07,,,,,-9.92,1.28,-13,-12,-10,-11,
6306,1CF4,A:B,"LA174A,LB449A",Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,9.20E-07,,,,,-9.92,1.83,-13,-13,-10,-16,
6307,1CF4,A:B,VA42A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,1.30E-06,,,,,-9.92,2.03,-13,-17,-10,-31,
6308,1CF4,A:B,IB463A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,1.80E-07,,,,,-9.92,0.88,-13,-12,-10,-10,
6309,1CF4,A:B,"VA42A,IB463A",Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Isothermal Titration Calorimetry,,293,,Literature,"17999470 (Table 1, p. 14092)",4.00E-08,3.88E-05,,,,,-9.92,4,-13,-17,-10,,
6310,1CF4,A:B,LA174A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (direct),,293,,Literature,"17999470 (Table 1, p. 14092)",2.50E-08,7.50E-07,,,,,-10.19,1.98,,,,,
6311,1CF4,A:B,LB449A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (direct),,293,,Literature,"17999470 (Table 1, p. 14092)",2.50E-08,2.70E-07,,,,,-10.19,1.39,,,,,
6312,1CF4,A:B,"LA174A,LB449A",Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (direct),,293,,Literature,"17999470 (Table 1, p. 14092)",2.50E-08,3.86E-06,,,,,-10.19,2.93,,,,,
6313,1CF4,A:B,VA42A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (direct),,293,,Literature,"17999470 (Table 1, p. 14092)",2.50E-08,2.80E-07,,,,,-10.19,1.41,,,,,
6314,1CF4,A:B,IB463A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (direct),,293,,Literature,"17999470 (Table 1, p. 14092)",2.50E-08,1.10E-07,,,,,-10.19,0.86,,,,,
6315,1CF4,A:B,LA174A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,1.30E-07,,,,,-11.02,1.79,,,,,
6316,1CF4,A:B,LB449A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,8.50E-08,,,,,-11.02,1.54,,,,,
6317,1CF4,A:B,"LA174A,LB449A",Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,5.80E-07,,,,,-11.02,2.66,,,,,
6318,1CF4,A:B,VA42A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,5.30E-08,,,,,-11.02,1.27,,,,,
6319,1CF4,A:B,IB463A,Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,3.00E-08,,,,,-11.02,0.94,,,,,
6320,1CF4,A:B,"VA42A,IB463A",Human cell division control protein 42 homolog (CDC42),Human activated CDC42 kinase 1 (ACK-1),GC,Scintillation Proximity Assay (competition),,293,,Literature,"17999470 (Table 1, p. 14092)",6.00E-09,4.00E-07,,,,,-11.02,2.45,,,,,
6321,1OHZ,A:B,EA120R,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,0.4,,,,,
6322,1OHZ,A:B,IA79F,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,-0.2,,,,,
6323,1OHZ,A:B,DA70F,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,-0.1,,,,,
6324,1OHZ,A:B,RA77E,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,-0.1,,,,,
6325,1OHZ,A:B,RA77N,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,0.2,,,,,
6326,1OHZ,A:B,DA70H,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,-0.2,,,,,
6327,1OHZ,A:B,NA37A,Clostridium thermocellum cohesin (Cellulosomal-scaffolding protein A cipA),"Clostridium thermocellum dockerin (Endo-1,4-beta-xylanase Y XylY)",,Yeast clonal titration,,300,,Literature,27699856 (Table S2),,,,,,,,-0.1,,,,,
6328,3AAA,AB:C,KA248A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,1.40E-06,,,,,7.503780633,-2.337975817,,,,,
6329,3AAA,AB:C,KA248E,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,7.10E-06,,,,,6.599909961,-3.241846489,,,,,
6330,3AAA,AB:C,RA252A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,3.60E-06,,,,,6.977998856,-2.863757594,,,,,
6331,3AAA,AB:C,RA252E,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,1.80E-05,,,,,6.08202477,-3.75973168,,,,,
6332,3AAA,AB:C,RA258A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,9.30E-07,,,,,7.731494832,-2.110261618,,,,,
6333,3AAA,AB:C,RA258E,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,8.60E-06,,,,,6.493208709,-3.348547741,,,,,
6334,3AAA,AB:C,"KA248A,RA258A",Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,6.90E-05,,,,,5.333967637,-4.507788814,,,,,
6335,3AAA,AB:C,WC7A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,6.40E-06,,,,,6.657693636,-3.184062814,,,,,
6336,3AAA,AB:C,DC43A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,1.20E-04,,,,,5.025898074,-4.815858376,,,,,
6337,3AAA,AB:C,EC77A,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,5.80E-07,,,,,7.994344346,-1.847412104,,,,,
6338,3AAA,AB:C,EC77R,Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Surface plasmon resonance,"50mM KCl, 1mM MgCl<sub>2</sub>, 0.005% Tween-20, 10mM imidazole",293,7,SKEMPI2,"20625546 (Tables 1 and 2, pp. 9, 11)",2.10E-08,2.10E-05,,,,,5.996209087,-3.845547364,,,,,
6339,2VN5,A:B,"SB42A,TB43F",Gallus gallus F-Actin-capping protein,Human Myotropin,Misc,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.54E-09,,,,,11.8745761,-0.25267907,-20.8,-19.3,-26.2,-22.2,
6340,2VN5,A:B,"SB42A,TB43F,TA35A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.67E-09,,,,,11.82715078,-0.300104386,-20.8,-19.8,-26.2,-24.1,
6341,2VN5,A:B,"SB42A,TB43F,NA37A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,7.41E-09,,,,,10.95519879,-1.172056373,-20.8,-18.2,-26.2,-21.8,
6342,2VN5,A:B,"SB42A,TB43F,YA39A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,8.33E-09,,,,,10.88671107,-1.240544095,-20.8,-18.2,-26.2,-21.9,
6343,2VN5,A:B,"SB42A,TB43F,SA66A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,8.62E-10,,,,,12.21415737,0.086902205,-20.8,-21.5,-26.2,-28.2,
6344,2VN5,A:B,"SB42A,TB43F,SA75A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.00E-09,,,,,12.12725517,0,-20.8,-22.4,-26.2,-31.3,
6345,2VN5,A:B,"SB42A,TB43F,LA77A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,2.04E-07,,,,,9.015091347,-3.11216382,-20.8,-14,-26.2,-12.9,
6346,2VN5,A:B,"SB42A,TB43F,LA79A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.22E-07,,,,,9.315942052,-2.811313115,-20.8,-23.2,-26.2,-39.3,
6347,2VN5,A:B,"SB42A,TB43F,NA81A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,2.72E-09,,,,,11.54168539,-0.585569776,-20.8,-22.3,-26.2,-33.1,
6348,2VN5,A:B,"SB42A,TB43F,IA83A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,4.72E-09,,,,,11.21913666,-0.90811851,-20.8,-26.7,-26.2,-48.7,
6349,2VN5,A:B,"SB42A,TB43F,MA125G",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.36E-08,,,,,10.59984233,-1.527412843,-20.8,-20.2,-26.2,-29.6,
6350,2VN5,A:B,"SB42A,TB43F,KA127G",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,2.35E-09,,,,,11.62725132,-0.50000385,-20.8,-22.1,-26.2,-32.3,
6351,2VN5,A:B,"SB42A,TB43F,TA35A,NA37A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.57E-08,,,,,10.51581292,-1.611442249,-20.8,-19.5,-26.2,-27.6,
6352,2VN5,A:B,"SB42A,TB43F,TA35A,NA37A,YA39A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,4.72E-07,,,,,8.524191065,-3.603064102,-20.8,-14.6,-26.2,-18.5,
6353,2VN5,A:B,"SB42A,TB43F,TA35A,NA37A,NA81A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.75E-07,,,,,9.104822416,-3.022432752,-20.8,-15.4,-26.2,-19,
6354,2VN5,A:B,"SB42A,TB43F,TA35A,NA37A,YA39A,NA81A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,5.00E-06,,,,,7.142993712,-4.984261456,-20.8,-15.4,-26.2,-25.7,
6355,2VN5,A:B,"SB42A,TB43F,SA66A,SA68A,SA75A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.26E-09,,,,,11.99200859,-0.135246579,-20.8,-24.2,-26.2,-37.7,
6356,2VN5,A:B,"SB42A,TB43F,LA77A,LA79A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.61E-05,,,,,6.458671741,-5.668583427,-20.8,-11.2,-26.2,-16.3,
6357,2VN5,A:B,"SB42A,TB43F,MA125G,KA127A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,5.21E-08,,,,,9.81386304,-2.313392128,-20.8,-19.8,-26.2,-31,
6358,2VN5,A:B,"SB42A,TB43F,AB14S,LB15T",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.80E-09,,,,,11.78328241,-0.343972756,-20.8,-18,-26.2,-18.5,
6359,2VN5,A:B,"SB42A,TB43F,AB14Q,LB15Q",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,1.29E-09,,,,,11.97823854,-0.149016626,-20.8,-17.5,-26.2,-16.1,
6360,2VN5,A:B,"AB14S,LB15T",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,8.62E-09,,,,,10.86668458,-1.260570592,-20.8,-18.6,-26.2,-23.5,
6361,2VN5,A:B,"SB42Q,TB43Q",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,4.88E-09,,,,,11.19962819,-0.927626983,-20.8,-22.6,-26.2,-35.1,
6362,2VN5,A:B,"SB42A,TB43F,FB17A,LB45A",C. cellulolyticum cipC cohesin,C. cellulolyticum celCCA dockerin,OE,Isothermal titration calorimetry,"50mM NaHepes, 2mM CaCl<sub>2</sub>",308,7.5,SKEMPI2,"18445585 (Table 2, p. 284)",1.00E-09,4.35E-06,,,,,7.224489874,-4.902765294,-20.8,-18.1,-26.2,-34.1,
6363,4L3E,ABC:DE,"YD26D,WE95L","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),2.40E-08,9.50E-06,,,,,6.547660662,-3.386438377,,,,,
6364,3QDJ,ABC:DE,DD26W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.10E-06,,,,,7.768377454,2.075626882,,,,,
6365,3QDJ,ABC:DE,DD26Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,4.50E-06,,,,,6.970733456,1.277982883,,,,,
6366,3QDJ,ABC:DE,RD27W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,6.20E-05,,,,,5.485558589,-0.207191983,,,,,
6367,3QDJ,ABC:DE,LE95W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.10E-05,,,,,6.464653774,0.771903202,,,,,
6368,3QDJ,ABC:DE,FE97W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,8.30E-05,,,,,5.320394526,-0.372356047,,,,,
6369,3QDJ,ABC:DE,TE99F,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,2.70E-05,,,,,5.956239244,0.263488672,,,,,
6370,3QDJ,ABC:DE,GD28I,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,3.60E-05,,,,,5.793353655,0.100603083,,,,,
6371,3QDJ,ABC:DE,GD28L,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.30E-04,,,,,5.066344072,-0.6264065,,,,,
6372,3QDJ,ABC:DE,GD28Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.10E-04,,,,,5.160930095,-0.531820478,,,,,
6373,3QDJ,ABC:DE,RD27P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,4.60E-05,,,,,5.654565319,-0.038185253,,,,,
6374,3QDJ,ABC:DE,GD28P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,3.40E-04,,,,,4.521993069,-1.170757503,,,,,
6375,3QDJ,ABC:DE,AE52P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,6.10E-05,,,,,5.494765296,-0.197985276,,,,,
6376,3QDJ,ABC:DE,GD28N,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,8.60E-05,,,,,5.300290639,-0.392459934,,,,,
6377,3QDJ,ABC:DE,FE97Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.60E-04,,,,,4.948778664,-0.743971909,,,,,
6378,3QDJ,ABC:DE,"DD26W,LE95W","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,6.00E-07,,,,,8.111571546,2.418820974,,,,,
6379,3QDJ,ABC:DE,"DD26Y,LE95W","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),4.30E-05,1.70E-06,,,,,7.521900362,1.82914979,,,,,
6380,3QDG,ABC:DE,DD26W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,6.80E-07,,,,,8.040704175,1.493043513,,,,,
6381,3QDG,ABC:DE,DD26Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,4.60E-07,,,,,8.262012679,1.714352017,,,,,
6382,3QDG,ABC:DE,RD27W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,2.60E-05,,,,,5.977607818,-0.570052843,,,,,
6383,3QDG,ABC:DE,LE95W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,2.90E-06,,,,,7.219502859,0.671842197,,,,,
6384,3QDG,ABC:DE,FE97W,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,4.60E-05,,,,,5.654565319,-0.893095342,,,,,
6385,3QDG,ABC:DE,TE99F,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,8.90E-06,,,,,6.584599845,0.036939183,,,,,
6386,3QDG,ABC:DE,GD28I,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,4.10E-05,,,,,5.719717574,-0.827943088,,,,,
6387,3QDG,ABC:DE,GD28L,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,9.90E-05,,,,,5.220585219,-1.327075443,,,,,
6388,3QDG,ABC:DE,GD28Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,1.20E-04,,,,,5.111664253,-1.435996408,,,,,
6389,3QDG,ABC:DE,RD27P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,1.20E-05,,,,,6.415387933,-0.132272729,,,,,
6390,3QDG,ABC:DE,GD28P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,6.00E-05,,,,,5.504124187,-1.043536475,,,,,
6391,3QDG,ABC:DE,AE52P,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,8.50E-06,,,,,6.610636616,0.062975955,,,,,
6392,3QDG,ABC:DE,GD28N,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,4.00E-05,,,,,5.733698531,-0.813962131,,,,,
6393,3QDG,ABC:DE,FE97Y,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,1.00E-04,,,,,5.214894719,-1.332765943,,,,,
6394,3QDG,ABC:DE,"DD26W,LE95W","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,3.30E-08,,,,,9.753790536,3.206129874,,,,,
6395,3QDG,ABC:DE,"DD26Y,LE95W","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,"20mM HEPES, 150mM NaCl, 0.005% Nonidet P-20",298,7.4,SKEMPI2,24550723 (Tables 1 and 2),9.50E-06,2.40E-08,,,,,9.934099038,3.386438377,,,,,
6396,3EG5,A:B,HA104F,Mouse Cell division control protein 42 homolog,Mouse protein diaphanous homolog 1 (MdiaN-TSH),GC,Isothermal titration calorimetry,,293,,SKEMPI2,"18829452 (Figure 3, p. 35240)",1.25E-06,3.70E-08,,,,,9.526444089,1.959573377,3.28,-0.67,38.22525597,31.70648464,
6397,3EG5,A:B,"TB73N,SB74N,HB75N",Mouse Cell division control protein 42 homolog,Mouse protein diaphanous homolog 1 (MdiaN-TSH),GC,Isothermal titration calorimetry,,293,,SKEMPI2,"18829452 (Figure 3, p. 35240)",1.25E-06,7.40E-06,,,,,6.576870812,-0.989999901,3.28,2.2,38.22525597,31.02389079,
6398,3EG5,A:B,"TB73N,SB74N,HB75N,HA104F",Mouse Cell division control protein 42 homolog,Mouse protein diaphanous homolog 1 (MdiaN-TSH),GC,Isothermal titration calorimetry,,293,,SKEMPI2,"18829452 (Figure 3, p. 35240)",1.25E-06,1.33E-07,,,,,8.814184732,1.247314019,3.28,-1.6,38.22525597,26.00682594,
6399,4HFK,A:BD,RB22A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,2.82E-09,129000,378000,3.46E-05,1.07E-03,11.14651269,-1.33044588,,,,,
6400,4HFK,A:BD,LB45A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,1.91E-08,129000,75700,3.46E-05,1.45E-03,10.06339958,-2.413558991,,,,,
6401,4HFK,A:BD,EB46A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,2.00E-09,129000,83600,3.46E-05,1.66E-04,11.34105318,-1.135905389,,,,,
6402,4HFK,A:BD,SB48A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,3.78E-10,129000,221000,3.46E-05,8.33E-05,12.28434706,-0.19261151,,,,,
6403,4HFK,A:BD,NB49A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,2.60E-10,129000,401000,3.46E-05,1.04E-04,12.49622622,0.019267644,,,,,
6404,4HFK,A:BD,LB50A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,2.83E-10,129000,448000,3.46E-05,1.27E-04,12.44823212,-0.02872645,,,,,
6405,4HFK,A:BD,EB56A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,1.32E-09,129000,154000,3.46E-05,2.03E-04,11.57631803,-0.900640545,,,,,
6406,4HFK,A:BD,TD72A,Tae4,Tai4,Misc,Surface plasmon resonance,"50mMHEPES, 150mMNaCl, 0.005% (v/v) Tween 20",298,8,SKEMPI2,"23288853 (Table 2, p. 5936)",2.69E-10,6.11E-09,129000,61700,3.46E-05,3.77E-04,10.70873258,-1.768225995,,,,,
6407,4JFE,ABC:DE,AC7I,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,6.00E-10,,,,,12.02274259,6.144724062,,,,,
6408,4JFE,ABC:DE,"AC7I,EC1A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,1.40E-04,,,,,5.024384138,-0.853634385,,,,,
6409,4JFE,ABC:DE,"AC7I,GC4A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,3.60E-05,,,,,5.793353655,-0.084664868,,,,,
6410,4JFE,ABC:DE,"AC7I,GC6A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,4.10E-05,,,,,5.719717574,-0.158300949,,,,,
6411,4JFE,ABC:DE,"AC7I,LC8A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,2.10E-05,,,,,6.098533474,0.220514951,,,,,
6412,4JFE,ABC:DE,"AC7I,TC9A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.10E-05,3.70E-05,,,,,5.777840356,-0.100178167,,,,,
6413,4JFF,ABC:DE,EC1A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,1.40E-04,,,,,5.024384138,-6.998358447,,,,,
6414,4JFF,ABC:DE,GC4A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,3.60E-05,,,,,5.793353655,-6.22938893,,,,,
6415,4JFF,ABC:DE,GC6A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,4.10E-05,,,,,5.719717574,-6.303025011,,,,,
6416,4JFF,ABC:DE,IC7A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,3.10E-05,,,,,5.878018523,-6.144724062,,,,,
6417,4JFF,ABC:DE,LC8A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,2.10E-05,,,,,6.098533474,-5.924209111,,,,,
6418,4JFF,ABC:DE,TC9A,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",6.00E-10,3.70E-05,,,,,5.777840356,-6.244902229,,,,,
6419,4JFD,ABC:DE,AC4G,"Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,6.00E-10,,,,,12.02274259,6.22938893,,,,,
6420,4JFD,ABC:DE,"AC4G,EC1A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,1.40E-04,,,,,5.024384138,-0.768969517,,,,,
6421,4JFD,ABC:DE,"AC4G,GC6A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,4.10E-05,,,,,5.719717574,-0.073636081,,,,,
6422,4JFD,ABC:DE,"AC4G,IC7A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,3.10E-05,,,,,5.878018523,0.084664868,,,,,
6423,4JFD,ABC:DE,"AC4G,LC8A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,2.10E-05,,,,,6.098533474,0.305179819,,,,,
6424,4JFD,ABC:DE,"AC4G,TC9A","Human HLA class I histocompatibility antigen, A alpha chain plus MART-1 peptide",Human T-cell receptor A6,Misc,Surface plasmon resonance,,298,,SKEMPI2,"23698002 (Table 2, p. 18770)",3.60E-05,3.70E-05,,,,,5.777840356,-0.015513299,,,,,
6425,3L5X,A:HL,"HL91Q,NL92D,EL93L,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.70E-11,1250000,1700000,9.40E-04,6.30E-05,13.60018243,1.706795437,,,,,
6426,3L5X,A:HL,"NL92D,EL93W,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,4.40E-11,1250000,1060000,9.40E-04,4.70E-05,13.50207599,1.608688988,,,,,
6427,3L5X,A:HL,"HL91Q,NL92D,EL93I,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,5.50E-11,1250000,980000,9.40E-04,5.40E-05,13.37573211,1.482345109,,,,,
6428,3L5X,A:HL,"NL92E,EL93W,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,5.50E-11,1250000,1290000,9.40E-04,7.10E-05,13.37573211,1.482345109,,,,,
6429,3L5X,A:HL,"NL92D,EL93P,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,6.30E-11,1250000,1710000,9.40E-04,1.10E-04,13.29884127,1.405454277,,,,,
6430,3L5X,A:HL,"HL91Q,NL92D,EL93Y,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,6.50E-11,1250000,1130000,9.40E-04,7.40E-05,13.28114608,1.387759087,,,,,
6431,3L5X,A:HL,"NL92S,EL93W,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,8.80E-11,1250000,880000,9.40E-04,7.80E-05,13.10961605,1.216229054,,,,,
6432,3L5X,A:HL,"NL92E,EL93S,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,8.90E-11,1250000,1020000,9.40E-04,9.00E-05,13.10321824,1.209831246,,,,,
6433,3L5X,A:HL,"NL92S,EL93H,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,9.20E-11,1250000,1390000,9.40E-04,1.30E-04,13.08444746,1.191060466,,,,,
6434,3L5X,A:HL,"NL92F,EL93W,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,9.40E-11,1250000,1060000,9.40E-04,9.90E-05,13.07227065,1.178883653,,,,,
6435,3L5X,A:HL,"NL92D,EL93W,YL94E",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.00E-10,1250000,1430000,9.40E-04,1.40E-04,13.0372368,1.143849799,,,,,
6436,3L5X,A:HL,"NL92S,EL93Y,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.48E-10,1250000,1240000,9.40E-04,1.80E-04,12.81526257,0.921875569,,,,,
6437,3L5X,A:HL,"HL91P,NL92L,EL93D,YL94V",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.77E-10,1250000,1880000,9.40E-04,3.30E-04,12.71394818,0.82056118,,,,,
6438,3L5X,A:HL,"NL92V,EL93W,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.84E-10,1250000,1200000,9.40E-04,2.20E-04,12.69198753,0.798600533,,,,,
6439,3L5X,A:HL,YL94A,Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.86E-10,1250000,1630000,9.40E-04,3.00E-04,12.68586639,0.792479392,,,,,
6440,3L5X,A:HL,"NL92L,EL93M,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.87E-10,1250000,1140000,9.40E-04,2.10E-04,12.68283046,0.78944346,,,,,
6441,3L5X,A:HL,"HL91P,NL92L,EL93D,YL94T",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.92E-10,1250000,1250000,9.40E-04,2.40E-04,12.66789028,0.774503279,,,,,
6442,3L5X,A:HL,"NL92D,EL93Y,YL94A",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.93E-10,1250000,1110000,9.40E-04,2.10E-04,12.66494897,0.771561974,,,,,
6443,3L5X,A:HL,"NL92S,EL93I,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,1.93E-10,1250000,1330000,9.40E-04,2.60E-04,12.66494897,0.771561974,,,,,
6444,3L5X,A:HL,"EL93H,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.08E-10,1250000,1190000,9.40E-04,2.50E-04,12.6225701,0.729183098,,,,,
6445,3L5X,A:HL,"NL92D,EL93W,YL94S",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.25E-10,1250000,970000,9.40E-04,2.20E-04,12.57808811,0.684701111,,,,,
6446,3L5X,A:HL,"NL92L,EL93N,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.33E-10,1250000,1160000,9.40E-04,2.70E-04,12.55830618,0.664919186,,,,,
6447,3L5X,A:HL,"NL92L,EL93D,YL94S",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.39E-10,1250000,1300000,9.40E-04,3.10E-04,12.54391049,0.650523496,,,,,
6448,3L5X,A:HL,"HL91P,NL92I,EL93D,YL94A",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.53E-10,1250000,1440000,9.40E-04,3.60E-04,12.51167903,0.61829203,,,,,
6449,3L5X,A:HL,"HL91P,NL92L,EL93D,YL94S",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.59E-10,1250000,1440000,9.40E-04,3.80E-04,12.49840811,0.60502111,,,,,
6450,3L5X,A:HL,"NL92L,EL93L,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.62E-10,1250000,1110000,9.40E-04,2.90E-04,12.4918875,0.598500501,,,,,
6451,3L5X,A:HL,"NL92L,EL93D,YL94S",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,2.96E-10,1250000,1020000,9.40E-04,3.00E-04,12.42280263,0.529415636,,,,,
6452,3L5X,A:HL,"NL92D,EL93N,YL94S",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.06E-10,1250000,1100000,9.40E-04,3.40E-04,12.40399027,0.510603274,,,,,
6453,3L5X,A:HL,"NL92D,EL93R,YL94D",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.12E-10,1250000,1290000,9.40E-04,4.00E-04,12.39299575,0.499608754,,,,,
6454,3L5X,A:HL,"NL92S,EL93V,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.15E-10,1250000,1020000,9.40E-04,3.20E-04,12.38757753,0.494190531,,,,,
6455,3L5X,A:HL,"NL92V,EL93G,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.45E-10,1250000,1350000,9.40E-04,4.70E-04,12.33606931,0.44268231,,,,,
6456,3L5X,A:HL,"HL91P,NL92L,YL94A",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.56E-10,1250000,1260000,9.40E-04,4.50E-04,12.31829838,0.424911379,,,,,
6457,3L5X,A:HL,"NL92D,EL93L,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.65E-10,1250000,950000,9.40E-04,3.50E-04,12.30416227,0.410775277,,,,,
6458,3L5X,A:HL,"EL93F,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,3.66E-10,1250000,1140000,9.40E-04,4.20E-04,12.30261316,0.409226165,,,,,
6459,3L5X,A:HL,"NL92S,EL93W,YL94A",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,4.52E-10,1250000,1000000,9.40E-04,4.60E-04,12.18311731,0.289730309,,,,,
6460,3L5X,A:HL,"NL92S,EL93S,YL94G",Human interleukin-13 (hIL-13),Mouse anti-human interleukin-13 antibody m836 Fab H2L6,Ag-Ab,Surface plasmon resonance,"PBS running buffer, 0.005% P20, 3mM ethylenediaminetetraacetic acid",298,,SKEMPI2,"20226193 (Table 2, p.221; Table 3, p.224)",7.54E-10,4.95E-10,1250000,970000,9.40E-04,4.80E-04,12.13166355,0.238276554,,,,,
6461,1K8R,A:B,QB11A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,6.22E-06,,,,,7.060779244,-1.78766307,,,,,
6462,1K8R,A:B,RB13A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,3.38E-05,,,,,6.063784306,-2.784658007,,,,,
6463,1K8R,A:B,KB23A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,8.05E-07,,,,,8.265097477,-0.583344837,,,,,
6464,1K8R,A:B,KB31A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,2.99E-05,,,,,6.135997074,-2.71244524,,,,,
6465,1K8R,A:B,RB76A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,1.00E-06,,,,,8.137335719,-0.711106595,,,,,
6466,1K8R,A:B,RB77A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,3.38E-06,,,,,7.420006926,-1.428435387,,,,,
6467,1K8R,A:B,EA31K,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,3.99E-07,,,,,8.678505303,-0.16993701,,,,,
6468,1K8R,A:B,"DA30K,EA31K",Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,5.97E-07,,,,,8.441164398,-0.407277915,,,,,
6469,1K8R,A:B,DA33A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,3.99E-06,,,,,7.322282684,-1.52615963,,,,,
6470,1K8R,A:B,EA37A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,5.01E-07,,,,,8.544422584,-0.304019729,,,,,
6471,1K8R,A:B,DA38A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,5.38E-06,,,,,7.146232266,-1.702210047,,,,,
6472,1K8R,A:B,DA38E,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,9.90E-05,,,,,5.430810127,-3.417632186,,,,,
6473,1K8R,A:B,DA38N,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,7.34E-06,,,,,6.96325914,-1.885183173,,,,,
6474,1K8R,A:B,SA39A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,1.00E-06,,,,,8.137335719,-0.711106595,,,,,
6475,1K8R,A:B,YA40C,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,9.90E-05,,,,,5.430810127,-3.417632186,,,,,
6476,1K8R,A:B,YA40F,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,3.71E-06,,,,,7.365137943,-1.48330437,,,,,
6477,1K8R,A:B,RA41A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,2.19E-06,,,,,7.675617709,-1.172824604,,,,,
6478,1K8R,A:B,DA57A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,2.19E-06,,,,,7.675617709,-1.172824604,,,,,
6479,1K8R,A:B,EA62A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,5.97E-07,,,,,8.441164398,-0.407277915,,,,,
6480,1K8R,A:B,EA63A,Human GTPase HRas,Schizosaccharomyces pombe protein kinase byr2 (MAPKKK),GC,GDI assay,"50mM Tris HCl, 5mM MgCl<sub>2</sub>, 100mM NaCl, 2mM DTE",310,7.4,SKEMPI2,"11709168 (Figure 3, p.1046)",2.99E-07,5.97E-07,,,,,8.441164398,-0.407277915,,,,,
